<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Effects and safety of periconceptional oral folate supplementation for preventing birth defects - De‐Regil, LM - 2015 | Cochrane Library</title> <meta content="Effects and safety of periconceptional oral folate supplementation for preventing birth defects - De‐Regil, LM - 2015 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007950.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Effects and safety of periconceptional oral folate supplementation for preventing birth defects - De‐Regil, LM - 2015 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007950.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD007950.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Effects and safety of periconceptional oral folate supplementation for preventing birth defects" name="citation_title"/> <meta content="Luz Maria De‐Regil" name="citation_author"/> <meta content="Micronutrient Initiative" name="citation_author_institution"/> <meta content="lderegil@micronutrient.org" name="citation_author_email"/> <meta content="Juan Pablo Peña‐Rosas" name="citation_author"/> <meta content="World Health Organization" name="citation_author_institution"/> <meta content="Ana C Fernández‐Gaxiola" name="citation_author"/> <meta content="Instituto Nacional de Salud Pública" name="citation_author_institution"/> <meta content="Pura Rayco‐Solon" name="citation_author"/> <meta content="World Health Organization" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="12" name="citation_issue"/> <meta content="10.1002/14651858.CD007950.pub3" name="citation_doi"/> <meta content="2015" name="citation_date"/> <meta content="2015/12/14" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007950.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007950.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007950.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Dietary Supplements; Folic Acid [*administration &amp; dosage]; Neural Tube Defects [*prevention &amp; control]; Preconception Care; Randomized Controlled Trials as Topic; Vitamin B Complex [*administration &amp; dosage]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007950.pub3&amp;doi=10.1002/14651858.CD007950.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007950.pub3&amp;doi=10.1002/14651858.CD007950.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007950.pub3&amp;doi=10.1002/14651858.CD007950.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007950.pub3&amp;doi=10.1002/14651858.CD007950.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007950.pub3&amp;doi=10.1002/14651858.CD007950.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007950.pub3&amp;doi=10.1002/14651858.CD007950.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007950.pub3&amp;doi=10.1002/14651858.CD007950.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007950.pub3&amp;doi=10.1002/14651858.CD007950.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007950.pub3&amp;doi=10.1002/14651858.CD007950.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007950.pub3&amp;doi=10.1002/14651858.CD007950.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007950.pub3&amp;doi=10.1002/14651858.CD007950.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007950.pub3&amp;doi=10.1002/14651858.CD007950.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007950.pub3&amp;doi=10.1002/14651858.CD007950.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007950.pub3&amp;doi=10.1002/14651858.CD007950.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007950.pub3&amp;doi=10.1002/14651858.CD007950.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007950.pub3&amp;doi=10.1002/14651858.CD007950.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007950.pub3&amp;doi=10.1002/14651858.CD007950.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007950.pub3&amp;doi=10.1002/14651858.CD007950.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007950.pub3&amp;doi=10.1002/14651858.CD007950.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007950.pub3&amp;doi=10.1002/14651858.CD007950.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007950.pub3&amp;doi=10.1002/14651858.CD007950.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007950.pub3&amp;doi=10.1002/14651858.CD007950.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007950.pub3&amp;doi=10.1002/14651858.CD007950.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="Oy81c7tH";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD007950\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD007950\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007950\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007950\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","zh_HANS","ru","ms","ja","hr","pl","fr","zh_HANT","fa","pt"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD007950.pub3",title:"Effects and safety of periconceptional oral folate supplementation for preventing birth defects",firstPublishedDate:"Dec 14, 2015 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Pregnancy and Childbirth Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=Oy81c7tH&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007950.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD007950.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD007950.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD007950.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007950.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD007950.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Abstract&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD007950.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD007950.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD007950.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD007950.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>23096 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD007950.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007950.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007950.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007950.pub3/full#CD007950-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007950.pub3/full#CD007950-sec-0198"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007950.pub3/full#CD007950-sec-0036"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007950.pub3/full#CD007950-sec-0037"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007950.pub3/full#CD007950-sec-0043"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007950.pub3/full#CD007950-sec-0044"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007950.pub3/full#CD007950-sec-0085"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007950.pub3/full#CD007950-sec-0190"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007950.pub3/appendices#CD007950-sec-0203"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/table_n/CD007950StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/table_n/CD007950StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007950.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007950.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007950.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD007950.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD007950.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD007950.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2015 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Effects and safety of periconceptional oral folate supplementation for preventing birth defects </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007950.pub3/information#CD007950-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Luz Maria De‐Regil</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007950.pub3/information#CD007950-cr-0003">Juan Pablo Peña‐Rosas</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007950.pub3/information#CD007950-cr-0004">Ana C Fernández‐Gaxiola</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007950.pub3/information#CD007950-cr-0005">Pura Rayco‐Solon</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/information/en#CD007950-sec-0207">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 14 December 2015 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD007950.pub3">https://doi.org/10.1002/14651858.CD007950.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD007950-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007950-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD007950-abs-0014">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD007950-abs-0016">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD007950-abs-0003">Français</a> </li> <li class="section-language"> <a class="" href="full/pt#CD007950-abs-0018">Português</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD007950-abs-0002">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD007950-abs-0001" lang="en"> <section id="CD007950-sec-0001"> <h3 class="title" id="CD007950-sec-0001">Background</h3> <p>It has been reported that neural tube defects (NTD) can be prevented with periconceptional folic acid supplementation. The effects of different doses, forms and schemes of folate supplementation for the prevention of other birth defects and maternal and infant outcomes are unclear. </p> </section> <section id="CD007950-sec-0002"> <h3 class="title" id="CD007950-sec-0002">Objectives</h3> <p>This review aims to examine whether periconceptional folate supplementation reduces the risk of neural tube and other congenital anomalies (including cleft palate) without causing adverse outcomes in mothers or babies. This is an update of a previously published Cochrane review on this topic. </p> </section> <section id="CD007950-sec-0003"> <h3 class="title" id="CD007950-sec-0003">Search methods</h3> <p>We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (31 August 2015). Additionally, we searched the World Health Organization (WHO) International Clinical Trials Registry Platform (<a href="http://apps.who.int/trialsearch/" target="_blank">ICTRP</a>) (31 August 2015) and contacted relevant organisations to identify ongoing and unpublished studies. </p> </section> <section id="CD007950-sec-0004"> <h3 class="title" id="CD007950-sec-0004">Selection criteria</h3> <p>We included all randomised or quasi‐randomised trials evaluating the effect of periconceptional folate supplementation alone, or in combination with other vitamins and minerals, in women independent of age and parity. </p> </section> <section id="CD007950-sec-0005"> <h3 class="title" id="CD007950-sec-0005">Data collection and analysis</h3> <p>Two review authors independently assessed the eligibility of studies against the inclusion criteria, extracted data from included studies, checked data entry for accuracy and assessed the risk of bias of the included studies. We assessed the quality of the body of evidence using the GRADE approach. </p> </section> <section id="CD007950-sec-0006"> <h3 class="title" id="CD007950-sec-0006">Main results</h3> <p>Five trials involving 7391 women (2033 with a history of a pregnancy affected by a NTD and 5358 with no history of NTDs) were included. Four comparisons were made: 1) supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials); 2) supplementation with folic acid alone versus no treatment or placebo (one trial); 3) supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials); and 4) supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials). The risk of bias of the trials was variable. Only one trial was considered to be at low risk of bias. The remaining studies lacked clarity regarding the randomisation method or whether the allocation to the intervention was concealed. All the participants were blinded to the intervention, though blinding was unclear for outcome assessors in the five trials. </p> <p>The results of the first comparison involving 6708 births with information on NTDs and other infant outcomes, show a protective effect of daily folic acid supplementation (alone or in combination with other vitamins and minerals) in preventing NTDs compared with no interventions/placebo or vitamins and minerals without folic acid (risk ratio (RR) 0.31, 95% confidence interval (CI) 0.17 to 0.58); five studies; 6708 births; <i>high quality evidence</i>). Only one study assessed the incidence of NTDs and showed no evidence of an effect (RR 0.07, 95% CI 0.00 to 1.32; 4862 births) although no events were found in the group that received folic acid. Folic acid had a significant protective effect for reoccurrence (RR 0.34, 95% CI 0.18 to 0.64); four studies; 1846 births). Subgroup analyses suggest that the positive effect of folic acid on NTD incidence and recurrence is not affected by the explored daily folic acid dosage (400 µg (0.4 mg) or higher) or whether folic acid is given alone or with other vitamins and minerals. These results are consistent across all four review comparisons. </p> <p>There is no evidence of any preventive or negative effects on cleft palate (RR 0.73, 95% CI 0.05 to 10.89; three studies; 5612 births; <i>low quality evidence</i> ), cleft lip ((RR 0.79, 95% CI 0.14 to 4.36; three studies; 5612 births; <i>low quality evidence</i> ), congenital cardiovascular defects (RR 0.57, 95% CI 0.24 to 1.33; three studies; 5612 births; <i>low quality evidence</i> ), miscarriages (RR 1.10, 95% CI 0.94 to 1.28; five studies; 7391 pregnancies; <i>moderate quality evidence</i> ) or any other birth defects (RR 0.94, 95% CI 0.53 to 1.66; three studies; 5612 births; <i>low quality evidence</i>). There were no included trials assessing the effects of this intervention on neonatal death, maternal blood folate or anaemia at term. </p> </section> <section id="CD007950-sec-0007"> <h3 class="title" id="CD007950-sec-0007">Authors' conclusions</h3> <p>Folic acid, alone or in combination with vitamins and minerals, prevents NTDs, but does not have a clear effect on other birth defects. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD007950-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007950-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD007950-abs-0005">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD007950-abs-0015">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD007950-abs-0017">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD007950-abs-0012">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD007950-abs-0010">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ja#CD007950-abs-0009">日本語</a> </li> <li class="section-language"> <a class="" href="full/ms#CD007950-abs-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD007950-abs-0011">Polski</a> </li> <li class="section-language"> <a class="" href="full/pt#CD007950-abs-0019">Português</a> </li> <li class="section-language"> <a class="" href="full/ru#CD007950-abs-0007">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD007950-abs-0006">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD007950-abs-0013">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD007950-abs-0004" lang="en"> <h3>Folic acid supplements before conception and in early pregnancy (up to 12 weeks) for the prevention of birth defects </h3> <p>Folic acid is a synthetic form of folate used in supplements and fortified staple foods (like wheat and maize flour) to reduce the occurrence of neural tube defects (NTDs). These include spina bifida (or cleft spine), where there is an opening in one or more of the bones (vertebrae) of the spinal column, and anencephaly where the head (cephalic) end of the neural tube fails to close. Supplementation with folic acid is internationally recommended to women from the moment they are trying to conceive until 12 weeks of pregnancy. Another option recommended by the World Health Organization (WHO) is that women of reproductive age take intermittent (weekly) iron and folic acid supplements, especially in populations where the prevalence of anaemia is above 20%. Supplementation may also reduce other birth defects such as cleft lip, with or without cleft palate, and congenital cardiovascular defects. Recently, 5‐methyl‐tetrahydrofolate (5‐MTHF) has been proposed as an alternative to folic acid supplementation. This is because most dietary folate and folic acid are metabolised to 5‐MTHF. Some women have gene characteristics which reduce folate concentration in blood. </p> <p>This review confirms that folic acid supplementation prevents the first and second time occurrence of NTDs and shows there is not enough evidence to determine if folic acid prevents other birth defects. Information about the safety of other current and alternative supplementation schemes and any possible effects on other outcomes for mothers and babies is also lacking. This review of five trials, involving 7391 pregnancies (2033 with a history of a pregnancy affected by a NTD and 5358 with no history of NTDs), shows the protective effect of daily folic acid supplementation in doses ranging from 0.36 mg (360 µg) to 4 mg (4000 µg) a day, with and without other vitamins and minerals, before conception and up to 12 weeks of pregnancy, for preventing the recurrence of these defects. There were insufficient data to evaluate the effects on other outcomes such as cleft lip and palate, miscarriages or any other birth defects. More research is needed on different types of supplementation programmes and the use of different types of supplements (such as 5‐methyl‐tetrahydrofolate ‐5‐MTHF), particularly in countries where folic acid fortification of staple foods like wheat or maize flour is not mandatory and where the prevalence of NTDs is still high. The overall quality of the evidence for neonatal outcomes was high for NTDs, whereas, it was of low quality for other neonatal outcomes. The overall quality of the evidence for maternal outcomes was rated as moderate. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD007950-sec-0198" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD007950-sec-0198"></div> <h3 class="title" id="CD007950-sec-0199">Implications for practice</h3> <section id="CD007950-sec-0199"> <p>The beneficial effects of folic acid supplementation for preventing birth defects depend on the timing of the intervention (before pregnancy and up to 12 weeks of pregnancy). Adequate targeting is needed to ensure the effectiveness of periconceptional folate supplementation for the prevention on birth defects. </p> </section> <h3 class="title" id="CD007950-sec-0200">Implications for research</h3> <section id="CD007950-sec-0200"> <p>The included trials were published before international recommendations for periconceptional folic acid supplementation emerged. There is a need for clinical trials using the current internationally recommended doses to determine the effect of folic acid supplementation on birth defects. Considering the high compliance of the weekly iron supplementation regimen, it is worth assessing the feasibility and impact of this scheme on birth defects. Recent studies suggest periconceptional micronutrient supplementation may have a potential protective effect against paediatric cancers and folic acid may be conferring the protective effect (<a href="./references#CD007950-bbs2-0107" title="GohYI , BollanoE , EinarsonTR , KorenG . Prenatal multivitamin supplementation and rates of pediatric cancer: a meta‐analysis. Clinical Pharmacology and Therapeutics2007;81(5):685‐91. ">Goh 2007</a>); these areas also merit further research attention. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD007950-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD007950-sec-0036"></div> <div class="table" id="CD007950-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Supplementation with folate versus no intervention, placebo or other micronutrients without folate (neonatal outcomes)</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Population:</b> all women who become pregnant or were 12 or less weeks' pregnant at the time of the intervention<br/> <b>Setting:</b> the studies took place in nine high‐income countries and one low‐middle‐income country<br/> <b>Intervention:</b> supplementation with folate<br/> <b>Comparison:</b> no intervention, placebo or other micronutrients without folate </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with no intervention, placebo or other micronutrients without folate</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with supplementation with folate</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Neural tube defects (All)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 0.31<br/> (0.17 to 0.58) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>6708<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/> <b>high</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>13 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>4 per 1000<br/> (2 to 7) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>35 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>11 per 1000<br/> (6 to 20) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Cleft lip (All)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 0.79<br/> (0.14 to 4.36) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>5612<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1 per 1000<br/> (0 to 6) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>2 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>2 per 1000<br/> (0 to 9) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Cleft palate (All)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>RR 0.73<br/> (0.05 to 10.89) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>5612<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1 per 1000<br/> (0 to 8) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>0 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>0 per 1000</p> <p>(0 to 0)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Congenital cardiovascular anomalies (All)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 0.57<br/> (0.24 to 1.33) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>5612<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>5 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>3 per 1000<br/> (1 to 7) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>5 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>3 per 1000<br/> (2 to 10) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Other congenital anomalies (All)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 0.94<br/> (0.53 to 1.66) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>5612<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>4,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>16 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>15 per 1000<br/> (8 to 26) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>17 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>16 per 1000<br/> (8 to 26) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Neonatal death</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>not pooled</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0<br/> (0 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No trial assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Most studies contributing data had design limitations (selection bias was unclear). </p> <p><sup>2</sup> Authors refrained from downgrading the quality of the evidence due to the large magnitude of effect. </p> <p><sup>2</sup> Wide confidence interval crossing the line of no effect &amp; few events. </p> <p><sup>3</sup> Wide confidence interval crossing the line of no effect. </p> <p><sup>4</sup> Statistical Heterogeneity (I² &gt; 60%). Variation in direction. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD007950-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Supplementation with folate versus no intervention, placebo or other micronutrients without folate (maternal outcomes)</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Population:</b> all women who become pregnant or were 12 or less weeks' pregnant at the time of the intervention<br/> <b>Setting:</b> the studies took place in nine high‐income countries and one low‐middle‐income country<br/> <b>Intervention:</b> supplementation with folate<br/> <b>Comparison:</b> no intervention, placebo or other micronutrients without folate </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with no intervention, placebo or other micronutrients without folate</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with supplementation with folate</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Maternal anaemia at or near term (All)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>not pooled</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>0<br/> (0 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>No trial assessed this outcome.</p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>not pooled</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>not pooled</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Maternal red blood cell folate at or near term (All)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>not estimable</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean maternal red blood cell folate at or near term (All) in the intervention group was 0 undefined more (0 more to 0 more) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>not pooled</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0<br/> (0 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No trial assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serum folate at or near term</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>not pooled</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0<br/> (0 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No trial assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Miscarriage (All)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 1.10<br/> (0.94 to 1.28) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>7391<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>99 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>109 per 1000<br/> (93 to 127) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>96 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>106 per 1000<br/> (90 to 123) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Most studies contributing data had design limitations (selection bias was unclear). </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD007950-sec-0037" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD007950-sec-0037"></div> <p>The main focus of this review is on the provision of oral supplements of folate (with or without other vitamins and minerals) before pregnancy and in early pregnancy (before 12 weeks’ gestation) to reduce the occurrence and recurrence of congenital anomalies, particularly neural tube defects (NTDs): spina bifida, anencephaly, encephalocoele, hydranencephaly, iniencephaly, schizencephaly, and other birth defects. We limited the review to the use of supplements in the form of capsules (hard and soft), modified release capsules, tablets (coated and uncoated) and suspensions, therefore excluding other ways of provision of folate. Other Cochrane reviews and protocols focus on related topics such as oral iron with or without folic acid during pregnancy (<a href="./references#CD007950-bbs2-0135" title="Peña‐RosasJP , De‐RegilLM , DowswellT , ViteriFE . Daily oral iron supplementation during pregnancy. Cochrane Database of Systematic Reviews2015, Issue 7. [DOI: 10.1002/14651858.CD004736.pub5] ">Peña‐Rosas 2015a</a>); intermittent iron and folic acid during pregnancy (<a href="./references#CD007950-bbs2-0136" title="Peña‐RosasJP , De‐RegilLM , Gomez MalaveH , Flores‐UrrutiaMC , DowswellT . Intermittent oral iron supplementation during pregnancy. Cochrane Database of Systematic Reviews2015, Issue 10. [DOI: 10.1002/14651858.CD009997.pub2] ">Peña‐Rosas 2015b</a>); treatment for iron deficiency and anaemia (<a href="./references#CD007950-bbs2-0143" title="ReveizL , GyteGML , CuervoLG , CasasbuenasA . Treatments for iron‐deficiency anaemia in pregnancy. Cochrane Database of Systematic Reviews2011, Issue 10. [DOI: 10.1002/14651858.CD003094.pub3] ">Reveiz 2011</a>); the use of various vitamin and multivitamin/micronutrient supplements for women during pregnancy (<a href="./references#CD007950-bbs2-0110" title="HaiderBA , BhuttaZA . Multiple‐micronutrient supplementation for women during pregnancy. Cochrane Database of Systematic Reviews2015, Issue 11. [DOI: 10.1002/14651858.CD004905.pub4] ">Haider 2015</a>), the effectiveness of oral folate supplementation alone during pregnancy on haematological and biochemical parameters during pregnancy and on pregnancy outcomes (<a href="./references#CD007950-bbs2-0120" title="LassiZS , SalamRA , HaiderBA , BhuttaZA . Folic acid supplementation during pregnancy for maternal health and pregnancy outcomes. Cochrane Database of Systematic Reviews2013, Issue 3. [DOI: 10.1002/14651858.CD006896.pub2] ">Lassi 2013</a>), the effects of intermittent iron and folic acid supplementation in menstruating women (<a href="./references#CD007950-bbs2-0102" title="Fernández‐GaxiolaAC , De‐RegilLM . Intermittent iron supplementation for reducing anaemia and its associated impairments in menstruating women. Cochrane Database of Systematic Reviews2011, Issue 12. [DOI: 10.1002/14651858.CD009218.pub2] ">Fernandez‐Gaxiola 2011</a>), or the effects or harms of folate supplementation on folate status and health outcomes (physical, psychological, and neurocognitive) among women of reproductive age outside the periconceptional period (<a href="./references#CD007950-bbs2-0153" title="TsangB , SandalinasF , De‐RegilLM . Folate supplementation in women of reproductive age. Cochrane Database of Systematic Reviews2015, Issue 6. [DOI: 10.1002/14651858.CD011766] ">Tsang 2015</a>). This is an update of a previously published systematic review on this topic (<a href="./references#CD007950-bbs2-0174" title="De‐RegilLM , Fernández‐GaxiolaAC , DowswellT , Peña‐RosasJP . Effects and safety of periconceptional folate supplementation for preventing birth defects. Cochrane Database of Systematic Reviews2010, Issue 10. [DOI: 10.1002/14651858.CD007950.pub2] ">De‐Regil 2010</a>). </p> <section id="CD007950-sec-0038"> <h3 class="title" id="CD007950-sec-0038">Introduction</h3> <p>Folate is a water‐soluble B vitamin present in legumes, leafy green vegetables (such as spinach and turnip greens) and some fruits (such as citrus fruits and juices). Folic acid is the synthetic and most stable form of folate and the form often used in supplements and in fortified foods (<a href="./references#CD007950-bbs2-0072" title="BaileyLB , StoverPJ , McNultyH , FenechMF , GregoryJF , MillsJL , et al. Biomarkers of nutrition for development‐folate review. Journal of Nutrition2015;145(7):1636S‐1680S. ">Bailey 2015</a>). The bioavailability of folic acid is approximately 70% higher than that of folate naturally contained in foods, although there are wide variations depending on the methodology used in the measurement (<a href="./references#CD007950-bbs2-0129" title="McNultyH , PentievaK . Folate bioavailability. Proceedings of the Nutrition Society2004;63(4):529‐36. ">McNulty 2004</a>).  Serum and red blood cell folate can increase in response to folic acid supplements in a dose‐response manner up to an intake of 400 μg (0.4 mg) daily (<a href="./references#CD007950-bbs2-0096" title="DuffyME , HoeyL , HughesCF , StrainJJ , RankinA , SouvereinOW , et al. Biomarker responses to folic acid intervention in healthy adults: A meta‐analysis of randomized controlled trials. American Journal of Clinical Nutrition2014;99(1):96–106. ">Duffy 2014</a>). It is estimated that non pregnant non lactating women would require an intake of natural food folate intake of at least 450 μg dietary folate equivalents daily to prevent NTDs (<a href="./references#CD007950-bbs2-0124" title="MarchettaCM , DevineOJ , CriderKS , TsangBL , CorderoAM , QiYP , et al. Assessing the association between natural food folate intake and blood folate concentrations: a systematic review and Bayesian meta‐analysis of trials and observational studies. Nutrients2015;7(4):2663‐86. ">Marchetta 2015</a>). </p> <p>Folate status in populations is generally assessed using static biochemical tests that directly measure folate in serum or in red blood cells (<a href="./references#CD007950-bbs2-0137" title="PfeifferC , SchleicherR , CaldwellK . Biochemical indices. In: CaballeroOB editor(s). Enclyclopedia of Human Nutrition. 3rd Edition. Waltham, MA: Academic Press, 2013:156–74. ">Pfeiffer 2013</a>). The cut‐off currently suggested to define deficiency is &lt; 6.8 nmol/L for serum folate, an indicator sensitive to recent usual intake; and &lt; 100 nmol/L for red blood cell folate, an indicator of folate storage (<a href="./references#CD007950-bbs2-0167" title="World Health Organization. Serum and red blood cell folate concentrations for assessing folate status in populations. Vol. WHO/NMH/NHD/EPG/15.01, Geneva: World Health Organization, 2015. ">WHO 2015a</a>). There are no universally accepted cut‐off points to define deficiency during pregnancy, as concentrations decline over gestation and recover at delivery (<a href="./references#CD007950-bbs2-0167" title="World Health Organization. Serum and red blood cell folate concentrations for assessing folate status in populations. Vol. WHO/NMH/NHD/EPG/15.01, Geneva: World Health Organization, 2015. ">WHO 2015a</a>), probably due to a physiologic haemodilution. However, the optimal folate level associated with lowest risk of NTDs is 906 nmol/L or above (<a href="./references#CD007950-bbs2-0166" title="World Health Organization. Guideline: optimal serum and red blood cell folate concentrations in women of reproductive age for prevention of neural tube defects. Geneva: World Health Organization, 2015. ">WHO 2014</a>), a concentration that can be reached within four weeks at supplemental daily doses (<a href="./references#CD007950-bbs2-0084" title="BrämswigS , Prinz‐LangenohlR , LamersY , TobolskiO , WintergerstE , BertholdHK , et al. Supplementation with a multivitamin containing 800 microg of folic acid shortens the time to reach the preventive red blood cell folate concentration in healthy women. International Journal for Vitamin and Nutrition Research. Internationale Zeitschrift fur Vitamin‐ und Ernahrungsforschung. Journal International de Vitaminologie et de Nutrition2009;79(2):61‐70. ">Brämswig 2009</a>). Thus, women with red blood cell concentrations below this threshold would be considered folate insufficient or to have sub‐optimal folate status. Folate concentrations measurements differ depending on the method used for assessment including radioimmunoassay and microbiological assays, particularly at the lower range of concentrations (<a href="./references#CD007950-bbs2-0086" title="Centers for Disease Control and Prevention. National Report on Biochemical Indicators of Diet and Nutrition in the US Population 1999‐2002. Water soluble vitamins and related biochemical compounds. Atlanta, GA: Department of Health and Human Services, 2008. ">CDC 2008a</a>; <a href="./references#CD007950-bbs2-0121" title="Life Sciences Research Office, Center for Food Safety and Applied Nutrition. Assessment of folate methodology used in the Third National Health and Nutrition Survey (NHANES 1988‐1994). Washington DC: U.S. Food and Drug Administration, Department of Health and Human Services, 1994. ">Life Sciences Research Office 1994</a>). The microbiological method remains as the recommended method to quantify folate, although there are many newly developed radioimmunoassays (<a href="./references#CD007950-bbs2-0167" title="World Health Organization. Serum and red blood cell folate concentrations for assessing folate status in populations. Vol. WHO/NMH/NHD/EPG/15.01, Geneva: World Health Organization, 2015. ">WHO 2015a</a>). </p> </section> <section id="CD007950-sec-0039"> <h3 class="title" id="CD007950-sec-0039">Description of the condition</h3> <p>An estimated 276,000 babies die within four weeks of birth every year worldwide from congenital anomalies (about 7% of all neonatal deaths), and congenital anomalies can also be important causes of chronic illness and disability in many countries (<a href="./references#CD007950-bbs2-0168" title="World Health Organization. Congenital anomalies. Congenital anomalies. Fact sheet N°370. Geneva: World Health Organization, 2015. ">WHO 2015b</a>). Congenital anomalies are structural or functional anomalies (e.g. metabolic disorders) that occur during intrauterine life and can be identified prenatally, at birth or later in life (<a href="./references#CD007950-bbs2-0168" title="World Health Organization. Congenital anomalies. Congenital anomalies. Fact sheet N°370. Geneva: World Health Organization, 2015. ">WHO 2015b</a>). Major anomalies involve structural changes that have significant medical, social or cosmetic consequences for the affected individual, and commonly require medical intervention (<a href="./references#CD007950-bbs2-0166" title="World Health Organization. Guideline: optimal serum and red blood cell folate concentrations in women of reproductive age for prevention of neural tube defects. Geneva: World Health Organization, 2015. ">WHO 2014</a>). NTDs are major congenital anomalies that arise during the structural development of the neural tube, a process that is completed within 28 days after conception. NTDs are among the most common of the congenital anomalies (<a href="./references#CD007950-bbs2-0169" title="World Health Organization, Centers for Disease Control and Prevention and International Clearinghouse for Birth Defects Surveillance and Research. Birth defects surveillance: a manual for programme managers. Geneva: World Health Organization, 2014. ">WHO/CDC/ICBDSR 2014</a>). </p> <p>In 1991, one randomised controlled trial demonstrated that periconceptional folic acid supplementation prevented the recurrence of NTDs (<a href="./references#CD007950-bbs2-0005" title="Anon . Folate supplements prevent recurrence of neural tube defects. Nutrition Review1992;50(Suppl 1):22‐4. Anon . Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet1991;338(8760):131‐7. ">MRC 1991</a>) and in 1992, another showed that a multiple micronutrient supplement containing folic acid prevented the occurrence of NTDs (<a href="./references#CD007950-bbs2-0091" title="CzeizelAE , DudasI . Prevention of the first occurrence of neural‐tube defects by periconceptional vitamin supplementation. New England Journal of Medicine1992;327(26):1832‐5. ">Czeizel 1992</a>). The latter results were confirmed in a public health campaign among women preparing for marriage conducted between 1993 and 1995 in China, after which the risk of NTDs among the fetuses or infants of the women who took a folic acid supplement more than 80% of the time decreased by between 40% and 85% (<a href="./references#CD007950-bbs2-0074" title="BerryRJ , LiZ , EricksonJD , LiS , MooreCA , WangH , et al. Prevention of neural‐tube defects with folic acid in China. China‐U.S. collaborative project for neural tube defect prevention. New England Journal of Medicine1999;341(20):1485‐90. ">Berry 1999</a>). It is estimated that in low‐ and middle‐income countries 2.55/1000 live births, still births and terminations are affected by a NTD, with 1.04 affected by spina bifida, 1.03 by anencephaly and 0.21 by encephalocoele (<a href="./references#CD007950-bbs2-0122" title="LoA , PolšekD , SidhuS . Estimating the burden of neural tube defects in low‐ and middle‐income countries. Journal of Global Health2014;4(1):010402. ">Lo 2014</a>). </p> <p>Insufficient periconceptional folate and folic acid intake is associated with a number of congenital anomalies that may also relate to genetic and environmental factors (<a href="./references#CD007950-bbs2-0115" title="BaleJR , StollBJ , LucasAO , editors. Reducing birth defects: meeting the challenge in the developing world. Washington: National Academies Press, 2003. ">IOM 2003</a>) (i.e. gene defects, chromosomal disorders, multifactorial inheritance, environmental teratogens, maternal infectious diseases or illnesses, exposure to medicines/chemicals and recreational drugs, high dose of radiation) operating before conception or during pregnancy (<a href="./references#CD007950-bbs2-0168" title="World Health Organization. Congenital anomalies. Congenital anomalies. Fact sheet N°370. Geneva: World Health Organization, 2015. ">WHO 2015b</a>). Congenital anomalies can cause lifelong problems affecting health, growth, and learning and may be immediately apparent after birth, or manifest later in life (<a href="./references#CD007950-bbs2-0130" title="MurrayCJ , LopezAD . Regional patterns of disability‐free life expectancy and disability‐adjusted life expectancy: Global Burden of Disease Study. Lancet1997;349(9062):1347‐52. ">Murray 1997</a>; <a href="./references#CD007950-bbs2-0162" title="World Health Organization. Human genetics: services for the prevention and management of genetic disorders and birth defects in developing countries. Report of a joint WHO/WOAPBD Meeting. Geneva: WHO, 1999. ">WHO 1999</a>; <a href="./references#CD007950-bbs2-0163" title="World Health Organization. Primary health care approaches for the prevention and control of congenital genetic disorders. Report of a WHO meeting. Geneva: WHO, 2000. ">WHO 2000</a>). Environmental factors, including folate status, are thought to contribute to about 5% to 10% of total congenital anomalies (<a href="./references#CD007950-bbs2-0115" title="BaleJR , StollBJ , LucasAO , editors. Reducing birth defects: meeting the challenge in the developing world. Washington: National Academies Press, 2003. ">IOM 2003</a>). in Europe, the regulatory agencies have assessed the evidence and approved claims indicating that Increasing maternal folate status by supplemental folate intake is a beneficial physiological effect in the context of reducing the risk of NTDs (<a href="./references#CD007950-bbs2-0101" title="European Food Safety Authority NDA Panel (EFSA Panel on Dietetic Products, Nutrition , Allergies) . Scientific Opinionon the substantiation of a health claim related to increasing maternal folate status by supplemental folate intake and reduced risk of neural tube defects pursuant to article 14 of regulation (EC) No 1924/2006. European Food Safety Authority Journal2013;11(7):3328. ">European Food Safety Authority NDA Panel 2013</a>). </p> <p>While maternal intake of folate and folic acid is specifically associated with a decreased risk for NTDs, they may also provide protection for other selected congenital anomalies. There is suggestive evidence of protection from cardiovascular defects, Down syndrome, limb defects, cleft lip with or without cleft palate, urinary tract anomalies and congenital hydrocephalus (<a href="./references#CD007950-bbs2-0090" title="CoppedeF . The complex relationship between folate/homocysteine metabolism and risk of Down syndrome. Mutation Research2009;682(1):54‐70. ">Coppede 2009</a>; <a href="./references#CD007950-bbs2-0100" title="EskesTK . Abnormal folate metabolism in mothers with Down syndrome offspring: review of the literature. European Journal of Obstetrics, Gynecology, and Reproductive Biology2006;124(2):130‐3. ">Eskes 2006</a>; <a href="./references#CD007950-bbs2-0106" title="GohYI , BollanoE , EinarsonTR , KorenG . Prenatal multivitamin supplementation and rates of congenital anomalies: a meta‐analysis. Journal of Obstetrics and Gynaecology Canada: JOGC2006;28:680‐9. ">Goh 2006</a>; <a href="./references#CD007950-bbs2-0066" title="WilcoxAJ , LieRT , SolvollK , TaylorJ , McConnaugheyDR , AbyholmF , et al. Folic acid supplements and risk of facial clefts: national population based case‐control study. BMJ2007;334(7591):464. ">Wilcox 2007</a>). In the case of orofacial clefts, there are several similarities with NTDs: their occurrence at a similar time during embryogenesis, their involvement with the midline of the embryo, their near identical population characteristics and similar gene contributions. There is also some evidence of a suggested protective effect of folic acid use, especially for cleft lip with or without cleft palate (<a href="./references#CD007950-bbs2-0161" title="WehbyGL , MurrayJC . Folic acid and orofacial clefts: a review of the evidence. Oral Diseases2010;16(1):11‐9. ">Wehby 2010</a>), although this remains controversial, possibly because of the differences in dosage and type of supplementation (e.g. folic acid alone or with other micronutrients) used among studies (<a href="./references#CD007950-bbs2-0080" title="BottoLD , OlneyRS , EricksonJD . Vitamin supplements and the risk for congenital anomalies other than neural tube defects. American Journal of Medical Genetics Part C. Seminars in Medical Genetics2004;125C(1):12‐21. ">Botto 2004</a>; <a href="./references#CD007950-bbs2-0012" title="BottoLD , LisiA , BowerC , CanfieldMA , DattaniN , DeViganC , et al. Trends of selected malformations in relation to folic acid recommendations and fortification: an international assessment. Birth Defects Research2006;76(10):693‐705. ">Botto 2006</a>). No effects have been shown in preventing pyloric stenosis, undescended testis or hypospadias. Approximately half of the congenital anomalies are limited to a single organ, and the other half frequently present additional congenital anomalies, such as heart malformations (<a href="./references#CD007950-bbs2-0148" title="ShibuyaK , MurrayC . Congenital anomalies. In: MurrayC , LopezA editor(s). Health Dimensions of Sex and Reproduction. Boston: Harvard School of Public Health, 1998:463‐73. ">Shibuya 1998</a>). </p> <p>Suspicion of a NTD may be raised by a maternal serum screening test during the second trimester of pregnancy which detects an elevated concentration of alpha fetoprotein. The diagnosis is confirmed by ultrasound examination during the second trimester of pregnancy. Cleft lip and palate can be identified on detailed ultrasound examination, but if there is only involvement of the palate, diagnosis by ultrasound can be difficult, and often not established until after birth. Unfortunately, these tests are not yet routinely done in most developing countries.  Affected infants have difficulty with feeding and later with speech development, hearing and tooth formation. Stigmatisation and discrimination may pose lifelong problems. Malnutrition and infection resulting from cleft lip or cleft palate, or both, can lead to severe illness and, in some cases, death (<a href="./references#CD007950-bbs2-0148" title="ShibuyaK , MurrayC . Congenital anomalies. In: MurrayC , LopezA editor(s). Health Dimensions of Sex and Reproduction. Boston: Harvard School of Public Health, 1998:463‐73. ">Shibuya 1998</a>). Recent evidence also shows that low maternal folate status during early pregnancy is associated with a higher risk of emotional and behavioural problems (<a href="./references#CD007950-bbs2-0145" title="RozaSJ , vanBatenburg‐EddesT , SteegersEA , JaddoeVW , MackenbachJP , HofmanA , et al. Maternal folic acid supplement use in early pregnancy and child behavioural problems: The Generation R Study. British Journal of Nutrition2010;103(3):445‐52. ">Roza 2010</a>; <a href="./references#CD007950-bbs2-0150" title="Steenweg‐de GraaffJ , RozaSJ , SteegersEA , HofmanA , VerhulstFC , JaddoeVW , TiemeierH . Maternal folate status in early pregnancy and child emotional and behavioral problems: the Generation R Study. American Journal of Clinical Nutrition2012;95(6):1413‐21. ">Steenweg‐de Graaff 2012</a>), and possibly hyperactivity/inattention problems during childhood (<a href="./references#CD007950-bbs2-0146" title="SchlotzW , JonesA , PhillipsDI , GaleCR , RobinsonSM , GodfreyKM . Lower maternal folate status in early pregnancy is associated with childhood hyperactivity and peer problems in offspring. Journal of Child Psychology and Psychiatry, and Allied Disciplines2010;51(5):594‐602. ">Schlotz 2010</a>). </p> <p>The impact of folate insufficiency on congenital anomalies in different populations varies with each healthcare system. It partly relates to the use and coverage of preventive strategies including education and awareness of the importance of folic acid intake among women of reproductive age, access to and/or distribution of pre‐pregnancy folic acid supplements, and/or fortification of staple foods with folic acid, in some cases with mandatory regulations for fortification of staple foods such as wheat (<a href="./references#CD007950-bbs2-0087" title="Centers for Disease Control and Prevention (CDC). Trends in wheat‐flour fortification with folic acid and iron ‐ worldwide, 2004 and 2007. MMWR. Morbidity and Mortality Weekly Report2008;57(1):8‐10. ">CDC 2008b</a>) and maize flours (<a href="./references#CD007950-bbs2-0134" title="Peña‐RosasJP , Garcia‐CasalMN , PachónH , McleanMS , ArabiM . Technical considerations for maize flour and corn meal fortification in public health: consultation rationale and summary. Annals of the New York Academy of Sciences2014;1312:1‐7. ">Peña‐Rosas 2014</a>). Recent evidence demonstrates that public health policies which include folic acid fortification of staple foods are likely to result in a large‐scale prevention of NTDs (<a href="./references#CD007950-bbs2-0081" title="BottoLD , LisiA , Robert‐GnansiaE , EricksonJD , VollsetSE , MastroiacovoP , et al. International retrospective cohort study of neural tube defects in relation to folic acid recommendations: are the recommendations working?. BMJ2005;330:571‐3. ">Botto 2005</a>; <a href="./references#CD007950-bbs2-0077" title="BerryRJ , BaileyL , MulinareJ , BowerC . Folic Acid Working Group. Fortification of flour with folic acid. Food Nutrition Bulletin2010;31(Suppl 1):S22‐35. ">Berry 2010</a>; <a href="./references#CD007950-bbs2-0095" title="DeWalsP , TairouF , VanAllenMI , UhSH , LowryRB , DibbaldB , et al. Reduction in neural‐tube defects after folic acid fortification in Canada. New England Journal of Medicine2007;357(2):135‐42. ">De Wals 2007</a>). It would seem reasonable to implement both interventions fully, especially in countries with a high prevalence of birth defects. </p> <p>Several gene polymorphisms affect folate metabolism and are associated with reduced folate absorption and therefore increased folate needs. Some of the most studied mutations are the methylene‐tetrahydrofolate reductase (MTHFR) gene and the reduced folate carrier (RFC1) gene (<a href="./references#CD007950-bbs2-0088" title="ChangoA , Emery‐FillonN , deCourcyGP , LambertD , PfisterM , RosenblattDS , et al. A polymorphism (80G‐&gt;A) in the reduced folate carrier gene and its associations with folate status and homocysteinemia. Molecular Genetics and Metabolism2000;70(4):310‐5. ">Chango 2000</a>). The former affects 8% to 35% of the population, depending on ethnicity (<a href="./references#CD007950-bbs2-0079" title="BottoLD , YangQ . 5,10‐Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. American Journal of Epidemiology2000;151(9):862‐77. ">Botto 2000</a>; <a href="./references#CD007950-bbs2-0109" title="Guéant‐RodriguezRM , GuéantJL , DebardR , ThirionS , HongLX , BronowickiJP , et al. Prevalence of methylenetetrahydrofolate reductase 677T and 1298C alleles and folate status: a comparative study in Mexican, West African, and European populations. American Journal of Clinical Nutrition2006;83(3):701‐7. ">Guéant‐Rodriguez 2006</a>). In the absence of a folate‐sufficient diet, these mutations are associated with increased risk of NTDs and conotruncal defects in the offspring (<a href="./references#CD007950-bbs2-0155" title="VanBeynumIM , KapustaL , denHeijerM , VermeulenSH , KouwenbergM , DaniëlsO , BlomHJ . Maternal MTHFR 677C&gt;T is a risk factor for congenital heart defects: effect modification by periconceptional folate supplementation. European Heart Journal2006;27(8):981‐7. ">Van Beynum 2006</a>; <a href="./references#CD007950-bbs2-0156" title="Van derPutNM , GabreelsF , StevensEM , SmeitinkJA , TrijbelsFJ , EskesTK , et al. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural‐tube defects?. American Journal of Human Genetics1998;62(5):1044‐51. ">Van der Put 1998</a>). </p> <p>Folic acid intake may also affect fetal and child growth. Observational and controlled trials have showed a positive effect of periconceptional folic acid supplementation on fetal growth (<a href="./references#CD007950-bbs2-0116" title="IyengarL , RajalakshmiK . Effect of folic acid supplement on birth weights of infants. American Journal of Obstetrics and Gynecology1975;122(3):332‐6. ">Iyengar 1975</a>; <a href="./references#CD007950-bbs2-0142" title="ReltonCL , PearceMS , ParkerL . The influence of erythrocyte folate and serum vitamin B12 status on birth weight. British Journal of Nutrition2005;93(5):593‐9. ">Relton 2005</a>; <a href="./references#CD007950-bbs2-0050" title="RolschauJ , KristoffersenK , UlrichM , GrinstedP , SchaumburgE , FogedN . The influence of folic acid supplement on the outcome of pregnancies in the county of Funen in Denmark. Part I. European Journal of Obstetric &amp; Gynecology and Reproductive Biology1999;87(2):105‐10; discussion 103‐4. UlrichM , KristoffersenK , RolschauJ , GrinsteadP , SchaumburgE , FogedN . The influence of folic acid supplement on the outcome of pregnancies in the county of Funen in Denmark. Part II. Congenital anomalies A randomised study. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology1999;87:111‐3. UlrichM , KristoffersenK , RolschauJ , GrinstedP , SchaumburgE , FogedN . The influence of folic acid supplement on the outcome of pregnancies in the county of Funen in Denmark. Part III. Congenital anomalies. An observational study. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology1999;87(2):115‐8; discussion 103‐4. ">Rolschau 1999</a>), although the evidence for this association remains controversial. </p> </section> <section id="CD007950-sec-0040"> <h3 class="title" id="CD007950-sec-0040">Description of the intervention</h3> <p>After the first consistent evidence about the protective effect of folic acid supplementation against NTDs emerged, the United States Public Health Service recommended daily supplementation with 400 μg (0.4 mg) of folic acid for all women who could get pregnant (<a href="./references#CD007950-bbs2-0074" title="BerryRJ , LiZ , EricksonJD , LiS , MooreCA , WangH , et al. Prevention of neural‐tube defects with folic acid in China. China‐U.S. collaborative project for neural tube defect prevention. New England Journal of Medicine1999;341(20):1485‐90. ">Berry 1999</a>). Supplementation with 400 μg (0.4 mg) of folic acid is internationally recommended to women from the moment they are trying to conceive until 12 weeks of pregnancy (<a href="./references#CD007950-bbs2-0164" title="World Health Organization. Prevention of neural tube defects. Standards for maternal and neonatal care. www.who.int/reproductive‐health/publications/standards/neural_tube_defects.pdf (accessed 22 January 2009). ">WHO 2006</a>). Despite policies in several countries on the periconceptional folic acid supplementation (<a href="./references#CD007950-bbs2-0108" title="GomesS , LopesC , PintoE . Folate and folic acid in the periconceptional period: recommendations from official health organizations in thirty‐six countries worldwide and WHO. Public Health Nutrition 2015 Apr 16;[Epub ahead of print]:1‐14. ">Gomes 2015</a>), many women still do not follow the recommendations, particularly women from low socioeconomic status (<a href="./references#CD007950-bbs2-0083" title="BranumAM , BaileyR , SingerBJ . Dietary supplement use and folate status during pregnancy in the United States. Journal of Nutrition2013;143(4):486‐92. ">Branum 2013</a>; <a href="./references#CD007950-bbs2-0104" title="FribergAK , JørgensenFS . Few Danish pregnant women follow guidelines on periconceptional use of folic acid. Danish Medical Journal2015;61(3):A5019. ">Friberg 2015</a>). </p> <p>For women with a previous history of delivery of a baby with a NTD, have diabetes, or are receiving an anticonvulsant treatment, the recommended daily dose is 5000 μg (5 mg) of folic acid in addition to dietary advice to increase food folate intake (<a href="./references#CD007950-bbs2-0115" title="BaleJR , StollBJ , LucasAO , editors. Reducing birth defects: meeting the challenge in the developing world. Washington: National Academies Press, 2003. ">IOM 2003</a>; <a href="./references#CD007950-bbs2-0164" title="World Health Organization. Prevention of neural tube defects. Standards for maternal and neonatal care. www.who.int/reproductive‐health/publications/standards/neural_tube_defects.pdf (accessed 22 January 2009). ">WHO 2006</a>). Daily supplementation with 400 μg (0.4 mg) of folic acid in addition to iron is routinely recommended for all pregnant women in areas of high prevalence of malnutrition to prevent anaemia (<a href="./references#CD007950-bbs2-0164" title="World Health Organization. Prevention of neural tube defects. Standards for maternal and neonatal care. www.who.int/reproductive‐health/publications/standards/neural_tube_defects.pdf (accessed 22 January 2009). ">WHO 2006</a>). The World Health Organization (WHO) also recommends intermittent iron and folic acid supplementation as a public health intervention in menstruating women living in settings where anaemia is highly prevalent, to improve their haemoglobin (Hb) concentrations and iron status and reduce the risk of anaemia (<a href="./references#CD007950-bbs2-0165" title="World Health Organization. Guideline Intermittent iron supplementation for menstruating women. Geneva: World Health Organization, 2011 (accessed 26 December 2013). ">WHO 2011</a>) although it is recognised that there was limited evidence for the effective dose of folic acid in intermittent supplementation, thus basing the recommendation for the folic acid dosage in the rationale of providing seven times the recommended supplemental dose to prevent NTDs (400 µg or 0.4 mg daily). Further limited experimental evidence suggests this dose can improve red cell folate concentrations to levels associated with a reduced risk of NTDs. </p> <p>Recently, the use of 5‐methyl‐tetrahydrofolate (5‐MTHF) has been proposed as an alternative to folic acid supplementation. The rationale for this is that most dietary folate and folic acid are metabolised to 5‐MTHF during its passage across the intestinal mucosa. The 5‐MTHF may be an adequate alternative for supplementation in the presence of MTHFR gene mutation. Four controlled trials using different doses have shown that supplementation with 5‐MTHF is at least as effective as folic acid in improving folate status in women of childbearing age (<a href="./references#CD007950-bbs2-0113" title="HoughtonLA , SherwoodKL , PawloskyR , ItoS , O'ConnorDL . [6S]‐5‐Methyltetrahydrofolate is at least as effective as folic acid in preventing a decline in blood folate concentrations during lactation. American Journal of Clinical Nutrition2006;83(4):842‐50. ">Houghton 2006</a>; <a href="./references#CD007950-bbs2-0119" title="LamersY , Prinz‐LangenohlR , MoserR , PietrzikK . Supplementation with [6S]‐5‐methyltetrahydrofolate or folic acid equally reduces plasma total homocysteine concentrations in healthy women. American Journal of Clinical Nutrition2004;79(3):473‐8. ">Lamers 2004</a>; <a href="./references#CD007950-bbs2-0158" title="VennBJ , GreenTJ , MoserR , McKenzieJE , SkeaffCM , MannJ . Increases in blood folate indices are similar in women of childbearing age supplemented with [6S]‐5‐methyltetrahydrofolate and folic acid. Journal of Nutrition2002;132(11):3353‐5. ">Venn 2002</a>; <a href="./references#CD007950-bbs2-0159" title="VennBJ , GreenTJ , MoserR , MannJI . Comparison of the effect of low‐dose supplementation with L‐5‐methyltetrahydrofolate or folic acid on plasma homocysteine: a randomized placebo‐controlled study. American Journal of Clinical Nutrition2003;77(3):658‐62. ">Venn 2003</a>). This form of folate may also be less likely to mask haematological symptoms of severe vitamin B<sub>12</sub> deficiency and it exhibits a lower interaction potential with antifolate antimalarial drugs (<a href="./references#CD007950-bbs2-0131" title="NduatiE , DiriyeA , OmmehS , MwaiL , KiaraS , MassenoV , et al. Effect of folate derivatives on the activity of antifolate drugs used against malaria and cancer. Parasitology Research2008;102(6):1227‐34. ">Nduati 2008</a>; <a href="./references#CD007950-bbs2-0138" title="PietrzikK , BaileyL , ShaneB . Folic acid and L‐5‐methyltetrahydrofolate: comparison of clinical pharmacokinetics and pharmacodynamics. Clinical Pharmacokinetics2010;49(8):535‐48. ">Pietrzik 2010</a>), specifically sulphadoxine‐pyrimethamine (SP), which might be affected by folic acid supplementation (<a href="./references#CD007950-bbs2-0085" title="CarterJY , LoolpapitMP , LemaOE , TomeJL , NagelkerkeNJ , WatkinsWM . Reduction of the efficacy of antifolate antimalarial therapy by folic acid supplementation. American Journal of Tropical Medicine and Hygiene2005;73(1):166‐70. ">Carter 2005</a>; <a href="./references#CD007950-bbs2-0098" title="EnglishM , SnowRW . Iron and folic acid supplementation and malaria risk. Lancet2006;367(9505):90‐1. ">English 2006</a>; <a href="./references#CD007950-bbs2-0157" title="VanEijkAM , OumaPO , WilliamsonJ , Ter KuileFO , PariseM , OtienoK , et al. Plasma folate level and high‐dose folate supplementation predict sulfadoxine‐pyrimethamine treatment failure in pregnant women in Western Kenya who have uncomplicated malaria. Journal of Infectious Diseases2008;198(10):1550‐3. ">Van Eijk 2008</a>). </p> </section> <section id="CD007950-sec-0041"> <h3 class="title" id="CD007950-sec-0041">How the intervention might work</h3> <p>The main function of folate is as coenzyme in one‐carbon transfer during the methylation cycle, a process essential for the syntheses of nucleic acids, which form part of DNA and the neurotransmitters. From these reactions it is immediately apparent why folate is so important to gene expression. Folate also plays an important role in protein synthesis and metabolism and other processes related to cell multiplication and tissue growth (<a href="./references#CD007950-bbs2-0167" title="World Health Organization. Serum and red blood cell folate concentrations for assessing folate status in populations. Vol. WHO/NMH/NHD/EPG/15.01, Geneva: World Health Organization, 2015. ">WHO 2015a</a>). The main consequence of folate deficiency in adults is megaloblastic anaemia, characterised by abnormally large red‐cell precursors in the bone marrow and larger than normal red cells in the peripheral blood. </p> <p>The methylation of homocysteine to produce methionine (both essential amino acids) uses 5‐MTHF as the methyl donor in the reaction. In folate deficiency, homocysteine accumulates in the serum resulting in negative effects for health. Elevated circulating homocysteine concentrations have been associated with an increased risk in cardiovascular disease (<a href="./references#CD007950-bbs2-0141" title="RefsumH , SmithAD . Are we ready for mandatory fortification with vitamin B‐12?. American Journal of Clinical Nutrition2008;88(2):253‐4. ">Refsum 2008</a>) and late pregnancy complications such as pre‐eclampsia (<a href="./references#CD007950-bbs2-0123" title="MakedosG , PapanicolaouA , HitoglouA , KalogiannidisI , MakedosA , VraziotiV , et al. Homocysteine, folic acid and B12 serum levels in pregnancy complicated with preeclampsia. Archives of Gynecology &amp; Obstetrics2007;275(2):121‐4. ">Makedos 2007</a>; <a href="./references#CD007950-bbs2-0133" title="PatrickTE , PowersRW , DaftaryAR , NessRB , RobertsJM . Homocysteine and folic acid are inversely related in black women with preeclampsia. Hypertension2004;43(6):1279‐82. ">Patrick 2004</a>; <a href="./references#CD007950-bbs2-0151" title="TamuraT , PiccianoMF . Folate and human reproduction. American Journal of Clinical Nutrition2006;83(5):993‐1016. ">Tamura 2006</a>), and possibly NTDs. Therefore, elevated plasma homocysteine may be a risk factor or, alternatively, merely a marker of risk that needs to be determined (<a href="./references#CD007950-bbs2-0167" title="World Health Organization. Serum and red blood cell folate concentrations for assessing folate status in populations. Vol. WHO/NMH/NHD/EPG/15.01, Geneva: World Health Organization, 2015. ">WHO 2015a</a>). </p> <p>Additional potentially undesired effects of pre‐pregnancy folic acid supplementation come from the possible association of the use of multivitamins containing folic acid and an increase in twin pregnancies found in the Swedish study (<a href="./references#CD007950-bbs2-0099" title="EricsonA , KällénB , AbergA . Use of multivitamins and folic acid in early pregnancy and multiple births in Sweden. Twin Research : the official journal of the International Society for Twin Studies2001;4(2):63‐6. ">Ericson 2001</a>), although these findings were confounded by in vitro fertilisation (<a href="./references#CD007950-bbs2-0076" title="BerryRJ , KihlbergR . Folic acid supplementation is not associated with an increase in dizygotic twinning. Early Human Development2005;81(5):465‐7. ">Berry 2005</a>; <a href="./references#CD007950-bbs2-0160" title="VollsetSE , GjessingHK , TandbergA , RønningT , IrgensLM , BasteV , et al. Folate supplementation and twin pregnancies. Epidemiology2005;16(2):201‐5. ">Vollset 2005</a>). Further studies have confirmed that there is no impact of supplementation with 400 µg (0.4 mg) of folic acid and fortification of staple foods with folic acid (<a href="./references#CD007950-bbs2-0118" title="KucikJ , CorreaA . Trends in twinning rates in metropolitan Atlanta before and after folic acid fortification. Journal of Reproductive Medicine2004;49(9):707‐12. ">Kucik 2004</a>; <a href="./references#CD007950-bbs2-0147" title="ShawGM , CarmichaelSL , NelsonV , SelvinS , SchafferDM . Food fortification with folic acid and twinning among California infants. American Journal of Medical Genetics. Part A2003;119A(2):137‐40. ">Shaw 2003</a>; <a href="./references#CD007950-bbs2-0149" title="SignoreC , MillsJL , CoxC , TrumbleAC . Effects of folic acid fortification on twin gestation rates. Obstetrics and Gynecology2005;105(4):757‐62. ">Signore 2005</a>), on twinning. </p> <p>From the safety perspective, an observational study on the fetal origins of disease proposed that normal to high maternal folate status coupled with low vitamin B<sub>12</sub> status was associated with higher adiposity and insulin resistance in Indian babies (<a href="./references#CD007950-bbs2-0172" title="YajnikCS , DeshmukhUS . Maternal nutrition, intrauterine programming and consequential risks in the offspring. Reviews in Endocrine &amp; Metabolic Disorders2008;9(3):203‐11. ">Yajnik 2008</a>), which could probably have a long‐term effect in the fetus later in life. Additional potentially undesired effects of folic acid supplementation come from the ambiguous findings on the effects of folic acid supplementation on colonic lesions (<a href="./references#CD007950-bbs2-0103" title="FifeJ , RanigaS , HiderPN , FrizelleFA . Folic acid supplementation and colorectal cancer risk; a meta‐analysis. Colorectal Disease2009;Oct 27:Epub ahead of print. ">Fife 2009</a>; <a href="./references#CD007950-bbs2-0117" title="JaszewskiR , MisraS , TobiM , UllahN , NaumoffJA , KucukO , et al. Folic acid supplementation inhibits recurrence of colorectal adenomas: a randomized chemoprevention trial. World Journal Gastroenterology2008;28(14):4492‐8. ">Jaszewski 2008</a>; <a href="./references#CD007950-bbs2-0171" title="WuK , PlatzEA , WillettWC , FuchsCS , SelhubJ , RosnerBA , et al. A randomized trial on folic acid supplementation and risk of recurrent colorectaladenoma. American Journal of Clinical Nutrition. 2009 90;90(6):1623‐31. ">Wu 2009</a>). However, a recent meta‐analysis with individual‐participant data from 50,000 participants receiving folic acid supplementation for 5.2 years on average concluded that folic acid supplementation does not substantially increase or decrease the incidence of site‐specific cancer during the first five years of treatment. </p> </section> <section id="CD007950-sec-0042"> <h3 class="title" id="CD007950-sec-0042">Why it is important to do this review</h3> <p>There seems to be sufficient evidence of known benefits of folic acid supplementation on NTDs but not on other congenital anomalies or on benefits to the mother. Furthermore, the best schemes (intermittent or daily), dose and/or form (5‐MTHF, folic acid or other) for providing oral folate supplements to women during the periconceptional period are not yet established. Additionally, concerns raised by some authors about the potential harm associated with high levels of folic acid, merit exploration (<a href="./references#CD007950-bbs2-0089" title="ColeBF , BaronJA , SandlerRS , HaileRW , AhnenDJ , BresalierRS , et al. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA2007;297(21):2351‐9. ">Cole 2007</a>; <a href="./references#CD007950-bbs2-0128" title="MasonJB , DicksteinA , JacquesPF , HaggartyP , SelhubJ , DallalG , et al. A temporal association between folic acid fortification and an increase in colorectal cancer rates may be illuminating important biological principles: a hypothesis. Cancer Epidemiology, Biomarkers &amp; Prevention2007;16(7):1325‐9. ">Mason 2007</a>). </p> <p>In countries where the prevalence of NTDs is high, the cost‐effectiveness of an integrated approach with supplementation and fortification may be more favourable. However, it is important to consider that countries with mandatory wheat flour fortification have achieved a significant increase in folate intake and a significant decline in the prevalence of NTDs, but the relative decline depends on the initial NTD rate: countries with lower NTD prevalence may have much smaller reductions in NTD rates with folic acid fortification (<a href="./references#CD007950-bbs2-0111" title="HesekerHB , MasonJB , SelhubJ , RosenbergIH , JacquesPF . Not all cases of neural‐tube defect can be prevented by increasing the intake of folic acid. British Journal of Nutrition2009;102(2):173‐80. ">Heseker 2009</a>). </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD007950-sec-0043" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD007950-sec-0043"></div> <p>This review aims to examine whether periconceptional folate supplementation reduces the risk of neural tube and other congenital anomalies (including cleft palate) without causing adverse outcomes in mothers or babies. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD007950-sec-0044" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD007950-sec-0044"></div> <section id="CD007950-sec-0045"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD007950-sec-0046"> <h4 class="title">Types of studies</h4> <p>We have included randomised trials only. We had planned to include quasi‐randomised and cluster‐randomised trials if they were otherwise eligible but none were identified. Other levels of evidence (e.g. cohort or case‐control studies) have not been included in meta‐analyses nor have they contributed to the results or conclusions, but we have considered such evidence in the discussion where relevant. </p> </section> <section id="CD007950-sec-0047"> <h4 class="title">Types of participants</h4> <p>All women who become pregnant or were 12 or less weeks' pregnant at the time of the intervention, independent of their age and parity or history of neural tube defect‐affected pregnancy. We have not included trials in which supplementation was continued beyond the first 12 weeks of gestation (even when supplementation was initiated during the periconceptional period or in the first 12 weeks of pregnancy). We did not include studies targeting women during their second or third semesters of pregnancy. </p> </section> <section id="CD007950-sec-0048"> <h4 class="title">Types of interventions</h4> <p>Oral supplements of folate alone (FA) and with other vitamins and minerals given on a daily or intermittent (one, two or three times a week on non‐consecutive days) basis and compared with receiving a placebo, no supplementation or other vitamins and minerals but no folate. </p> <p>For the purpose of this review, oral folate supplementation refers to the delivery of folate compounds (e.g. folic acid, 5MTHF or folinic acid) directly to the oral cavity, either as a tablet, capsule, dispersible tablet or liquid. </p> <p>Where data were available we planned to compare:</p> <p> <ol id="CD007950-list-0001"> <li> <p>supplementation with any folate versus no treatment/placebo/other micronutrients without folate; </p> </li> <li> <p>supplementation with folate alone versus no intervention/placebo;</p> </li> <li> <p>supplementation with folate plus other micronutrients versus other micronutrients (no folate). </p> </li> </ol> </p> <p>We excluded multiple micronutrient powders for point‐of‐use fortification of foods, fortification of staple foods, water, condiments or seasonings with folic acid and other micronutrients or the provision of oral contraceptives that contain folic acid in this review. </p> </section> <section id="CD007950-sec-0049"> <h4 class="title">Types of outcome measures</h4> <section id="CD007950-sec-0050"> <h5 class="title">Primary outcomes</h5> <section id="CD007950-sec-0051"> <h6 class="title">Infant</h6> <p> <ol id="CD007950-list-0002"> <li> <p>Neural tube defects (any)</p> </li> <li> <p>Cleft lip</p> </li> <li> <p>Cleft palate</p> </li> <li> <p>Congenital cardiovascular anomalies</p> </li> <li> <p>Other congenital anomalies (excluding neural tube defects, cleft lip, cleft palate and cardiovascular defects) </p> </li> <li> <p>Neonatal deaths (death occurring within the first 28 days after birth)</p> </li> </ol> </p> </section> <section id="CD007950-sec-0052"> <h6 class="title">Maternal</h6> <p> <ol id="CD007950-list-0003"> <li> <p>Anaemia at or near term (defined as haemoglobin (Hb) less than 110 g/L at 34 weeks of gestation or more) </p> </li> <li> <p>Red blood cell folate at or near term (nmol/L at 34 weeks of gestation or more)</p> </li> <li> <p>Serum folate at or near term (nmol/L at 34 weeks of gestation or more))</p> </li> <li> <p>Miscarriage (as defined by trial authors)</p> </li> </ol> </p> </section> </section> <section id="CD007950-sec-0053"> <h5 class="title">Secondary outcomes</h5> <section id="CD007950-sec-0054"> <h6 class="title">Infant</h6> <p> <ol id="CD007950-list-0004"> <li> <p>Spina bifida</p> </li> <li> <p>Anencephaly</p> </li> <li> <p>Encephaloceles</p> </li> <li> <p>Hydranencephaly</p> </li> <li> <p>Iniencephaly</p> </li> <li> <p>Schizencephaly</p> </li> <li> <p>Stillbirths (as defined by trial authors)</p> </li> <li> <p>Low birthweight (&lt; 2500 g)</p> </li> <li> <p>Very low birthweight (&lt; 1500 g)</p> </li> <li> <p>Macrosomia (birthweight greater than 4000 g)</p> </li> <li> <p>Preterm birth (less than 37 weeks' gestation</p> </li> <li> <p>Infant optimal health status at birth (as defined by trial authors)</p> </li> <li> <p>Admission to special care for any cause (as defined by trial authors)</p> </li> <li> <p>Infant insulin resistance (as defined by trial authors)</p> </li> <li> <p>Apgar at one minute after birth (&gt; eight)</p> </li> <li> <p>Apgar score at five minutes after birth (&gt; eight)</p> </li> </ol> </p> </section> <section id="CD007950-sec-0055"> <h6 class="title">Maternal</h6> <p> <ol id="CD007950-list-0005"> <li> <p>Multiple pregnancy (defined as a pregnancy with two or more fetuses)</p> </li> <li> <p>Homocysteine at or near term (µmol/L at 34 weeks' gestation or more)</p> </li> <li> <p>Serum vitamin B<sub>6</sub> concentration at or near term (nmol/L at 34 weeks' gestation or more) </p> </li> <li> <p>Serum vitamin B<sub>12</sub> concentration at or near term (pmol/L at 34 weeks' gestation or more) </p> </li> <li> <p>Pre‐eclampsia (defined as gestational hypertension ‐ blood pressure higher than 140/90 mmHg ‐ and proteinuria ‐ more than 300 mg of protein in a 24‐hour urine sample) </p> </li> <li> <p>Pregnancy termination for fetal anomaly (as defined by trial authors)</p> </li> <li> <p>Any side effects (as defined by trial authors)</p> </li> </ol> </p> </section> </section> </section> </section> <section id="CD007950-sec-0056"> <h3 class="title">Search methods for identification of studies</h3> <p>The following methods section of this review is based on a standard template used by the Cochrane Pregnancy and Childbirth Group. </p> <section id="CD007950-sec-0057"> <h4 class="title">Electronic searches</h4> <p>We searched the Cochrane Pregnancy and Childbirth Group’s Trials Register by contacting the Trials Search Co‐ordinator (31 August 2015). </p> <p>For full search methods used to populate the PCG Trials Register including the detailed search strategies for CENTRAL, MEDLINE, Embase and CINAHL; the list of handsearched journals and conference proceedings, and the list of journals reviewed via the current awareness service, please follow this link to the editorial information about the <a href="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/PREG/frame.html" target="_blank">Cochrane Pregnancy and Childbirth Group</a> in <i>The Cochrane Library</i> and select the ‘<i><b>Specialized Register</b> </i> ’ section from the options on the left side of the screen. </p> <p>Briefly, the Cochrane Pregnancy and Childbirth Group’s Trials Register is maintained by the Trials Search Co‐ordinator and contains trials identified from: </p> <p> <ol id="CD007950-list-0006"> <li> <p>monthly searches of the Cochrane Central Register of Controlled Trials (CENTRAL);</p> </li> <li> <p>weekly searches of MEDLINE (Ovid);</p> </li> <li> <p>weekly searches of Embase (Ovid);</p> </li> <li> <p>monthly searches of CINAHL (EBSCO);</p> </li> <li> <p>handsearches of 30 journals and the proceedings of major conferences;</p> </li> <li> <p>weekly current awareness alerts for a further 44 journals plus monthly BioMed Central email alerts. </p> </li> </ol> </p> <p>Search results are screened by two people and the full text of all relevant trial reports identified through the searching activities described above is reviewed. Based on the intervention described, each trial report is assigned a number that corresponds to a specific Pregnancy and Childbirth Group review topic (or topics), and is then added to the Register. The Trials Search Co‐ordinator searches the Register for each review using this topic number rather than keywords. This results in a more specific search set which has been fully accounted for in the relevant review sections (Included, Excluded, Awaiting Classification or Ongoing). </p> <p>In addition, we searched the World Health Organization (WHO) International Clinical Trials Registry Platform (<a href="http://apps.who.int/trialsearch/" target="_blank">ICTRP</a>) for unpublished, planned and ongoing trial reports (31 August 2015). </p> </section> <section id="CD007950-sec-0058"> <h4 class="title">Searching other resources</h4> <p>We contacted the WHO headquarters and regional offices, the International Clearinghouse for Birth Defects Surveillance and Research (ICBDSR) March of Dimes, the nutrition section of the United Nations Children's Fund (UNICEF), the World Food Programme (WFP), the US Centers for Disease Control and Prevention (CDC)'s National Center on Birth Defects and Developmental Dissabilities, US Agency for International Development (USAID) micronutrient programme, Micronutrient Initiative (MI), the Global Alliance for Improved Nutrition (GAIN), Hellen Keller International (HKI), Sight and Life Foundation to identify ongoing trials and unpublished reports (correspondence is available upon request). </p> <p>We did not apply any language or date restrictions. For those articles written in other language than English and Spanish, we commissioned their translation into English to assess them for eligibility according to the prespecified selection criteria. We did not handsearch printed journals but screened previously published reviews to identify other possible studies. </p> <p>We did not apply any language or date restrictions</p> </section> </section> <section id="CD007950-sec-0059"> <h3 class="title" id="CD007950-sec-0059">Data collection and analysis</h3> <p>For methods used in the previous version of this review, <i>see '</i><a href="./references#CD007950-bbs2-0174" title="De‐RegilLM , Fernández‐GaxiolaAC , DowswellT , Peña‐RosasJP . Effects and safety of periconceptional folate supplementation for preventing birth defects. Cochrane Database of Systematic Reviews2010, Issue 10. [DOI: 10.1002/14651858.CD007950.pub2] ">De‐Regil 2010</a>'. </p> <p>For this update, the following methods were used for assessing the new reports that were identified as a result of the updated search. </p> <p>The following methods section of this review is based on a standard template used by the Cochrane Pregnancy and Childbirth Group. </p> <section id="CD007950-sec-0060"> <h4 class="title">Selection of studies</h4> <p>Two review authors (JPPR and LMD) independently assessed the titles and abstracts of all the studies we identified as a result of the search strategy against the inclusion criteria and obtained full‐text reports of all relevant or potentially relevant studies. We resolved any disagreement through discussion or, if required, we consulted a third author (AFG). </p> <p>In this version of the review all studies were reported in journal articles. Had we identified trials published only as abstracts, or study reports containing insufficient information on methods, we would have attempted to contact the trial authors to obtain further details of study design and results; if there was insufficient information for us to be able to assess risk of bias, studies would await assessment until further information was published, or made available to us. </p> </section> <section id="CD007950-sec-0061"> <h4 class="title">Data extraction and management</h4> <p>We designed an electronic form to extract data and record information on the study setting and participants (inclusion and exclusion criteria), details of study methods and risk of bias. The review authors (JPPR, LMD, TD, AFG and PRS) independently extracted the data from eligible studies using the agreed form. We entered data into Review Manager software (<a href="./references#CD007950-bbs2-0144" title="The Nordic Cochrane Centre. Review Manager (RevMan). 5.3. Copenhagen: The Cochrane Collaboration, 2014. ">RevMan 2014</a>) and carried out checks for accuracy. We resolved discrepancies through discussion. </p> <p>When information regarding any of the above was unclear, we attempted to contact authors of the original reports to provide further details. </p> </section> <section id="CD007950-sec-0062"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (JPPR and LMD) independently assessed risk of bias for each included study using the domain‐based evaluation criteria outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD007950-bbs2-0112" title="HigginsJPT , GreenS , editors. Review Manager (RevMan). Cochrane Handbook for Systematic Reviews of Interventions. 5.1.0 [updated March 2011]. Available from www.cochrane‐handbook.org: The Cochrane Collaboration, 2011. ">Higgins 2011</a>). We resolved any disagreement by discussion or by involving a third assessor (PRS). </p> <section id="CD007950-sec-0063"> <h5 class="title">(1) Sequence generation (checking for possible selection bias)</h5> <p>We described for each included study the method used to generate the allocation sequence.</p> <p>We assessed the method as:</p> <p> <ul id="CD007950-list-0007"> <li> <p>low risk of bias (any truly random process, e.g. random number table; computer random number generator); </p> </li> <li> <p>high risk of bias (any non‐random process, e.g. odd or even date of birth; hospital or clinic record number); </p> </li> <li> <p>unclear risk of bias.   </p> </li> </ul> </p> </section> <section id="CD007950-sec-0064"> <h5 class="title">(2) Allocation concealment (checking for possible selection bias)</h5> <p>We described for each included study the method used to conceal the allocation sequence and assessed whether intervention allocation could have been foreseen in advance of, or during recruitment, or changed after assignment. </p> <p>We assessed the methods as:</p> <p> <ul id="CD007950-list-0008"> <li> <p>low risk of bias (e.g. telephone or central randomisation; consecutively numbered sealed opaque envelopes); </p> </li> <li> <p>high risk of bias (open random allocation; unsealed or non‐opaque envelopes, alternation; date of birth); </p> </li> <li> <p>unclear risk of bias.   </p> </li> </ul> </p> </section> <section id="CD007950-sec-0065"> <h5 class="title">(3.1) Blinding of participants and personnel (checking for possible performance)</h5> <p>We described for each included study the methods used, if any, to blind study participants and personnel from knowledge of which intervention a participant received. For this type of intervention, where different regimens were compared, it would be theoretically possible to blind study participants and staff by providing both active and placebo tablets to women allocated to intermittent regimens and placebo tablets to women in no supplementation arms of trials. </p> <p>Blinding was assessed separately for different outcomes or classes of outcomes and we have noted where there was partial blinding. We assessed the methods as: </p> <p> <ul id="CD007950-list-0009"> <li> <p>low, high or unclear risk of bias for participants;</p> </li> <li> <p>low, high or unclear risk of bias for personnel.</p> </li> </ul> </p> </section> <section id="CD007950-sec-0066"> <h5 class="title">(3.2) Blinding of outcome assessment (checking for possible detection bias)</h5> <p>We described for each included study the methods used, if any, to blind outcome assessors from knowledge of which intervention a participant received. We assessed blinding separately for different outcomes or classes of outcomes. </p> <p>We assessed the methods used to blind outcome assessment as:</p> <p> <ul id="CD007950-list-0010"> <li> <p>low, high or unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD007950-sec-0067"> <h5 class="title">(4) Incomplete outcome data (checking for possible attrition bias through withdrawals, dropouts, protocol deviations) </h5> <p>We assessed losses to follow‐up and post‐randomisation exclusions systematically for each trial. We described for each included study, and for each outcome or class of outcomes, the completeness of data including attrition and exclusions from the analysis. </p> <p>We noted whether attrition and exclusions were reported, the numbers included in the analysis at each stage (compared with the total randomised participants), reasons for attrition or exclusion where reported, and whether missing data were balanced across groups or were related to outcomes. </p> <p>We assessed the methods as:</p> <p> <ul id="CD007950-list-0011"> <li> <p>low risk of bias;</p> </li> <li> <p>high risk of bias;</p> </li> <li> <p>unclear.</p> </li> </ul> </p> <p>We considered follow‐up to be adequate if more than 80% of participants initially randomised in a trial were included in the analysis and any loss was balanced across groups, unclear if the percentage of initially randomised participants included in the analysis was unclear, and inadequate if less than 80% of those initially randomised were included in the analysis, or if loss was imbalanced in different treatment groups. </p> </section> <section id="CD007950-sec-0068"> <h5 class="title">(5) Selective reporting bias</h5> <p>We described for each included study how we investigated the possibility of selective outcome reporting bias and what we found. </p> <p>We assessed the methods as:</p> <p> <ul id="CD007950-list-0012"> <li> <p>low risk of bias (where it is clear that all of the study’s pre‐specified outcomes and all expected outcomes of interest to the review have been reported); </p> </li> <li> <p>high risk of bias inadequate (where not all the study’s pre‐specified outcomes have been reported; one or more reported primary outcomes were not pre‐specified; outcomes of interest are reported incompletely and so cannot be used; study failed to include results of a key outcome that would have been expected to have been reported); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD007950-sec-0069"> <h5 class="title">(6) Other sources of bias</h5> <p>We assessed whether each study was free of other problems that could put it at risk of bias. We have noted for each included study any important concerns we had about other possible sources of bias. </p> <p>We assessed whether each study was free of other problems that could put it at risk of bias: </p> <p> <ul id="CD007950-list-0013"> <li> <p>low risk of further bias;</p> </li> <li> <p>high risk of further bias;</p> </li> <li> <p>unclear whether there is a risk of further bias.</p> </li> </ul> </p> </section> <section id="CD007950-sec-0070"> <h5 class="title">(7) Overall risk of bias</h5> <p>We assessed the overall risk of bias at two levels: within studies (within domains) and across studies. We have made explicit judgements about whether studies were at high risk of bias, according to the criteria given in the <i>Handbook</i> (<a href="./references#CD007950-bbs2-0112" title="HigginsJPT , GreenS , editors. Review Manager (RevMan). Cochrane Handbook for Systematic Reviews of Interventions. 5.1.0 [updated March 2011]. Available from www.cochrane‐handbook.org: The Cochrane Collaboration, 2011. ">Higgins 2011</a>) and for primary outcomes, we explored the impact of the level of bias through undertaking sensitivity analyses ‐ <i>see</i><a href="#CD007950-sec-0084">Sensitivity analysis</a>. </p> </section> <section id="CD007950-sec-0071"> <h5 class="title">Assessment of the quality of evidence using GRADE</h5> <p>For the assessment across studies, we employed the GRADE approach as outlined in the <a href="http://gdt.guidelinedevelopment.org/central_prod/_design/client/handbook/handbook.html" target="_blank">GRADE Handbook</a> and used the <a href="http://www.gradepro.org/" target="_blank">GRADEpro</a> Guideline Development Tool to import data from Review Manager 5.3 (<a href="./references#CD007950-bbs2-0144" title="The Nordic Cochrane Centre. Review Manager (RevMan). 5.3. Copenhagen: The Cochrane Collaboration, 2014. ">RevMan 2014</a>) to create 'Summary of findings' (SoF) tables (set out in <a href="./full#CD007950-tbl-0001">summary of findings Table for the main comparison</a>; <a href="./full#CD007950-tbl-0002">summary of findings Table 2</a>). The primary neonatal and maternal outcomes for the main comparison have been listed with estimates of relative effects along with the number of participants and studies contributing data for those outcomes. These tables provide outcome‐specific information concerning the overall quality of evidence from studies included in the comparison, the magnitude of effect of the interventions examined, and the sum of available data on the outcomes we considered. We only included primary outcomes in the 'Summary of findings' tables. For each individual outcome, two review authors independently assessed the quality of the evidence using the GRADE approach (<a href="./references#CD007950-bbs2-0073" title="BalshemH , HelfandM , SchünemannHJ , OxmanAD , KunzR , BrozekJ , et al. GRADE guidelines: Rating the quality of evidence. Journal of Clinical  Epidemiology2011;64(4):401‐6. ">Balshem 2010</a>). </p> <p>For assessments of the overall quality of evidence for each outcome that included pooled data from included trials, we downgraded the evidence from 'high quality' by one level for serious (or by two for very serious) study limitations (risk of bias), indirectness of evidence, serious inconsistency, imprecision of effect estimates or potential publication bias. This assessment was limited only to the trials included in this review and, as we did not consider there was a serious risk of indirectness or publication bias, we did not downgrade in these domains. </p> </section> </section> <section id="CD007950-sec-0072"> <h4 class="title">Measures of treatment effect</h4> <section id="CD007950-sec-0073"> <h5 class="title">Dichotomous data</h5> <p>We presented results as average risk ratio (RR) with 95% confidence intervals (CI). </p> </section> <section id="CD007950-sec-0074"> <h5 class="title">Continuous data</h5> <p>No continuous data were analysed in this update. In future updates, if appropriate, we will use the mean difference (MD) with 95% CIs if outcomes are measured in the same way between trials. We will use the standardised mean difference (SMD) to combine trials that measure the same outcome (e.g. serum folate concentration) but use different methods. </p> </section> </section> <section id="CD007950-sec-0075"> <h4 class="title">Unit of analysis issues</h4> <section id="CD007950-sec-0076"> <h5 class="title">Cluster‐randomised trials</h5> <p>We planned to include cluster‐randomised trials in the analyses along with individually‐randomised trials. If in future updates of this review we identify any such trials, we will adjust the standard error of the effect estimate from cluster trials using the methods described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD007950-bbs2-0112" title="HigginsJPT , GreenS , editors. Review Manager (RevMan). Cochrane Handbook for Systematic Reviews of Interventions. 5.1.0 [updated March 2011]. Available from www.cochrane‐handbook.org: The Cochrane Collaboration, 2011. ">Higgins 2011</a>). Meta‐analyses will be carried out using the generic inverse‐variance method available in RevMan (<a href="./references#CD007950-bbs2-0144" title="The Nordic Cochrane Centre. Review Manager (RevMan). 5.3. Copenhagen: The Cochrane Collaboration, 2014. ">RevMan 2014</a>). We will use an estimate of the intra cluster correlation co‐efficient (ICC) derived from the trial (if possible), or from another source. If ICCs from other sources are used, we will report this and conduct sensitivity analyses to investigate the effect of variation in the ICC. If we identify both cluster‐randomised trials and individually‐randomised trials, we plan to synthesise the relevant information. We will consider it reasonable to combine the results from both if there is little heterogeneity between the study designs, and the interaction between the effect of intervention and the choice of randomisation unit is considered to be unlikely. </p> <p>We will also acknowledge heterogeneity in the randomisation unit and perform a separate meta‐analysis. </p> </section> <section id="CD007950-sec-0077"> <h5 class="title">Cross‐over trials</h5> <p>Cross‐over trials are not an appropriate study design for the interventions considered in this review and have been excluded. </p> </section> <section id="CD007950-sec-0078"> <h5 class="title">Studies with more than two treatment groups</h5> <p>For studies with more than two intervention groups (multi‐arm studies), we included the directly relevant arm only. When we identified studies with various relevant arms, we combined groups to create a single pair‐wise comparison (<a href="./references#CD007950-bbs2-0112" title="HigginsJPT , GreenS , editors. Review Manager (RevMan). Cochrane Handbook for Systematic Reviews of Interventions. 5.1.0 [updated March 2011]. Available from www.cochrane‐handbook.org: The Cochrane Collaboration, 2011. ">Higgins 2011</a>) and included the disaggregated data in the corresponding subgroup category. </p> </section> </section> <section id="CD007950-sec-0079"> <h4 class="title">Dealing with missing data</h4> <p>For included studies, we noted levels of attrition. We explored the impact of including studies with high levels of missing data in the overall assessment of treatment effect by using sensitivity analysis. </p> <p>We planned to carry out analyses, as far as possible, on an intention‐to‐treat (ITT) basis, i.e. by attempting to include all participants randomised to each group in the analyses, so the denominator for each outcome in each trial would be the number randomised minus any participants whose outcomes are known to be missing. In those studies where women were recruited before conception for outcomes relating to pregnancy, we have taken a pragmatic approach and included in the denominators only those women known to become pregnant (for maternal outcomes) and the number of informative pregnancies (for neonatal outcomes). </p> </section> <section id="CD007950-sec-0080"> <h4 class="title">Assessment of heterogeneity</h4> <p>We examined the forest plots from meta‐analysis and the risk of bias to look for methodological heterogeneity among studies, and used the I² and Tau² statistics to quantify the level of heterogeneity among the trials in each analysis. Where we identified substantial heterogeneity (an I² greater than approximately 50%), we noted this in the text and explored it by pre‐specified subgroup analysis. We would advise caution in the interpretation of those results where there are high levels of unexplained heterogeneity. </p> </section> <section id="CD007950-sec-0081"> <h4 class="title">Assessment of reporting biases</h4> <p>Where we suspected reporting bias (<i>see</i><a href="#CD007950-sec-0106">Selective reporting (reporting bias)</a> above), we attempted to contact study authors, to ask them to provide missing outcome data. We have not explored possible publication bias by producing funnel plots as too few studies contributed data to the review. In future updates, if there are 10 or more studies in the meta‐analysis, we will investigate reporting biases (such as publication bias) using funnel plots. We will assess funnel plot asymmetry visually. If asymmetry is suggested by a visual assessment, we will perform exploratory analyses to investigate it. </p> </section> <section id="CD007950-sec-0082"> <h4 class="title">Data synthesis</h4> <p>We carried out statistical analysis using the Review Manager software (<a href="./references#CD007950-bbs2-0144" title="The Nordic Cochrane Centre. Review Manager (RevMan). 5.3. Copenhagen: The Cochrane Collaboration, 2014. ">RevMan 2014</a>). </p> <p>Because of our experience in conducting other reviews in this area, we anticipated high heterogeneity amongst trials and we pooled trial results using a random‐effects model and were cautious in our interpretation of the pooled results. We have indicated in the text that the random‐effects model gives the average treatment effect. For statistically significant results where there are high levels of heterogeneity ((an I² greater than 50%), we have given the values of I², Tau² and the P value of the Chi² test for heterogeneity and have provided an estimate of the 95% range of underlying intervention effects (prediction interval (PI)). </p> </section> <section id="CD007950-sec-0083"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>Where data were available we had planned to carry out subgroup analysis for primary outcomes: </p> <p> <ol id="CD007950-list-0014"> <li> <p>by scheme: daily supplementation; or intermittent supplementation;</p> </li> <li> <p>by daily dose: 400 µg/d (0.4 mg/d) or less of folic acid; more than 400 µg (0.4 mg) folic acid per day; </p> </li> <li> <p>by timing of supplementation: before pregnancy; during first trimester only; periconceptional period; </p> </li> <li> <p>by history of a pregnancy affected by a neural tube defect (recurrence): yes; no; or unknown/unreported/mixed; </p> </li> <li> <p>by folate compound: folic acid; 5MTHF; other compound; or unknown/unreported/mixed;</p> </li> <li> <p>by micronutrient composition: folate alone; folate + iron; folate + other micronutrient (except iron); or folate + multiple micronutrients; </p> </li> <li> <p>by malaria setting at the time of the study: yes; no; or unknown/unreported/mixed.</p> </li> </ol> </p> <p>We planned to assess subgroup differences by interaction tests available within RevMan (<a href="./references#CD007950-bbs2-0144" title="The Nordic Cochrane Centre. Review Manager (RevMan). 5.3. Copenhagen: The Cochrane Collaboration, 2014. ">RevMan 2014</a>) and to report the results of subgroup analyses quoting the Chi² statistic and P value, and the interaction test I² value. </p> </section> <section id="CD007950-sec-0084"> <h4 class="title">Sensitivity analysis</h4> <p>We considered a study to be of high quality if it was assessed as low risk of bias in both the randomisation and allocation concealment and in either blinding or loss to follow‐up. We planned to conduct a sensitivity analysis by quality of the study but it was not possible as only one study was considered to be of high quality (<a href="./references#CD007950-bbs2-0003" title="KirkePN , DalyLE , ElwoodJH . A randomized trial of low dose folic acid to prevent neural tube defects. Archives of Disease in Childhood1992;67:1442‐6. ">Kirke 1992</a>). </p> <p>If, in future updates of the review, if cluster‐randomised trials are included, we will carry out sensitivity analysis using a range of intra cluster correlation (ICC) values. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD007950-sec-0085" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD007950-sec-0085"></div> <section id="CD007950-sec-0086"> <h3 class="title">Description of studies</h3> <section id="CD007950-sec-0087"> <h4 class="title">Results of the search</h4> <p>See: <a href="#CD007950-fig-0001">Figure 1</a> </p> <div class="figure" id="CD007950-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD007950-fig-0001" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> <p>The updated search retrieved 31 new reports to assess. Two were duplicates. Twenty‐five of these reports were excluded, 11 of which were additional reports of already excluded trials. We also identified four <a href="./references#CD007950-bbs1-0003" title="">Ongoing studies</a>. Additionally, we deleted two exact duplicate references: one from an included study (<a href="./references#CD007950-bbs2-0001" title="CzeizelA , FritzG . Randomized trial of periconceptional vitamins. JAMA1989;262:1634. CzeizelA , RodeK . Trial to prevent first occurrence of neural tube defects by periconceptional multivitamin supplementation. Lancet1984;2(8393):40. CzeizelAE . Controlled studies of multivitamin supplementation on pregnancy outcomes. Annals of the New York Academy of Sciences1993;678:266‐75. CzeizelAE . Limb‐reduction defects and folic acid supplementation. Lancet1995;345(8954):932. CzeizelAE . Nutritional supplementation and prevention of congenital abnormalities. Current Opinion in Obstetrics &amp; Gynecology1995;7(2):88‐94. CzeizelAE . Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ1993;306:1645‐8. CzeizelAE . Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. American Journal of Medical Genetics1996;62(2):179‐83. CzeizelAE , DoboM . Postnatal somatic and mental development after periconceptional multivitamin supplementation. Archives of Disease in Childhood1994;70(3):229‐33. CzeizelAE , DudasI . Prevention of the first occurrence of neural‐tube defects by periconceptional vitamin supplementation. New England Journal of Medicine1992;327:1832‐5. CzeizelAE , DudasI , FritzG , TecsoiA , HanckA , KunovitsG . The effect of periconceptional multivitamin‐mineral supplementation on vertigo, nausea and vomiting in the first trimester of pregnancy. Archives of Gynecology and Obstetrics1992;251:181‐5. CzeizelAE , DudasI , MetnekiJ . Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Archives of Gynecology and Obstetrics1994;255:131‐9. CzeizelAE , MedveczkyE . Periconceptional multivitamin supplementation and multimalformed offspring. Obstetrics &amp; Gynecology2003;102:1255‐61. CzeizelAE , MetnekiJ , DudasI . Higher rate of multiple births after periconceptional vitamin supplementation. New England Journal of Medicine1994;330(23):1687‐8. CzeizelAE , MetnekiJ , DudasI . The effect of preconceptional multivitamin supplementation on fertility. International Journal for Vitamin and Nutrition Research1996;66:55‐8. CzeizelAE , MetnekiJ , DudasI . The higher rate of multiple births after periconceptional multivitamin supplementation: an analysis of causes. Acta Geneticae Medicae et Gemellologiae1994;43:175‐84. CzeizelAE , RockenbauerM , SusanskyE . No change in sexual activity during preconceptional multivitamin supplementation. British Journal of Obstetrics and Gynaecology1996;103:569‐73. CzeizelAE , VarghaP . Periconceptional folic acid/multivitamin supplementation and twin pregnancy. American Journal of Obstetrics and Gynecology2004;191(3):790‐4. CzeizelE , DudasI . Prevention of the first occurrence of anencephaly and spina bifida with periconceptional multivitamin supplementation (conclusion). Orvosi Hetilap1994;135(42):2313‐7. DoboM , CzeizelAE . Long‐term somatic and mental development of children after periconceptional multivitamin supplementation. European Journal of Pediatrics1998;157:719‐23. DudasI , RockenbauerM , CzeizelAE . The effect of preconceptional multivitamin supplementation on the menstrual cycle. Archives of Gynecology and Obstetrics1995;256(3):115‐23. MetnekiJ , DudasI , CzeizelAE . Higher rate of multiple births after periconceptual multivitamin supplementation. Orvosi Hetilap1996;137(43):2401‐5. ">Czeizel 1994</a>), and one from an excluded study (<a href="./references#CD007950-bbs2-0016" title="ChristianP . Personal communication 28 September 2007. ChristianP , DarmstadtGL , WuL , KhatrySK , LeClerqSC , KatzJ , et al. The effect of maternal micronutrient supplementation on early neonatal morbidity in rural Nepal: a randomised, controlled, community trial. Archives of Disease in Childhood2008;93(8):660‐4. ChristianP , JiangT , KhatrySK , LeClerqSC , ShresthaSR , WestKPJr . Antenatal supplementation with micronutrients and biochemical indicators of status and subclinical infection in rural Nepal. American Journal of Clinical Nutrition2006;83(4):788‐94. ChristianP , KhatrySK , KatzJ , PradhanEK , LeClerqSC , ShresthaSR , et al. Effects of alternative maternal micronutrient supplements on low birth weight in rural Nepal: double blind randomised community trial. BMJ2003;326(7389):571. ChristianP , KhatrySK , LeClerqSC , DaliSM . Effects of prenatal micronutrient supplementation on complications of labor and delivery and puerperal morbidity in rural Nepal. International Journal of Gynecology &amp; Obstetrics2009;106(1):3‐7. ChristianP , Murray‐KolbLE , KhatrySK , KatzJ , SchaeferBA , ColePM , et al. Prenatal micronutrient supplementation and intellectual and motor function in early school‐aged children in Nepal. JAMA2010;304(24):2716‐23. ChristianP , ShresthaJ , LeClerqSC , KhatrySK , JiangT , WagnerT , et al. Supplementation with micronutrients in addition to iron and folic acid does not further improve the hematologic status of pregnant women in rural Nepal. Journal of Nutrition2003;133(11):3492‐8. ChristianP , StewartCP , LeClerqSC , WuL , KatzJ , WestKPJr , et al. Antenatal and postnatal iron supplementation and childhood mortality in rural Nepal: a prospective follow‐up in a randomized, controlled community trial. American Journal of Epidemiology2009;170(9):1127‐36. ChristianP , WestKP , KhatrySK , LeclerqSC , PradhanEK , KatzJ , et al. Effects of maternal micronutrient supplementation on fetal loss and infant mortality: a cluster‐randomized trial in Nepal. American Journal of Clinical Nutrition2003;78(6):1194‐202. ChristianPS , DarmstadtGL , WuL , KhatrySK , LeclerqSC , KatzJ , et al. The impact of maternal micronutrient supplementation on early neonatal morbidity in rural Nepal: a randomized, controlled, community trial. Archives of Disease in Childhood. Fetal and Neonatal Edition (http://fn.bmj.com/content/early/2007/08/03/adc.2006.114009.full.pdf+html)(accessed August 2007). [DOI: 10.1136/adc.2006.114009] KatzJ , ChristianP , DominiciF , ZegerSL . Treatment effects of maternal micronutrient supplementation vary by percentiles of the birth weight distribution in rural Nepal. Journal of Nutrition2006;136(5):1389‐94. KulkarniB , ChristianP , LeClerqSC , KhatrySK . Determinants of compliance to antenatal micronutrient supplementation and women's perceptions of supplement use in rural Nepal. Public Health Nutrition2010;13(1):82‐90. StewartCP , ChristianP , LeClerqSC , WestKPJr , KhatrySK . Antenatal supplementation with folic acid + iron + zinc improves linear growth and reduces peripheral adiposity in school‐age children in rural Nepal. American Journal of Clinical Nutrition2009;90(1):132‐40. StewartCP , ChristianP , SchulzeKJ , ArguelloM , LeclerqSC , KhatrySK , et al. Low maternal vitamin B‐12 status is associated with offspring insulin resistance regardless of antenatal micronutrient supplementation in rural Nepal. Journal of Nutrition2011;141(10):1912‐7. StewartCP , ChristianP , SchulzeKJ , LeclerqSC , WestKPJr , KhatrySK . Antenatal micronutrient supplementation reduces metabolic syndrome in 6‐ to 8‐year‐old children in rural Nepal. Journal of Nutrition2009;139(8):1575‐81. StewartCP , KatzJ , KhatrySK , LeClerqSC , ShresthaSR , WestKPJr , et al. Preterm delivery but not intrauterine growth retardation is associated with young maternal age among primiparae in rural Nepal. Maternal &amp; Child Nutrition2007;3(3):174‐85. ">Christian 2003</a>). </p> <p>Five trials (30 references) were included and four trials are still ongoing and results are expected in 2015 (see <a href="#CD007950-fig-0001">Figure 1</a> and <a href="./references#CD007950-sec-0215" title="">Characteristics of ongoing studies</a> for details). </p> </section> <section id="CD007950-sec-0088"> <h4 class="title">Included studies</h4> <p>We included five trials involving 7391 women in the review, all of which met the pre‐stated inclusion criteria. Most of the studies focused on infant outcomes and few of the results reported related to the maternal outcomes we had pre‐specified in the protocol. All of the studies that we included were published before 2001. Sample sizes varied among trials. </p> <section id="CD007950-sec-0089"> <h5 class="title">Settings</h5> <p>Four studies had study participants from high‐income countries: Wales (<a href="./references#CD007950-bbs2-0004" title="LaurenceKM . Prevention of neural tube defects by improvement in maternal diet and preconceptional folic acid supplementation. Progress in Clinical and Biological Research1985;163:383‐8. LaurenceKM . The role of maternal nutrition and folic acid therapy before conception to prevent neural tube defects [Die Rolle der mütterlichen Ernährung und Folinsaure‐Therapie vor der Empfangnis zur Verhutung von Nervenkanal‐Defekten]. Monatsschrift fur Kinderheilkunde1982;130:646. LaurenceKM , CampbellH , JamesNE . The role of improvement in the maternal diet and preconceptional folic acid supplementation in the prevention of neural tube defects. Prevention of spina bifida and other neural tube defects. Academic Press, 1983:85‐125. LaurenceKM , JamesN , MillerM , CampbellH , TennantGB . A double randomised controlled trial for preconceptional folic acid supplementation for the prevention of recurrence of neural tube defects in high risk pregnancies. Journal of Medical Genetics1982;19(1):66. LaurenceKM , JamesN , MillerMH , TennantGB , CampbellH . Double blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural tube defects. BMJ (Clinical Research Edition)1981;282:1509‐11. ">Laurence 1981</a>), Australia, Canada, France, Hungary, Israel, Russia and the UK (<a href="./references#CD007950-bbs2-0005" title="Anon . Folate supplements prevent recurrence of neural tube defects. Nutrition Review1992;50(Suppl 1):22‐4. Anon . Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet1991;338(8760):131‐7. ">MRC 1991</a>), Ireland (<a href="./references#CD007950-bbs2-0003" title="KirkePN , DalyLE , ElwoodJH . A randomized trial of low dose folic acid to prevent neural tube defects. Archives of Disease in Childhood1992;67:1442‐6. ">Kirke 1992</a>). Hungary (<a href="./references#CD007950-bbs2-0001" title="CzeizelA , FritzG . Randomized trial of periconceptional vitamins. JAMA1989;262:1634. CzeizelA , RodeK . Trial to prevent first occurrence of neural tube defects by periconceptional multivitamin supplementation. Lancet1984;2(8393):40. CzeizelAE . Controlled studies of multivitamin supplementation on pregnancy outcomes. Annals of the New York Academy of Sciences1993;678:266‐75. CzeizelAE . Limb‐reduction defects and folic acid supplementation. Lancet1995;345(8954):932. CzeizelAE . Nutritional supplementation and prevention of congenital abnormalities. Current Opinion in Obstetrics &amp; Gynecology1995;7(2):88‐94. CzeizelAE . Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ1993;306:1645‐8. CzeizelAE . Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. American Journal of Medical Genetics1996;62(2):179‐83. CzeizelAE , DoboM . Postnatal somatic and mental development after periconceptional multivitamin supplementation. Archives of Disease in Childhood1994;70(3):229‐33. CzeizelAE , DudasI . Prevention of the first occurrence of neural‐tube defects by periconceptional vitamin supplementation. New England Journal of Medicine1992;327:1832‐5. CzeizelAE , DudasI , FritzG , TecsoiA , HanckA , KunovitsG . The effect of periconceptional multivitamin‐mineral supplementation on vertigo, nausea and vomiting in the first trimester of pregnancy. Archives of Gynecology and Obstetrics1992;251:181‐5. CzeizelAE , DudasI , MetnekiJ . Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Archives of Gynecology and Obstetrics1994;255:131‐9. CzeizelAE , MedveczkyE . Periconceptional multivitamin supplementation and multimalformed offspring. Obstetrics &amp; Gynecology2003;102:1255‐61. CzeizelAE , MetnekiJ , DudasI . Higher rate of multiple births after periconceptional vitamin supplementation. New England Journal of Medicine1994;330(23):1687‐8. CzeizelAE , MetnekiJ , DudasI . The effect of preconceptional multivitamin supplementation on fertility. International Journal for Vitamin and Nutrition Research1996;66:55‐8. CzeizelAE , MetnekiJ , DudasI . The higher rate of multiple births after periconceptional multivitamin supplementation: an analysis of causes. Acta Geneticae Medicae et Gemellologiae1994;43:175‐84. CzeizelAE , RockenbauerM , SusanskyE . No change in sexual activity during preconceptional multivitamin supplementation. British Journal of Obstetrics and Gynaecology1996;103:569‐73. CzeizelAE , VarghaP . Periconceptional folic acid/multivitamin supplementation and twin pregnancy. American Journal of Obstetrics and Gynecology2004;191(3):790‐4. CzeizelE , DudasI . Prevention of the first occurrence of anencephaly and spina bifida with periconceptional multivitamin supplementation (conclusion). Orvosi Hetilap1994;135(42):2313‐7. DoboM , CzeizelAE . Long‐term somatic and mental development of children after periconceptional multivitamin supplementation. European Journal of Pediatrics1998;157:719‐23. DudasI , RockenbauerM , CzeizelAE . The effect of preconceptional multivitamin supplementation on the menstrual cycle. Archives of Gynecology and Obstetrics1995;256(3):115‐23. MetnekiJ , DudasI , CzeizelAE . Higher rate of multiple births after periconceptual multivitamin supplementation. Orvosi Hetilap1996;137(43):2401‐5. ">Czeizel 1994</a>). One study had study participants from a lower middle‐income country: India (<a href="./references#CD007950-bbs2-0002" title="Indian Council of Medical Research (ICMR) Collaborating Centres, Central Technical Co‐ordinatingUnit . Multicentric study of efficacy of periconceptional folic acid containing vitamin supplementation in prevention of open neural tube defects from India. Indian Journal of Medical Research2000;112:206‐11. ">ICMR 2000</a>). </p> <p>None of the studies reported on malaria incidence or testing at any point during the study, though the locations of the studies make it very unlikely that malaria was a significant issue. </p> </section> <section id="CD007950-sec-0090"> <h5 class="title">Participants</h5> <section id="CD007950-sec-0091"> <h6 class="title">History of pregnancy with neural tube defects</h6> <p>Four trials evaluated neural tube defects (NTD) recurrence (n = 2033) (<a href="./references#CD007950-bbs2-0002" title="Indian Council of Medical Research (ICMR) Collaborating Centres, Central Technical Co‐ordinatingUnit . Multicentric study of efficacy of periconceptional folic acid containing vitamin supplementation in prevention of open neural tube defects from India. Indian Journal of Medical Research2000;112:206‐11. ">ICMR 2000</a>; <a href="./references#CD007950-bbs2-0003" title="KirkePN , DalyLE , ElwoodJH . A randomized trial of low dose folic acid to prevent neural tube defects. Archives of Disease in Childhood1992;67:1442‐6. ">Kirke 1992</a>; <a href="./references#CD007950-bbs2-0004" title="LaurenceKM . Prevention of neural tube defects by improvement in maternal diet and preconceptional folic acid supplementation. Progress in Clinical and Biological Research1985;163:383‐8. LaurenceKM . The role of maternal nutrition and folic acid therapy before conception to prevent neural tube defects [Die Rolle der mütterlichen Ernährung und Folinsaure‐Therapie vor der Empfangnis zur Verhutung von Nervenkanal‐Defekten]. Monatsschrift fur Kinderheilkunde1982;130:646. LaurenceKM , CampbellH , JamesNE . The role of improvement in the maternal diet and preconceptional folic acid supplementation in the prevention of neural tube defects. Prevention of spina bifida and other neural tube defects. Academic Press, 1983:85‐125. LaurenceKM , JamesN , MillerM , CampbellH , TennantGB . A double randomised controlled trial for preconceptional folic acid supplementation for the prevention of recurrence of neural tube defects in high risk pregnancies. Journal of Medical Genetics1982;19(1):66. LaurenceKM , JamesN , MillerMH , TennantGB , CampbellH . Double blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural tube defects. BMJ (Clinical Research Edition)1981;282:1509‐11. ">Laurence 1981</a>; <a href="./references#CD007950-bbs2-0005" title="Anon . Folate supplements prevent recurrence of neural tube defects. Nutrition Review1992;50(Suppl 1):22‐4. Anon . Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet1991;338(8760):131‐7. ">MRC 1991</a>), and only one evaluated first‐time NTD occurrence (n = 5358) (<a href="./references#CD007950-bbs2-0001" title="CzeizelA , FritzG . Randomized trial of periconceptional vitamins. JAMA1989;262:1634. CzeizelA , RodeK . Trial to prevent first occurrence of neural tube defects by periconceptional multivitamin supplementation. Lancet1984;2(8393):40. CzeizelAE . Controlled studies of multivitamin supplementation on pregnancy outcomes. Annals of the New York Academy of Sciences1993;678:266‐75. CzeizelAE . Limb‐reduction defects and folic acid supplementation. Lancet1995;345(8954):932. CzeizelAE . Nutritional supplementation and prevention of congenital abnormalities. Current Opinion in Obstetrics &amp; Gynecology1995;7(2):88‐94. CzeizelAE . Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ1993;306:1645‐8. CzeizelAE . Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. American Journal of Medical Genetics1996;62(2):179‐83. CzeizelAE , DoboM . Postnatal somatic and mental development after periconceptional multivitamin supplementation. Archives of Disease in Childhood1994;70(3):229‐33. CzeizelAE , DudasI . Prevention of the first occurrence of neural‐tube defects by periconceptional vitamin supplementation. New England Journal of Medicine1992;327:1832‐5. CzeizelAE , DudasI , FritzG , TecsoiA , HanckA , KunovitsG . The effect of periconceptional multivitamin‐mineral supplementation on vertigo, nausea and vomiting in the first trimester of pregnancy. Archives of Gynecology and Obstetrics1992;251:181‐5. CzeizelAE , DudasI , MetnekiJ . Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Archives of Gynecology and Obstetrics1994;255:131‐9. CzeizelAE , MedveczkyE . Periconceptional multivitamin supplementation and multimalformed offspring. Obstetrics &amp; Gynecology2003;102:1255‐61. CzeizelAE , MetnekiJ , DudasI . Higher rate of multiple births after periconceptional vitamin supplementation. New England Journal of Medicine1994;330(23):1687‐8. CzeizelAE , MetnekiJ , DudasI . The effect of preconceptional multivitamin supplementation on fertility. International Journal for Vitamin and Nutrition Research1996;66:55‐8. CzeizelAE , MetnekiJ , DudasI . The higher rate of multiple births after periconceptional multivitamin supplementation: an analysis of causes. Acta Geneticae Medicae et Gemellologiae1994;43:175‐84. CzeizelAE , RockenbauerM , SusanskyE . No change in sexual activity during preconceptional multivitamin supplementation. British Journal of Obstetrics and Gynaecology1996;103:569‐73. CzeizelAE , VarghaP . Periconceptional folic acid/multivitamin supplementation and twin pregnancy. American Journal of Obstetrics and Gynecology2004;191(3):790‐4. CzeizelE , DudasI . Prevention of the first occurrence of anencephaly and spina bifida with periconceptional multivitamin supplementation (conclusion). Orvosi Hetilap1994;135(42):2313‐7. DoboM , CzeizelAE . Long‐term somatic and mental development of children after periconceptional multivitamin supplementation. European Journal of Pediatrics1998;157:719‐23. DudasI , RockenbauerM , CzeizelAE . The effect of preconceptional multivitamin supplementation on the menstrual cycle. Archives of Gynecology and Obstetrics1995;256(3):115‐23. MetnekiJ , DudasI , CzeizelAE . Higher rate of multiple births after periconceptual multivitamin supplementation. Orvosi Hetilap1996;137(43):2401‐5. ">Czeizel 1994</a>). </p> </section> </section> <section id="CD007950-sec-0092"> <h5 class="title">Interventions</h5> <section id="CD007950-sec-0093"> <h6 class="title">Micronutrient composition</h6> <p>One study used folate alone (<a href="./references#CD007950-bbs2-0004" title="LaurenceKM . Prevention of neural tube defects by improvement in maternal diet and preconceptional folic acid supplementation. Progress in Clinical and Biological Research1985;163:383‐8. LaurenceKM . The role of maternal nutrition and folic acid therapy before conception to prevent neural tube defects [Die Rolle der mütterlichen Ernährung und Folinsaure‐Therapie vor der Empfangnis zur Verhutung von Nervenkanal‐Defekten]. Monatsschrift fur Kinderheilkunde1982;130:646. LaurenceKM , CampbellH , JamesNE . The role of improvement in the maternal diet and preconceptional folic acid supplementation in the prevention of neural tube defects. Prevention of spina bifida and other neural tube defects. Academic Press, 1983:85‐125. LaurenceKM , JamesN , MillerM , CampbellH , TennantGB . A double randomised controlled trial for preconceptional folic acid supplementation for the prevention of recurrence of neural tube defects in high risk pregnancies. Journal of Medical Genetics1982;19(1):66. LaurenceKM , JamesN , MillerMH , TennantGB , CampbellH . Double blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural tube defects. BMJ (Clinical Research Edition)1981;282:1509‐11. ">Laurence 1981</a>); three studies used folate + multiple micronutrients (<a href="./references#CD007950-bbs2-0001" title="CzeizelA , FritzG . Randomized trial of periconceptional vitamins. JAMA1989;262:1634. CzeizelA , RodeK . Trial to prevent first occurrence of neural tube defects by periconceptional multivitamin supplementation. Lancet1984;2(8393):40. CzeizelAE . Controlled studies of multivitamin supplementation on pregnancy outcomes. Annals of the New York Academy of Sciences1993;678:266‐75. CzeizelAE . Limb‐reduction defects and folic acid supplementation. Lancet1995;345(8954):932. CzeizelAE . Nutritional supplementation and prevention of congenital abnormalities. Current Opinion in Obstetrics &amp; Gynecology1995;7(2):88‐94. CzeizelAE . Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ1993;306:1645‐8. CzeizelAE . Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. American Journal of Medical Genetics1996;62(2):179‐83. CzeizelAE , DoboM . Postnatal somatic and mental development after periconceptional multivitamin supplementation. Archives of Disease in Childhood1994;70(3):229‐33. CzeizelAE , DudasI . Prevention of the first occurrence of neural‐tube defects by periconceptional vitamin supplementation. New England Journal of Medicine1992;327:1832‐5. CzeizelAE , DudasI , FritzG , TecsoiA , HanckA , KunovitsG . The effect of periconceptional multivitamin‐mineral supplementation on vertigo, nausea and vomiting in the first trimester of pregnancy. Archives of Gynecology and Obstetrics1992;251:181‐5. CzeizelAE , DudasI , MetnekiJ . Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Archives of Gynecology and Obstetrics1994;255:131‐9. CzeizelAE , MedveczkyE . Periconceptional multivitamin supplementation and multimalformed offspring. Obstetrics &amp; Gynecology2003;102:1255‐61. CzeizelAE , MetnekiJ , DudasI . Higher rate of multiple births after periconceptional vitamin supplementation. New England Journal of Medicine1994;330(23):1687‐8. CzeizelAE , MetnekiJ , DudasI . The effect of preconceptional multivitamin supplementation on fertility. International Journal for Vitamin and Nutrition Research1996;66:55‐8. CzeizelAE , MetnekiJ , DudasI . The higher rate of multiple births after periconceptional multivitamin supplementation: an analysis of causes. Acta Geneticae Medicae et Gemellologiae1994;43:175‐84. CzeizelAE , RockenbauerM , SusanskyE . No change in sexual activity during preconceptional multivitamin supplementation. British Journal of Obstetrics and Gynaecology1996;103:569‐73. CzeizelAE , VarghaP . Periconceptional folic acid/multivitamin supplementation and twin pregnancy. American Journal of Obstetrics and Gynecology2004;191(3):790‐4. CzeizelE , DudasI . Prevention of the first occurrence of anencephaly and spina bifida with periconceptional multivitamin supplementation (conclusion). Orvosi Hetilap1994;135(42):2313‐7. DoboM , CzeizelAE . Long‐term somatic and mental development of children after periconceptional multivitamin supplementation. European Journal of Pediatrics1998;157:719‐23. DudasI , RockenbauerM , CzeizelAE . The effect of preconceptional multivitamin supplementation on the menstrual cycle. Archives of Gynecology and Obstetrics1995;256(3):115‐23. MetnekiJ , DudasI , CzeizelAE . Higher rate of multiple births after periconceptual multivitamin supplementation. Orvosi Hetilap1996;137(43):2401‐5. ">Czeizel 1994</a>; <a href="./references#CD007950-bbs2-0002" title="Indian Council of Medical Research (ICMR) Collaborating Centres, Central Technical Co‐ordinatingUnit . Multicentric study of efficacy of periconceptional folic acid containing vitamin supplementation in prevention of open neural tube defects from India. Indian Journal of Medical Research2000;112:206‐11. ">ICMR 2000</a>; <a href="./references#CD007950-bbs2-0005" title="Anon . Folate supplements prevent recurrence of neural tube defects. Nutrition Review1992;50(Suppl 1):22‐4. Anon . Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet1991;338(8760):131‐7. ">MRC 1991</a>); and one study used folate alone in one group and folate + multiple micronutrients in another group (<a href="./references#CD007950-bbs2-0003" title="KirkePN , DalyLE , ElwoodJH . A randomized trial of low dose folic acid to prevent neural tube defects. Archives of Disease in Childhood1992;67:1442‐6. ">Kirke 1992</a>). </p> </section> <section id="CD007950-sec-0094"> <h6 class="title">Dose of folic acid</h6> <p>In one trial, women received less than 400 µg (0.4 mg) of folic acid per day (<a href="./references#CD007950-bbs2-0003" title="KirkePN , DalyLE , ElwoodJH . A randomized trial of low dose folic acid to prevent neural tube defects. Archives of Disease in Childhood1992;67:1442‐6. ">Kirke 1992</a>), while in the remaining studies women consumed 800 µg (0.8 mg) (<a href="./references#CD007950-bbs2-0001" title="CzeizelA , FritzG . Randomized trial of periconceptional vitamins. JAMA1989;262:1634. CzeizelA , RodeK . Trial to prevent first occurrence of neural tube defects by periconceptional multivitamin supplementation. Lancet1984;2(8393):40. CzeizelAE . Controlled studies of multivitamin supplementation on pregnancy outcomes. Annals of the New York Academy of Sciences1993;678:266‐75. CzeizelAE . Limb‐reduction defects and folic acid supplementation. Lancet1995;345(8954):932. CzeizelAE . Nutritional supplementation and prevention of congenital abnormalities. Current Opinion in Obstetrics &amp; Gynecology1995;7(2):88‐94. CzeizelAE . Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ1993;306:1645‐8. CzeizelAE . Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. American Journal of Medical Genetics1996;62(2):179‐83. CzeizelAE , DoboM . Postnatal somatic and mental development after periconceptional multivitamin supplementation. Archives of Disease in Childhood1994;70(3):229‐33. CzeizelAE , DudasI . Prevention of the first occurrence of neural‐tube defects by periconceptional vitamin supplementation. New England Journal of Medicine1992;327:1832‐5. CzeizelAE , DudasI , FritzG , TecsoiA , HanckA , KunovitsG . The effect of periconceptional multivitamin‐mineral supplementation on vertigo, nausea and vomiting in the first trimester of pregnancy. Archives of Gynecology and Obstetrics1992;251:181‐5. CzeizelAE , DudasI , MetnekiJ . Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Archives of Gynecology and Obstetrics1994;255:131‐9. CzeizelAE , MedveczkyE . Periconceptional multivitamin supplementation and multimalformed offspring. Obstetrics &amp; Gynecology2003;102:1255‐61. CzeizelAE , MetnekiJ , DudasI . Higher rate of multiple births after periconceptional vitamin supplementation. New England Journal of Medicine1994;330(23):1687‐8. CzeizelAE , MetnekiJ , DudasI . The effect of preconceptional multivitamin supplementation on fertility. International Journal for Vitamin and Nutrition Research1996;66:55‐8. CzeizelAE , MetnekiJ , DudasI . The higher rate of multiple births after periconceptional multivitamin supplementation: an analysis of causes. Acta Geneticae Medicae et Gemellologiae1994;43:175‐84. CzeizelAE , RockenbauerM , SusanskyE . No change in sexual activity during preconceptional multivitamin supplementation. British Journal of Obstetrics and Gynaecology1996;103:569‐73. CzeizelAE , VarghaP . Periconceptional folic acid/multivitamin supplementation and twin pregnancy. American Journal of Obstetrics and Gynecology2004;191(3):790‐4. CzeizelE , DudasI . Prevention of the first occurrence of anencephaly and spina bifida with periconceptional multivitamin supplementation (conclusion). Orvosi Hetilap1994;135(42):2313‐7. DoboM , CzeizelAE . Long‐term somatic and mental development of children after periconceptional multivitamin supplementation. European Journal of Pediatrics1998;157:719‐23. DudasI , RockenbauerM , CzeizelAE . The effect of preconceptional multivitamin supplementation on the menstrual cycle. Archives of Gynecology and Obstetrics1995;256(3):115‐23. MetnekiJ , DudasI , CzeizelAE . Higher rate of multiple births after periconceptual multivitamin supplementation. Orvosi Hetilap1996;137(43):2401‐5. ">Czeizel 1994</a>); 2000 µg (2.0 mg) per day (<a href="./references#CD007950-bbs2-0004" title="LaurenceKM . Prevention of neural tube defects by improvement in maternal diet and preconceptional folic acid supplementation. Progress in Clinical and Biological Research1985;163:383‐8. LaurenceKM . The role of maternal nutrition and folic acid therapy before conception to prevent neural tube defects [Die Rolle der mütterlichen Ernährung und Folinsaure‐Therapie vor der Empfangnis zur Verhutung von Nervenkanal‐Defekten]. Monatsschrift fur Kinderheilkunde1982;130:646. LaurenceKM , CampbellH , JamesNE . The role of improvement in the maternal diet and preconceptional folic acid supplementation in the prevention of neural tube defects. Prevention of spina bifida and other neural tube defects. Academic Press, 1983:85‐125. LaurenceKM , JamesN , MillerM , CampbellH , TennantGB . A double randomised controlled trial for preconceptional folic acid supplementation for the prevention of recurrence of neural tube defects in high risk pregnancies. Journal of Medical Genetics1982;19(1):66. LaurenceKM , JamesN , MillerMH , TennantGB , CampbellH . Double blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural tube defects. BMJ (Clinical Research Edition)1981;282:1509‐11. ">Laurence 1981</a>) and 4000 µg (4.0 mg) per day (<a href="./references#CD007950-bbs2-0002" title="Indian Council of Medical Research (ICMR) Collaborating Centres, Central Technical Co‐ordinatingUnit . Multicentric study of efficacy of periconceptional folic acid containing vitamin supplementation in prevention of open neural tube defects from India. Indian Journal of Medical Research2000;112:206‐11. ">ICMR 2000</a>; <a href="./references#CD007950-bbs2-0005" title="Anon . Folate supplements prevent recurrence of neural tube defects. Nutrition Review1992;50(Suppl 1):22‐4. Anon . Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet1991;338(8760):131‐7. ">MRC 1991</a>). </p> </section> <section id="CD007950-sec-0095"> <h6 class="title">Folate compound</h6> <p>All studies used folic acid. We did not identify any randomised controlled trials which examined the use of 5‐MTHF. </p> </section> <section id="CD007950-sec-0096"> <h6 class="title">Regimen</h6> <p>In all studies, participants were supplemented daily. In one trial, supplements were divided into two equal doses (<a href="./references#CD007950-bbs2-0002" title="Indian Council of Medical Research (ICMR) Collaborating Centres, Central Technical Co‐ordinatingUnit . Multicentric study of efficacy of periconceptional folic acid containing vitamin supplementation in prevention of open neural tube defects from India. Indian Journal of Medical Research2000;112:206‐11. ">ICMR 2000</a>) and in another, the supplements were divided into three equal doses (<a href="./references#CD007950-bbs2-0003" title="KirkePN , DalyLE , ElwoodJH . A randomized trial of low dose folic acid to prevent neural tube defects. Archives of Disease in Childhood1992;67:1442‐6. ">Kirke 1992</a>). We did not identify any randomised controlled trials which examined intermittent supplementation. </p> </section> <section id="CD007950-sec-0097"> <h6 class="title">Timing of supplementation</h6> <p>All trials gave the supplements in the periconceptional period. In all trials women started supplementation before pregnancy and discontinued them after 12 weeks of pregnancy. </p> </section> <section id="CD007950-sec-0098"> <h6 class="title">Comparison group</h6> <p>There were three studies with two arms. One trial compared folic acid supplementation with a placebo group (<a href="./references#CD007950-bbs2-0004" title="LaurenceKM . Prevention of neural tube defects by improvement in maternal diet and preconceptional folic acid supplementation. Progress in Clinical and Biological Research1985;163:383‐8. LaurenceKM . The role of maternal nutrition and folic acid therapy before conception to prevent neural tube defects [Die Rolle der mütterlichen Ernährung und Folinsaure‐Therapie vor der Empfangnis zur Verhutung von Nervenkanal‐Defekten]. Monatsschrift fur Kinderheilkunde1982;130:646. LaurenceKM , CampbellH , JamesNE . The role of improvement in the maternal diet and preconceptional folic acid supplementation in the prevention of neural tube defects. Prevention of spina bifida and other neural tube defects. Academic Press, 1983:85‐125. LaurenceKM , JamesN , MillerM , CampbellH , TennantGB . A double randomised controlled trial for preconceptional folic acid supplementation for the prevention of recurrence of neural tube defects in high risk pregnancies. Journal of Medical Genetics1982;19(1):66. LaurenceKM , JamesN , MillerMH , TennantGB , CampbellH . Double blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural tube defects. BMJ (Clinical Research Edition)1981;282:1509‐11. ">Laurence 1981</a>). Two trials compared folic acid plus multiple micronutrients versus multiple micronutrients (<a href="./references#CD007950-bbs2-0001" title="CzeizelA , FritzG . Randomized trial of periconceptional vitamins. JAMA1989;262:1634. CzeizelA , RodeK . Trial to prevent first occurrence of neural tube defects by periconceptional multivitamin supplementation. Lancet1984;2(8393):40. CzeizelAE . Controlled studies of multivitamin supplementation on pregnancy outcomes. Annals of the New York Academy of Sciences1993;678:266‐75. CzeizelAE . Limb‐reduction defects and folic acid supplementation. Lancet1995;345(8954):932. CzeizelAE . Nutritional supplementation and prevention of congenital abnormalities. Current Opinion in Obstetrics &amp; Gynecology1995;7(2):88‐94. CzeizelAE . Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ1993;306:1645‐8. CzeizelAE . Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. American Journal of Medical Genetics1996;62(2):179‐83. CzeizelAE , DoboM . Postnatal somatic and mental development after periconceptional multivitamin supplementation. Archives of Disease in Childhood1994;70(3):229‐33. CzeizelAE , DudasI . Prevention of the first occurrence of neural‐tube defects by periconceptional vitamin supplementation. New England Journal of Medicine1992;327:1832‐5. CzeizelAE , DudasI , FritzG , TecsoiA , HanckA , KunovitsG . The effect of periconceptional multivitamin‐mineral supplementation on vertigo, nausea and vomiting in the first trimester of pregnancy. Archives of Gynecology and Obstetrics1992;251:181‐5. CzeizelAE , DudasI , MetnekiJ . Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Archives of Gynecology and Obstetrics1994;255:131‐9. CzeizelAE , MedveczkyE . Periconceptional multivitamin supplementation and multimalformed offspring. Obstetrics &amp; Gynecology2003;102:1255‐61. CzeizelAE , MetnekiJ , DudasI . Higher rate of multiple births after periconceptional vitamin supplementation. New England Journal of Medicine1994;330(23):1687‐8. CzeizelAE , MetnekiJ , DudasI . The effect of preconceptional multivitamin supplementation on fertility. International Journal for Vitamin and Nutrition Research1996;66:55‐8. CzeizelAE , MetnekiJ , DudasI . The higher rate of multiple births after periconceptional multivitamin supplementation: an analysis of causes. Acta Geneticae Medicae et Gemellologiae1994;43:175‐84. CzeizelAE , RockenbauerM , SusanskyE . No change in sexual activity during preconceptional multivitamin supplementation. British Journal of Obstetrics and Gynaecology1996;103:569‐73. CzeizelAE , VarghaP . Periconceptional folic acid/multivitamin supplementation and twin pregnancy. American Journal of Obstetrics and Gynecology2004;191(3):790‐4. CzeizelE , DudasI . Prevention of the first occurrence of anencephaly and spina bifida with periconceptional multivitamin supplementation (conclusion). Orvosi Hetilap1994;135(42):2313‐7. DoboM , CzeizelAE . Long‐term somatic and mental development of children after periconceptional multivitamin supplementation. European Journal of Pediatrics1998;157:719‐23. DudasI , RockenbauerM , CzeizelAE . The effect of preconceptional multivitamin supplementation on the menstrual cycle. Archives of Gynecology and Obstetrics1995;256(3):115‐23. MetnekiJ , DudasI , CzeizelAE . Higher rate of multiple births after periconceptual multivitamin supplementation. Orvosi Hetilap1996;137(43):2401‐5. ">Czeizel 1994</a>; <a href="./references#CD007950-bbs2-0002" title="Indian Council of Medical Research (ICMR) Collaborating Centres, Central Technical Co‐ordinatingUnit . Multicentric study of efficacy of periconceptional folic acid containing vitamin supplementation in prevention of open neural tube defects from India. Indian Journal of Medical Research2000;112:206‐11. ">ICMR 2000</a>), although the control groups received different formulations. <a href="./references#CD007950-bbs2-0001" title="CzeizelA , FritzG . Randomized trial of periconceptional vitamins. JAMA1989;262:1634. CzeizelA , RodeK . Trial to prevent first occurrence of neural tube defects by periconceptional multivitamin supplementation. Lancet1984;2(8393):40. CzeizelAE . Controlled studies of multivitamin supplementation on pregnancy outcomes. Annals of the New York Academy of Sciences1993;678:266‐75. CzeizelAE . Limb‐reduction defects and folic acid supplementation. Lancet1995;345(8954):932. CzeizelAE . Nutritional supplementation and prevention of congenital abnormalities. Current Opinion in Obstetrics &amp; Gynecology1995;7(2):88‐94. CzeizelAE . Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ1993;306:1645‐8. CzeizelAE . Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. American Journal of Medical Genetics1996;62(2):179‐83. CzeizelAE , DoboM . Postnatal somatic and mental development after periconceptional multivitamin supplementation. Archives of Disease in Childhood1994;70(3):229‐33. CzeizelAE , DudasI . Prevention of the first occurrence of neural‐tube defects by periconceptional vitamin supplementation. New England Journal of Medicine1992;327:1832‐5. CzeizelAE , DudasI , FritzG , TecsoiA , HanckA , KunovitsG . The effect of periconceptional multivitamin‐mineral supplementation on vertigo, nausea and vomiting in the first trimester of pregnancy. Archives of Gynecology and Obstetrics1992;251:181‐5. CzeizelAE , DudasI , MetnekiJ . Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Archives of Gynecology and Obstetrics1994;255:131‐9. CzeizelAE , MedveczkyE . Periconceptional multivitamin supplementation and multimalformed offspring. Obstetrics &amp; Gynecology2003;102:1255‐61. CzeizelAE , MetnekiJ , DudasI . Higher rate of multiple births after periconceptional vitamin supplementation. New England Journal of Medicine1994;330(23):1687‐8. CzeizelAE , MetnekiJ , DudasI . The effect of preconceptional multivitamin supplementation on fertility. International Journal for Vitamin and Nutrition Research1996;66:55‐8. CzeizelAE , MetnekiJ , DudasI . The higher rate of multiple births after periconceptional multivitamin supplementation: an analysis of causes. Acta Geneticae Medicae et Gemellologiae1994;43:175‐84. CzeizelAE , RockenbauerM , SusanskyE . No change in sexual activity during preconceptional multivitamin supplementation. British Journal of Obstetrics and Gynaecology1996;103:569‐73. CzeizelAE , VarghaP . Periconceptional folic acid/multivitamin supplementation and twin pregnancy. American Journal of Obstetrics and Gynecology2004;191(3):790‐4. CzeizelE , DudasI . Prevention of the first occurrence of anencephaly and spina bifida with periconceptional multivitamin supplementation (conclusion). Orvosi Hetilap1994;135(42):2313‐7. DoboM , CzeizelAE . Long‐term somatic and mental development of children after periconceptional multivitamin supplementation. European Journal of Pediatrics1998;157:719‐23. DudasI , RockenbauerM , CzeizelAE . The effect of preconceptional multivitamin supplementation on the menstrual cycle. Archives of Gynecology and Obstetrics1995;256(3):115‐23. MetnekiJ , DudasI , CzeizelAE . Higher rate of multiple births after periconceptual multivitamin supplementation. Orvosi Hetilap1996;137(43):2401‐5. ">Czeizel 1994</a> provided in comparison group 1 mg copper; 1 mg manganese; 7.5 mg zinc; 7.5 mg (calcium ascorbate) vitamin C and lactose 736.27 mg. <a href="./references#CD007950-bbs2-0002" title="Indian Council of Medical Research (ICMR) Collaborating Centres, Central Technical Co‐ordinatingUnit . Multicentric study of efficacy of periconceptional folic acid containing vitamin supplementation in prevention of open neural tube defects from India. Indian Journal of Medical Research2000;112:206‐11. ">ICMR 2000</a> provided iron (120 mg ferrous sulphate and 240 mg calcium phosphate). </p> <p>One trial had three arms (<a href="./references#CD007950-bbs2-0003" title="KirkePN , DalyLE , ElwoodJH . A randomized trial of low dose folic acid to prevent neural tube defects. Archives of Disease in Childhood1992;67:1442‐6. ">Kirke 1992</a>). One arm provided folic acid only while women in the second group received Pregnavite Forte® containing 4000 international units (IU) vitamin A; 400 IU vitamin D (calciferol); 1.5 mg vitamin B<sub>1</sub> (thiamine hydrochloride); 1.5 mg vitamin B<sub>2</sub> (riboflavin); 1 mg vitamin B<sub>6</sub> (pyridoxine hydrochloride); 15 mg niacin (nicotinamide); 40 mg vitamin C; 480 mg calcium phosphate, and iron (252 mg ferrous sulphate) daily. A third group received Pregnavite Forte F® containing 360 µg (0.36 mg) folic acid in addition to 4000 IU vitamin A; 400 IU vitamin D (as calciferol); 1.5 mg vitamin B<sub>1</sub> (thiamine hydrochloride); 1.5 mg vitamin B<sub>2</sub> (riboflavin); 1 mg vitamin B<sub>6</sub> (pyridoxine hydrochloride); 15 mg niacin (nicotinamide); 40 mg vitamin C; 480 mg calcium phosphate, and iron (252 mg ferrous sulphate) daily. </p> <p>One trial included four comparison groups: one with folic acid with iron and calcium, one with folic acid plus iron, calcium and multiple micronutrients, another with iron, calcium and multiple micronutrients without folic acid, and a control group that only received iron and calcium but did not receive multiple micronutrients nor folic acid (<a href="./references#CD007950-bbs2-0005" title="Anon . Folate supplements prevent recurrence of neural tube defects. Nutrition Review1992;50(Suppl 1):22‐4. Anon . Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet1991;338(8760):131‐7. ">MRC 1991</a>). In this study the iron and calcium in the capsules was provided as ferrous sulphate and dicalcium phosphate. In the another included study (<a href="./references#CD007950-bbs2-0003" title="KirkePN , DalyLE , ElwoodJH . A randomized trial of low dose folic acid to prevent neural tube defects. Archives of Disease in Childhood1992;67:1442‐6. ">Kirke 1992</a>), there were three comparison groups: one with folic acid; another with multiple micronutrients and another with multiple micronutrients and folic acid. </p> <p>See <a href="./references#CD007950-sec-0213" title="">Characteristics of included studies</a> tables for a detailed description of the studies and their interventions. </p> </section> <section id="CD007950-sec-0099"> <h6 class="title">Supervision and co‐interventions</h6> <p>In only one study were participants delineated by geography. Residents of Glamorgan and Gwent in south Wales who were qualified to join the study were visited by medically qualified field workers in their homes for the enrolment and an initial assessment of their diet (<a href="./references#CD007950-bbs2-0004" title="LaurenceKM . Prevention of neural tube defects by improvement in maternal diet and preconceptional folic acid supplementation. Progress in Clinical and Biological Research1985;163:383‐8. LaurenceKM . The role of maternal nutrition and folic acid therapy before conception to prevent neural tube defects [Die Rolle der mütterlichen Ernährung und Folinsaure‐Therapie vor der Empfangnis zur Verhutung von Nervenkanal‐Defekten]. Monatsschrift fur Kinderheilkunde1982;130:646. LaurenceKM , CampbellH , JamesNE . The role of improvement in the maternal diet and preconceptional folic acid supplementation in the prevention of neural tube defects. Prevention of spina bifida and other neural tube defects. Academic Press, 1983:85‐125. LaurenceKM , JamesN , MillerM , CampbellH , TennantGB . A double randomised controlled trial for preconceptional folic acid supplementation for the prevention of recurrence of neural tube defects in high risk pregnancies. Journal of Medical Genetics1982;19(1):66. LaurenceKM , JamesN , MillerMH , TennantGB , CampbellH . Double blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural tube defects. BMJ (Clinical Research Edition)1981;282:1509‐11. ">Laurence 1981</a>). The participants were then instructed to report to the authors within six weeks of a missed period. They were revisited at six months and at the end of pregnancy. </p> <p>One study was set in 33 centres across seven countries: 17 in the UK and 16 in Australia, Canada, France, Hungary, Israel and Russia (<a href="./references#CD007950-bbs2-0005" title="Anon . Folate supplements prevent recurrence of neural tube defects. Nutrition Review1992;50(Suppl 1):22‐4. Anon . Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet1991;338(8760):131‐7. ">MRC 1991</a>). All centres had capability for antenatal diagnosis of NTDs. The potency of the capsules was checked every three months. </p> <p>One study was conducted in 12 Irish hospitals and co‐ordinated with the Health Research Board (<a href="./references#CD007950-bbs2-0003" title="KirkePN , DalyLE , ElwoodJH . A randomized trial of low dose folic acid to prevent neural tube defects. Archives of Disease in Childhood1992;67:1442‐6. ">Kirke 1992</a>). Eligible participants (women who had a previous pregnancy with a child with NTD, not pregnant at the time of enrolment and were planning a further pregnancy) were block randomised (12 women per block) and stratified by hospital. Otherwise eligible women who were pregnant when first contacted constituted the non‐randomised control group. The stability of the supplements was assessed regularly during the study period. </p> <p>One study was part of the Hungarian Optimal Family Planning Programme (HOFPP) where a qualified nurse performed or supervised the reproductive health check‐up, the preparation for conception, the initiation of the intervention and the follow‐up visits up to the 12<sup>th</sup> week of pregnancy (<a href="./references#CD007950-bbs2-0001" title="CzeizelA , FritzG . Randomized trial of periconceptional vitamins. JAMA1989;262:1634. CzeizelA , RodeK . Trial to prevent first occurrence of neural tube defects by periconceptional multivitamin supplementation. Lancet1984;2(8393):40. CzeizelAE . Controlled studies of multivitamin supplementation on pregnancy outcomes. Annals of the New York Academy of Sciences1993;678:266‐75. CzeizelAE . Limb‐reduction defects and folic acid supplementation. Lancet1995;345(8954):932. CzeizelAE . Nutritional supplementation and prevention of congenital abnormalities. Current Opinion in Obstetrics &amp; Gynecology1995;7(2):88‐94. CzeizelAE . Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ1993;306:1645‐8. CzeizelAE . Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. American Journal of Medical Genetics1996;62(2):179‐83. CzeizelAE , DoboM . Postnatal somatic and mental development after periconceptional multivitamin supplementation. Archives of Disease in Childhood1994;70(3):229‐33. CzeizelAE , DudasI . Prevention of the first occurrence of neural‐tube defects by periconceptional vitamin supplementation. New England Journal of Medicine1992;327:1832‐5. CzeizelAE , DudasI , FritzG , TecsoiA , HanckA , KunovitsG . The effect of periconceptional multivitamin‐mineral supplementation on vertigo, nausea and vomiting in the first trimester of pregnancy. Archives of Gynecology and Obstetrics1992;251:181‐5. CzeizelAE , DudasI , MetnekiJ . Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Archives of Gynecology and Obstetrics1994;255:131‐9. CzeizelAE , MedveczkyE . Periconceptional multivitamin supplementation and multimalformed offspring. Obstetrics &amp; Gynecology2003;102:1255‐61. CzeizelAE , MetnekiJ , DudasI . Higher rate of multiple births after periconceptional vitamin supplementation. New England Journal of Medicine1994;330(23):1687‐8. CzeizelAE , MetnekiJ , DudasI . The effect of preconceptional multivitamin supplementation on fertility. International Journal for Vitamin and Nutrition Research1996;66:55‐8. CzeizelAE , MetnekiJ , DudasI . The higher rate of multiple births after periconceptional multivitamin supplementation: an analysis of causes. Acta Geneticae Medicae et Gemellologiae1994;43:175‐84. CzeizelAE , RockenbauerM , SusanskyE . No change in sexual activity during preconceptional multivitamin supplementation. British Journal of Obstetrics and Gynaecology1996;103:569‐73. CzeizelAE , VarghaP . Periconceptional folic acid/multivitamin supplementation and twin pregnancy. American Journal of Obstetrics and Gynecology2004;191(3):790‐4. CzeizelE , DudasI . Prevention of the first occurrence of anencephaly and spina bifida with periconceptional multivitamin supplementation (conclusion). Orvosi Hetilap1994;135(42):2313‐7. DoboM , CzeizelAE . Long‐term somatic and mental development of children after periconceptional multivitamin supplementation. European Journal of Pediatrics1998;157:719‐23. DudasI , RockenbauerM , CzeizelAE . The effect of preconceptional multivitamin supplementation on the menstrual cycle. Archives of Gynecology and Obstetrics1995;256(3):115‐23. MetnekiJ , DudasI , CzeizelAE . Higher rate of multiple births after periconceptual multivitamin supplementation. Orvosi Hetilap1996;137(43):2401‐5. ">Czeizel 1994</a>). </p> <p>One study was carried out in five human genetics or paediatrics centres in Bangalore, Lucknow, Mumbai, New Delhi and Pune, India (<a href="./references#CD007950-bbs2-0002" title="Indian Council of Medical Research (ICMR) Collaborating Centres, Central Technical Co‐ordinatingUnit . Multicentric study of efficacy of periconceptional folic acid containing vitamin supplementation in prevention of open neural tube defects from India. Indian Journal of Medical Research2000;112:206‐11. ">ICMR 2000</a>). The reproductive history, history of addictions, intake of medicines, consanguinity and a three‐generation pedigree chart were ascertained during enrolment and a physical examination was performed. </p> </section> <section id="CD007950-sec-0100"> <h6 class="title">Intervention settings and health worker cadre</h6> <p>Compliance to folate intake was assessed using blood tests in two studies (<a href="./references#CD007950-bbs2-0003" title="KirkePN , DalyLE , ElwoodJH . A randomized trial of low dose folic acid to prevent neural tube defects. Archives of Disease in Childhood1992;67:1442‐6. ">Kirke 1992</a>; <a href="./references#CD007950-bbs2-0004" title="LaurenceKM . Prevention of neural tube defects by improvement in maternal diet and preconceptional folic acid supplementation. Progress in Clinical and Biological Research1985;163:383‐8. LaurenceKM . The role of maternal nutrition and folic acid therapy before conception to prevent neural tube defects [Die Rolle der mütterlichen Ernährung und Folinsaure‐Therapie vor der Empfangnis zur Verhutung von Nervenkanal‐Defekten]. Monatsschrift fur Kinderheilkunde1982;130:646. LaurenceKM , CampbellH , JamesNE . The role of improvement in the maternal diet and preconceptional folic acid supplementation in the prevention of neural tube defects. Prevention of spina bifida and other neural tube defects. Academic Press, 1983:85‐125. LaurenceKM , JamesN , MillerM , CampbellH , TennantGB . A double randomised controlled trial for preconceptional folic acid supplementation for the prevention of recurrence of neural tube defects in high risk pregnancies. Journal of Medical Genetics1982;19(1):66. LaurenceKM , JamesN , MillerMH , TennantGB , CampbellH . Double blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural tube defects. BMJ (Clinical Research Edition)1981;282:1509‐11. ">Laurence 1981</a>), and with both blood and urine radioimmunoassay tests in one study (<a href="./references#CD007950-bbs2-0005" title="Anon . Folate supplements prevent recurrence of neural tube defects. Nutrition Review1992;50(Suppl 1):22‐4. Anon . Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet1991;338(8760):131‐7. ">MRC 1991</a>). In the two remaining studies, compliance to folate intake was assessed using diary or tick cards and the number of capsules returned (<a href="./references#CD007950-bbs2-0001" title="CzeizelA , FritzG . Randomized trial of periconceptional vitamins. JAMA1989;262:1634. CzeizelA , RodeK . Trial to prevent first occurrence of neural tube defects by periconceptional multivitamin supplementation. Lancet1984;2(8393):40. CzeizelAE . Controlled studies of multivitamin supplementation on pregnancy outcomes. Annals of the New York Academy of Sciences1993;678:266‐75. CzeizelAE . Limb‐reduction defects and folic acid supplementation. Lancet1995;345(8954):932. CzeizelAE . Nutritional supplementation and prevention of congenital abnormalities. Current Opinion in Obstetrics &amp; Gynecology1995;7(2):88‐94. CzeizelAE . Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ1993;306:1645‐8. CzeizelAE . Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. American Journal of Medical Genetics1996;62(2):179‐83. CzeizelAE , DoboM . Postnatal somatic and mental development after periconceptional multivitamin supplementation. Archives of Disease in Childhood1994;70(3):229‐33. CzeizelAE , DudasI . Prevention of the first occurrence of neural‐tube defects by periconceptional vitamin supplementation. New England Journal of Medicine1992;327:1832‐5. CzeizelAE , DudasI , FritzG , TecsoiA , HanckA , KunovitsG . The effect of periconceptional multivitamin‐mineral supplementation on vertigo, nausea and vomiting in the first trimester of pregnancy. Archives of Gynecology and Obstetrics1992;251:181‐5. CzeizelAE , DudasI , MetnekiJ . Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Archives of Gynecology and Obstetrics1994;255:131‐9. CzeizelAE , MedveczkyE . Periconceptional multivitamin supplementation and multimalformed offspring. Obstetrics &amp; Gynecology2003;102:1255‐61. CzeizelAE , MetnekiJ , DudasI . Higher rate of multiple births after periconceptional vitamin supplementation. New England Journal of Medicine1994;330(23):1687‐8. CzeizelAE , MetnekiJ , DudasI . The effect of preconceptional multivitamin supplementation on fertility. International Journal for Vitamin and Nutrition Research1996;66:55‐8. CzeizelAE , MetnekiJ , DudasI . The higher rate of multiple births after periconceptional multivitamin supplementation: an analysis of causes. Acta Geneticae Medicae et Gemellologiae1994;43:175‐84. CzeizelAE , RockenbauerM , SusanskyE . No change in sexual activity during preconceptional multivitamin supplementation. British Journal of Obstetrics and Gynaecology1996;103:569‐73. CzeizelAE , VarghaP . Periconceptional folic acid/multivitamin supplementation and twin pregnancy. American Journal of Obstetrics and Gynecology2004;191(3):790‐4. CzeizelE , DudasI . Prevention of the first occurrence of anencephaly and spina bifida with periconceptional multivitamin supplementation (conclusion). Orvosi Hetilap1994;135(42):2313‐7. DoboM , CzeizelAE . Long‐term somatic and mental development of children after periconceptional multivitamin supplementation. European Journal of Pediatrics1998;157:719‐23. DudasI , RockenbauerM , CzeizelAE . The effect of preconceptional multivitamin supplementation on the menstrual cycle. Archives of Gynecology and Obstetrics1995;256(3):115‐23. MetnekiJ , DudasI , CzeizelAE . Higher rate of multiple births after periconceptual multivitamin supplementation. Orvosi Hetilap1996;137(43):2401‐5. ">Czeizel 1994</a>; <a href="./references#CD007950-bbs2-0002" title="Indian Council of Medical Research (ICMR) Collaborating Centres, Central Technical Co‐ordinatingUnit . Multicentric study of efficacy of periconceptional folic acid containing vitamin supplementation in prevention of open neural tube defects from India. Indian Journal of Medical Research2000;112:206‐11. ">ICMR 2000</a>). </p> <p>Pregnancy was ascertained by stopping of menstrual period and follow‐up in three studies (<a href="./references#CD007950-bbs2-0003" title="KirkePN , DalyLE , ElwoodJH . A randomized trial of low dose folic acid to prevent neural tube defects. Archives of Disease in Childhood1992;67:1442‐6. ">Kirke 1992</a>; <a href="./references#CD007950-bbs2-0004" title="LaurenceKM . Prevention of neural tube defects by improvement in maternal diet and preconceptional folic acid supplementation. Progress in Clinical and Biological Research1985;163:383‐8. LaurenceKM . The role of maternal nutrition and folic acid therapy before conception to prevent neural tube defects [Die Rolle der mütterlichen Ernährung und Folinsaure‐Therapie vor der Empfangnis zur Verhutung von Nervenkanal‐Defekten]. Monatsschrift fur Kinderheilkunde1982;130:646. LaurenceKM , CampbellH , JamesNE . The role of improvement in the maternal diet and preconceptional folic acid supplementation in the prevention of neural tube defects. Prevention of spina bifida and other neural tube defects. Academic Press, 1983:85‐125. LaurenceKM , JamesN , MillerM , CampbellH , TennantGB . A double randomised controlled trial for preconceptional folic acid supplementation for the prevention of recurrence of neural tube defects in high risk pregnancies. Journal of Medical Genetics1982;19(1):66. LaurenceKM , JamesN , MillerMH , TennantGB , CampbellH . Double blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural tube defects. BMJ (Clinical Research Edition)1981;282:1509‐11. ">Laurence 1981</a>; <a href="./references#CD007950-bbs2-0005" title="Anon . Folate supplements prevent recurrence of neural tube defects. Nutrition Review1992;50(Suppl 1):22‐4. Anon . Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet1991;338(8760):131‐7. ">MRC 1991</a>); by a urinary human chorionic gonadotrophin (HCG) test after the first missed period in one study (<a href="./references#CD007950-bbs2-0002" title="Indian Council of Medical Research (ICMR) Collaborating Centres, Central Technical Co‐ordinatingUnit . Multicentric study of efficacy of periconceptional folic acid containing vitamin supplementation in prevention of open neural tube defects from India. Indian Journal of Medical Research2000;112:206‐11. ">ICMR 2000</a>); and, by maternal serum test after the first missed period and an ultrasound at two weeks of gestation in one study (<a href="./references#CD007950-bbs2-0001" title="CzeizelA , FritzG . Randomized trial of periconceptional vitamins. JAMA1989;262:1634. CzeizelA , RodeK . Trial to prevent first occurrence of neural tube defects by periconceptional multivitamin supplementation. Lancet1984;2(8393):40. CzeizelAE . Controlled studies of multivitamin supplementation on pregnancy outcomes. Annals of the New York Academy of Sciences1993;678:266‐75. CzeizelAE . Limb‐reduction defects and folic acid supplementation. Lancet1995;345(8954):932. CzeizelAE . Nutritional supplementation and prevention of congenital abnormalities. Current Opinion in Obstetrics &amp; Gynecology1995;7(2):88‐94. CzeizelAE . Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ1993;306:1645‐8. CzeizelAE . Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. American Journal of Medical Genetics1996;62(2):179‐83. CzeizelAE , DoboM . Postnatal somatic and mental development after periconceptional multivitamin supplementation. Archives of Disease in Childhood1994;70(3):229‐33. CzeizelAE , DudasI . Prevention of the first occurrence of neural‐tube defects by periconceptional vitamin supplementation. New England Journal of Medicine1992;327:1832‐5. CzeizelAE , DudasI , FritzG , TecsoiA , HanckA , KunovitsG . The effect of periconceptional multivitamin‐mineral supplementation on vertigo, nausea and vomiting in the first trimester of pregnancy. Archives of Gynecology and Obstetrics1992;251:181‐5. CzeizelAE , DudasI , MetnekiJ . Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Archives of Gynecology and Obstetrics1994;255:131‐9. CzeizelAE , MedveczkyE . Periconceptional multivitamin supplementation and multimalformed offspring. Obstetrics &amp; Gynecology2003;102:1255‐61. CzeizelAE , MetnekiJ , DudasI . Higher rate of multiple births after periconceptional vitamin supplementation. New England Journal of Medicine1994;330(23):1687‐8. CzeizelAE , MetnekiJ , DudasI . The effect of preconceptional multivitamin supplementation on fertility. International Journal for Vitamin and Nutrition Research1996;66:55‐8. CzeizelAE , MetnekiJ , DudasI . The higher rate of multiple births after periconceptional multivitamin supplementation: an analysis of causes. Acta Geneticae Medicae et Gemellologiae1994;43:175‐84. CzeizelAE , RockenbauerM , SusanskyE . No change in sexual activity during preconceptional multivitamin supplementation. British Journal of Obstetrics and Gynaecology1996;103:569‐73. CzeizelAE , VarghaP . Periconceptional folic acid/multivitamin supplementation and twin pregnancy. American Journal of Obstetrics and Gynecology2004;191(3):790‐4. CzeizelE , DudasI . Prevention of the first occurrence of anencephaly and spina bifida with periconceptional multivitamin supplementation (conclusion). Orvosi Hetilap1994;135(42):2313‐7. DoboM , CzeizelAE . Long‐term somatic and mental development of children after periconceptional multivitamin supplementation. European Journal of Pediatrics1998;157:719‐23. DudasI , RockenbauerM , CzeizelAE . The effect of preconceptional multivitamin supplementation on the menstrual cycle. Archives of Gynecology and Obstetrics1995;256(3):115‐23. MetnekiJ , DudasI , CzeizelAE . Higher rate of multiple births after periconceptual multivitamin supplementation. Orvosi Hetilap1996;137(43):2401‐5. ">Czeizel 1994</a>). </p> <p>NTDs were detected using maternal serum alpha fetoprotein levels and ultrasound at the 16<sup>th</sup> week of gestation and further confirmed by amniotic fluid AFP and acetyl cholinesterase by amniocentesis and repeat ultrasound in one study (<a href="./references#CD007950-bbs2-0002" title="Indian Council of Medical Research (ICMR) Collaborating Centres, Central Technical Co‐ordinatingUnit . Multicentric study of efficacy of periconceptional folic acid containing vitamin supplementation in prevention of open neural tube defects from India. Indian Journal of Medical Research2000;112:206‐11. ">ICMR 2000</a>). In one study, antenatal diagnosis of NTDs was available in all study centres, outcomes of all completed pregnancies were recorded and reports of NTDs were corroborated by independent reports such as a necropsy report of description of lesion at the trial centre in London (<a href="./references#CD007950-bbs2-0005" title="Anon . Folate supplements prevent recurrence of neural tube defects. Nutrition Review1992;50(Suppl 1):22‐4. Anon . Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet1991;338(8760):131‐7. ">MRC 1991</a>). In three studies, the NTDs were confirmed by examination by a medical personnel such as an obstetrician (<a href="./references#CD007950-bbs2-0001" title="CzeizelA , FritzG . Randomized trial of periconceptional vitamins. JAMA1989;262:1634. CzeizelA , RodeK . Trial to prevent first occurrence of neural tube defects by periconceptional multivitamin supplementation. Lancet1984;2(8393):40. CzeizelAE . Controlled studies of multivitamin supplementation on pregnancy outcomes. Annals of the New York Academy of Sciences1993;678:266‐75. CzeizelAE . Limb‐reduction defects and folic acid supplementation. Lancet1995;345(8954):932. CzeizelAE . Nutritional supplementation and prevention of congenital abnormalities. Current Opinion in Obstetrics &amp; Gynecology1995;7(2):88‐94. CzeizelAE . Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ1993;306:1645‐8. CzeizelAE . Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. American Journal of Medical Genetics1996;62(2):179‐83. CzeizelAE , DoboM . Postnatal somatic and mental development after periconceptional multivitamin supplementation. Archives of Disease in Childhood1994;70(3):229‐33. CzeizelAE , DudasI . Prevention of the first occurrence of neural‐tube defects by periconceptional vitamin supplementation. New England Journal of Medicine1992;327:1832‐5. CzeizelAE , DudasI , FritzG , TecsoiA , HanckA , KunovitsG . The effect of periconceptional multivitamin‐mineral supplementation on vertigo, nausea and vomiting in the first trimester of pregnancy. Archives of Gynecology and Obstetrics1992;251:181‐5. CzeizelAE , DudasI , MetnekiJ . Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Archives of Gynecology and Obstetrics1994;255:131‐9. CzeizelAE , MedveczkyE . Periconceptional multivitamin supplementation and multimalformed offspring. Obstetrics &amp; Gynecology2003;102:1255‐61. CzeizelAE , MetnekiJ , DudasI . Higher rate of multiple births after periconceptional vitamin supplementation. New England Journal of Medicine1994;330(23):1687‐8. CzeizelAE , MetnekiJ , DudasI . The effect of preconceptional multivitamin supplementation on fertility. International Journal for Vitamin and Nutrition Research1996;66:55‐8. CzeizelAE , MetnekiJ , DudasI . The higher rate of multiple births after periconceptional multivitamin supplementation: an analysis of causes. Acta Geneticae Medicae et Gemellologiae1994;43:175‐84. CzeizelAE , RockenbauerM , SusanskyE . No change in sexual activity during preconceptional multivitamin supplementation. British Journal of Obstetrics and Gynaecology1996;103:569‐73. CzeizelAE , VarghaP . Periconceptional folic acid/multivitamin supplementation and twin pregnancy. American Journal of Obstetrics and Gynecology2004;191(3):790‐4. CzeizelE , DudasI . Prevention of the first occurrence of anencephaly and spina bifida with periconceptional multivitamin supplementation (conclusion). Orvosi Hetilap1994;135(42):2313‐7. DoboM , CzeizelAE . Long‐term somatic and mental development of children after periconceptional multivitamin supplementation. European Journal of Pediatrics1998;157:719‐23. DudasI , RockenbauerM , CzeizelAE . The effect of preconceptional multivitamin supplementation on the menstrual cycle. Archives of Gynecology and Obstetrics1995;256(3):115‐23. MetnekiJ , DudasI , CzeizelAE . Higher rate of multiple births after periconceptual multivitamin supplementation. Orvosi Hetilap1996;137(43):2401‐5. ">Czeizel 1994</a>), a pathologist (<a href="./references#CD007950-bbs2-0003" title="KirkePN , DalyLE , ElwoodJH . A randomized trial of low dose folic acid to prevent neural tube defects. Archives of Disease in Childhood1992;67:1442‐6. ">Kirke 1992</a>), or the study's medically qualified fieldworker (<a href="./references#CD007950-bbs2-0004" title="LaurenceKM . Prevention of neural tube defects by improvement in maternal diet and preconceptional folic acid supplementation. Progress in Clinical and Biological Research1985;163:383‐8. LaurenceKM . The role of maternal nutrition and folic acid therapy before conception to prevent neural tube defects [Die Rolle der mütterlichen Ernährung und Folinsaure‐Therapie vor der Empfangnis zur Verhutung von Nervenkanal‐Defekten]. Monatsschrift fur Kinderheilkunde1982;130:646. LaurenceKM , CampbellH , JamesNE . The role of improvement in the maternal diet and preconceptional folic acid supplementation in the prevention of neural tube defects. Prevention of spina bifida and other neural tube defects. Academic Press, 1983:85‐125. LaurenceKM , JamesN , MillerM , CampbellH , TennantGB . A double randomised controlled trial for preconceptional folic acid supplementation for the prevention of recurrence of neural tube defects in high risk pregnancies. Journal of Medical Genetics1982;19(1):66. LaurenceKM , JamesN , MillerMH , TennantGB , CampbellH . Double blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural tube defects. BMJ (Clinical Research Edition)1981;282:1509‐11. ">Laurence 1981</a>). </p> </section> </section> </section> <section id="CD007950-sec-0101"> <h4 class="title">Excluded studies</h4> <p>We excluded 62 studies: 34 studies because their study design or scope did not match the objectives of this review (cohort or case‐control studies, or reviews; five studies were performed in non‐pregnant women; 11 studies gave folic acid to all participants; and, eight studies had interventions that were out of scope of this review (two studies were on fortification, two were on dietary advise, and four were on folic acid supplementation that started in the first trimester of gestation but that continued throughout pregnancy). </p> <p><i>See</i><a href="./references#CD007950-sec-0214" title="">Characteristics of excluded studies</a> tables for a detailed description of the studies and the reasons for exclusion. </p> </section> </section> <section id="CD007950-sec-0102"> <h3 class="title">Risk of bias in included studies</h3> <section id="CD007950-sec-0103"> <h4 class="title">Allocation</h4> <p><i>Sequence generation</i>: three trials adequately randomised the participants to the treatment groups (<a href="./references#CD007950-bbs2-0001" title="CzeizelA , FritzG . Randomized trial of periconceptional vitamins. JAMA1989;262:1634. CzeizelA , RodeK . Trial to prevent first occurrence of neural tube defects by periconceptional multivitamin supplementation. Lancet1984;2(8393):40. CzeizelAE . Controlled studies of multivitamin supplementation on pregnancy outcomes. Annals of the New York Academy of Sciences1993;678:266‐75. CzeizelAE . Limb‐reduction defects and folic acid supplementation. Lancet1995;345(8954):932. CzeizelAE . Nutritional supplementation and prevention of congenital abnormalities. Current Opinion in Obstetrics &amp; Gynecology1995;7(2):88‐94. CzeizelAE . Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ1993;306:1645‐8. CzeizelAE . Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. American Journal of Medical Genetics1996;62(2):179‐83. CzeizelAE , DoboM . Postnatal somatic and mental development after periconceptional multivitamin supplementation. Archives of Disease in Childhood1994;70(3):229‐33. CzeizelAE , DudasI . Prevention of the first occurrence of neural‐tube defects by periconceptional vitamin supplementation. New England Journal of Medicine1992;327:1832‐5. CzeizelAE , DudasI , FritzG , TecsoiA , HanckA , KunovitsG . The effect of periconceptional multivitamin‐mineral supplementation on vertigo, nausea and vomiting in the first trimester of pregnancy. Archives of Gynecology and Obstetrics1992;251:181‐5. CzeizelAE , DudasI , MetnekiJ . Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Archives of Gynecology and Obstetrics1994;255:131‐9. CzeizelAE , MedveczkyE . Periconceptional multivitamin supplementation and multimalformed offspring. Obstetrics &amp; Gynecology2003;102:1255‐61. CzeizelAE , MetnekiJ , DudasI . Higher rate of multiple births after periconceptional vitamin supplementation. New England Journal of Medicine1994;330(23):1687‐8. CzeizelAE , MetnekiJ , DudasI . The effect of preconceptional multivitamin supplementation on fertility. International Journal for Vitamin and Nutrition Research1996;66:55‐8. CzeizelAE , MetnekiJ , DudasI . The higher rate of multiple births after periconceptional multivitamin supplementation: an analysis of causes. Acta Geneticae Medicae et Gemellologiae1994;43:175‐84. CzeizelAE , RockenbauerM , SusanskyE . No change in sexual activity during preconceptional multivitamin supplementation. British Journal of Obstetrics and Gynaecology1996;103:569‐73. CzeizelAE , VarghaP . Periconceptional folic acid/multivitamin supplementation and twin pregnancy. American Journal of Obstetrics and Gynecology2004;191(3):790‐4. CzeizelE , DudasI . Prevention of the first occurrence of anencephaly and spina bifida with periconceptional multivitamin supplementation (conclusion). Orvosi Hetilap1994;135(42):2313‐7. DoboM , CzeizelAE . Long‐term somatic and mental development of children after periconceptional multivitamin supplementation. European Journal of Pediatrics1998;157:719‐23. DudasI , RockenbauerM , CzeizelAE . The effect of preconceptional multivitamin supplementation on the menstrual cycle. Archives of Gynecology and Obstetrics1995;256(3):115‐23. MetnekiJ , DudasI , CzeizelAE . Higher rate of multiple births after periconceptual multivitamin supplementation. Orvosi Hetilap1996;137(43):2401‐5. ">Czeizel 1994</a>; <a href="./references#CD007950-bbs2-0003" title="KirkePN , DalyLE , ElwoodJH . A randomized trial of low dose folic acid to prevent neural tube defects. Archives of Disease in Childhood1992;67:1442‐6. ">Kirke 1992</a>; <a href="./references#CD007950-bbs2-0004" title="LaurenceKM . Prevention of neural tube defects by improvement in maternal diet and preconceptional folic acid supplementation. Progress in Clinical and Biological Research1985;163:383‐8. LaurenceKM . The role of maternal nutrition and folic acid therapy before conception to prevent neural tube defects [Die Rolle der mütterlichen Ernährung und Folinsaure‐Therapie vor der Empfangnis zur Verhutung von Nervenkanal‐Defekten]. Monatsschrift fur Kinderheilkunde1982;130:646. LaurenceKM , CampbellH , JamesNE . The role of improvement in the maternal diet and preconceptional folic acid supplementation in the prevention of neural tube defects. Prevention of spina bifida and other neural tube defects. Academic Press, 1983:85‐125. LaurenceKM , JamesN , MillerM , CampbellH , TennantGB . A double randomised controlled trial for preconceptional folic acid supplementation for the prevention of recurrence of neural tube defects in high risk pregnancies. Journal of Medical Genetics1982;19(1):66. LaurenceKM , JamesN , MillerMH , TennantGB , CampbellH . Double blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural tube defects. BMJ (Clinical Research Edition)1981;282:1509‐11. ">Laurence 1981</a>); one of them used block randomisation (<a href="./references#CD007950-bbs2-0003" title="KirkePN , DalyLE , ElwoodJH . A randomized trial of low dose folic acid to prevent neural tube defects. Archives of Disease in Childhood1992;67:1442‐6. ">Kirke 1992</a>). Two multi‐centre trials did not report, or did not state clearly the method used to generate the randomisation sequence (<a href="./references#CD007950-bbs2-0002" title="Indian Council of Medical Research (ICMR) Collaborating Centres, Central Technical Co‐ordinatingUnit . Multicentric study of efficacy of periconceptional folic acid containing vitamin supplementation in prevention of open neural tube defects from India. Indian Journal of Medical Research2000;112:206‐11. ">ICMR 2000</a>; <a href="./references#CD007950-bbs2-0005" title="Anon . Folate supplements prevent recurrence of neural tube defects. Nutrition Review1992;50(Suppl 1):22‐4. Anon . Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet1991;338(8760):131‐7. ">MRC 1991</a>). </p> <p><i>Allocation concealment: t</i>wo trials reported using sealed envelopes, opaque bottles or similar pills when allocating the women to treatment groups (<a href="./references#CD007950-bbs2-0002" title="Indian Council of Medical Research (ICMR) Collaborating Centres, Central Technical Co‐ordinatingUnit . Multicentric study of efficacy of periconceptional folic acid containing vitamin supplementation in prevention of open neural tube defects from India. Indian Journal of Medical Research2000;112:206‐11. ">ICMR 2000</a>; <a href="./references#CD007950-bbs2-0003" title="KirkePN , DalyLE , ElwoodJH . A randomized trial of low dose folic acid to prevent neural tube defects. Archives of Disease in Childhood1992;67:1442‐6. ">Kirke 1992</a>). In this last study pills were changed after one year resulting in a partial loss of blinding. The three remaining studies were reported as blinded, but were unclear in their method of concealment of treatment allocation. </p> </section> <section id="CD007950-sec-0104"> <h4 class="title">Blinding</h4> <p>All of these trials were described as "double‐blind" although it was not clear whether outcome assessors were blind to group allocation. Women in all treatment groups received capsules or tablets containing active treatment ingredients or placebo although it was not always clear whether the preparations were of identical appearance. </p> </section> <section id="CD007950-sec-0105"> <h4 class="title">Incomplete outcome data</h4> <p>For those women becoming pregnant, loss to follow‐up ranged from 1% (<a href="./references#CD007950-bbs2-0001" title="CzeizelA , FritzG . Randomized trial of periconceptional vitamins. JAMA1989;262:1634. CzeizelA , RodeK . Trial to prevent first occurrence of neural tube defects by periconceptional multivitamin supplementation. Lancet1984;2(8393):40. CzeizelAE . Controlled studies of multivitamin supplementation on pregnancy outcomes. Annals of the New York Academy of Sciences1993;678:266‐75. CzeizelAE . Limb‐reduction defects and folic acid supplementation. Lancet1995;345(8954):932. CzeizelAE . Nutritional supplementation and prevention of congenital abnormalities. Current Opinion in Obstetrics &amp; Gynecology1995;7(2):88‐94. CzeizelAE . Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ1993;306:1645‐8. CzeizelAE . Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. American Journal of Medical Genetics1996;62(2):179‐83. CzeizelAE , DoboM . Postnatal somatic and mental development after periconceptional multivitamin supplementation. Archives of Disease in Childhood1994;70(3):229‐33. CzeizelAE , DudasI . Prevention of the first occurrence of neural‐tube defects by periconceptional vitamin supplementation. New England Journal of Medicine1992;327:1832‐5. CzeizelAE , DudasI , FritzG , TecsoiA , HanckA , KunovitsG . The effect of periconceptional multivitamin‐mineral supplementation on vertigo, nausea and vomiting in the first trimester of pregnancy. Archives of Gynecology and Obstetrics1992;251:181‐5. CzeizelAE , DudasI , MetnekiJ . Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Archives of Gynecology and Obstetrics1994;255:131‐9. CzeizelAE , MedveczkyE . Periconceptional multivitamin supplementation and multimalformed offspring. Obstetrics &amp; Gynecology2003;102:1255‐61. CzeizelAE , MetnekiJ , DudasI . Higher rate of multiple births after periconceptional vitamin supplementation. New England Journal of Medicine1994;330(23):1687‐8. CzeizelAE , MetnekiJ , DudasI . The effect of preconceptional multivitamin supplementation on fertility. International Journal for Vitamin and Nutrition Research1996;66:55‐8. CzeizelAE , MetnekiJ , DudasI . The higher rate of multiple births after periconceptional multivitamin supplementation: an analysis of causes. Acta Geneticae Medicae et Gemellologiae1994;43:175‐84. CzeizelAE , RockenbauerM , SusanskyE . No change in sexual activity during preconceptional multivitamin supplementation. British Journal of Obstetrics and Gynaecology1996;103:569‐73. CzeizelAE , VarghaP . Periconceptional folic acid/multivitamin supplementation and twin pregnancy. American Journal of Obstetrics and Gynecology2004;191(3):790‐4. CzeizelE , DudasI . Prevention of the first occurrence of anencephaly and spina bifida with periconceptional multivitamin supplementation (conclusion). Orvosi Hetilap1994;135(42):2313‐7. DoboM , CzeizelAE . Long‐term somatic and mental development of children after periconceptional multivitamin supplementation. European Journal of Pediatrics1998;157:719‐23. DudasI , RockenbauerM , CzeizelAE . The effect of preconceptional multivitamin supplementation on the menstrual cycle. Archives of Gynecology and Obstetrics1995;256(3):115‐23. MetnekiJ , DudasI , CzeizelAE . Higher rate of multiple births after periconceptual multivitamin supplementation. Orvosi Hetilap1996;137(43):2401‐5. ">Czeizel 1994</a>; <a href="./references#CD007950-bbs2-0005" title="Anon . Folate supplements prevent recurrence of neural tube defects. Nutrition Review1992;50(Suppl 1):22‐4. Anon . Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet1991;338(8760):131‐7. ">MRC 1991</a>) to 20% (<a href="./references#CD007950-bbs2-0003" title="KirkePN , DalyLE , ElwoodJH . A randomized trial of low dose folic acid to prevent neural tube defects. Archives of Disease in Childhood1992;67:1442‐6. ">Kirke 1992</a>). The remaining two trials lost less than 10% of the randomised participants. </p> <p>We noted in the methods section above, that for pregnancy outcomes we would include in the denominators only those women with confirmed pregnancies. In all studies women were randomised before conception and not all women became pregnant. For example, in the study by <a href="./references#CD007950-bbs2-0001" title="CzeizelA , FritzG . Randomized trial of periconceptional vitamins. JAMA1989;262:1634. CzeizelA , RodeK . Trial to prevent first occurrence of neural tube defects by periconceptional multivitamin supplementation. Lancet1984;2(8393):40. CzeizelAE . Controlled studies of multivitamin supplementation on pregnancy outcomes. Annals of the New York Academy of Sciences1993;678:266‐75. CzeizelAE . Limb‐reduction defects and folic acid supplementation. Lancet1995;345(8954):932. CzeizelAE . Nutritional supplementation and prevention of congenital abnormalities. Current Opinion in Obstetrics &amp; Gynecology1995;7(2):88‐94. CzeizelAE . Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ1993;306:1645‐8. CzeizelAE . Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. American Journal of Medical Genetics1996;62(2):179‐83. CzeizelAE , DoboM . Postnatal somatic and mental development after periconceptional multivitamin supplementation. Archives of Disease in Childhood1994;70(3):229‐33. CzeizelAE , DudasI . Prevention of the first occurrence of neural‐tube defects by periconceptional vitamin supplementation. New England Journal of Medicine1992;327:1832‐5. CzeizelAE , DudasI , FritzG , TecsoiA , HanckA , KunovitsG . The effect of periconceptional multivitamin‐mineral supplementation on vertigo, nausea and vomiting in the first trimester of pregnancy. Archives of Gynecology and Obstetrics1992;251:181‐5. CzeizelAE , DudasI , MetnekiJ . Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Archives of Gynecology and Obstetrics1994;255:131‐9. CzeizelAE , MedveczkyE . Periconceptional multivitamin supplementation and multimalformed offspring. Obstetrics &amp; Gynecology2003;102:1255‐61. CzeizelAE , MetnekiJ , DudasI . Higher rate of multiple births after periconceptional vitamin supplementation. New England Journal of Medicine1994;330(23):1687‐8. CzeizelAE , MetnekiJ , DudasI . The effect of preconceptional multivitamin supplementation on fertility. International Journal for Vitamin and Nutrition Research1996;66:55‐8. CzeizelAE , MetnekiJ , DudasI . The higher rate of multiple births after periconceptional multivitamin supplementation: an analysis of causes. Acta Geneticae Medicae et Gemellologiae1994;43:175‐84. CzeizelAE , RockenbauerM , SusanskyE . No change in sexual activity during preconceptional multivitamin supplementation. British Journal of Obstetrics and Gynaecology1996;103:569‐73. CzeizelAE , VarghaP . Periconceptional folic acid/multivitamin supplementation and twin pregnancy. American Journal of Obstetrics and Gynecology2004;191(3):790‐4. CzeizelE , DudasI . Prevention of the first occurrence of anencephaly and spina bifida with periconceptional multivitamin supplementation (conclusion). Orvosi Hetilap1994;135(42):2313‐7. DoboM , CzeizelAE . Long‐term somatic and mental development of children after periconceptional multivitamin supplementation. European Journal of Pediatrics1998;157:719‐23. DudasI , RockenbauerM , CzeizelAE . The effect of preconceptional multivitamin supplementation on the menstrual cycle. Archives of Gynecology and Obstetrics1995;256(3):115‐23. MetnekiJ , DudasI , CzeizelAE . Higher rate of multiple births after periconceptual multivitamin supplementation. Orvosi Hetilap1996;137(43):2401‐5. ">Czeizel 1994</a> of 7905 randomised, 5502 had confirmed pregnancy (69.6%); so 30% of those randomised did not become eligible to experience pregnancy and birth outcomes. Of these confirmed pregnancies, 49 were lost of follow‐up and a further 95 were later found to be not pregnant ("chemical pregnancies"). Overall, we included 5358 evaluated pregnancies from this study. We are aware that this makes results more difficult to interpret. Where data were available, we have provided information on the number of women randomised and the numbers with confirmed pregnancies in the <a href="./references#CD007950-sec-0213" title="">Characteristics of included studies</a> tables. </p> <p>In some cases, we did not find it simple to determine the denominators as detailed information on attrition at different stages was not reported. For some competing/overlapping outcomes (e.g. perinatal deaths, miscarriages and pregnancy termination for fetal anomaly), we have reported figures provided in the trial reports but we advise caution in interpreting such data. </p> </section> <section id="CD007950-sec-0106"> <h4 class="title">Selective reporting</h4> <p>Assessing selective reporting bias was difficult as we did not have access to study protocols. We were not able to explore possible reporting bias as too few studies have been included to allow us to carry out meaningful analyses. </p> </section> <section id="CD007950-sec-0107"> <h4 class="title">Other potential sources of bias</h4> <p>In one study (<a href="./references#CD007950-bbs2-0001" title="CzeizelA , FritzG . Randomized trial of periconceptional vitamins. JAMA1989;262:1634. CzeizelA , RodeK . Trial to prevent first occurrence of neural tube defects by periconceptional multivitamin supplementation. Lancet1984;2(8393):40. CzeizelAE . Controlled studies of multivitamin supplementation on pregnancy outcomes. Annals of the New York Academy of Sciences1993;678:266‐75. CzeizelAE . Limb‐reduction defects and folic acid supplementation. Lancet1995;345(8954):932. CzeizelAE . Nutritional supplementation and prevention of congenital abnormalities. Current Opinion in Obstetrics &amp; Gynecology1995;7(2):88‐94. CzeizelAE . Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ1993;306:1645‐8. CzeizelAE . Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. American Journal of Medical Genetics1996;62(2):179‐83. CzeizelAE , DoboM . Postnatal somatic and mental development after periconceptional multivitamin supplementation. Archives of Disease in Childhood1994;70(3):229‐33. CzeizelAE , DudasI . Prevention of the first occurrence of neural‐tube defects by periconceptional vitamin supplementation. New England Journal of Medicine1992;327:1832‐5. CzeizelAE , DudasI , FritzG , TecsoiA , HanckA , KunovitsG . The effect of periconceptional multivitamin‐mineral supplementation on vertigo, nausea and vomiting in the first trimester of pregnancy. Archives of Gynecology and Obstetrics1992;251:181‐5. CzeizelAE , DudasI , MetnekiJ . Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Archives of Gynecology and Obstetrics1994;255:131‐9. CzeizelAE , MedveczkyE . Periconceptional multivitamin supplementation and multimalformed offspring. Obstetrics &amp; Gynecology2003;102:1255‐61. CzeizelAE , MetnekiJ , DudasI . Higher rate of multiple births after periconceptional vitamin supplementation. New England Journal of Medicine1994;330(23):1687‐8. CzeizelAE , MetnekiJ , DudasI . The effect of preconceptional multivitamin supplementation on fertility. International Journal for Vitamin and Nutrition Research1996;66:55‐8. CzeizelAE , MetnekiJ , DudasI . The higher rate of multiple births after periconceptional multivitamin supplementation: an analysis of causes. Acta Geneticae Medicae et Gemellologiae1994;43:175‐84. CzeizelAE , RockenbauerM , SusanskyE . No change in sexual activity during preconceptional multivitamin supplementation. British Journal of Obstetrics and Gynaecology1996;103:569‐73. CzeizelAE , VarghaP . Periconceptional folic acid/multivitamin supplementation and twin pregnancy. American Journal of Obstetrics and Gynecology2004;191(3):790‐4. CzeizelE , DudasI . Prevention of the first occurrence of anencephaly and spina bifida with periconceptional multivitamin supplementation (conclusion). Orvosi Hetilap1994;135(42):2313‐7. DoboM , CzeizelAE . Long‐term somatic and mental development of children after periconceptional multivitamin supplementation. European Journal of Pediatrics1998;157:719‐23. DudasI , RockenbauerM , CzeizelAE . The effect of preconceptional multivitamin supplementation on the menstrual cycle. Archives of Gynecology and Obstetrics1995;256(3):115‐23. MetnekiJ , DudasI , CzeizelAE . Higher rate of multiple births after periconceptual multivitamin supplementation. Orvosi Hetilap1996;137(43):2401‐5. ">Czeizel 1994</a>), the randomisation code was broken twice: once to analyse the teratogenic effect of vitamin A and at the end of the trial to analyse the effect of the supplementation. One study (<a href="./references#CD007950-bbs2-0002" title="Indian Council of Medical Research (ICMR) Collaborating Centres, Central Technical Co‐ordinatingUnit . Multicentric study of efficacy of periconceptional folic acid containing vitamin supplementation in prevention of open neural tube defects from India. Indian Journal of Medical Research2000;112:206‐11. ">ICMR 2000</a>) was terminated before expected as a consequence of the publication of the results from another trial (<a href="./references#CD007950-bbs2-0005" title="Anon . Folate supplements prevent recurrence of neural tube defects. Nutrition Review1992;50(Suppl 1):22‐4. Anon . Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet1991;338(8760):131‐7. ">MRC 1991</a>); however the calculated sample size was almost achieved. </p> <p><i>See</i><a href="./references#CD007950-sec-0213" title="">Characteristics of included studies</a> tables for assessments of the methodological quality of each included trial and <a href="#CD007950-fig-0002">Figure 2</a> and <a href="#CD007950-fig-0003">Figure 3</a> for summaries of the quality of included studies. </p> <div class="figure" id="CD007950-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies." data-id="CD007950-fig-0002" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD007950-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Methodological quality summary: review authors' judgements about each methodological quality item for each included study." data-id="CD007950-fig-0003" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Methodological quality summary: review authors' judgements about each methodological quality item for each included study. </p> </div> </div> </div> </section> </section> <section id="CD007950-sec-0108"> <h3 class="title" id="CD007950-sec-0108">Effects of interventions</h3> <p>See: <a href="./full#CD007950-tbl-0001"><b>Summary of findings for the main comparison</b> Supplementation with folate versus no intervention, placebo or other micronutrients without folate (neonatal outcomes)</a>; <a href="./full#CD007950-tbl-0002"><b>Summary of findings 2</b> Supplementation with folate versus no intervention, placebo or other micronutrients without folate (maternal outcomes)</a> </p> <p>The summary of results is organised by comparisons and by infant and maternal outcomes. <i>See</i> the <a href="./references#CD007950-sec-0202" title="">Data and analyses</a> section for detailed results on primary and secondary outcomes. </p> <p>Four of the five trials included in the review recruited women with a history of NTDs and subgroup analyses suggested no clear differences in trials examining first occurrence and recurrence of NTDs. However, to aid interpretation of results, along with reporting overall findings from trials, we have described the results from the trials examining first occurrence and recurrence of NTDs separately. </p> <p>Only one out of the five studies (<a href="./references#CD007950-bbs2-0003" title="KirkePN , DalyLE , ElwoodJH . A randomized trial of low dose folic acid to prevent neural tube defects. Archives of Disease in Childhood1992;67:1442‐6. ">Kirke 1992</a>) was considered to be of high quality as per our criteria. </p> <section id="CD007950-sec-0109"> <h4 class="title">(1) Supplementation with any folate versus no treatment, placebo or other micronutrients without folate (five trials) </h4> <section id="CD007950-sec-0110"> <h5 class="title">Primary outcomes</h5> <section id="CD007950-sec-0111"> <h6 class="title">Infant outcomes</h6> <section id="CD007950-sec-0112"> <p><b>Neural tube defects (NTDs) (all)</b></p> <p>Five trials (<a href="./references#CD007950-bbs2-0001" title="CzeizelA , FritzG . Randomized trial of periconceptional vitamins. JAMA1989;262:1634. CzeizelA , RodeK . Trial to prevent first occurrence of neural tube defects by periconceptional multivitamin supplementation. Lancet1984;2(8393):40. CzeizelAE . Controlled studies of multivitamin supplementation on pregnancy outcomes. Annals of the New York Academy of Sciences1993;678:266‐75. CzeizelAE . Limb‐reduction defects and folic acid supplementation. Lancet1995;345(8954):932. CzeizelAE . Nutritional supplementation and prevention of congenital abnormalities. Current Opinion in Obstetrics &amp; Gynecology1995;7(2):88‐94. CzeizelAE . Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ1993;306:1645‐8. CzeizelAE . Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. American Journal of Medical Genetics1996;62(2):179‐83. CzeizelAE , DoboM . Postnatal somatic and mental development after periconceptional multivitamin supplementation. Archives of Disease in Childhood1994;70(3):229‐33. CzeizelAE , DudasI . Prevention of the first occurrence of neural‐tube defects by periconceptional vitamin supplementation. New England Journal of Medicine1992;327:1832‐5. CzeizelAE , DudasI , FritzG , TecsoiA , HanckA , KunovitsG . The effect of periconceptional multivitamin‐mineral supplementation on vertigo, nausea and vomiting in the first trimester of pregnancy. Archives of Gynecology and Obstetrics1992;251:181‐5. CzeizelAE , DudasI , MetnekiJ . Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Archives of Gynecology and Obstetrics1994;255:131‐9. CzeizelAE , MedveczkyE . Periconceptional multivitamin supplementation and multimalformed offspring. Obstetrics &amp; Gynecology2003;102:1255‐61. CzeizelAE , MetnekiJ , DudasI . Higher rate of multiple births after periconceptional vitamin supplementation. New England Journal of Medicine1994;330(23):1687‐8. CzeizelAE , MetnekiJ , DudasI . The effect of preconceptional multivitamin supplementation on fertility. International Journal for Vitamin and Nutrition Research1996;66:55‐8. CzeizelAE , MetnekiJ , DudasI . The higher rate of multiple births after periconceptional multivitamin supplementation: an analysis of causes. Acta Geneticae Medicae et Gemellologiae1994;43:175‐84. CzeizelAE , RockenbauerM , SusanskyE . No change in sexual activity during preconceptional multivitamin supplementation. British Journal of Obstetrics and Gynaecology1996;103:569‐73. CzeizelAE , VarghaP . Periconceptional folic acid/multivitamin supplementation and twin pregnancy. American Journal of Obstetrics and Gynecology2004;191(3):790‐4. CzeizelE , DudasI . Prevention of the first occurrence of anencephaly and spina bifida with periconceptional multivitamin supplementation (conclusion). Orvosi Hetilap1994;135(42):2313‐7. DoboM , CzeizelAE . Long‐term somatic and mental development of children after periconceptional multivitamin supplementation. European Journal of Pediatrics1998;157:719‐23. DudasI , RockenbauerM , CzeizelAE . The effect of preconceptional multivitamin supplementation on the menstrual cycle. Archives of Gynecology and Obstetrics1995;256(3):115‐23. MetnekiJ , DudasI , CzeizelAE . Higher rate of multiple births after periconceptual multivitamin supplementation. Orvosi Hetilap1996;137(43):2401‐5. ">Czeizel 1994</a>; <a href="./references#CD007950-bbs2-0002" title="Indian Council of Medical Research (ICMR) Collaborating Centres, Central Technical Co‐ordinatingUnit . Multicentric study of efficacy of periconceptional folic acid containing vitamin supplementation in prevention of open neural tube defects from India. Indian Journal of Medical Research2000;112:206‐11. ">ICMR 2000</a>; <a href="./references#CD007950-bbs2-0003" title="KirkePN , DalyLE , ElwoodJH . A randomized trial of low dose folic acid to prevent neural tube defects. Archives of Disease in Childhood1992;67:1442‐6. ">Kirke 1992</a>; <a href="./references#CD007950-bbs2-0004" title="LaurenceKM . Prevention of neural tube defects by improvement in maternal diet and preconceptional folic acid supplementation. Progress in Clinical and Biological Research1985;163:383‐8. LaurenceKM . The role of maternal nutrition and folic acid therapy before conception to prevent neural tube defects [Die Rolle der mütterlichen Ernährung und Folinsaure‐Therapie vor der Empfangnis zur Verhutung von Nervenkanal‐Defekten]. Monatsschrift fur Kinderheilkunde1982;130:646. LaurenceKM , CampbellH , JamesNE . The role of improvement in the maternal diet and preconceptional folic acid supplementation in the prevention of neural tube defects. Prevention of spina bifida and other neural tube defects. Academic Press, 1983:85‐125. LaurenceKM , JamesN , MillerM , CampbellH , TennantGB . A double randomised controlled trial for preconceptional folic acid supplementation for the prevention of recurrence of neural tube defects in high risk pregnancies. Journal of Medical Genetics1982;19(1):66. LaurenceKM , JamesN , MillerMH , TennantGB , CampbellH . Double blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural tube defects. BMJ (Clinical Research Edition)1981;282:1509‐11. ">Laurence 1981</a>; <a href="./references#CD007950-bbs2-0005" title="Anon . Folate supplements prevent recurrence of neural tube defects. Nutrition Review1992;50(Suppl 1):22‐4. Anon . Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet1991;338(8760):131‐7. ">MRC 1991</a>) with 6708 births examined the prevalence of NTDs in women receiving folic acid supplementation (alone or in combination with other vitamins and minerals) compared with women receiving placebo or other vitamins and minerals (not including folic acid). In all of these trials, supplementation started before pregnancy, continued throughout the first trimester, and involved daily supplementation. Periconceptional folate supplementation (alone, or in combination with other vitamins and minerals) reduces the prevalence of NTDs in comparison with no intervention, placebo or multiple micronutrients without folic acid (risk ratio (RR) 0.31, 95% confidence interval (CI) 0.17 to 0.58) (<a href="./references#CD007950-fig-0004" title="">Analysis 1.1</a>). </p> <p>Four trials recruited women with a history of NTDs (<a href="./references#CD007950-bbs2-0002" title="Indian Council of Medical Research (ICMR) Collaborating Centres, Central Technical Co‐ordinatingUnit . Multicentric study of efficacy of periconceptional folic acid containing vitamin supplementation in prevention of open neural tube defects from India. Indian Journal of Medical Research2000;112:206‐11. ">ICMR 2000</a>; <a href="./references#CD007950-bbs2-0003" title="KirkePN , DalyLE , ElwoodJH . A randomized trial of low dose folic acid to prevent neural tube defects. Archives of Disease in Childhood1992;67:1442‐6. ">Kirke 1992</a>; <a href="./references#CD007950-bbs2-0004" title="LaurenceKM . Prevention of neural tube defects by improvement in maternal diet and preconceptional folic acid supplementation. Progress in Clinical and Biological Research1985;163:383‐8. LaurenceKM . The role of maternal nutrition and folic acid therapy before conception to prevent neural tube defects [Die Rolle der mütterlichen Ernährung und Folinsaure‐Therapie vor der Empfangnis zur Verhutung von Nervenkanal‐Defekten]. Monatsschrift fur Kinderheilkunde1982;130:646. LaurenceKM , CampbellH , JamesNE . The role of improvement in the maternal diet and preconceptional folic acid supplementation in the prevention of neural tube defects. Prevention of spina bifida and other neural tube defects. Academic Press, 1983:85‐125. LaurenceKM , JamesN , MillerM , CampbellH , TennantGB . A double randomised controlled trial for preconceptional folic acid supplementation for the prevention of recurrence of neural tube defects in high risk pregnancies. Journal of Medical Genetics1982;19(1):66. LaurenceKM , JamesN , MillerMH , TennantGB , CampbellH . Double blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural tube defects. BMJ (Clinical Research Edition)1981;282:1509‐11. ">Laurence 1981</a>; <a href="./references#CD007950-bbs2-0005" title="Anon . Folate supplements prevent recurrence of neural tube defects. Nutrition Review1992;50(Suppl 1):22‐4. Anon . Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet1991;338(8760):131‐7. ">MRC 1991</a>) and supplementation was associated with a reduction in the recurrence of a pregnancy affected by a NTD (RR 0.34, 95% CI 0.18 to 0.64; n = 1846) (<a href="./references#CD007950-fig-0008" title="">Analysis 1.5</a>). In the single trial (4862 births) (<a href="./references#CD007950-bbs2-0001" title="CzeizelA , FritzG . Randomized trial of periconceptional vitamins. JAMA1989;262:1634. CzeizelA , RodeK . Trial to prevent first occurrence of neural tube defects by periconceptional multivitamin supplementation. Lancet1984;2(8393):40. CzeizelAE . Controlled studies of multivitamin supplementation on pregnancy outcomes. Annals of the New York Academy of Sciences1993;678:266‐75. CzeizelAE . Limb‐reduction defects and folic acid supplementation. Lancet1995;345(8954):932. CzeizelAE . Nutritional supplementation and prevention of congenital abnormalities. Current Opinion in Obstetrics &amp; Gynecology1995;7(2):88‐94. CzeizelAE . Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ1993;306:1645‐8. CzeizelAE . Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. American Journal of Medical Genetics1996;62(2):179‐83. CzeizelAE , DoboM . Postnatal somatic and mental development after periconceptional multivitamin supplementation. Archives of Disease in Childhood1994;70(3):229‐33. CzeizelAE , DudasI . Prevention of the first occurrence of neural‐tube defects by periconceptional vitamin supplementation. New England Journal of Medicine1992;327:1832‐5. CzeizelAE , DudasI , FritzG , TecsoiA , HanckA , KunovitsG . The effect of periconceptional multivitamin‐mineral supplementation on vertigo, nausea and vomiting in the first trimester of pregnancy. Archives of Gynecology and Obstetrics1992;251:181‐5. CzeizelAE , DudasI , MetnekiJ . Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Archives of Gynecology and Obstetrics1994;255:131‐9. CzeizelAE , MedveczkyE . Periconceptional multivitamin supplementation and multimalformed offspring. Obstetrics &amp; Gynecology2003;102:1255‐61. CzeizelAE , MetnekiJ , DudasI . Higher rate of multiple births after periconceptional vitamin supplementation. New England Journal of Medicine1994;330(23):1687‐8. CzeizelAE , MetnekiJ , DudasI . The effect of preconceptional multivitamin supplementation on fertility. International Journal for Vitamin and Nutrition Research1996;66:55‐8. CzeizelAE , MetnekiJ , DudasI . The higher rate of multiple births after periconceptional multivitamin supplementation: an analysis of causes. Acta Geneticae Medicae et Gemellologiae1994;43:175‐84. CzeizelAE , RockenbauerM , SusanskyE . No change in sexual activity during preconceptional multivitamin supplementation. British Journal of Obstetrics and Gynaecology1996;103:569‐73. CzeizelAE , VarghaP . Periconceptional folic acid/multivitamin supplementation and twin pregnancy. American Journal of Obstetrics and Gynecology2004;191(3):790‐4. CzeizelE , DudasI . Prevention of the first occurrence of anencephaly and spina bifida with periconceptional multivitamin supplementation (conclusion). Orvosi Hetilap1994;135(42):2313‐7. DoboM , CzeizelAE . Long‐term somatic and mental development of children after periconceptional multivitamin supplementation. European Journal of Pediatrics1998;157:719‐23. DudasI , RockenbauerM , CzeizelAE . The effect of preconceptional multivitamin supplementation on the menstrual cycle. Archives of Gynecology and Obstetrics1995;256(3):115‐23. MetnekiJ , DudasI , CzeizelAE . Higher rate of multiple births after periconceptual multivitamin supplementation. Orvosi Hetilap1996;137(43):2401‐5. ">Czeizel 1994</a>) recruiting women with no history of NTDs, and examining the first occurrence of NTDs, results favoured the group receiving supplementation, (RR 0.07, 95% CI 0.00 to 1.32) (<a href="./references#CD007950-fig-0008" title="">Analysis 1.5</a>); however, no cases of NTDs were observed in the supplemented group. </p> <p>In one of the trials involving 261 births (<a href="./references#CD007950-bbs2-0003" title="KirkePN , DalyLE , ElwoodJH . A randomized trial of low dose folic acid to prevent neural tube defects. Archives of Disease in Childhood1992;67:1442‐6. ">Kirke 1992</a>) the daily supplementation dose was 360 µg (0.36 mg); the results from this study favoured the intervention group (RR 0.17, 95% CI 0.01 to 4.21) (<a href="./references#CD007950-fig-0006" title="">Analysis 1.3</a>). In the remaining four trials (<a href="./references#CD007950-bbs2-0001" title="CzeizelA , FritzG . Randomized trial of periconceptional vitamins. JAMA1989;262:1634. CzeizelA , RodeK . Trial to prevent first occurrence of neural tube defects by periconceptional multivitamin supplementation. Lancet1984;2(8393):40. CzeizelAE . Controlled studies of multivitamin supplementation on pregnancy outcomes. Annals of the New York Academy of Sciences1993;678:266‐75. CzeizelAE . Limb‐reduction defects and folic acid supplementation. Lancet1995;345(8954):932. CzeizelAE . Nutritional supplementation and prevention of congenital abnormalities. Current Opinion in Obstetrics &amp; Gynecology1995;7(2):88‐94. CzeizelAE . Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ1993;306:1645‐8. CzeizelAE . Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. American Journal of Medical Genetics1996;62(2):179‐83. CzeizelAE , DoboM . Postnatal somatic and mental development after periconceptional multivitamin supplementation. Archives of Disease in Childhood1994;70(3):229‐33. CzeizelAE , DudasI . Prevention of the first occurrence of neural‐tube defects by periconceptional vitamin supplementation. New England Journal of Medicine1992;327:1832‐5. CzeizelAE , DudasI , FritzG , TecsoiA , HanckA , KunovitsG . The effect of periconceptional multivitamin‐mineral supplementation on vertigo, nausea and vomiting in the first trimester of pregnancy. Archives of Gynecology and Obstetrics1992;251:181‐5. CzeizelAE , DudasI , MetnekiJ . Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Archives of Gynecology and Obstetrics1994;255:131‐9. CzeizelAE , MedveczkyE . Periconceptional multivitamin supplementation and multimalformed offspring. Obstetrics &amp; Gynecology2003;102:1255‐61. CzeizelAE , MetnekiJ , DudasI . Higher rate of multiple births after periconceptional vitamin supplementation. New England Journal of Medicine1994;330(23):1687‐8. CzeizelAE , MetnekiJ , DudasI . The effect of preconceptional multivitamin supplementation on fertility. International Journal for Vitamin and Nutrition Research1996;66:55‐8. CzeizelAE , MetnekiJ , DudasI . The higher rate of multiple births after periconceptional multivitamin supplementation: an analysis of causes. Acta Geneticae Medicae et Gemellologiae1994;43:175‐84. CzeizelAE , RockenbauerM , SusanskyE . No change in sexual activity during preconceptional multivitamin supplementation. British Journal of Obstetrics and Gynaecology1996;103:569‐73. CzeizelAE , VarghaP . Periconceptional folic acid/multivitamin supplementation and twin pregnancy. American Journal of Obstetrics and Gynecology2004;191(3):790‐4. CzeizelE , DudasI . Prevention of the first occurrence of anencephaly and spina bifida with periconceptional multivitamin supplementation (conclusion). Orvosi Hetilap1994;135(42):2313‐7. DoboM , CzeizelAE . Long‐term somatic and mental development of children after periconceptional multivitamin supplementation. European Journal of Pediatrics1998;157:719‐23. DudasI , RockenbauerM , CzeizelAE . The effect of preconceptional multivitamin supplementation on the menstrual cycle. Archives of Gynecology and Obstetrics1995;256(3):115‐23. MetnekiJ , DudasI , CzeizelAE . Higher rate of multiple births after periconceptual multivitamin supplementation. Orvosi Hetilap1996;137(43):2401‐5. ">Czeizel 1994</a>; <a href="./references#CD007950-bbs2-0002" title="Indian Council of Medical Research (ICMR) Collaborating Centres, Central Technical Co‐ordinatingUnit . Multicentric study of efficacy of periconceptional folic acid containing vitamin supplementation in prevention of open neural tube defects from India. Indian Journal of Medical Research2000;112:206‐11. ">ICMR 2000</a>; <a href="./references#CD007950-bbs2-0004" title="LaurenceKM . Prevention of neural tube defects by improvement in maternal diet and preconceptional folic acid supplementation. Progress in Clinical and Biological Research1985;163:383‐8. LaurenceKM . The role of maternal nutrition and folic acid therapy before conception to prevent neural tube defects [Die Rolle der mütterlichen Ernährung und Folinsaure‐Therapie vor der Empfangnis zur Verhutung von Nervenkanal‐Defekten]. Monatsschrift fur Kinderheilkunde1982;130:646. LaurenceKM , CampbellH , JamesNE . The role of improvement in the maternal diet and preconceptional folic acid supplementation in the prevention of neural tube defects. Prevention of spina bifida and other neural tube defects. Academic Press, 1983:85‐125. LaurenceKM , JamesN , MillerM , CampbellH , TennantGB . A double randomised controlled trial for preconceptional folic acid supplementation for the prevention of recurrence of neural tube defects in high risk pregnancies. Journal of Medical Genetics1982;19(1):66. LaurenceKM , JamesN , MillerMH , TennantGB , CampbellH . Double blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural tube defects. BMJ (Clinical Research Edition)1981;282:1509‐11. ">Laurence 1981</a>; <a href="./references#CD007950-bbs2-0005" title="Anon . Folate supplements prevent recurrence of neural tube defects. Nutrition Review1992;50(Suppl 1):22‐4. Anon . Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet1991;338(8760):131‐7. ">MRC 1991</a>), the daily dose of folic acid was more than 400 µg (0.4 mg) and NTDs were reduced in the intervention group (RR 0.32, 95% CI 0.17 to 0.60; n = 6447 births) (<a href="./references#CD007950-fig-0006" title="">Analysis 1.3</a>). There was no evidence of a difference between subgroups, although only one study was included in one of the subgroups (Test for subgroup differences: Chi² = 0.14, df = 1 (P = 0.71), I² = 0%). </p> </section> <section id="CD007950-sec-0113"> <p><b>Cleft lip</b></p> <p>In the three trials (<a href="./references#CD007950-bbs2-0001" title="CzeizelA , FritzG . Randomized trial of periconceptional vitamins. JAMA1989;262:1634. CzeizelA , RodeK . Trial to prevent first occurrence of neural tube defects by periconceptional multivitamin supplementation. Lancet1984;2(8393):40. CzeizelAE . Controlled studies of multivitamin supplementation on pregnancy outcomes. Annals of the New York Academy of Sciences1993;678:266‐75. CzeizelAE . Limb‐reduction defects and folic acid supplementation. Lancet1995;345(8954):932. CzeizelAE . Nutritional supplementation and prevention of congenital abnormalities. Current Opinion in Obstetrics &amp; Gynecology1995;7(2):88‐94. CzeizelAE . Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ1993;306:1645‐8. CzeizelAE . Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. American Journal of Medical Genetics1996;62(2):179‐83. CzeizelAE , DoboM . Postnatal somatic and mental development after periconceptional multivitamin supplementation. Archives of Disease in Childhood1994;70(3):229‐33. CzeizelAE , DudasI . Prevention of the first occurrence of neural‐tube defects by periconceptional vitamin supplementation. New England Journal of Medicine1992;327:1832‐5. CzeizelAE , DudasI , FritzG , TecsoiA , HanckA , KunovitsG . The effect of periconceptional multivitamin‐mineral supplementation on vertigo, nausea and vomiting in the first trimester of pregnancy. Archives of Gynecology and Obstetrics1992;251:181‐5. CzeizelAE , DudasI , MetnekiJ . Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Archives of Gynecology and Obstetrics1994;255:131‐9. CzeizelAE , MedveczkyE . Periconceptional multivitamin supplementation and multimalformed offspring. Obstetrics &amp; Gynecology2003;102:1255‐61. CzeizelAE , MetnekiJ , DudasI . Higher rate of multiple births after periconceptional vitamin supplementation. New England Journal of Medicine1994;330(23):1687‐8. CzeizelAE , MetnekiJ , DudasI . The effect of preconceptional multivitamin supplementation on fertility. International Journal for Vitamin and Nutrition Research1996;66:55‐8. CzeizelAE , MetnekiJ , DudasI . The higher rate of multiple births after periconceptional multivitamin supplementation: an analysis of causes. Acta Geneticae Medicae et Gemellologiae1994;43:175‐84. CzeizelAE , RockenbauerM , SusanskyE . No change in sexual activity during preconceptional multivitamin supplementation. British Journal of Obstetrics and Gynaecology1996;103:569‐73. CzeizelAE , VarghaP . Periconceptional folic acid/multivitamin supplementation and twin pregnancy. American Journal of Obstetrics and Gynecology2004;191(3):790‐4. CzeizelE , DudasI . Prevention of the first occurrence of anencephaly and spina bifida with periconceptional multivitamin supplementation (conclusion). Orvosi Hetilap1994;135(42):2313‐7. DoboM , CzeizelAE . Long‐term somatic and mental development of children after periconceptional multivitamin supplementation. European Journal of Pediatrics1998;157:719‐23. DudasI , RockenbauerM , CzeizelAE . The effect of preconceptional multivitamin supplementation on the menstrual cycle. Archives of Gynecology and Obstetrics1995;256(3):115‐23. MetnekiJ , DudasI , CzeizelAE . Higher rate of multiple births after periconceptual multivitamin supplementation. Orvosi Hetilap1996;137(43):2401‐5. ">Czeizel 1994</a>; <a href="./references#CD007950-bbs2-0003" title="KirkePN , DalyLE , ElwoodJH . A randomized trial of low dose folic acid to prevent neural tube defects. Archives of Disease in Childhood1992;67:1442‐6. ">Kirke 1992</a>; <a href="./references#CD007950-bbs2-0005" title="Anon . Folate supplements prevent recurrence of neural tube defects. Nutrition Review1992;50(Suppl 1):22‐4. Anon . Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet1991;338(8760):131‐7. ">MRC 1991</a>) reporting the number of babies affected by cleft lip, there was no evidence of a difference between groups; overall eight babies were affected by cleft lip, four in each treatment group (<a href="./references#CD007950-fig-0012" title="">Analysis 1.9</a>). </p> </section> <section id="CD007950-sec-0114"> <p><b>Cleft palate</b></p> <p>Overall, only three babies were affected with cleft palate in the studies examining this outcome (<a href="./references#CD007950-bbs2-0001" title="CzeizelA , FritzG . Randomized trial of periconceptional vitamins. JAMA1989;262:1634. CzeizelA , RodeK . Trial to prevent first occurrence of neural tube defects by periconceptional multivitamin supplementation. Lancet1984;2(8393):40. CzeizelAE . Controlled studies of multivitamin supplementation on pregnancy outcomes. Annals of the New York Academy of Sciences1993;678:266‐75. CzeizelAE . Limb‐reduction defects and folic acid supplementation. Lancet1995;345(8954):932. CzeizelAE . Nutritional supplementation and prevention of congenital abnormalities. Current Opinion in Obstetrics &amp; Gynecology1995;7(2):88‐94. CzeizelAE . Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ1993;306:1645‐8. CzeizelAE . Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. American Journal of Medical Genetics1996;62(2):179‐83. CzeizelAE , DoboM . Postnatal somatic and mental development after periconceptional multivitamin supplementation. Archives of Disease in Childhood1994;70(3):229‐33. CzeizelAE , DudasI . Prevention of the first occurrence of neural‐tube defects by periconceptional vitamin supplementation. New England Journal of Medicine1992;327:1832‐5. CzeizelAE , DudasI , FritzG , TecsoiA , HanckA , KunovitsG . The effect of periconceptional multivitamin‐mineral supplementation on vertigo, nausea and vomiting in the first trimester of pregnancy. Archives of Gynecology and Obstetrics1992;251:181‐5. CzeizelAE , DudasI , MetnekiJ . Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Archives of Gynecology and Obstetrics1994;255:131‐9. CzeizelAE , MedveczkyE . Periconceptional multivitamin supplementation and multimalformed offspring. Obstetrics &amp; Gynecology2003;102:1255‐61. CzeizelAE , MetnekiJ , DudasI . Higher rate of multiple births after periconceptional vitamin supplementation. New England Journal of Medicine1994;330(23):1687‐8. CzeizelAE , MetnekiJ , DudasI . The effect of preconceptional multivitamin supplementation on fertility. International Journal for Vitamin and Nutrition Research1996;66:55‐8. CzeizelAE , MetnekiJ , DudasI . The higher rate of multiple births after periconceptional multivitamin supplementation: an analysis of causes. Acta Geneticae Medicae et Gemellologiae1994;43:175‐84. CzeizelAE , RockenbauerM , SusanskyE . No change in sexual activity during preconceptional multivitamin supplementation. British Journal of Obstetrics and Gynaecology1996;103:569‐73. CzeizelAE , VarghaP . Periconceptional folic acid/multivitamin supplementation and twin pregnancy. American Journal of Obstetrics and Gynecology2004;191(3):790‐4. CzeizelE , DudasI . Prevention of the first occurrence of anencephaly and spina bifida with periconceptional multivitamin supplementation (conclusion). Orvosi Hetilap1994;135(42):2313‐7. DoboM , CzeizelAE . Long‐term somatic and mental development of children after periconceptional multivitamin supplementation. European Journal of Pediatrics1998;157:719‐23. DudasI , RockenbauerM , CzeizelAE . The effect of preconceptional multivitamin supplementation on the menstrual cycle. Archives of Gynecology and Obstetrics1995;256(3):115‐23. MetnekiJ , DudasI , CzeizelAE . Higher rate of multiple births after periconceptual multivitamin supplementation. Orvosi Hetilap1996;137(43):2401‐5. ">Czeizel 1994</a>; <a href="./references#CD007950-bbs2-0003" title="KirkePN , DalyLE , ElwoodJH . A randomized trial of low dose folic acid to prevent neural tube defects. Archives of Disease in Childhood1992;67:1442‐6. ">Kirke 1992</a>; <a href="./references#CD007950-bbs2-0005" title="Anon . Folate supplements prevent recurrence of neural tube defects. Nutrition Review1992;50(Suppl 1):22‐4. Anon . Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet1991;338(8760):131‐7. ">MRC 1991</a>); there was no significant difference between the group receiving folic acid supplementation and comparison groups (RR 0.73, 95% CI 0.05 to 10.89; n = 5612 births) (<a href="./references#CD007950-fig-0020" title="">Analysis 1.17</a>). </p> </section> <section id="CD007950-sec-0115"> <p><b>Congenital cardiovascular anomalies</b></p> <p>This outcome was reported in three trials (<a href="./references#CD007950-bbs2-0001" title="CzeizelA , FritzG . Randomized trial of periconceptional vitamins. JAMA1989;262:1634. CzeizelA , RodeK . Trial to prevent first occurrence of neural tube defects by periconceptional multivitamin supplementation. Lancet1984;2(8393):40. CzeizelAE . Controlled studies of multivitamin supplementation on pregnancy outcomes. Annals of the New York Academy of Sciences1993;678:266‐75. CzeizelAE . Limb‐reduction defects and folic acid supplementation. Lancet1995;345(8954):932. CzeizelAE . Nutritional supplementation and prevention of congenital abnormalities. Current Opinion in Obstetrics &amp; Gynecology1995;7(2):88‐94. CzeizelAE . Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ1993;306:1645‐8. CzeizelAE . Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. American Journal of Medical Genetics1996;62(2):179‐83. CzeizelAE , DoboM . Postnatal somatic and mental development after periconceptional multivitamin supplementation. Archives of Disease in Childhood1994;70(3):229‐33. CzeizelAE , DudasI . Prevention of the first occurrence of neural‐tube defects by periconceptional vitamin supplementation. New England Journal of Medicine1992;327:1832‐5. CzeizelAE , DudasI , FritzG , TecsoiA , HanckA , KunovitsG . The effect of periconceptional multivitamin‐mineral supplementation on vertigo, nausea and vomiting in the first trimester of pregnancy. Archives of Gynecology and Obstetrics1992;251:181‐5. CzeizelAE , DudasI , MetnekiJ . Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Archives of Gynecology and Obstetrics1994;255:131‐9. CzeizelAE , MedveczkyE . Periconceptional multivitamin supplementation and multimalformed offspring. Obstetrics &amp; Gynecology2003;102:1255‐61. CzeizelAE , MetnekiJ , DudasI . Higher rate of multiple births after periconceptional vitamin supplementation. New England Journal of Medicine1994;330(23):1687‐8. CzeizelAE , MetnekiJ , DudasI . The effect of preconceptional multivitamin supplementation on fertility. International Journal for Vitamin and Nutrition Research1996;66:55‐8. CzeizelAE , MetnekiJ , DudasI . The higher rate of multiple births after periconceptional multivitamin supplementation: an analysis of causes. Acta Geneticae Medicae et Gemellologiae1994;43:175‐84. CzeizelAE , RockenbauerM , SusanskyE . No change in sexual activity during preconceptional multivitamin supplementation. British Journal of Obstetrics and Gynaecology1996;103:569‐73. CzeizelAE , VarghaP . Periconceptional folic acid/multivitamin supplementation and twin pregnancy. American Journal of Obstetrics and Gynecology2004;191(3):790‐4. CzeizelE , DudasI . Prevention of the first occurrence of anencephaly and spina bifida with periconceptional multivitamin supplementation (conclusion). Orvosi Hetilap1994;135(42):2313‐7. DoboM , CzeizelAE . Long‐term somatic and mental development of children after periconceptional multivitamin supplementation. European Journal of Pediatrics1998;157:719‐23. DudasI , RockenbauerM , CzeizelAE . The effect of preconceptional multivitamin supplementation on the menstrual cycle. Archives of Gynecology and Obstetrics1995;256(3):115‐23. MetnekiJ , DudasI , CzeizelAE . Higher rate of multiple births after periconceptual multivitamin supplementation. Orvosi Hetilap1996;137(43):2401‐5. ">Czeizel 1994</a>; <a href="./references#CD007950-bbs2-0003" title="KirkePN , DalyLE , ElwoodJH . A randomized trial of low dose folic acid to prevent neural tube defects. Archives of Disease in Childhood1992;67:1442‐6. ">Kirke 1992</a>; <a href="./references#CD007950-bbs2-0005" title="Anon . Folate supplements prevent recurrence of neural tube defects. Nutrition Review1992;50(Suppl 1):22‐4. Anon . Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet1991;338(8760):131‐7. ">MRC 1991</a>). There was no significant evidence of a difference between experimental and control groups in the number of babies with congenital cardiovascular defects irrespective of dose of drug, or history of NTDs (<a href="./references#CD007950-fig-0028" title="">Analysis 1.25</a>). </p> </section> <section id="CD007950-sec-0116"> <p><b>Other birth defects (excluding NTDs, cleft lip, cleft palate and cardiovascular defects)</b></p> <p>Three trials reported the number of babies with other birth defects (<a href="./references#CD007950-bbs2-0001" title="CzeizelA , FritzG . Randomized trial of periconceptional vitamins. JAMA1989;262:1634. CzeizelA , RodeK . Trial to prevent first occurrence of neural tube defects by periconceptional multivitamin supplementation. Lancet1984;2(8393):40. CzeizelAE . Controlled studies of multivitamin supplementation on pregnancy outcomes. Annals of the New York Academy of Sciences1993;678:266‐75. CzeizelAE . Limb‐reduction defects and folic acid supplementation. Lancet1995;345(8954):932. CzeizelAE . Nutritional supplementation and prevention of congenital abnormalities. Current Opinion in Obstetrics &amp; Gynecology1995;7(2):88‐94. CzeizelAE . Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ1993;306:1645‐8. CzeizelAE . Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. American Journal of Medical Genetics1996;62(2):179‐83. CzeizelAE , DoboM . Postnatal somatic and mental development after periconceptional multivitamin supplementation. Archives of Disease in Childhood1994;70(3):229‐33. CzeizelAE , DudasI . Prevention of the first occurrence of neural‐tube defects by periconceptional vitamin supplementation. New England Journal of Medicine1992;327:1832‐5. CzeizelAE , DudasI , FritzG , TecsoiA , HanckA , KunovitsG . The effect of periconceptional multivitamin‐mineral supplementation on vertigo, nausea and vomiting in the first trimester of pregnancy. Archives of Gynecology and Obstetrics1992;251:181‐5. CzeizelAE , DudasI , MetnekiJ . Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Archives of Gynecology and Obstetrics1994;255:131‐9. CzeizelAE , MedveczkyE . Periconceptional multivitamin supplementation and multimalformed offspring. Obstetrics &amp; Gynecology2003;102:1255‐61. CzeizelAE , MetnekiJ , DudasI . Higher rate of multiple births after periconceptional vitamin supplementation. New England Journal of Medicine1994;330(23):1687‐8. CzeizelAE , MetnekiJ , DudasI . The effect of preconceptional multivitamin supplementation on fertility. International Journal for Vitamin and Nutrition Research1996;66:55‐8. CzeizelAE , MetnekiJ , DudasI . The higher rate of multiple births after periconceptional multivitamin supplementation: an analysis of causes. Acta Geneticae Medicae et Gemellologiae1994;43:175‐84. CzeizelAE , RockenbauerM , SusanskyE . No change in sexual activity during preconceptional multivitamin supplementation. British Journal of Obstetrics and Gynaecology1996;103:569‐73. CzeizelAE , VarghaP . Periconceptional folic acid/multivitamin supplementation and twin pregnancy. American Journal of Obstetrics and Gynecology2004;191(3):790‐4. CzeizelE , DudasI . Prevention of the first occurrence of anencephaly and spina bifida with periconceptional multivitamin supplementation (conclusion). Orvosi Hetilap1994;135(42):2313‐7. DoboM , CzeizelAE . Long‐term somatic and mental development of children after periconceptional multivitamin supplementation. European Journal of Pediatrics1998;157:719‐23. DudasI , RockenbauerM , CzeizelAE . The effect of preconceptional multivitamin supplementation on the menstrual cycle. Archives of Gynecology and Obstetrics1995;256(3):115‐23. MetnekiJ , DudasI , CzeizelAE . Higher rate of multiple births after periconceptual multivitamin supplementation. Orvosi Hetilap1996;137(43):2401‐5. ">Czeizel 1994</a>; <a href="./references#CD007950-bbs2-0003" title="KirkePN , DalyLE , ElwoodJH . A randomized trial of low dose folic acid to prevent neural tube defects. Archives of Disease in Childhood1992;67:1442‐6. ">Kirke 1992</a>; <a href="./references#CD007950-bbs2-0005" title="Anon . Folate supplements prevent recurrence of neural tube defects. Nutrition Review1992;50(Suppl 1):22‐4. Anon . Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet1991;338(8760):131‐7. ">MRC 1991</a>). Overall, when results from these three trials were pooled, there was no significant evidence of a difference between groups (RR 0.94, 95% CI 0.53 to 1.66; n = 5612 births) (<a href="./references#CD007950-fig-0036" title="">Analysis 1.33</a>). </p> </section> </section> <section id="CD007950-sec-0117"> <h6 class="title">Maternal outcomes</h6> <section id="CD007950-sec-0118"> <p><b>Maternal anaemia at term (defined as haemoglobin (Hb) less than 110 g/L); red blood cell folate at term; serum folate at term</b></p> <p>No trials reported on these outcomes.</p> </section> <section id="CD007950-sec-0119"> <p><b>Miscarriage</b></p> <p>All five trials examined the rate of miscarriage in women with confirmed pregnancy receiving daily folic acid supplements compared with the comparison groups (<a href="./references#CD007950-bbs2-0001" title="CzeizelA , FritzG . Randomized trial of periconceptional vitamins. JAMA1989;262:1634. CzeizelA , RodeK . Trial to prevent first occurrence of neural tube defects by periconceptional multivitamin supplementation. Lancet1984;2(8393):40. CzeizelAE . Controlled studies of multivitamin supplementation on pregnancy outcomes. Annals of the New York Academy of Sciences1993;678:266‐75. CzeizelAE . Limb‐reduction defects and folic acid supplementation. Lancet1995;345(8954):932. CzeizelAE . Nutritional supplementation and prevention of congenital abnormalities. Current Opinion in Obstetrics &amp; Gynecology1995;7(2):88‐94. CzeizelAE . Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ1993;306:1645‐8. CzeizelAE . Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. American Journal of Medical Genetics1996;62(2):179‐83. CzeizelAE , DoboM . Postnatal somatic and mental development after periconceptional multivitamin supplementation. Archives of Disease in Childhood1994;70(3):229‐33. CzeizelAE , DudasI . Prevention of the first occurrence of neural‐tube defects by periconceptional vitamin supplementation. New England Journal of Medicine1992;327:1832‐5. CzeizelAE , DudasI , FritzG , TecsoiA , HanckA , KunovitsG . The effect of periconceptional multivitamin‐mineral supplementation on vertigo, nausea and vomiting in the first trimester of pregnancy. Archives of Gynecology and Obstetrics1992;251:181‐5. CzeizelAE , DudasI , MetnekiJ . Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Archives of Gynecology and Obstetrics1994;255:131‐9. CzeizelAE , MedveczkyE . Periconceptional multivitamin supplementation and multimalformed offspring. Obstetrics &amp; Gynecology2003;102:1255‐61. CzeizelAE , MetnekiJ , DudasI . Higher rate of multiple births after periconceptional vitamin supplementation. New England Journal of Medicine1994;330(23):1687‐8. CzeizelAE , MetnekiJ , DudasI . The effect of preconceptional multivitamin supplementation on fertility. International Journal for Vitamin and Nutrition Research1996;66:55‐8. CzeizelAE , MetnekiJ , DudasI . The higher rate of multiple births after periconceptional multivitamin supplementation: an analysis of causes. Acta Geneticae Medicae et Gemellologiae1994;43:175‐84. CzeizelAE , RockenbauerM , SusanskyE . No change in sexual activity during preconceptional multivitamin supplementation. British Journal of Obstetrics and Gynaecology1996;103:569‐73. CzeizelAE , VarghaP . Periconceptional folic acid/multivitamin supplementation and twin pregnancy. American Journal of Obstetrics and Gynecology2004;191(3):790‐4. CzeizelE , DudasI . Prevention of the first occurrence of anencephaly and spina bifida with periconceptional multivitamin supplementation (conclusion). Orvosi Hetilap1994;135(42):2313‐7. DoboM , CzeizelAE . Long‐term somatic and mental development of children after periconceptional multivitamin supplementation. European Journal of Pediatrics1998;157:719‐23. DudasI , RockenbauerM , CzeizelAE . The effect of preconceptional multivitamin supplementation on the menstrual cycle. Archives of Gynecology and Obstetrics1995;256(3):115‐23. MetnekiJ , DudasI , CzeizelAE . Higher rate of multiple births after periconceptual multivitamin supplementation. Orvosi Hetilap1996;137(43):2401‐5. ">Czeizel 1994</a>; <a href="./references#CD007950-bbs2-0002" title="Indian Council of Medical Research (ICMR) Collaborating Centres, Central Technical Co‐ordinatingUnit . Multicentric study of efficacy of periconceptional folic acid containing vitamin supplementation in prevention of open neural tube defects from India. Indian Journal of Medical Research2000;112:206‐11. ">ICMR 2000</a>; <a href="./references#CD007950-bbs2-0003" title="KirkePN , DalyLE , ElwoodJH . A randomized trial of low dose folic acid to prevent neural tube defects. Archives of Disease in Childhood1992;67:1442‐6. ">Kirke 1992</a>; <a href="./references#CD007950-bbs2-0004" title="LaurenceKM . Prevention of neural tube defects by improvement in maternal diet and preconceptional folic acid supplementation. Progress in Clinical and Biological Research1985;163:383‐8. LaurenceKM . The role of maternal nutrition and folic acid therapy before conception to prevent neural tube defects [Die Rolle der mütterlichen Ernährung und Folinsaure‐Therapie vor der Empfangnis zur Verhutung von Nervenkanal‐Defekten]. Monatsschrift fur Kinderheilkunde1982;130:646. LaurenceKM , CampbellH , JamesNE . The role of improvement in the maternal diet and preconceptional folic acid supplementation in the prevention of neural tube defects. Prevention of spina bifida and other neural tube defects. Academic Press, 1983:85‐125. LaurenceKM , JamesN , MillerM , CampbellH , TennantGB . A double randomised controlled trial for preconceptional folic acid supplementation for the prevention of recurrence of neural tube defects in high risk pregnancies. Journal of Medical Genetics1982;19(1):66. LaurenceKM , JamesN , MillerMH , TennantGB , CampbellH . Double blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural tube defects. BMJ (Clinical Research Edition)1981;282:1509‐11. ">Laurence 1981</a>; <a href="./references#CD007950-bbs2-0005" title="Anon . Folate supplements prevent recurrence of neural tube defects. Nutrition Review1992;50(Suppl 1):22‐4. Anon . Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet1991;338(8760):131‐7. ">MRC 1991</a>); the number of miscarriages was less in the group receiving supplements containing folic acid, (RR 1.10, 95% CI 0.94 to 1.28; n = 7391 pregnancies). There were no significant differences between experimental and comparison groups for any of the subgroups we examined (<a href="./references#CD007950-fig-0044" title="">Analysis 1.41</a>). </p> </section> </section> </section> <section id="CD007950-sec-0120"> <h5 class="title">Secondary outcomes</h5> <section id="CD007950-sec-0121"> <h6 class="title">Infant outcomes</h6> <section id="CD007950-sec-0122"> <p><b>Spina bifida</b></p> <p>Three studies (<a href="./references#CD007950-bbs2-0001" title="CzeizelA , FritzG . Randomized trial of periconceptional vitamins. JAMA1989;262:1634. CzeizelA , RodeK . Trial to prevent first occurrence of neural tube defects by periconceptional multivitamin supplementation. Lancet1984;2(8393):40. CzeizelAE . Controlled studies of multivitamin supplementation on pregnancy outcomes. Annals of the New York Academy of Sciences1993;678:266‐75. CzeizelAE . Limb‐reduction defects and folic acid supplementation. Lancet1995;345(8954):932. CzeizelAE . Nutritional supplementation and prevention of congenital abnormalities. Current Opinion in Obstetrics &amp; Gynecology1995;7(2):88‐94. CzeizelAE . Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ1993;306:1645‐8. CzeizelAE . Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. American Journal of Medical Genetics1996;62(2):179‐83. CzeizelAE , DoboM . Postnatal somatic and mental development after periconceptional multivitamin supplementation. Archives of Disease in Childhood1994;70(3):229‐33. CzeizelAE , DudasI . Prevention of the first occurrence of neural‐tube defects by periconceptional vitamin supplementation. New England Journal of Medicine1992;327:1832‐5. CzeizelAE , DudasI , FritzG , TecsoiA , HanckA , KunovitsG . The effect of periconceptional multivitamin‐mineral supplementation on vertigo, nausea and vomiting in the first trimester of pregnancy. Archives of Gynecology and Obstetrics1992;251:181‐5. CzeizelAE , DudasI , MetnekiJ . Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Archives of Gynecology and Obstetrics1994;255:131‐9. CzeizelAE , MedveczkyE . Periconceptional multivitamin supplementation and multimalformed offspring. Obstetrics &amp; Gynecology2003;102:1255‐61. CzeizelAE , MetnekiJ , DudasI . Higher rate of multiple births after periconceptional vitamin supplementation. New England Journal of Medicine1994;330(23):1687‐8. CzeizelAE , MetnekiJ , DudasI . The effect of preconceptional multivitamin supplementation on fertility. International Journal for Vitamin and Nutrition Research1996;66:55‐8. CzeizelAE , MetnekiJ , DudasI . The higher rate of multiple births after periconceptional multivitamin supplementation: an analysis of causes. Acta Geneticae Medicae et Gemellologiae1994;43:175‐84. CzeizelAE , RockenbauerM , SusanskyE . No change in sexual activity during preconceptional multivitamin supplementation. British Journal of Obstetrics and Gynaecology1996;103:569‐73. CzeizelAE , VarghaP . Periconceptional folic acid/multivitamin supplementation and twin pregnancy. American Journal of Obstetrics and Gynecology2004;191(3):790‐4. CzeizelE , DudasI . Prevention of the first occurrence of anencephaly and spina bifida with periconceptional multivitamin supplementation (conclusion). Orvosi Hetilap1994;135(42):2313‐7. DoboM , CzeizelAE . Long‐term somatic and mental development of children after periconceptional multivitamin supplementation. European Journal of Pediatrics1998;157:719‐23. DudasI , RockenbauerM , CzeizelAE . The effect of preconceptional multivitamin supplementation on the menstrual cycle. Archives of Gynecology and Obstetrics1995;256(3):115‐23. MetnekiJ , DudasI , CzeizelAE . Higher rate of multiple births after periconceptual multivitamin supplementation. Orvosi Hetilap1996;137(43):2401‐5. ">Czeizel 1994</a>; <a href="./references#CD007950-bbs2-0002" title="Indian Council of Medical Research (ICMR) Collaborating Centres, Central Technical Co‐ordinatingUnit . Multicentric study of efficacy of periconceptional folic acid containing vitamin supplementation in prevention of open neural tube defects from India. Indian Journal of Medical Research2000;112:206‐11. ">ICMR 2000</a>; <a href="./references#CD007950-bbs2-0004" title="LaurenceKM . Prevention of neural tube defects by improvement in maternal diet and preconceptional folic acid supplementation. Progress in Clinical and Biological Research1985;163:383‐8. LaurenceKM . The role of maternal nutrition and folic acid therapy before conception to prevent neural tube defects [Die Rolle der mütterlichen Ernährung und Folinsaure‐Therapie vor der Empfangnis zur Verhutung von Nervenkanal‐Defekten]. Monatsschrift fur Kinderheilkunde1982;130:646. LaurenceKM , CampbellH , JamesNE . The role of improvement in the maternal diet and preconceptional folic acid supplementation in the prevention of neural tube defects. Prevention of spina bifida and other neural tube defects. Academic Press, 1983:85‐125. LaurenceKM , JamesN , MillerM , CampbellH , TennantGB . A double randomised controlled trial for preconceptional folic acid supplementation for the prevention of recurrence of neural tube defects in high risk pregnancies. Journal of Medical Genetics1982;19(1):66. LaurenceKM , JamesN , MillerMH , TennantGB , CampbellH . Double blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural tube defects. BMJ (Clinical Research Edition)1981;282:1509‐11. ">Laurence 1981</a>) reported six spina bifida cases from 4546 births. Although the numbers of spina bifida cases were less in the folate supplemented groups, there was no significant difference between treatment groups (RR 0.32, 95% CI 0.06 to 1.62) (<a href="./references#CD007950-fig-0052" title="">Analysis 1.49</a>). </p> </section> <section id="CD007950-sec-0123"> <p><b>Anencephaly</b></p> <p>Four studies reported 17 cases of anencephaly (<a href="./references#CD007950-bbs2-0001" title="CzeizelA , FritzG . Randomized trial of periconceptional vitamins. JAMA1989;262:1634. CzeizelA , RodeK . Trial to prevent first occurrence of neural tube defects by periconceptional multivitamin supplementation. Lancet1984;2(8393):40. CzeizelAE . Controlled studies of multivitamin supplementation on pregnancy outcomes. Annals of the New York Academy of Sciences1993;678:266‐75. CzeizelAE . Limb‐reduction defects and folic acid supplementation. Lancet1995;345(8954):932. CzeizelAE . Nutritional supplementation and prevention of congenital abnormalities. Current Opinion in Obstetrics &amp; Gynecology1995;7(2):88‐94. CzeizelAE . Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ1993;306:1645‐8. CzeizelAE . Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. American Journal of Medical Genetics1996;62(2):179‐83. CzeizelAE , DoboM . Postnatal somatic and mental development after periconceptional multivitamin supplementation. Archives of Disease in Childhood1994;70(3):229‐33. CzeizelAE , DudasI . Prevention of the first occurrence of neural‐tube defects by periconceptional vitamin supplementation. New England Journal of Medicine1992;327:1832‐5. CzeizelAE , DudasI , FritzG , TecsoiA , HanckA , KunovitsG . The effect of periconceptional multivitamin‐mineral supplementation on vertigo, nausea and vomiting in the first trimester of pregnancy. Archives of Gynecology and Obstetrics1992;251:181‐5. CzeizelAE , DudasI , MetnekiJ . Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Archives of Gynecology and Obstetrics1994;255:131‐9. CzeizelAE , MedveczkyE . Periconceptional multivitamin supplementation and multimalformed offspring. Obstetrics &amp; Gynecology2003;102:1255‐61. CzeizelAE , MetnekiJ , DudasI . Higher rate of multiple births after periconceptional vitamin supplementation. New England Journal of Medicine1994;330(23):1687‐8. CzeizelAE , MetnekiJ , DudasI . The effect of preconceptional multivitamin supplementation on fertility. International Journal for Vitamin and Nutrition Research1996;66:55‐8. CzeizelAE , MetnekiJ , DudasI . The higher rate of multiple births after periconceptional multivitamin supplementation: an analysis of causes. Acta Geneticae Medicae et Gemellologiae1994;43:175‐84. CzeizelAE , RockenbauerM , SusanskyE . No change in sexual activity during preconceptional multivitamin supplementation. British Journal of Obstetrics and Gynaecology1996;103:569‐73. CzeizelAE , VarghaP . Periconceptional folic acid/multivitamin supplementation and twin pregnancy. American Journal of Obstetrics and Gynecology2004;191(3):790‐4. CzeizelE , DudasI . Prevention of the first occurrence of anencephaly and spina bifida with periconceptional multivitamin supplementation (conclusion). Orvosi Hetilap1994;135(42):2313‐7. DoboM , CzeizelAE . Long‐term somatic and mental development of children after periconceptional multivitamin supplementation. European Journal of Pediatrics1998;157:719‐23. DudasI , RockenbauerM , CzeizelAE . The effect of preconceptional multivitamin supplementation on the menstrual cycle. Archives of Gynecology and Obstetrics1995;256(3):115‐23. MetnekiJ , DudasI , CzeizelAE . Higher rate of multiple births after periconceptual multivitamin supplementation. Orvosi Hetilap1996;137(43):2401‐5. ">Czeizel 1994</a>; <a href="./references#CD007950-bbs2-0002" title="Indian Council of Medical Research (ICMR) Collaborating Centres, Central Technical Co‐ordinatingUnit . Multicentric study of efficacy of periconceptional folic acid containing vitamin supplementation in prevention of open neural tube defects from India. Indian Journal of Medical Research2000;112:206‐11. ">ICMR 2000</a>; <a href="./references#CD007950-bbs2-0003" title="KirkePN , DalyLE , ElwoodJH . A randomized trial of low dose folic acid to prevent neural tube defects. Archives of Disease in Childhood1992;67:1442‐6. ">Kirke 1992</a>; <a href="./references#CD007950-bbs2-0005" title="Anon . Folate supplements prevent recurrence of neural tube defects. Nutrition Review1992;50(Suppl 1):22‐4. Anon . Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet1991;338(8760):131‐7. ">MRC 1991</a>), with no significant difference between the two treatment groups (RR 0.36, 95% CI 0.13 to 1.03; n = 4807 births) (<a href="./references#CD007950-fig-0053" title="">Analysis 1.50</a>). </p> </section> <section id="CD007950-sec-0124"> <p><b>Stillbirths</b></p> <p>Stillbirths were reported in four trials (<a href="./references#CD007950-bbs2-0001" title="CzeizelA , FritzG . Randomized trial of periconceptional vitamins. JAMA1989;262:1634. CzeizelA , RodeK . Trial to prevent first occurrence of neural tube defects by periconceptional multivitamin supplementation. Lancet1984;2(8393):40. CzeizelAE . Controlled studies of multivitamin supplementation on pregnancy outcomes. Annals of the New York Academy of Sciences1993;678:266‐75. CzeizelAE . Limb‐reduction defects and folic acid supplementation. Lancet1995;345(8954):932. CzeizelAE . Nutritional supplementation and prevention of congenital abnormalities. Current Opinion in Obstetrics &amp; Gynecology1995;7(2):88‐94. CzeizelAE . Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ1993;306:1645‐8. CzeizelAE . Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. American Journal of Medical Genetics1996;62(2):179‐83. CzeizelAE , DoboM . Postnatal somatic and mental development after periconceptional multivitamin supplementation. Archives of Disease in Childhood1994;70(3):229‐33. CzeizelAE , DudasI . Prevention of the first occurrence of neural‐tube defects by periconceptional vitamin supplementation. New England Journal of Medicine1992;327:1832‐5. CzeizelAE , DudasI , FritzG , TecsoiA , HanckA , KunovitsG . The effect of periconceptional multivitamin‐mineral supplementation on vertigo, nausea and vomiting in the first trimester of pregnancy. Archives of Gynecology and Obstetrics1992;251:181‐5. CzeizelAE , DudasI , MetnekiJ . Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Archives of Gynecology and Obstetrics1994;255:131‐9. CzeizelAE , MedveczkyE . Periconceptional multivitamin supplementation and multimalformed offspring. Obstetrics &amp; Gynecology2003;102:1255‐61. CzeizelAE , MetnekiJ , DudasI . Higher rate of multiple births after periconceptional vitamin supplementation. New England Journal of Medicine1994;330(23):1687‐8. CzeizelAE , MetnekiJ , DudasI . The effect of preconceptional multivitamin supplementation on fertility. International Journal for Vitamin and Nutrition Research1996;66:55‐8. CzeizelAE , MetnekiJ , DudasI . The higher rate of multiple births after periconceptional multivitamin supplementation: an analysis of causes. Acta Geneticae Medicae et Gemellologiae1994;43:175‐84. CzeizelAE , RockenbauerM , SusanskyE . No change in sexual activity during preconceptional multivitamin supplementation. British Journal of Obstetrics and Gynaecology1996;103:569‐73. CzeizelAE , VarghaP . Periconceptional folic acid/multivitamin supplementation and twin pregnancy. American Journal of Obstetrics and Gynecology2004;191(3):790‐4. CzeizelE , DudasI . Prevention of the first occurrence of anencephaly and spina bifida with periconceptional multivitamin supplementation (conclusion). Orvosi Hetilap1994;135(42):2313‐7. DoboM , CzeizelAE . Long‐term somatic and mental development of children after periconceptional multivitamin supplementation. European Journal of Pediatrics1998;157:719‐23. DudasI , RockenbauerM , CzeizelAE . The effect of preconceptional multivitamin supplementation on the menstrual cycle. Archives of Gynecology and Obstetrics1995;256(3):115‐23. MetnekiJ , DudasI , CzeizelAE . Higher rate of multiple births after periconceptual multivitamin supplementation. Orvosi Hetilap1996;137(43):2401‐5. ">Czeizel 1994</a>; <a href="./references#CD007950-bbs2-0002" title="Indian Council of Medical Research (ICMR) Collaborating Centres, Central Technical Co‐ordinatingUnit . Multicentric study of efficacy of periconceptional folic acid containing vitamin supplementation in prevention of open neural tube defects from India. Indian Journal of Medical Research2000;112:206‐11. ">ICMR 2000</a>; <a href="./references#CD007950-bbs2-0003" title="KirkePN , DalyLE , ElwoodJH . A randomized trial of low dose folic acid to prevent neural tube defects. Archives of Disease in Childhood1992;67:1442‐6. ">Kirke 1992</a>; <a href="./references#CD007950-bbs2-0005" title="Anon . Folate supplements prevent recurrence of neural tube defects. Nutrition Review1992;50(Suppl 1):22‐4. Anon . Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet1991;338(8760):131‐7. ">MRC 1991</a>). There was no significant evidence of any difference between treatment groups in the pooled analysis (RR 1.05, 95% CI 0.54 to 2.05), or in any subgroup analyses (<a href="./references#CD007950-fig-0054" title="">Analysis 1.51</a>). </p> </section> <section id="CD007950-sec-0125"> <p><b>Pregnancy termination for fetal anomaly</b></p> <p>Overall, in the four studies examining this outcome (<a href="./references#CD007950-bbs2-0001" title="CzeizelA , FritzG . Randomized trial of periconceptional vitamins. JAMA1989;262:1634. CzeizelA , RodeK . Trial to prevent first occurrence of neural tube defects by periconceptional multivitamin supplementation. Lancet1984;2(8393):40. CzeizelAE . Controlled studies of multivitamin supplementation on pregnancy outcomes. Annals of the New York Academy of Sciences1993;678:266‐75. CzeizelAE . Limb‐reduction defects and folic acid supplementation. Lancet1995;345(8954):932. CzeizelAE . Nutritional supplementation and prevention of congenital abnormalities. Current Opinion in Obstetrics &amp; Gynecology1995;7(2):88‐94. CzeizelAE . Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ1993;306:1645‐8. CzeizelAE . Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. American Journal of Medical Genetics1996;62(2):179‐83. CzeizelAE , DoboM . Postnatal somatic and mental development after periconceptional multivitamin supplementation. Archives of Disease in Childhood1994;70(3):229‐33. CzeizelAE , DudasI . Prevention of the first occurrence of neural‐tube defects by periconceptional vitamin supplementation. New England Journal of Medicine1992;327:1832‐5. CzeizelAE , DudasI , FritzG , TecsoiA , HanckA , KunovitsG . The effect of periconceptional multivitamin‐mineral supplementation on vertigo, nausea and vomiting in the first trimester of pregnancy. Archives of Gynecology and Obstetrics1992;251:181‐5. CzeizelAE , DudasI , MetnekiJ . Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Archives of Gynecology and Obstetrics1994;255:131‐9. CzeizelAE , MedveczkyE . Periconceptional multivitamin supplementation and multimalformed offspring. Obstetrics &amp; Gynecology2003;102:1255‐61. CzeizelAE , MetnekiJ , DudasI . Higher rate of multiple births after periconceptional vitamin supplementation. New England Journal of Medicine1994;330(23):1687‐8. CzeizelAE , MetnekiJ , DudasI . The effect of preconceptional multivitamin supplementation on fertility. International Journal for Vitamin and Nutrition Research1996;66:55‐8. CzeizelAE , MetnekiJ , DudasI . The higher rate of multiple births after periconceptional multivitamin supplementation: an analysis of causes. Acta Geneticae Medicae et Gemellologiae1994;43:175‐84. CzeizelAE , RockenbauerM , SusanskyE . No change in sexual activity during preconceptional multivitamin supplementation. British Journal of Obstetrics and Gynaecology1996;103:569‐73. CzeizelAE , VarghaP . Periconceptional folic acid/multivitamin supplementation and twin pregnancy. American Journal of Obstetrics and Gynecology2004;191(3):790‐4. CzeizelE , DudasI . Prevention of the first occurrence of anencephaly and spina bifida with periconceptional multivitamin supplementation (conclusion). Orvosi Hetilap1994;135(42):2313‐7. DoboM , CzeizelAE . Long‐term somatic and mental development of children after periconceptional multivitamin supplementation. European Journal of Pediatrics1998;157:719‐23. DudasI , RockenbauerM , CzeizelAE . The effect of preconceptional multivitamin supplementation on the menstrual cycle. Archives of Gynecology and Obstetrics1995;256(3):115‐23. MetnekiJ , DudasI , CzeizelAE . Higher rate of multiple births after periconceptual multivitamin supplementation. Orvosi Hetilap1996;137(43):2401‐5. ">Czeizel 1994</a>; <a href="./references#CD007950-bbs2-0002" title="Indian Council of Medical Research (ICMR) Collaborating Centres, Central Technical Co‐ordinatingUnit . Multicentric study of efficacy of periconceptional folic acid containing vitamin supplementation in prevention of open neural tube defects from India. Indian Journal of Medical Research2000;112:206‐11. ">ICMR 2000</a>; <a href="./references#CD007950-bbs2-0004" title="LaurenceKM . Prevention of neural tube defects by improvement in maternal diet and preconceptional folic acid supplementation. Progress in Clinical and Biological Research1985;163:383‐8. LaurenceKM . The role of maternal nutrition and folic acid therapy before conception to prevent neural tube defects [Die Rolle der mütterlichen Ernährung und Folinsaure‐Therapie vor der Empfangnis zur Verhutung von Nervenkanal‐Defekten]. Monatsschrift fur Kinderheilkunde1982;130:646. LaurenceKM , CampbellH , JamesNE . The role of improvement in the maternal diet and preconceptional folic acid supplementation in the prevention of neural tube defects. Prevention of spina bifida and other neural tube defects. Academic Press, 1983:85‐125. LaurenceKM , JamesN , MillerM , CampbellH , TennantGB . A double randomised controlled trial for preconceptional folic acid supplementation for the prevention of recurrence of neural tube defects in high risk pregnancies. Journal of Medical Genetics1982;19(1):66. LaurenceKM , JamesN , MillerMH , TennantGB , CampbellH . Double blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural tube defects. BMJ (Clinical Research Edition)1981;282:1509‐11. ">Laurence 1981</a>; <a href="./references#CD007950-bbs2-0005" title="Anon . Folate supplements prevent recurrence of neural tube defects. Nutrition Review1992;50(Suppl 1):22‐4. Anon . Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet1991;338(8760):131‐7. ">MRC 1991</a>) there were 50 pregnancies terminated for fetal anomaly; 11/3612 in the experimental group and 39/3498 in the control group. The difference between groups was significant in the pooled analysis (RR 0.29, 95% CI 0.15 to 0.56; n = 7110). In all of these studies daily supplementation was greater than 400 µg (0.4 mg) and women started supplements before pregnancy (<a href="./references#CD007950-fig-0055" title="">Analysis 1.52</a>). </p> </section> <section id="CD007950-sec-0126"> <p><b>Low birthweight (less than 2500 g)</b></p> <p>The number of babies with low birthweight was examined in two trials (<a href="./references#CD007950-bbs2-0001" title="CzeizelA , FritzG . Randomized trial of periconceptional vitamins. JAMA1989;262:1634. CzeizelA , RodeK . Trial to prevent first occurrence of neural tube defects by periconceptional multivitamin supplementation. Lancet1984;2(8393):40. CzeizelAE . Controlled studies of multivitamin supplementation on pregnancy outcomes. Annals of the New York Academy of Sciences1993;678:266‐75. CzeizelAE . Limb‐reduction defects and folic acid supplementation. Lancet1995;345(8954):932. CzeizelAE . Nutritional supplementation and prevention of congenital abnormalities. Current Opinion in Obstetrics &amp; Gynecology1995;7(2):88‐94. CzeizelAE . Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ1993;306:1645‐8. CzeizelAE . Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. American Journal of Medical Genetics1996;62(2):179‐83. CzeizelAE , DoboM . Postnatal somatic and mental development after periconceptional multivitamin supplementation. Archives of Disease in Childhood1994;70(3):229‐33. CzeizelAE , DudasI . Prevention of the first occurrence of neural‐tube defects by periconceptional vitamin supplementation. New England Journal of Medicine1992;327:1832‐5. CzeizelAE , DudasI , FritzG , TecsoiA , HanckA , KunovitsG . The effect of periconceptional multivitamin‐mineral supplementation on vertigo, nausea and vomiting in the first trimester of pregnancy. Archives of Gynecology and Obstetrics1992;251:181‐5. CzeizelAE , DudasI , MetnekiJ . Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Archives of Gynecology and Obstetrics1994;255:131‐9. CzeizelAE , MedveczkyE . Periconceptional multivitamin supplementation and multimalformed offspring. Obstetrics &amp; Gynecology2003;102:1255‐61. CzeizelAE , MetnekiJ , DudasI . Higher rate of multiple births after periconceptional vitamin supplementation. New England Journal of Medicine1994;330(23):1687‐8. CzeizelAE , MetnekiJ , DudasI . The effect of preconceptional multivitamin supplementation on fertility. International Journal for Vitamin and Nutrition Research1996;66:55‐8. CzeizelAE , MetnekiJ , DudasI . The higher rate of multiple births after periconceptional multivitamin supplementation: an analysis of causes. Acta Geneticae Medicae et Gemellologiae1994;43:175‐84. CzeizelAE , RockenbauerM , SusanskyE . No change in sexual activity during preconceptional multivitamin supplementation. British Journal of Obstetrics and Gynaecology1996;103:569‐73. CzeizelAE , VarghaP . Periconceptional folic acid/multivitamin supplementation and twin pregnancy. American Journal of Obstetrics and Gynecology2004;191(3):790‐4. CzeizelE , DudasI . Prevention of the first occurrence of anencephaly and spina bifida with periconceptional multivitamin supplementation (conclusion). Orvosi Hetilap1994;135(42):2313‐7. DoboM , CzeizelAE . Long‐term somatic and mental development of children after periconceptional multivitamin supplementation. European Journal of Pediatrics1998;157:719‐23. DudasI , RockenbauerM , CzeizelAE . The effect of preconceptional multivitamin supplementation on the menstrual cycle. Archives of Gynecology and Obstetrics1995;256(3):115‐23. MetnekiJ , DudasI , CzeizelAE . Higher rate of multiple births after periconceptual multivitamin supplementation. Orvosi Hetilap1996;137(43):2401‐5. ">Czeizel 1994</a>; <a href="./references#CD007950-bbs2-0002" title="Indian Council of Medical Research (ICMR) Collaborating Centres, Central Technical Co‐ordinatingUnit . Multicentric study of efficacy of periconceptional folic acid containing vitamin supplementation in prevention of open neural tube defects from India. Indian Journal of Medical Research2000;112:206‐11. ">ICMR 2000</a>). There was no significant evidence of a difference between treatment groups (RR 1.13, 95% CI 0.84 to 1.52; n = 5048 births), (<a href="./references#CD007950-fig-0056" title="">Analysis 1.53</a>). </p> </section> <section id="CD007950-sec-0127"> <p><b>Macrosomia (birthweight greater than 4000 g)</b></p> <p>Macrosomia was reported by one study (<a href="./references#CD007950-bbs2-0001" title="CzeizelA , FritzG . Randomized trial of periconceptional vitamins. JAMA1989;262:1634. CzeizelA , RodeK . Trial to prevent first occurrence of neural tube defects by periconceptional multivitamin supplementation. Lancet1984;2(8393):40. CzeizelAE . Controlled studies of multivitamin supplementation on pregnancy outcomes. Annals of the New York Academy of Sciences1993;678:266‐75. CzeizelAE . Limb‐reduction defects and folic acid supplementation. Lancet1995;345(8954):932. CzeizelAE . Nutritional supplementation and prevention of congenital abnormalities. Current Opinion in Obstetrics &amp; Gynecology1995;7(2):88‐94. CzeizelAE . Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ1993;306:1645‐8. CzeizelAE . Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. American Journal of Medical Genetics1996;62(2):179‐83. CzeizelAE , DoboM . Postnatal somatic and mental development after periconceptional multivitamin supplementation. Archives of Disease in Childhood1994;70(3):229‐33. CzeizelAE , DudasI . Prevention of the first occurrence of neural‐tube defects by periconceptional vitamin supplementation. New England Journal of Medicine1992;327:1832‐5. CzeizelAE , DudasI , FritzG , TecsoiA , HanckA , KunovitsG . The effect of periconceptional multivitamin‐mineral supplementation on vertigo, nausea and vomiting in the first trimester of pregnancy. Archives of Gynecology and Obstetrics1992;251:181‐5. CzeizelAE , DudasI , MetnekiJ . Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Archives of Gynecology and Obstetrics1994;255:131‐9. CzeizelAE , MedveczkyE . Periconceptional multivitamin supplementation and multimalformed offspring. Obstetrics &amp; Gynecology2003;102:1255‐61. CzeizelAE , MetnekiJ , DudasI . Higher rate of multiple births after periconceptional vitamin supplementation. New England Journal of Medicine1994;330(23):1687‐8. CzeizelAE , MetnekiJ , DudasI . The effect of preconceptional multivitamin supplementation on fertility. International Journal for Vitamin and Nutrition Research1996;66:55‐8. CzeizelAE , MetnekiJ , DudasI . The higher rate of multiple births after periconceptional multivitamin supplementation: an analysis of causes. Acta Geneticae Medicae et Gemellologiae1994;43:175‐84. CzeizelAE , RockenbauerM , SusanskyE . No change in sexual activity during preconceptional multivitamin supplementation. British Journal of Obstetrics and Gynaecology1996;103:569‐73. CzeizelAE , VarghaP . Periconceptional folic acid/multivitamin supplementation and twin pregnancy. American Journal of Obstetrics and Gynecology2004;191(3):790‐4. CzeizelE , DudasI . Prevention of the first occurrence of anencephaly and spina bifida with periconceptional multivitamin supplementation (conclusion). Orvosi Hetilap1994;135(42):2313‐7. DoboM , CzeizelAE . Long‐term somatic and mental development of children after periconceptional multivitamin supplementation. European Journal of Pediatrics1998;157:719‐23. DudasI , RockenbauerM , CzeizelAE . The effect of preconceptional multivitamin supplementation on the menstrual cycle. Archives of Gynecology and Obstetrics1995;256(3):115‐23. MetnekiJ , DudasI , CzeizelAE . Higher rate of multiple births after periconceptual multivitamin supplementation. Orvosi Hetilap1996;137(43):2401‐5. ">Czeizel 1994</a>) and did not show significant difference between treatment groups (RR 0.98, 95% CI 0.79 to 1.22; n = 4862 births) (<a href="./references#CD007950-fig-0057" title="">Analysis 1.54</a>). </p> <p><i>Preterm births (less than 37 weeks' gestation)</i> </p> <p>One study reported on preterm births (<a href="./references#CD007950-bbs2-0001" title="CzeizelA , FritzG . Randomized trial of periconceptional vitamins. JAMA1989;262:1634. CzeizelA , RodeK . Trial to prevent first occurrence of neural tube defects by periconceptional multivitamin supplementation. Lancet1984;2(8393):40. CzeizelAE . Controlled studies of multivitamin supplementation on pregnancy outcomes. Annals of the New York Academy of Sciences1993;678:266‐75. CzeizelAE . Limb‐reduction defects and folic acid supplementation. Lancet1995;345(8954):932. CzeizelAE . Nutritional supplementation and prevention of congenital abnormalities. Current Opinion in Obstetrics &amp; Gynecology1995;7(2):88‐94. CzeizelAE . Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ1993;306:1645‐8. CzeizelAE . Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. American Journal of Medical Genetics1996;62(2):179‐83. CzeizelAE , DoboM . Postnatal somatic and mental development after periconceptional multivitamin supplementation. Archives of Disease in Childhood1994;70(3):229‐33. CzeizelAE , DudasI . Prevention of the first occurrence of neural‐tube defects by periconceptional vitamin supplementation. New England Journal of Medicine1992;327:1832‐5. CzeizelAE , DudasI , FritzG , TecsoiA , HanckA , KunovitsG . The effect of periconceptional multivitamin‐mineral supplementation on vertigo, nausea and vomiting in the first trimester of pregnancy. Archives of Gynecology and Obstetrics1992;251:181‐5. CzeizelAE , DudasI , MetnekiJ . Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Archives of Gynecology and Obstetrics1994;255:131‐9. CzeizelAE , MedveczkyE . Periconceptional multivitamin supplementation and multimalformed offspring. Obstetrics &amp; Gynecology2003;102:1255‐61. CzeizelAE , MetnekiJ , DudasI . Higher rate of multiple births after periconceptional vitamin supplementation. New England Journal of Medicine1994;330(23):1687‐8. CzeizelAE , MetnekiJ , DudasI . The effect of preconceptional multivitamin supplementation on fertility. International Journal for Vitamin and Nutrition Research1996;66:55‐8. CzeizelAE , MetnekiJ , DudasI . The higher rate of multiple births after periconceptional multivitamin supplementation: an analysis of causes. Acta Geneticae Medicae et Gemellologiae1994;43:175‐84. CzeizelAE , RockenbauerM , SusanskyE . No change in sexual activity during preconceptional multivitamin supplementation. British Journal of Obstetrics and Gynaecology1996;103:569‐73. CzeizelAE , VarghaP . Periconceptional folic acid/multivitamin supplementation and twin pregnancy. American Journal of Obstetrics and Gynecology2004;191(3):790‐4. CzeizelE , DudasI . Prevention of the first occurrence of anencephaly and spina bifida with periconceptional multivitamin supplementation (conclusion). Orvosi Hetilap1994;135(42):2313‐7. DoboM , CzeizelAE . Long‐term somatic and mental development of children after periconceptional multivitamin supplementation. European Journal of Pediatrics1998;157:719‐23. DudasI , RockenbauerM , CzeizelAE . The effect of preconceptional multivitamin supplementation on the menstrual cycle. Archives of Gynecology and Obstetrics1995;256(3):115‐23. MetnekiJ , DudasI , CzeizelAE . Higher rate of multiple births after periconceptual multivitamin supplementation. Orvosi Hetilap1996;137(43):2401‐5. ">Czeizel 1994</a>) and showed no significant difference between treatment groups (RR 1.14, 95% CI 0.93 to 1.41; n = 4862 births) (<a href="./references#CD007950-fig-0057" title="">Analysis 1.54</a>). </p> </section> <section id="CD007950-sec-0128"> <p><b>Other infant outcomes</b></p> <p>No trials reported results for our other pre‐specified secondary outcomes.</p> <p> <ol id="CD007950-list-0015"> <li> <p>Very low birthweight (less than 1500 g)</p> </li> <li> <p>Infant optimal health status at birth (as defined by trial authors)</p> </li> <li> <p>Neonatal deaths</p> </li> <li> <p>Admission to special care for any cause (as defined by trial authors)</p> </li> <li> <p>Infant insulin resistance (as defined by trial authors)</p> </li> <li> <p>Apgar at one minute after birth (eight or greater)</p> </li> <li> <p>Apgar score at five minutes after birth (eight or greater)</p> </li> <li> <p>Long‐term outcomes (as defined by trial authors)</p> </li> </ol> </p> </section> </section> <section id="CD007950-sec-0129"> <h6 class="title">Maternal</h6> <section id="CD007950-sec-0130"> <p><b>Multiple pregnancy  </b></p> <p>The number of women affected by multiple pregnancy was examined in four trials (<a href="./references#CD007950-bbs2-0001" title="CzeizelA , FritzG . Randomized trial of periconceptional vitamins. JAMA1989;262:1634. CzeizelA , RodeK . Trial to prevent first occurrence of neural tube defects by periconceptional multivitamin supplementation. Lancet1984;2(8393):40. CzeizelAE . Controlled studies of multivitamin supplementation on pregnancy outcomes. Annals of the New York Academy of Sciences1993;678:266‐75. CzeizelAE . Limb‐reduction defects and folic acid supplementation. Lancet1995;345(8954):932. CzeizelAE . Nutritional supplementation and prevention of congenital abnormalities. Current Opinion in Obstetrics &amp; Gynecology1995;7(2):88‐94. CzeizelAE . Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ1993;306:1645‐8. CzeizelAE . Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. American Journal of Medical Genetics1996;62(2):179‐83. CzeizelAE , DoboM . Postnatal somatic and mental development after periconceptional multivitamin supplementation. Archives of Disease in Childhood1994;70(3):229‐33. CzeizelAE , DudasI . Prevention of the first occurrence of neural‐tube defects by periconceptional vitamin supplementation. New England Journal of Medicine1992;327:1832‐5. CzeizelAE , DudasI , FritzG , TecsoiA , HanckA , KunovitsG . The effect of periconceptional multivitamin‐mineral supplementation on vertigo, nausea and vomiting in the first trimester of pregnancy. Archives of Gynecology and Obstetrics1992;251:181‐5. CzeizelAE , DudasI , MetnekiJ . Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Archives of Gynecology and Obstetrics1994;255:131‐9. CzeizelAE , MedveczkyE . Periconceptional multivitamin supplementation and multimalformed offspring. Obstetrics &amp; Gynecology2003;102:1255‐61. CzeizelAE , MetnekiJ , DudasI . Higher rate of multiple births after periconceptional vitamin supplementation. New England Journal of Medicine1994;330(23):1687‐8. CzeizelAE , MetnekiJ , DudasI . The effect of preconceptional multivitamin supplementation on fertility. International Journal for Vitamin and Nutrition Research1996;66:55‐8. CzeizelAE , MetnekiJ , DudasI . The higher rate of multiple births after periconceptional multivitamin supplementation: an analysis of causes. Acta Geneticae Medicae et Gemellologiae1994;43:175‐84. CzeizelAE , RockenbauerM , SusanskyE . No change in sexual activity during preconceptional multivitamin supplementation. British Journal of Obstetrics and Gynaecology1996;103:569‐73. CzeizelAE , VarghaP . Periconceptional folic acid/multivitamin supplementation and twin pregnancy. American Journal of Obstetrics and Gynecology2004;191(3):790‐4. CzeizelE , DudasI . Prevention of the first occurrence of anencephaly and spina bifida with periconceptional multivitamin supplementation (conclusion). Orvosi Hetilap1994;135(42):2313‐7. DoboM , CzeizelAE . Long‐term somatic and mental development of children after periconceptional multivitamin supplementation. European Journal of Pediatrics1998;157:719‐23. DudasI , RockenbauerM , CzeizelAE . The effect of preconceptional multivitamin supplementation on the menstrual cycle. Archives of Gynecology and Obstetrics1995;256(3):115‐23. MetnekiJ , DudasI , CzeizelAE . Higher rate of multiple births after periconceptual multivitamin supplementation. Orvosi Hetilap1996;137(43):2401‐5. ">Czeizel 1994</a>; <a href="./references#CD007950-bbs2-0002" title="Indian Council of Medical Research (ICMR) Collaborating Centres, Central Technical Co‐ordinatingUnit . Multicentric study of efficacy of periconceptional folic acid containing vitamin supplementation in prevention of open neural tube defects from India. Indian Journal of Medical Research2000;112:206‐11. ">ICMR 2000</a>; <a href="./references#CD007950-bbs2-0003" title="KirkePN , DalyLE , ElwoodJH . A randomized trial of low dose folic acid to prevent neural tube defects. Archives of Disease in Childhood1992;67:1442‐6. ">Kirke 1992</a>; <a href="./references#CD007950-bbs2-0005" title="Anon . Folate supplements prevent recurrence of neural tube defects. Nutrition Review1992;50(Suppl 1):22‐4. Anon . Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet1991;338(8760):131‐7. ">MRC 1991</a>). Overall, there was no evidence of any significant difference between women receiving supplements with folic acid and those in the controls (RR 1.38, 95% CI 0.89 to 2.14; n = 7280 pregnancies) (<a href="./references#CD007950-fig-0059" title="">Analysis 1.56</a>). </p> </section> <section id="CD007950-sec-0131"> <p><b>Side effects</b></p> <p>Only one study reported findings on side effects like nausea, vomiting, constipation or diarrhoea (<a href="./references#CD007950-bbs2-0001" title="CzeizelA , FritzG . Randomized trial of periconceptional vitamins. JAMA1989;262:1634. CzeizelA , RodeK . Trial to prevent first occurrence of neural tube defects by periconceptional multivitamin supplementation. Lancet1984;2(8393):40. CzeizelAE . Controlled studies of multivitamin supplementation on pregnancy outcomes. Annals of the New York Academy of Sciences1993;678:266‐75. CzeizelAE . Limb‐reduction defects and folic acid supplementation. Lancet1995;345(8954):932. CzeizelAE . Nutritional supplementation and prevention of congenital abnormalities. Current Opinion in Obstetrics &amp; Gynecology1995;7(2):88‐94. CzeizelAE . Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ1993;306:1645‐8. CzeizelAE . Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. American Journal of Medical Genetics1996;62(2):179‐83. CzeizelAE , DoboM . Postnatal somatic and mental development after periconceptional multivitamin supplementation. Archives of Disease in Childhood1994;70(3):229‐33. CzeizelAE , DudasI . Prevention of the first occurrence of neural‐tube defects by periconceptional vitamin supplementation. New England Journal of Medicine1992;327:1832‐5. CzeizelAE , DudasI , FritzG , TecsoiA , HanckA , KunovitsG . The effect of periconceptional multivitamin‐mineral supplementation on vertigo, nausea and vomiting in the first trimester of pregnancy. Archives of Gynecology and Obstetrics1992;251:181‐5. CzeizelAE , DudasI , MetnekiJ . Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Archives of Gynecology and Obstetrics1994;255:131‐9. CzeizelAE , MedveczkyE . Periconceptional multivitamin supplementation and multimalformed offspring. Obstetrics &amp; Gynecology2003;102:1255‐61. CzeizelAE , MetnekiJ , DudasI . Higher rate of multiple births after periconceptional vitamin supplementation. New England Journal of Medicine1994;330(23):1687‐8. CzeizelAE , MetnekiJ , DudasI . The effect of preconceptional multivitamin supplementation on fertility. International Journal for Vitamin and Nutrition Research1996;66:55‐8. CzeizelAE , MetnekiJ , DudasI . The higher rate of multiple births after periconceptional multivitamin supplementation: an analysis of causes. Acta Geneticae Medicae et Gemellologiae1994;43:175‐84. CzeizelAE , RockenbauerM , SusanskyE . No change in sexual activity during preconceptional multivitamin supplementation. British Journal of Obstetrics and Gynaecology1996;103:569‐73. CzeizelAE , VarghaP . Periconceptional folic acid/multivitamin supplementation and twin pregnancy. American Journal of Obstetrics and Gynecology2004;191(3):790‐4. CzeizelE , DudasI . Prevention of the first occurrence of anencephaly and spina bifida with periconceptional multivitamin supplementation (conclusion). Orvosi Hetilap1994;135(42):2313‐7. DoboM , CzeizelAE . Long‐term somatic and mental development of children after periconceptional multivitamin supplementation. European Journal of Pediatrics1998;157:719‐23. DudasI , RockenbauerM , CzeizelAE . The effect of preconceptional multivitamin supplementation on the menstrual cycle. Archives of Gynecology and Obstetrics1995;256(3):115‐23. MetnekiJ , DudasI , CzeizelAE . Higher rate of multiple births after periconceptual multivitamin supplementation. Orvosi Hetilap1996;137(43):2401‐5. ">Czeizel 1994</a>), and the number of reported cases was very low in both the group of women receiving folic acid with multiple micronutrients and the control group during the pre‐pregnancy and pregnancy period. </p> </section> <section id="CD007950-sec-0132"> <p><b>Other maternal outcomes</b></p> <p>No trials reported on our other pre‐specified secondary outcomes.</p> <p> <ol id="CD007950-list-0016"> <li> <p>Homocysteine at term (µmol/L)</p> </li> <li> <p>Serum vitamin B<sub>6</sub> concentration at term (nmol/L) </p> </li> <li> <p>Plasma or serum vitamin B<sub>12</sub> concentration at term (pmol/L) </p> </li> <li> <p>Pre‐eclampsia (defined as gestational hypertension (blood pressure higher than 140/90 mmHg) and proteinuria (more than 300 mg of protein in a 24‐hour urine sample) </p> </li> </ol> </p> </section> </section> </section> </section> <section id="CD007950-sec-0133"> <h4 class="title">(2) Supplementation with folic acid alone versus no treatment or placebo (one trial)</h4> <section id="CD007950-sec-0134"> <h5 class="title">Primary outcomes</h5> <section id="CD007950-sec-0135"> <h6 class="title">Infant outcomes</h6> <section id="CD007950-sec-0136"> <p><b>Neural tube defects (NTDs) (all)</b></p> <p>One trial (<a href="./references#CD007950-bbs2-0004" title="LaurenceKM . Prevention of neural tube defects by improvement in maternal diet and preconceptional folic acid supplementation. Progress in Clinical and Biological Research1985;163:383‐8. LaurenceKM . The role of maternal nutrition and folic acid therapy before conception to prevent neural tube defects [Die Rolle der mütterlichen Ernährung und Folinsaure‐Therapie vor der Empfangnis zur Verhutung von Nervenkanal‐Defekten]. Monatsschrift fur Kinderheilkunde1982;130:646. LaurenceKM , CampbellH , JamesNE . The role of improvement in the maternal diet and preconceptional folic acid supplementation in the prevention of neural tube defects. Prevention of spina bifida and other neural tube defects. Academic Press, 1983:85‐125. LaurenceKM , JamesN , MillerM , CampbellH , TennantGB . A double randomised controlled trial for preconceptional folic acid supplementation for the prevention of recurrence of neural tube defects in high risk pregnancies. Journal of Medical Genetics1982;19(1):66. LaurenceKM , JamesN , MillerMH , TennantGB , CampbellH . Double blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural tube defects. BMJ (Clinical Research Edition)1981;282:1509‐11. ">Laurence 1981</a>) involving 111 births was included in this comparison. There was no significant difference in the risk of NTDs between those receiving folic acid alone and those receiving placebo (RR 0.43, 95% CI 0.08 to 2.23). (<a href="./references#CD007950-fig-0060" title="">Analysis 2.1</a>). </p> </section> </section> <section id="CD007950-sec-0137"> <h6 class="title">Maternal outcomes</h6> <section id="CD007950-sec-0138"> <p><b>Miscarriage</b></p> <p>One trial (111 pregnancies) examined the rate of miscarriage in women with confirmed pregnancies receiving folic acid supplements compared with controls (<a href="./references#CD007950-bbs2-0004" title="LaurenceKM . Prevention of neural tube defects by improvement in maternal diet and preconceptional folic acid supplementation. Progress in Clinical and Biological Research1985;163:383‐8. LaurenceKM . The role of maternal nutrition and folic acid therapy before conception to prevent neural tube defects [Die Rolle der mütterlichen Ernährung und Folinsaure‐Therapie vor der Empfangnis zur Verhutung von Nervenkanal‐Defekten]. Monatsschrift fur Kinderheilkunde1982;130:646. LaurenceKM , CampbellH , JamesNE . The role of improvement in the maternal diet and preconceptional folic acid supplementation in the prevention of neural tube defects. Prevention of spina bifida and other neural tube defects. Academic Press, 1983:85‐125. LaurenceKM , JamesN , MillerM , CampbellH , TennantGB . A double randomised controlled trial for preconceptional folic acid supplementation for the prevention of recurrence of neural tube defects in high risk pregnancies. Journal of Medical Genetics1982;19(1):66. LaurenceKM , JamesN , MillerMH , TennantGB , CampbellH . Double blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural tube defects. BMJ (Clinical Research Edition)1981;282:1509‐11. ">Laurence 1981</a>); there was no significant evidence of a difference between treatment groups in the number of women having miscarriage (RR 0.85, 95% CI 0.05 to 13.25) (<a href="./references#CD007950-fig-0061" title="">Analysis 2.2</a>). </p> </section> </section> </section> <section id="CD007950-sec-0139"> <h5 class="title">Secondary outcomes</h5> <section id="CD007950-sec-0140"> <h6 class="title">Infant outcomes</h6> <section id="CD007950-sec-0141"> <p><b>Spina bifida</b></p> <p>One trial reported on the rate of spina bifida among women receiving folic acid daily during the periconceptional period compared with those receiving placebo (<a href="./references#CD007950-bbs2-0004" title="LaurenceKM . Prevention of neural tube defects by improvement in maternal diet and preconceptional folic acid supplementation. Progress in Clinical and Biological Research1985;163:383‐8. LaurenceKM . The role of maternal nutrition and folic acid therapy before conception to prevent neural tube defects [Die Rolle der mütterlichen Ernährung und Folinsaure‐Therapie vor der Empfangnis zur Verhutung von Nervenkanal‐Defekten]. Monatsschrift fur Kinderheilkunde1982;130:646. LaurenceKM , CampbellH , JamesNE . The role of improvement in the maternal diet and preconceptional folic acid supplementation in the prevention of neural tube defects. Prevention of spina bifida and other neural tube defects. Academic Press, 1983:85‐125. LaurenceKM , JamesN , MillerM , CampbellH , TennantGB . A double randomised controlled trial for preconceptional folic acid supplementation for the prevention of recurrence of neural tube defects in high risk pregnancies. Journal of Medical Genetics1982;19(1):66. LaurenceKM , JamesN , MillerMH , TennantGB , CampbellH . Double blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural tube defects. BMJ (Clinical Research Edition)1981;282:1509‐11. ">Laurence 1981</a>) and showed no evidence of a significant difference between treatment groups (RR 0.43, 95% CI 0.04 to 4.55) (<a href="./references#CD007950-fig-0062" title="">Analysis 2.3</a>). </p> </section> <section id="CD007950-sec-0142"> <p><b>Anencephaly</b></p> <p>One trial reported on the rate of anencephaly among women receiving daily doses of 4.0 mg folic acid during the periconceptional period compared with those receiving placebo (<a href="./references#CD007950-bbs2-0004" title="LaurenceKM . Prevention of neural tube defects by improvement in maternal diet and preconceptional folic acid supplementation. Progress in Clinical and Biological Research1985;163:383‐8. LaurenceKM . The role of maternal nutrition and folic acid therapy before conception to prevent neural tube defects [Die Rolle der mütterlichen Ernährung und Folinsaure‐Therapie vor der Empfangnis zur Verhutung von Nervenkanal‐Defekten]. Monatsschrift fur Kinderheilkunde1982;130:646. LaurenceKM , CampbellH , JamesNE . The role of improvement in the maternal diet and preconceptional folic acid supplementation in the prevention of neural tube defects. Prevention of spina bifida and other neural tube defects. Academic Press, 1983:85‐125. LaurenceKM , JamesN , MillerM , CampbellH , TennantGB . A double randomised controlled trial for preconceptional folic acid supplementation for the prevention of recurrence of neural tube defects in high risk pregnancies. Journal of Medical Genetics1982;19(1):66. LaurenceKM , JamesN , MillerMH , TennantGB , CampbellH . Double blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural tube defects. BMJ (Clinical Research Edition)1981;282:1509‐11. ">Laurence 1981</a>) and showed no evidence of a significant difference between treatment groups (RR 0.43, 95% CI 0.04 to 4.55) (<a href="./references#CD007950-fig-0063" title="">Analysis 2.4</a>). </p> </section> <section id="CD007950-sec-0143"> <p><b>Other secondary outcomes</b></p> <p>No trials reported on our other pre‐specified secondary outcomes.</p> </section> </section> <section id="CD007950-sec-0144"> <h6 class="title">Maternal</h6> <section id="CD007950-sec-0145"> <p><b>Pregnancy termination for fetal anomaly</b></p> <p><a href="./references#CD007950-bbs2-0004" title="LaurenceKM . Prevention of neural tube defects by improvement in maternal diet and preconceptional folic acid supplementation. Progress in Clinical and Biological Research1985;163:383‐8. LaurenceKM . The role of maternal nutrition and folic acid therapy before conception to prevent neural tube defects [Die Rolle der mütterlichen Ernährung und Folinsaure‐Therapie vor der Empfangnis zur Verhutung von Nervenkanal‐Defekten]. Monatsschrift fur Kinderheilkunde1982;130:646. LaurenceKM , CampbellH , JamesNE . The role of improvement in the maternal diet and preconceptional folic acid supplementation in the prevention of neural tube defects. Prevention of spina bifida and other neural tube defects. Academic Press, 1983:85‐125. LaurenceKM , JamesN , MillerM , CampbellH , TennantGB . A double randomised controlled trial for preconceptional folic acid supplementation for the prevention of recurrence of neural tube defects in high risk pregnancies. Journal of Medical Genetics1982;19(1):66. LaurenceKM , JamesN , MillerMH , TennantGB , CampbellH . Double blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural tube defects. BMJ (Clinical Research Edition)1981;282:1509‐11. ">Laurence 1981</a> reported one pregnancy termination due to NTD in the group that did not receive folate while in the experimental group there were zero cases (RR 0.28, 95% CI 0.01 to 6.83) (<a href="./references#CD007950-fig-0064" title="">Analysis 2.5</a>) </p> <p>No trials reported on other pre‐specified secondary outcomes.</p> </section> </section> </section> </section> <section id="CD007950-sec-0146"> <h4 class="title">(3) Supplementation with folic acid plus other micronutrients versus other micronutrients without folic acid (four trials) </h4> <section id="CD007950-sec-0147"> <h5 class="title">Primary outcomes</h5> <section id="CD007950-sec-0148"> <h6 class="title">Infant outcomes</h6> <section id="CD007950-sec-0149"> <p><b>Neural tube defects (NTDs) (all)</b></p> <p>Four of the trials (<a href="./references#CD007950-bbs2-0001" title="CzeizelA , FritzG . Randomized trial of periconceptional vitamins. JAMA1989;262:1634. CzeizelA , RodeK . Trial to prevent first occurrence of neural tube defects by periconceptional multivitamin supplementation. Lancet1984;2(8393):40. CzeizelAE . Controlled studies of multivitamin supplementation on pregnancy outcomes. Annals of the New York Academy of Sciences1993;678:266‐75. CzeizelAE . Limb‐reduction defects and folic acid supplementation. Lancet1995;345(8954):932. CzeizelAE . Nutritional supplementation and prevention of congenital abnormalities. Current Opinion in Obstetrics &amp; Gynecology1995;7(2):88‐94. CzeizelAE . Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ1993;306:1645‐8. CzeizelAE . Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. American Journal of Medical Genetics1996;62(2):179‐83. CzeizelAE , DoboM . Postnatal somatic and mental development after periconceptional multivitamin supplementation. Archives of Disease in Childhood1994;70(3):229‐33. CzeizelAE , DudasI . Prevention of the first occurrence of neural‐tube defects by periconceptional vitamin supplementation. New England Journal of Medicine1992;327:1832‐5. CzeizelAE , DudasI , FritzG , TecsoiA , HanckA , KunovitsG . The effect of periconceptional multivitamin‐mineral supplementation on vertigo, nausea and vomiting in the first trimester of pregnancy. Archives of Gynecology and Obstetrics1992;251:181‐5. CzeizelAE , DudasI , MetnekiJ . Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Archives of Gynecology and Obstetrics1994;255:131‐9. CzeizelAE , MedveczkyE . Periconceptional multivitamin supplementation and multimalformed offspring. Obstetrics &amp; Gynecology2003;102:1255‐61. CzeizelAE , MetnekiJ , DudasI . Higher rate of multiple births after periconceptional vitamin supplementation. New England Journal of Medicine1994;330(23):1687‐8. CzeizelAE , MetnekiJ , DudasI . The effect of preconceptional multivitamin supplementation on fertility. International Journal for Vitamin and Nutrition Research1996;66:55‐8. CzeizelAE , MetnekiJ , DudasI . The higher rate of multiple births after periconceptional multivitamin supplementation: an analysis of causes. Acta Geneticae Medicae et Gemellologiae1994;43:175‐84. CzeizelAE , RockenbauerM , SusanskyE . No change in sexual activity during preconceptional multivitamin supplementation. British Journal of Obstetrics and Gynaecology1996;103:569‐73. CzeizelAE , VarghaP . Periconceptional folic acid/multivitamin supplementation and twin pregnancy. American Journal of Obstetrics and Gynecology2004;191(3):790‐4. CzeizelE , DudasI . Prevention of the first occurrence of anencephaly and spina bifida with periconceptional multivitamin supplementation (conclusion). Orvosi Hetilap1994;135(42):2313‐7. DoboM , CzeizelAE . Long‐term somatic and mental development of children after periconceptional multivitamin supplementation. European Journal of Pediatrics1998;157:719‐23. DudasI , RockenbauerM , CzeizelAE . The effect of preconceptional multivitamin supplementation on the menstrual cycle. Archives of Gynecology and Obstetrics1995;256(3):115‐23. MetnekiJ , DudasI , CzeizelAE . Higher rate of multiple births after periconceptual multivitamin supplementation. Orvosi Hetilap1996;137(43):2401‐5. ">Czeizel 1994</a>; <a href="./references#CD007950-bbs2-0002" title="Indian Council of Medical Research (ICMR) Collaborating Centres, Central Technical Co‐ordinatingUnit . Multicentric study of efficacy of periconceptional folic acid containing vitamin supplementation in prevention of open neural tube defects from India. Indian Journal of Medical Research2000;112:206‐11. ">ICMR 2000</a>; <a href="./references#CD007950-bbs2-0003" title="KirkePN , DalyLE , ElwoodJH . A randomized trial of low dose folic acid to prevent neural tube defects. Archives of Disease in Childhood1992;67:1442‐6. ">Kirke 1992</a>; <a href="./references#CD007950-bbs2-0005" title="Anon . Folate supplements prevent recurrence of neural tube defects. Nutrition Review1992;50(Suppl 1):22‐4. Anon . Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet1991;338(8760):131‐7. ">MRC 1991</a>) (6512 births) included comparisons of women receiving folic acid with other micronutrients compared with women receiving other micronutrients without folic acid. There was a significant difference between groups favouring those who received the folic acid supplementation (RR 0.31, 95% CI 0.16 to 0.60). In all of these trials supplementation started before pregnancy, continued throughout the first trimester and involved daily supplementation (<a href="./references#CD007950-fig-0065" title="">Analysis 3.1</a>). </p> <p>Three of these trials involved women with a previous history of NTD‐affected pregnancy (<a href="./references#CD007950-bbs2-0002" title="Indian Council of Medical Research (ICMR) Collaborating Centres, Central Technical Co‐ordinatingUnit . Multicentric study of efficacy of periconceptional folic acid containing vitamin supplementation in prevention of open neural tube defects from India. Indian Journal of Medical Research2000;112:206‐11. ">ICMR 2000</a>; <a href="./references#CD007950-bbs2-0003" title="KirkePN , DalyLE , ElwoodJH . A randomized trial of low dose folic acid to prevent neural tube defects. Archives of Disease in Childhood1992;67:1442‐6. ">Kirke 1992</a>; <a href="./references#CD007950-bbs2-0005" title="Anon . Folate supplements prevent recurrence of neural tube defects. Nutrition Review1992;50(Suppl 1):22‐4. Anon . Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet1991;338(8760):131‐7. ">MRC 1991</a>). There were fewer recurrences of NTDs among those who received folate compared to those who did not (RR 0.33, 95% CI 0.17 to 0.66); n = 1650 births). In one trial with no history of NTDs (<a href="./references#CD007950-bbs2-0001" title="CzeizelA , FritzG . Randomized trial of periconceptional vitamins. JAMA1989;262:1634. CzeizelA , RodeK . Trial to prevent first occurrence of neural tube defects by periconceptional multivitamin supplementation. Lancet1984;2(8393):40. CzeizelAE . Controlled studies of multivitamin supplementation on pregnancy outcomes. Annals of the New York Academy of Sciences1993;678:266‐75. CzeizelAE . Limb‐reduction defects and folic acid supplementation. Lancet1995;345(8954):932. CzeizelAE . Nutritional supplementation and prevention of congenital abnormalities. Current Opinion in Obstetrics &amp; Gynecology1995;7(2):88‐94. CzeizelAE . Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ1993;306:1645‐8. CzeizelAE . Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. American Journal of Medical Genetics1996;62(2):179‐83. CzeizelAE , DoboM . Postnatal somatic and mental development after periconceptional multivitamin supplementation. Archives of Disease in Childhood1994;70(3):229‐33. CzeizelAE , DudasI . Prevention of the first occurrence of neural‐tube defects by periconceptional vitamin supplementation. New England Journal of Medicine1992;327:1832‐5. CzeizelAE , DudasI , FritzG , TecsoiA , HanckA , KunovitsG . The effect of periconceptional multivitamin‐mineral supplementation on vertigo, nausea and vomiting in the first trimester of pregnancy. Archives of Gynecology and Obstetrics1992;251:181‐5. CzeizelAE , DudasI , MetnekiJ . Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Archives of Gynecology and Obstetrics1994;255:131‐9. CzeizelAE , MedveczkyE . Periconceptional multivitamin supplementation and multimalformed offspring. Obstetrics &amp; Gynecology2003;102:1255‐61. CzeizelAE , MetnekiJ , DudasI . Higher rate of multiple births after periconceptional vitamin supplementation. New England Journal of Medicine1994;330(23):1687‐8. CzeizelAE , MetnekiJ , DudasI . The effect of preconceptional multivitamin supplementation on fertility. International Journal for Vitamin and Nutrition Research1996;66:55‐8. CzeizelAE , MetnekiJ , DudasI . The higher rate of multiple births after periconceptional multivitamin supplementation: an analysis of causes. Acta Geneticae Medicae et Gemellologiae1994;43:175‐84. CzeizelAE , RockenbauerM , SusanskyE . No change in sexual activity during preconceptional multivitamin supplementation. British Journal of Obstetrics and Gynaecology1996;103:569‐73. CzeizelAE , VarghaP . Periconceptional folic acid/multivitamin supplementation and twin pregnancy. American Journal of Obstetrics and Gynecology2004;191(3):790‐4. CzeizelE , DudasI . Prevention of the first occurrence of anencephaly and spina bifida with periconceptional multivitamin supplementation (conclusion). Orvosi Hetilap1994;135(42):2313‐7. DoboM , CzeizelAE . Long‐term somatic and mental development of children after periconceptional multivitamin supplementation. European Journal of Pediatrics1998;157:719‐23. DudasI , RockenbauerM , CzeizelAE . The effect of preconceptional multivitamin supplementation on the menstrual cycle. Archives of Gynecology and Obstetrics1995;256(3):115‐23. MetnekiJ , DudasI , CzeizelAE . Higher rate of multiple births after periconceptual multivitamin supplementation. Orvosi Hetilap1996;137(43):2401‐5. ">Czeizel 1994</a>), there was no significant difference in risk of incidence of NTDs (RR 0.07, 95% CI 0.00 to 1.32; n = 4862 births) though there were no cases of NTDs in the group receiving folate (<a href="./references#CD007950-fig-0069" title="">Analysis 3.5</a>). </p> <p>One trial (<a href="./references#CD007950-bbs2-0003" title="KirkePN , DalyLE , ElwoodJH . A randomized trial of low dose folic acid to prevent neural tube defects. Archives of Disease in Childhood1992;67:1442‐6. ">Kirke 1992</a>) supplemented folic acid at a daily dose of 360 µg (0.36 mg) and did not show a significant difference between treatment groups (RR 0.34, 95% CI 0.01 to 8.26; n = 176 births). Three trials gave doses of 4.0 mg daily folic acid and found a difference in the risk of NTDs among treatment groups (RR 0.31, 95% CI 0.15 to 0.61; n = 6336 births) (<a href="./references#CD007950-fig-0067" title="">Analysis 3.3</a>). There was no evidence of difference between subgroups (Test for subgroup differences: Chi² = 0.00, df = 1 (P = 0.95), I² = 0%). </p> </section> <section id="CD007950-sec-0150"> <p><b>Cleft lip</b></p> <p>In the two trials (<a href="./references#CD007950-bbs2-0001" title="CzeizelA , FritzG . Randomized trial of periconceptional vitamins. JAMA1989;262:1634. CzeizelA , RodeK . Trial to prevent first occurrence of neural tube defects by periconceptional multivitamin supplementation. Lancet1984;2(8393):40. CzeizelAE . Controlled studies of multivitamin supplementation on pregnancy outcomes. Annals of the New York Academy of Sciences1993;678:266‐75. CzeizelAE . Limb‐reduction defects and folic acid supplementation. Lancet1995;345(8954):932. CzeizelAE . Nutritional supplementation and prevention of congenital abnormalities. Current Opinion in Obstetrics &amp; Gynecology1995;7(2):88‐94. CzeizelAE . Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ1993;306:1645‐8. CzeizelAE . Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. American Journal of Medical Genetics1996;62(2):179‐83. CzeizelAE , DoboM . Postnatal somatic and mental development after periconceptional multivitamin supplementation. Archives of Disease in Childhood1994;70(3):229‐33. CzeizelAE , DudasI . Prevention of the first occurrence of neural‐tube defects by periconceptional vitamin supplementation. New England Journal of Medicine1992;327:1832‐5. CzeizelAE , DudasI , FritzG , TecsoiA , HanckA , KunovitsG . The effect of periconceptional multivitamin‐mineral supplementation on vertigo, nausea and vomiting in the first trimester of pregnancy. Archives of Gynecology and Obstetrics1992;251:181‐5. CzeizelAE , DudasI , MetnekiJ . Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Archives of Gynecology and Obstetrics1994;255:131‐9. CzeizelAE , MedveczkyE . Periconceptional multivitamin supplementation and multimalformed offspring. Obstetrics &amp; Gynecology2003;102:1255‐61. CzeizelAE , MetnekiJ , DudasI . Higher rate of multiple births after periconceptional vitamin supplementation. New England Journal of Medicine1994;330(23):1687‐8. CzeizelAE , MetnekiJ , DudasI . The effect of preconceptional multivitamin supplementation on fertility. International Journal for Vitamin and Nutrition Research1996;66:55‐8. CzeizelAE , MetnekiJ , DudasI . The higher rate of multiple births after periconceptional multivitamin supplementation: an analysis of causes. Acta Geneticae Medicae et Gemellologiae1994;43:175‐84. CzeizelAE , RockenbauerM , SusanskyE . No change in sexual activity during preconceptional multivitamin supplementation. British Journal of Obstetrics and Gynaecology1996;103:569‐73. CzeizelAE , VarghaP . Periconceptional folic acid/multivitamin supplementation and twin pregnancy. American Journal of Obstetrics and Gynecology2004;191(3):790‐4. CzeizelE , DudasI . Prevention of the first occurrence of anencephaly and spina bifida with periconceptional multivitamin supplementation (conclusion). Orvosi Hetilap1994;135(42):2313‐7. DoboM , CzeizelAE . Long‐term somatic and mental development of children after periconceptional multivitamin supplementation. European Journal of Pediatrics1998;157:719‐23. DudasI , RockenbauerM , CzeizelAE . The effect of preconceptional multivitamin supplementation on the menstrual cycle. Archives of Gynecology and Obstetrics1995;256(3):115‐23. MetnekiJ , DudasI , CzeizelAE . Higher rate of multiple births after periconceptual multivitamin supplementation. Orvosi Hetilap1996;137(43):2401‐5. ">Czeizel 1994</a>; <a href="./references#CD007950-bbs2-0003" title="KirkePN , DalyLE , ElwoodJH . A randomized trial of low dose folic acid to prevent neural tube defects. Archives of Disease in Childhood1992;67:1442‐6. ">Kirke 1992</a>) reporting the number of babies affected by cleft lip, there was no evidence of a difference between groups; overall eight babies were affected by cleft lip, four in each treatment group (<a href="./references#CD007950-fig-0073" title="">Analysis 3.9</a>). </p> </section> <section id="CD007950-sec-0151"> <p><b>Cleft palate</b></p> <p>Three babies (one in the intervention group and one in the control group) were affected with cleft palate in the three studies examining this outcome (<a href="./references#CD007950-bbs2-0001" title="CzeizelA , FritzG . Randomized trial of periconceptional vitamins. JAMA1989;262:1634. CzeizelA , RodeK . Trial to prevent first occurrence of neural tube defects by periconceptional multivitamin supplementation. Lancet1984;2(8393):40. CzeizelAE . Controlled studies of multivitamin supplementation on pregnancy outcomes. Annals of the New York Academy of Sciences1993;678:266‐75. CzeizelAE . Limb‐reduction defects and folic acid supplementation. Lancet1995;345(8954):932. CzeizelAE . Nutritional supplementation and prevention of congenital abnormalities. Current Opinion in Obstetrics &amp; Gynecology1995;7(2):88‐94. CzeizelAE . Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ1993;306:1645‐8. CzeizelAE . Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. American Journal of Medical Genetics1996;62(2):179‐83. CzeizelAE , DoboM . Postnatal somatic and mental development after periconceptional multivitamin supplementation. Archives of Disease in Childhood1994;70(3):229‐33. CzeizelAE , DudasI . Prevention of the first occurrence of neural‐tube defects by periconceptional vitamin supplementation. New England Journal of Medicine1992;327:1832‐5. CzeizelAE , DudasI , FritzG , TecsoiA , HanckA , KunovitsG . The effect of periconceptional multivitamin‐mineral supplementation on vertigo, nausea and vomiting in the first trimester of pregnancy. Archives of Gynecology and Obstetrics1992;251:181‐5. CzeizelAE , DudasI , MetnekiJ . Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Archives of Gynecology and Obstetrics1994;255:131‐9. CzeizelAE , MedveczkyE . Periconceptional multivitamin supplementation and multimalformed offspring. Obstetrics &amp; Gynecology2003;102:1255‐61. CzeizelAE , MetnekiJ , DudasI . Higher rate of multiple births after periconceptional vitamin supplementation. New England Journal of Medicine1994;330(23):1687‐8. CzeizelAE , MetnekiJ , DudasI . The effect of preconceptional multivitamin supplementation on fertility. International Journal for Vitamin and Nutrition Research1996;66:55‐8. CzeizelAE , MetnekiJ , DudasI . The higher rate of multiple births after periconceptional multivitamin supplementation: an analysis of causes. Acta Geneticae Medicae et Gemellologiae1994;43:175‐84. CzeizelAE , RockenbauerM , SusanskyE . No change in sexual activity during preconceptional multivitamin supplementation. British Journal of Obstetrics and Gynaecology1996;103:569‐73. CzeizelAE , VarghaP . Periconceptional folic acid/multivitamin supplementation and twin pregnancy. American Journal of Obstetrics and Gynecology2004;191(3):790‐4. CzeizelE , DudasI . Prevention of the first occurrence of anencephaly and spina bifida with periconceptional multivitamin supplementation (conclusion). Orvosi Hetilap1994;135(42):2313‐7. DoboM , CzeizelAE . Long‐term somatic and mental development of children after periconceptional multivitamin supplementation. European Journal of Pediatrics1998;157:719‐23. DudasI , RockenbauerM , CzeizelAE . The effect of preconceptional multivitamin supplementation on the menstrual cycle. Archives of Gynecology and Obstetrics1995;256(3):115‐23. MetnekiJ , DudasI , CzeizelAE . Higher rate of multiple births after periconceptual multivitamin supplementation. Orvosi Hetilap1996;137(43):2401‐5. ">Czeizel 1994</a>; <a href="./references#CD007950-bbs2-0003" title="KirkePN , DalyLE , ElwoodJH . A randomized trial of low dose folic acid to prevent neural tube defects. Archives of Disease in Childhood1992;67:1442‐6. ">Kirke 1992</a>; <a href="./references#CD007950-bbs2-0005" title="Anon . Folate supplements prevent recurrence of neural tube defects. Nutrition Review1992;50(Suppl 1):22‐4. Anon . Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet1991;338(8760):131‐7. ">MRC 1991</a>); there was no evidence of a difference between groups (RR 0.73, 95% CI 0.05 to 10.89; n = 5527 births) (<a href="./references#CD007950-fig-0081" title="">Analysis 3.17</a>). </p> </section> <section id="CD007950-sec-0152"> <p><b>Congenital cardiovascular anomalies</b></p> <p>This outcome was reported in three trials (<a href="./references#CD007950-bbs2-0001" title="CzeizelA , FritzG . Randomized trial of periconceptional vitamins. JAMA1989;262:1634. CzeizelA , RodeK . Trial to prevent first occurrence of neural tube defects by periconceptional multivitamin supplementation. Lancet1984;2(8393):40. CzeizelAE . Controlled studies of multivitamin supplementation on pregnancy outcomes. Annals of the New York Academy of Sciences1993;678:266‐75. CzeizelAE . Limb‐reduction defects and folic acid supplementation. Lancet1995;345(8954):932. CzeizelAE . Nutritional supplementation and prevention of congenital abnormalities. Current Opinion in Obstetrics &amp; Gynecology1995;7(2):88‐94. CzeizelAE . Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ1993;306:1645‐8. CzeizelAE . Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. American Journal of Medical Genetics1996;62(2):179‐83. CzeizelAE , DoboM . Postnatal somatic and mental development after periconceptional multivitamin supplementation. Archives of Disease in Childhood1994;70(3):229‐33. CzeizelAE , DudasI . Prevention of the first occurrence of neural‐tube defects by periconceptional vitamin supplementation. New England Journal of Medicine1992;327:1832‐5. CzeizelAE , DudasI , FritzG , TecsoiA , HanckA , KunovitsG . The effect of periconceptional multivitamin‐mineral supplementation on vertigo, nausea and vomiting in the first trimester of pregnancy. Archives of Gynecology and Obstetrics1992;251:181‐5. CzeizelAE , DudasI , MetnekiJ . Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Archives of Gynecology and Obstetrics1994;255:131‐9. CzeizelAE , MedveczkyE . Periconceptional multivitamin supplementation and multimalformed offspring. Obstetrics &amp; Gynecology2003;102:1255‐61. CzeizelAE , MetnekiJ , DudasI . Higher rate of multiple births after periconceptional vitamin supplementation. New England Journal of Medicine1994;330(23):1687‐8. CzeizelAE , MetnekiJ , DudasI . The effect of preconceptional multivitamin supplementation on fertility. International Journal for Vitamin and Nutrition Research1996;66:55‐8. CzeizelAE , MetnekiJ , DudasI . The higher rate of multiple births after periconceptional multivitamin supplementation: an analysis of causes. Acta Geneticae Medicae et Gemellologiae1994;43:175‐84. CzeizelAE , RockenbauerM , SusanskyE . No change in sexual activity during preconceptional multivitamin supplementation. British Journal of Obstetrics and Gynaecology1996;103:569‐73. CzeizelAE , VarghaP . Periconceptional folic acid/multivitamin supplementation and twin pregnancy. American Journal of Obstetrics and Gynecology2004;191(3):790‐4. CzeizelE , DudasI . Prevention of the first occurrence of anencephaly and spina bifida with periconceptional multivitamin supplementation (conclusion). Orvosi Hetilap1994;135(42):2313‐7. DoboM , CzeizelAE . Long‐term somatic and mental development of children after periconceptional multivitamin supplementation. European Journal of Pediatrics1998;157:719‐23. DudasI , RockenbauerM , CzeizelAE . The effect of preconceptional multivitamin supplementation on the menstrual cycle. Archives of Gynecology and Obstetrics1995;256(3):115‐23. MetnekiJ , DudasI , CzeizelAE . Higher rate of multiple births after periconceptual multivitamin supplementation. Orvosi Hetilap1996;137(43):2401‐5. ">Czeizel 1994</a>; <a href="./references#CD007950-bbs2-0003" title="KirkePN , DalyLE , ElwoodJH . A randomized trial of low dose folic acid to prevent neural tube defects. Archives of Disease in Childhood1992;67:1442‐6. ">Kirke 1992</a>; <a href="./references#CD007950-bbs2-0005" title="Anon . Folate supplements prevent recurrence of neural tube defects. Nutrition Review1992;50(Suppl 1):22‐4. Anon . Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet1991;338(8760):131‐7. ">MRC 1991</a>). There was no evidence of a difference between experimental and control groups in the number of babies with congenital cardiovascular defects irrespective of dose of drug, or history of NTDs (<a href="./references#CD007950-fig-0089" title="">Analysis 3.25</a>). </p> </section> <section id="CD007950-sec-0153"> <p><b>Other birth defects (excluding neural tube defects, cleft lip, cleft palate and cardiovascular defects)</b></p> <p>Three trials reported the number of babies with other birth defects (<a href="./references#CD007950-bbs2-0001" title="CzeizelA , FritzG . Randomized trial of periconceptional vitamins. JAMA1989;262:1634. CzeizelA , RodeK . Trial to prevent first occurrence of neural tube defects by periconceptional multivitamin supplementation. Lancet1984;2(8393):40. CzeizelAE . Controlled studies of multivitamin supplementation on pregnancy outcomes. Annals of the New York Academy of Sciences1993;678:266‐75. CzeizelAE . Limb‐reduction defects and folic acid supplementation. Lancet1995;345(8954):932. CzeizelAE . Nutritional supplementation and prevention of congenital abnormalities. Current Opinion in Obstetrics &amp; Gynecology1995;7(2):88‐94. CzeizelAE . Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ1993;306:1645‐8. CzeizelAE . Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. American Journal of Medical Genetics1996;62(2):179‐83. CzeizelAE , DoboM . Postnatal somatic and mental development after periconceptional multivitamin supplementation. Archives of Disease in Childhood1994;70(3):229‐33. CzeizelAE , DudasI . Prevention of the first occurrence of neural‐tube defects by periconceptional vitamin supplementation. New England Journal of Medicine1992;327:1832‐5. CzeizelAE , DudasI , FritzG , TecsoiA , HanckA , KunovitsG . The effect of periconceptional multivitamin‐mineral supplementation on vertigo, nausea and vomiting in the first trimester of pregnancy. Archives of Gynecology and Obstetrics1992;251:181‐5. CzeizelAE , DudasI , MetnekiJ . Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Archives of Gynecology and Obstetrics1994;255:131‐9. CzeizelAE , MedveczkyE . Periconceptional multivitamin supplementation and multimalformed offspring. Obstetrics &amp; Gynecology2003;102:1255‐61. CzeizelAE , MetnekiJ , DudasI . Higher rate of multiple births after periconceptional vitamin supplementation. New England Journal of Medicine1994;330(23):1687‐8. CzeizelAE , MetnekiJ , DudasI . The effect of preconceptional multivitamin supplementation on fertility. International Journal for Vitamin and Nutrition Research1996;66:55‐8. CzeizelAE , MetnekiJ , DudasI . The higher rate of multiple births after periconceptional multivitamin supplementation: an analysis of causes. Acta Geneticae Medicae et Gemellologiae1994;43:175‐84. CzeizelAE , RockenbauerM , SusanskyE . No change in sexual activity during preconceptional multivitamin supplementation. British Journal of Obstetrics and Gynaecology1996;103:569‐73. CzeizelAE , VarghaP . Periconceptional folic acid/multivitamin supplementation and twin pregnancy. American Journal of Obstetrics and Gynecology2004;191(3):790‐4. CzeizelE , DudasI . Prevention of the first occurrence of anencephaly and spina bifida with periconceptional multivitamin supplementation (conclusion). Orvosi Hetilap1994;135(42):2313‐7. DoboM , CzeizelAE . Long‐term somatic and mental development of children after periconceptional multivitamin supplementation. European Journal of Pediatrics1998;157:719‐23. DudasI , RockenbauerM , CzeizelAE . The effect of preconceptional multivitamin supplementation on the menstrual cycle. Archives of Gynecology and Obstetrics1995;256(3):115‐23. MetnekiJ , DudasI , CzeizelAE . Higher rate of multiple births after periconceptual multivitamin supplementation. Orvosi Hetilap1996;137(43):2401‐5. ">Czeizel 1994</a>; <a href="./references#CD007950-bbs2-0003" title="KirkePN , DalyLE , ElwoodJH . A randomized trial of low dose folic acid to prevent neural tube defects. Archives of Disease in Childhood1992;67:1442‐6. ">Kirke 1992</a>; <a href="./references#CD007950-bbs2-0005" title="Anon . Folate supplements prevent recurrence of neural tube defects. Nutrition Review1992;50(Suppl 1):22‐4. Anon . Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet1991;338(8760):131‐7. ">MRC 1991</a>). There was no significant evidence of a difference between groups (RR 0.98, 95% CI 0.54 to 1.77; n = 5527 births) (<a href="./references#CD007950-fig-0100" title="">Analysis 3.36</a>). In the <a href="./references#CD007950-bbs2-0001" title="CzeizelA , FritzG . Randomized trial of periconceptional vitamins. JAMA1989;262:1634. CzeizelA , RodeK . Trial to prevent first occurrence of neural tube defects by periconceptional multivitamin supplementation. Lancet1984;2(8393):40. CzeizelAE . Controlled studies of multivitamin supplementation on pregnancy outcomes. Annals of the New York Academy of Sciences1993;678:266‐75. CzeizelAE . Limb‐reduction defects and folic acid supplementation. Lancet1995;345(8954):932. CzeizelAE . Nutritional supplementation and prevention of congenital abnormalities. Current Opinion in Obstetrics &amp; Gynecology1995;7(2):88‐94. CzeizelAE . Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ1993;306:1645‐8. CzeizelAE . Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. American Journal of Medical Genetics1996;62(2):179‐83. CzeizelAE , DoboM . Postnatal somatic and mental development after periconceptional multivitamin supplementation. Archives of Disease in Childhood1994;70(3):229‐33. CzeizelAE , DudasI . Prevention of the first occurrence of neural‐tube defects by periconceptional vitamin supplementation. New England Journal of Medicine1992;327:1832‐5. CzeizelAE , DudasI , FritzG , TecsoiA , HanckA , KunovitsG . The effect of periconceptional multivitamin‐mineral supplementation on vertigo, nausea and vomiting in the first trimester of pregnancy. Archives of Gynecology and Obstetrics1992;251:181‐5. CzeizelAE , DudasI , MetnekiJ . Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Archives of Gynecology and Obstetrics1994;255:131‐9. CzeizelAE , MedveczkyE . Periconceptional multivitamin supplementation and multimalformed offspring. Obstetrics &amp; Gynecology2003;102:1255‐61. CzeizelAE , MetnekiJ , DudasI . Higher rate of multiple births after periconceptional vitamin supplementation. New England Journal of Medicine1994;330(23):1687‐8. CzeizelAE , MetnekiJ , DudasI . The effect of preconceptional multivitamin supplementation on fertility. International Journal for Vitamin and Nutrition Research1996;66:55‐8. CzeizelAE , MetnekiJ , DudasI . The higher rate of multiple births after periconceptional multivitamin supplementation: an analysis of causes. Acta Geneticae Medicae et Gemellologiae1994;43:175‐84. CzeizelAE , RockenbauerM , SusanskyE . No change in sexual activity during preconceptional multivitamin supplementation. British Journal of Obstetrics and Gynaecology1996;103:569‐73. CzeizelAE , VarghaP . Periconceptional folic acid/multivitamin supplementation and twin pregnancy. American Journal of Obstetrics and Gynecology2004;191(3):790‐4. CzeizelE , DudasI . Prevention of the first occurrence of anencephaly and spina bifida with periconceptional multivitamin supplementation (conclusion). Orvosi Hetilap1994;135(42):2313‐7. DoboM , CzeizelAE . Long‐term somatic and mental development of children after periconceptional multivitamin supplementation. European Journal of Pediatrics1998;157:719‐23. DudasI , RockenbauerM , CzeizelAE . The effect of preconceptional multivitamin supplementation on the menstrual cycle. Archives of Gynecology and Obstetrics1995;256(3):115‐23. MetnekiJ , DudasI , CzeizelAE . Higher rate of multiple births after periconceptual multivitamin supplementation. Orvosi Hetilap1996;137(43):2401‐5. ">Czeizel 1994</a> trial which recruited women with no history of NTDs, the difference between groups was not significant (RR 0.65, 95% CI 0.36 to 1.18; n = 4156 births) as were the pooled results from the two studies (<a href="./references#CD007950-bbs2-0003" title="KirkePN , DalyLE , ElwoodJH . A randomized trial of low dose folic acid to prevent neural tube defects. Archives of Disease in Childhood1992;67:1442‐6. ">Kirke 1992</a>; <a href="./references#CD007950-bbs2-0005" title="Anon . Folate supplements prevent recurrence of neural tube defects. Nutrition Review1992;50(Suppl 1):22‐4. Anon . Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet1991;338(8760):131‐7. ">MRC 1991</a>), which recruited women with previous history of NTDs (RR 1.39, 95% CI 0.74 to 2.62; n = 1371 births) (<a href="./references#CD007950-fig-0101" title="">Analysis 3.37</a>). </p> </section> </section> <section id="CD007950-sec-0154"> <h6 class="title">Maternal outcomes</h6> <section id="CD007950-sec-0155"> <p><b>Maternal anaemia at term (defined as Hb less than 110 g/L); red blood cell folate at term (nmol/L); serum folate at term (nmol/L)</b></p> <p>No trials reported on these outcomes.</p> </section> <section id="CD007950-sec-0156"> <p><b>Miscarriage</b></p> <p>Four trials reported the number of women with confirmed pregnancy suffering miscarriage (<a href="./references#CD007950-bbs2-0001" title="CzeizelA , FritzG . Randomized trial of periconceptional vitamins. JAMA1989;262:1634. CzeizelA , RodeK . Trial to prevent first occurrence of neural tube defects by periconceptional multivitamin supplementation. Lancet1984;2(8393):40. CzeizelAE . Controlled studies of multivitamin supplementation on pregnancy outcomes. Annals of the New York Academy of Sciences1993;678:266‐75. CzeizelAE . Limb‐reduction defects and folic acid supplementation. Lancet1995;345(8954):932. CzeizelAE . Nutritional supplementation and prevention of congenital abnormalities. Current Opinion in Obstetrics &amp; Gynecology1995;7(2):88‐94. CzeizelAE . Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ1993;306:1645‐8. CzeizelAE . Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. American Journal of Medical Genetics1996;62(2):179‐83. CzeizelAE , DoboM . Postnatal somatic and mental development after periconceptional multivitamin supplementation. Archives of Disease in Childhood1994;70(3):229‐33. CzeizelAE , DudasI . Prevention of the first occurrence of neural‐tube defects by periconceptional vitamin supplementation. New England Journal of Medicine1992;327:1832‐5. CzeizelAE , DudasI , FritzG , TecsoiA , HanckA , KunovitsG . The effect of periconceptional multivitamin‐mineral supplementation on vertigo, nausea and vomiting in the first trimester of pregnancy. Archives of Gynecology and Obstetrics1992;251:181‐5. CzeizelAE , DudasI , MetnekiJ . Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Archives of Gynecology and Obstetrics1994;255:131‐9. CzeizelAE , MedveczkyE . Periconceptional multivitamin supplementation and multimalformed offspring. Obstetrics &amp; Gynecology2003;102:1255‐61. CzeizelAE , MetnekiJ , DudasI . Higher rate of multiple births after periconceptional vitamin supplementation. New England Journal of Medicine1994;330(23):1687‐8. CzeizelAE , MetnekiJ , DudasI . The effect of preconceptional multivitamin supplementation on fertility. International Journal for Vitamin and Nutrition Research1996;66:55‐8. CzeizelAE , MetnekiJ , DudasI . The higher rate of multiple births after periconceptional multivitamin supplementation: an analysis of causes. Acta Geneticae Medicae et Gemellologiae1994;43:175‐84. CzeizelAE , RockenbauerM , SusanskyE . No change in sexual activity during preconceptional multivitamin supplementation. British Journal of Obstetrics and Gynaecology1996;103:569‐73. CzeizelAE , VarghaP . Periconceptional folic acid/multivitamin supplementation and twin pregnancy. American Journal of Obstetrics and Gynecology2004;191(3):790‐4. CzeizelE , DudasI . Prevention of the first occurrence of anencephaly and spina bifida with periconceptional multivitamin supplementation (conclusion). Orvosi Hetilap1994;135(42):2313‐7. DoboM , CzeizelAE . Long‐term somatic and mental development of children after periconceptional multivitamin supplementation. European Journal of Pediatrics1998;157:719‐23. DudasI , RockenbauerM , CzeizelAE . The effect of preconceptional multivitamin supplementation on the menstrual cycle. Archives of Gynecology and Obstetrics1995;256(3):115‐23. MetnekiJ , DudasI , CzeizelAE . Higher rate of multiple births after periconceptual multivitamin supplementation. Orvosi Hetilap1996;137(43):2401‐5. ">Czeizel 1994</a>; <a href="./references#CD007950-bbs2-0002" title="Indian Council of Medical Research (ICMR) Collaborating Centres, Central Technical Co‐ordinatingUnit . Multicentric study of efficacy of periconceptional folic acid containing vitamin supplementation in prevention of open neural tube defects from India. Indian Journal of Medical Research2000;112:206‐11. ">ICMR 2000</a>; <a href="./references#CD007950-bbs2-0003" title="KirkePN , DalyLE , ElwoodJH . A randomized trial of low dose folic acid to prevent neural tube defects. Archives of Disease in Childhood1992;67:1442‐6. ">Kirke 1992</a>; <a href="./references#CD007950-bbs2-0005" title="Anon . Folate supplements prevent recurrence of neural tube defects. Nutrition Review1992;50(Suppl 1):22‐4. Anon . Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet1991;338(8760):131‐7. ">MRC 1991</a>); there were no differences between groups (RR 1.08, 95% CI 0.87 to 1.32; n = 7187 pregnancies) (<a href="./references#CD007950-fig-0105" title="">Analysis 3.41</a>). There were no significant differences between groups for any of the subgroups we examined (<a href="./references#CD007950-fig-0106" title="">Analysis 3.42</a> to <a href="./references#CD007950-fig-0112" title="">Analysis 3.48</a>). </p> </section> </section> </section> <section id="CD007950-sec-0157"> <h5 class="title">Secondary outcomes</h5> <section id="CD007950-sec-0158"> <h6 class="title">Infant outcomes</h6> <section id="CD007950-sec-0159"> <p><b>Spina bifida</b></p> <p>Two trials (<a href="./references#CD007950-bbs2-0001" title="CzeizelA , FritzG . Randomized trial of periconceptional vitamins. JAMA1989;262:1634. CzeizelA , RodeK . Trial to prevent first occurrence of neural tube defects by periconceptional multivitamin supplementation. Lancet1984;2(8393):40. CzeizelAE . Controlled studies of multivitamin supplementation on pregnancy outcomes. Annals of the New York Academy of Sciences1993;678:266‐75. CzeizelAE . Limb‐reduction defects and folic acid supplementation. Lancet1995;345(8954):932. CzeizelAE . Nutritional supplementation and prevention of congenital abnormalities. Current Opinion in Obstetrics &amp; Gynecology1995;7(2):88‐94. CzeizelAE . Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ1993;306:1645‐8. CzeizelAE . Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. American Journal of Medical Genetics1996;62(2):179‐83. CzeizelAE , DoboM . Postnatal somatic and mental development after periconceptional multivitamin supplementation. Archives of Disease in Childhood1994;70(3):229‐33. CzeizelAE , DudasI . Prevention of the first occurrence of neural‐tube defects by periconceptional vitamin supplementation. New England Journal of Medicine1992;327:1832‐5. CzeizelAE , DudasI , FritzG , TecsoiA , HanckA , KunovitsG . The effect of periconceptional multivitamin‐mineral supplementation on vertigo, nausea and vomiting in the first trimester of pregnancy. Archives of Gynecology and Obstetrics1992;251:181‐5. CzeizelAE , DudasI , MetnekiJ . Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Archives of Gynecology and Obstetrics1994;255:131‐9. CzeizelAE , MedveczkyE . Periconceptional multivitamin supplementation and multimalformed offspring. Obstetrics &amp; Gynecology2003;102:1255‐61. CzeizelAE , MetnekiJ , DudasI . Higher rate of multiple births after periconceptional vitamin supplementation. New England Journal of Medicine1994;330(23):1687‐8. CzeizelAE , MetnekiJ , DudasI . The effect of preconceptional multivitamin supplementation on fertility. International Journal for Vitamin and Nutrition Research1996;66:55‐8. CzeizelAE , MetnekiJ , DudasI . The higher rate of multiple births after periconceptional multivitamin supplementation: an analysis of causes. Acta Geneticae Medicae et Gemellologiae1994;43:175‐84. CzeizelAE , RockenbauerM , SusanskyE . No change in sexual activity during preconceptional multivitamin supplementation. British Journal of Obstetrics and Gynaecology1996;103:569‐73. CzeizelAE , VarghaP . Periconceptional folic acid/multivitamin supplementation and twin pregnancy. American Journal of Obstetrics and Gynecology2004;191(3):790‐4. CzeizelE , DudasI . Prevention of the first occurrence of anencephaly and spina bifida with periconceptional multivitamin supplementation (conclusion). Orvosi Hetilap1994;135(42):2313‐7. DoboM , CzeizelAE . Long‐term somatic and mental development of children after periconceptional multivitamin supplementation. European Journal of Pediatrics1998;157:719‐23. DudasI , RockenbauerM , CzeizelAE . The effect of preconceptional multivitamin supplementation on the menstrual cycle. Archives of Gynecology and Obstetrics1995;256(3):115‐23. MetnekiJ , DudasI , CzeizelAE . Higher rate of multiple births after periconceptual multivitamin supplementation. Orvosi Hetilap1996;137(43):2401‐5. ">Czeizel 1994</a>; <a href="./references#CD007950-bbs2-0002" title="Indian Council of Medical Research (ICMR) Collaborating Centres, Central Technical Co‐ordinatingUnit . Multicentric study of efficacy of periconceptional folic acid containing vitamin supplementation in prevention of open neural tube defects from India. Indian Journal of Medical Research2000;112:206‐11. ">ICMR 2000</a>) reported three cases of spina bifida, all in the control group, though no significant differences between groups were seen (RR 0.26, 95% CI 0.03 to 2.31; n = 4435 births) (<a href="./references#CD007950-fig-0113" title="">Analysis 3.49</a>). </p> </section> <section id="CD007950-sec-0160"> <p><b>Anencephaly</b></p> <p>Three studies (<a href="./references#CD007950-bbs2-0001" title="CzeizelA , FritzG . Randomized trial of periconceptional vitamins. JAMA1989;262:1634. CzeizelA , RodeK . Trial to prevent first occurrence of neural tube defects by periconceptional multivitamin supplementation. Lancet1984;2(8393):40. CzeizelAE . Controlled studies of multivitamin supplementation on pregnancy outcomes. Annals of the New York Academy of Sciences1993;678:266‐75. CzeizelAE . Limb‐reduction defects and folic acid supplementation. Lancet1995;345(8954):932. CzeizelAE . Nutritional supplementation and prevention of congenital abnormalities. Current Opinion in Obstetrics &amp; Gynecology1995;7(2):88‐94. CzeizelAE . Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ1993;306:1645‐8. CzeizelAE . Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. American Journal of Medical Genetics1996;62(2):179‐83. CzeizelAE , DoboM . Postnatal somatic and mental development after periconceptional multivitamin supplementation. Archives of Disease in Childhood1994;70(3):229‐33. CzeizelAE , DudasI . Prevention of the first occurrence of neural‐tube defects by periconceptional vitamin supplementation. New England Journal of Medicine1992;327:1832‐5. CzeizelAE , DudasI , FritzG , TecsoiA , HanckA , KunovitsG . The effect of periconceptional multivitamin‐mineral supplementation on vertigo, nausea and vomiting in the first trimester of pregnancy. Archives of Gynecology and Obstetrics1992;251:181‐5. CzeizelAE , DudasI , MetnekiJ . Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Archives of Gynecology and Obstetrics1994;255:131‐9. CzeizelAE , MedveczkyE . Periconceptional multivitamin supplementation and multimalformed offspring. Obstetrics &amp; Gynecology2003;102:1255‐61. CzeizelAE , MetnekiJ , DudasI . Higher rate of multiple births after periconceptional vitamin supplementation. New England Journal of Medicine1994;330(23):1687‐8. CzeizelAE , MetnekiJ , DudasI . The effect of preconceptional multivitamin supplementation on fertility. International Journal for Vitamin and Nutrition Research1996;66:55‐8. CzeizelAE , MetnekiJ , DudasI . The higher rate of multiple births after periconceptional multivitamin supplementation: an analysis of causes. Acta Geneticae Medicae et Gemellologiae1994;43:175‐84. CzeizelAE , RockenbauerM , SusanskyE . No change in sexual activity during preconceptional multivitamin supplementation. British Journal of Obstetrics and Gynaecology1996;103:569‐73. CzeizelAE , VarghaP . Periconceptional folic acid/multivitamin supplementation and twin pregnancy. American Journal of Obstetrics and Gynecology2004;191(3):790‐4. CzeizelE , DudasI . Prevention of the first occurrence of anencephaly and spina bifida with periconceptional multivitamin supplementation (conclusion). Orvosi Hetilap1994;135(42):2313‐7. DoboM , CzeizelAE . Long‐term somatic and mental development of children after periconceptional multivitamin supplementation. European Journal of Pediatrics1998;157:719‐23. DudasI , RockenbauerM , CzeizelAE . The effect of preconceptional multivitamin supplementation on the menstrual cycle. Archives of Gynecology and Obstetrics1995;256(3):115‐23. MetnekiJ , DudasI , CzeizelAE . Higher rate of multiple births after periconceptual multivitamin supplementation. Orvosi Hetilap1996;137(43):2401‐5. ">Czeizel 1994</a>; <a href="./references#CD007950-bbs2-0002" title="Indian Council of Medical Research (ICMR) Collaborating Centres, Central Technical Co‐ordinatingUnit . Multicentric study of efficacy of periconceptional folic acid containing vitamin supplementation in prevention of open neural tube defects from India. Indian Journal of Medical Research2000;112:206‐11. ">ICMR 2000</a>; <a href="./references#CD007950-bbs2-0003" title="KirkePN , DalyLE , ElwoodJH . A randomized trial of low dose folic acid to prevent neural tube defects. Archives of Disease in Childhood1992;67:1442‐6. ">Kirke 1992</a>) reported 10 cases of anencephaly (three in the treatment group with folate and seven in the control group though the pooled results showed no evidence of a difference (RR 0.38, 95% CI 0.12 to 1.22; n = 4611 births) (<a href="./references#CD007950-fig-0114" title="">Analysis 3.50</a>). </p> </section> <section id="CD007950-sec-0161"> <p><b>Stillbirths</b></p> <p>Stillbirths were reported in four trials included in this comparison (<a href="./references#CD007950-bbs2-0001" title="CzeizelA , FritzG . Randomized trial of periconceptional vitamins. JAMA1989;262:1634. CzeizelA , RodeK . Trial to prevent first occurrence of neural tube defects by periconceptional multivitamin supplementation. Lancet1984;2(8393):40. CzeizelAE . Controlled studies of multivitamin supplementation on pregnancy outcomes. Annals of the New York Academy of Sciences1993;678:266‐75. CzeizelAE . Limb‐reduction defects and folic acid supplementation. Lancet1995;345(8954):932. CzeizelAE . Nutritional supplementation and prevention of congenital abnormalities. Current Opinion in Obstetrics &amp; Gynecology1995;7(2):88‐94. CzeizelAE . Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ1993;306:1645‐8. CzeizelAE . Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. American Journal of Medical Genetics1996;62(2):179‐83. CzeizelAE , DoboM . Postnatal somatic and mental development after periconceptional multivitamin supplementation. Archives of Disease in Childhood1994;70(3):229‐33. CzeizelAE , DudasI . Prevention of the first occurrence of neural‐tube defects by periconceptional vitamin supplementation. New England Journal of Medicine1992;327:1832‐5. CzeizelAE , DudasI , FritzG , TecsoiA , HanckA , KunovitsG . The effect of periconceptional multivitamin‐mineral supplementation on vertigo, nausea and vomiting in the first trimester of pregnancy. Archives of Gynecology and Obstetrics1992;251:181‐5. CzeizelAE , DudasI , MetnekiJ . Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Archives of Gynecology and Obstetrics1994;255:131‐9. CzeizelAE , MedveczkyE . Periconceptional multivitamin supplementation and multimalformed offspring. Obstetrics &amp; Gynecology2003;102:1255‐61. CzeizelAE , MetnekiJ , DudasI . Higher rate of multiple births after periconceptional vitamin supplementation. New England Journal of Medicine1994;330(23):1687‐8. CzeizelAE , MetnekiJ , DudasI . The effect of preconceptional multivitamin supplementation on fertility. International Journal for Vitamin and Nutrition Research1996;66:55‐8. CzeizelAE , MetnekiJ , DudasI . The higher rate of multiple births after periconceptional multivitamin supplementation: an analysis of causes. Acta Geneticae Medicae et Gemellologiae1994;43:175‐84. CzeizelAE , RockenbauerM , SusanskyE . No change in sexual activity during preconceptional multivitamin supplementation. British Journal of Obstetrics and Gynaecology1996;103:569‐73. CzeizelAE , VarghaP . Periconceptional folic acid/multivitamin supplementation and twin pregnancy. American Journal of Obstetrics and Gynecology2004;191(3):790‐4. CzeizelE , DudasI . Prevention of the first occurrence of anencephaly and spina bifida with periconceptional multivitamin supplementation (conclusion). Orvosi Hetilap1994;135(42):2313‐7. DoboM , CzeizelAE . Long‐term somatic and mental development of children after periconceptional multivitamin supplementation. European Journal of Pediatrics1998;157:719‐23. DudasI , RockenbauerM , CzeizelAE . The effect of preconceptional multivitamin supplementation on the menstrual cycle. Archives of Gynecology and Obstetrics1995;256(3):115‐23. MetnekiJ , DudasI , CzeizelAE . Higher rate of multiple births after periconceptual multivitamin supplementation. Orvosi Hetilap1996;137(43):2401‐5. ">Czeizel 1994</a>; <a href="./references#CD007950-bbs2-0002" title="Indian Council of Medical Research (ICMR) Collaborating Centres, Central Technical Co‐ordinatingUnit . Multicentric study of efficacy of periconceptional folic acid containing vitamin supplementation in prevention of open neural tube defects from India. Indian Journal of Medical Research2000;112:206‐11. ">ICMR 2000</a>; <a href="./references#CD007950-bbs2-0003" title="KirkePN , DalyLE , ElwoodJH . A randomized trial of low dose folic acid to prevent neural tube defects. Archives of Disease in Childhood1992;67:1442‐6. ">Kirke 1992</a>; <a href="./references#CD007950-bbs2-0005" title="Anon . Folate supplements prevent recurrence of neural tube defects. Nutrition Review1992;50(Suppl 1):22‐4. Anon . Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet1991;338(8760):131‐7. ">MRC 1991</a>). There was no significant evidence of any difference between treatment groups in the pooled analysis (RR 1.09, 95% CI 0.56 to 2.12; n = 6512 births) (<a href="./references#CD007950-fig-0115" title="">Analysis 3.51</a>). </p> </section> <section id="CD007950-sec-0162"> <p><b>Pregnancy termination for fetal anomaly</b></p> <p>Overall, in the three studies examining this outcome (<a href="./references#CD007950-bbs2-0001" title="CzeizelA , FritzG . Randomized trial of periconceptional vitamins. JAMA1989;262:1634. CzeizelA , RodeK . Trial to prevent first occurrence of neural tube defects by periconceptional multivitamin supplementation. Lancet1984;2(8393):40. CzeizelAE . Controlled studies of multivitamin supplementation on pregnancy outcomes. Annals of the New York Academy of Sciences1993;678:266‐75. CzeizelAE . Limb‐reduction defects and folic acid supplementation. Lancet1995;345(8954):932. CzeizelAE . Nutritional supplementation and prevention of congenital abnormalities. Current Opinion in Obstetrics &amp; Gynecology1995;7(2):88‐94. CzeizelAE . Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ1993;306:1645‐8. CzeizelAE . Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. American Journal of Medical Genetics1996;62(2):179‐83. CzeizelAE , DoboM . Postnatal somatic and mental development after periconceptional multivitamin supplementation. Archives of Disease in Childhood1994;70(3):229‐33. CzeizelAE , DudasI . Prevention of the first occurrence of neural‐tube defects by periconceptional vitamin supplementation. New England Journal of Medicine1992;327:1832‐5. CzeizelAE , DudasI , FritzG , TecsoiA , HanckA , KunovitsG . The effect of periconceptional multivitamin‐mineral supplementation on vertigo, nausea and vomiting in the first trimester of pregnancy. Archives of Gynecology and Obstetrics1992;251:181‐5. CzeizelAE , DudasI , MetnekiJ . Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Archives of Gynecology and Obstetrics1994;255:131‐9. CzeizelAE , MedveczkyE . Periconceptional multivitamin supplementation and multimalformed offspring. Obstetrics &amp; Gynecology2003;102:1255‐61. CzeizelAE , MetnekiJ , DudasI . Higher rate of multiple births after periconceptional vitamin supplementation. New England Journal of Medicine1994;330(23):1687‐8. CzeizelAE , MetnekiJ , DudasI . The effect of preconceptional multivitamin supplementation on fertility. International Journal for Vitamin and Nutrition Research1996;66:55‐8. CzeizelAE , MetnekiJ , DudasI . The higher rate of multiple births after periconceptional multivitamin supplementation: an analysis of causes. Acta Geneticae Medicae et Gemellologiae1994;43:175‐84. CzeizelAE , RockenbauerM , SusanskyE . No change in sexual activity during preconceptional multivitamin supplementation. British Journal of Obstetrics and Gynaecology1996;103:569‐73. CzeizelAE , VarghaP . Periconceptional folic acid/multivitamin supplementation and twin pregnancy. American Journal of Obstetrics and Gynecology2004;191(3):790‐4. CzeizelE , DudasI . Prevention of the first occurrence of anencephaly and spina bifida with periconceptional multivitamin supplementation (conclusion). Orvosi Hetilap1994;135(42):2313‐7. DoboM , CzeizelAE . Long‐term somatic and mental development of children after periconceptional multivitamin supplementation. European Journal of Pediatrics1998;157:719‐23. DudasI , RockenbauerM , CzeizelAE . The effect of preconceptional multivitamin supplementation on the menstrual cycle. Archives of Gynecology and Obstetrics1995;256(3):115‐23. MetnekiJ , DudasI , CzeizelAE . Higher rate of multiple births after periconceptual multivitamin supplementation. Orvosi Hetilap1996;137(43):2401‐5. ">Czeizel 1994</a>; <a href="./references#CD007950-bbs2-0002" title="Indian Council of Medical Research (ICMR) Collaborating Centres, Central Technical Co‐ordinatingUnit . Multicentric study of efficacy of periconceptional folic acid containing vitamin supplementation in prevention of open neural tube defects from India. Indian Journal of Medical Research2000;112:206‐11. ">ICMR 2000</a>; <a href="./references#CD007950-bbs2-0005" title="Anon . Folate supplements prevent recurrence of neural tube defects. Nutrition Review1992;50(Suppl 1):22‐4. Anon . Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet1991;338(8760):131‐7. ">MRC 1991</a>) there were 49 pregnancies terminated for fetal anomaly; 11/3552 in the women who received folic acid with other micronutrients and 38/3447 in the control group who received other micronutrients supplements without folic acid. The difference between groups was significant in the pooled analysis (RR 0.29, 95% CI 0.15 to 0.57; n = 6999) (<a href="./references#CD007950-fig-0116" title="">Analysis 3.52</a>). </p> </section> <section id="CD007950-sec-0163"> <p><b>Low birthweight (less than 2500 g)</b></p> <p>The number of babies with low birthweight was examined in two trials (5048 births) (<a href="./references#CD007950-bbs2-0001" title="CzeizelA , FritzG . Randomized trial of periconceptional vitamins. JAMA1989;262:1634. CzeizelA , RodeK . Trial to prevent first occurrence of neural tube defects by periconceptional multivitamin supplementation. Lancet1984;2(8393):40. CzeizelAE . Controlled studies of multivitamin supplementation on pregnancy outcomes. Annals of the New York Academy of Sciences1993;678:266‐75. CzeizelAE . Limb‐reduction defects and folic acid supplementation. Lancet1995;345(8954):932. CzeizelAE . Nutritional supplementation and prevention of congenital abnormalities. Current Opinion in Obstetrics &amp; Gynecology1995;7(2):88‐94. CzeizelAE . Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ1993;306:1645‐8. CzeizelAE . Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. American Journal of Medical Genetics1996;62(2):179‐83. CzeizelAE , DoboM . Postnatal somatic and mental development after periconceptional multivitamin supplementation. Archives of Disease in Childhood1994;70(3):229‐33. CzeizelAE , DudasI . Prevention of the first occurrence of neural‐tube defects by periconceptional vitamin supplementation. New England Journal of Medicine1992;327:1832‐5. CzeizelAE , DudasI , FritzG , TecsoiA , HanckA , KunovitsG . The effect of periconceptional multivitamin‐mineral supplementation on vertigo, nausea and vomiting in the first trimester of pregnancy. Archives of Gynecology and Obstetrics1992;251:181‐5. CzeizelAE , DudasI , MetnekiJ . Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Archives of Gynecology and Obstetrics1994;255:131‐9. CzeizelAE , MedveczkyE . Periconceptional multivitamin supplementation and multimalformed offspring. Obstetrics &amp; Gynecology2003;102:1255‐61. CzeizelAE , MetnekiJ , DudasI . Higher rate of multiple births after periconceptional vitamin supplementation. New England Journal of Medicine1994;330(23):1687‐8. CzeizelAE , MetnekiJ , DudasI . The effect of preconceptional multivitamin supplementation on fertility. International Journal for Vitamin and Nutrition Research1996;66:55‐8. CzeizelAE , MetnekiJ , DudasI . The higher rate of multiple births after periconceptional multivitamin supplementation: an analysis of causes. Acta Geneticae Medicae et Gemellologiae1994;43:175‐84. CzeizelAE , RockenbauerM , SusanskyE . No change in sexual activity during preconceptional multivitamin supplementation. British Journal of Obstetrics and Gynaecology1996;103:569‐73. CzeizelAE , VarghaP . Periconceptional folic acid/multivitamin supplementation and twin pregnancy. American Journal of Obstetrics and Gynecology2004;191(3):790‐4. CzeizelE , DudasI . Prevention of the first occurrence of anencephaly and spina bifida with periconceptional multivitamin supplementation (conclusion). Orvosi Hetilap1994;135(42):2313‐7. DoboM , CzeizelAE . Long‐term somatic and mental development of children after periconceptional multivitamin supplementation. European Journal of Pediatrics1998;157:719‐23. DudasI , RockenbauerM , CzeizelAE . The effect of preconceptional multivitamin supplementation on the menstrual cycle. Archives of Gynecology and Obstetrics1995;256(3):115‐23. MetnekiJ , DudasI , CzeizelAE . Higher rate of multiple births after periconceptual multivitamin supplementation. Orvosi Hetilap1996;137(43):2401‐5. ">Czeizel 1994</a>; <a href="./references#CD007950-bbs2-0002" title="Indian Council of Medical Research (ICMR) Collaborating Centres, Central Technical Co‐ordinatingUnit . Multicentric study of efficacy of periconceptional folic acid containing vitamin supplementation in prevention of open neural tube defects from India. Indian Journal of Medical Research2000;112:206‐11. ">ICMR 2000</a>). There was no significant evidence of a difference between treatment groups (<a href="./references#CD007950-fig-0117" title="">Analysis 3.53</a>). </p> </section> <section id="CD007950-sec-0164"> <p><b>Macrosomia (birthweight greater than 4000 g)</b></p> <p>One study (<a href="./references#CD007950-bbs2-0001" title="CzeizelA , FritzG . Randomized trial of periconceptional vitamins. JAMA1989;262:1634. CzeizelA , RodeK . Trial to prevent first occurrence of neural tube defects by periconceptional multivitamin supplementation. Lancet1984;2(8393):40. CzeizelAE . Controlled studies of multivitamin supplementation on pregnancy outcomes. Annals of the New York Academy of Sciences1993;678:266‐75. CzeizelAE . Limb‐reduction defects and folic acid supplementation. Lancet1995;345(8954):932. CzeizelAE . Nutritional supplementation and prevention of congenital abnormalities. Current Opinion in Obstetrics &amp; Gynecology1995;7(2):88‐94. CzeizelAE . Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ1993;306:1645‐8. CzeizelAE . Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. American Journal of Medical Genetics1996;62(2):179‐83. CzeizelAE , DoboM . Postnatal somatic and mental development after periconceptional multivitamin supplementation. Archives of Disease in Childhood1994;70(3):229‐33. CzeizelAE , DudasI . Prevention of the first occurrence of neural‐tube defects by periconceptional vitamin supplementation. New England Journal of Medicine1992;327:1832‐5. CzeizelAE , DudasI , FritzG , TecsoiA , HanckA , KunovitsG . The effect of periconceptional multivitamin‐mineral supplementation on vertigo, nausea and vomiting in the first trimester of pregnancy. Archives of Gynecology and Obstetrics1992;251:181‐5. CzeizelAE , DudasI , MetnekiJ . Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Archives of Gynecology and Obstetrics1994;255:131‐9. CzeizelAE , MedveczkyE . Periconceptional multivitamin supplementation and multimalformed offspring. Obstetrics &amp; Gynecology2003;102:1255‐61. CzeizelAE , MetnekiJ , DudasI . Higher rate of multiple births after periconceptional vitamin supplementation. New England Journal of Medicine1994;330(23):1687‐8. CzeizelAE , MetnekiJ , DudasI . The effect of preconceptional multivitamin supplementation on fertility. International Journal for Vitamin and Nutrition Research1996;66:55‐8. CzeizelAE , MetnekiJ , DudasI . The higher rate of multiple births after periconceptional multivitamin supplementation: an analysis of causes. Acta Geneticae Medicae et Gemellologiae1994;43:175‐84. CzeizelAE , RockenbauerM , SusanskyE . No change in sexual activity during preconceptional multivitamin supplementation. British Journal of Obstetrics and Gynaecology1996;103:569‐73. CzeizelAE , VarghaP . Periconceptional folic acid/multivitamin supplementation and twin pregnancy. American Journal of Obstetrics and Gynecology2004;191(3):790‐4. CzeizelE , DudasI . Prevention of the first occurrence of anencephaly and spina bifida with periconceptional multivitamin supplementation (conclusion). Orvosi Hetilap1994;135(42):2313‐7. DoboM , CzeizelAE . Long‐term somatic and mental development of children after periconceptional multivitamin supplementation. European Journal of Pediatrics1998;157:719‐23. DudasI , RockenbauerM , CzeizelAE . The effect of preconceptional multivitamin supplementation on the menstrual cycle. Archives of Gynecology and Obstetrics1995;256(3):115‐23. MetnekiJ , DudasI , CzeizelAE . Higher rate of multiple births after periconceptual multivitamin supplementation. Orvosi Hetilap1996;137(43):2401‐5. ">Czeizel 1994</a>) reported 304 macrosomic births out of 4862 with no significant difference between treatment groups (RR 0.98, 95% CI 0.79 to 1.22) (<a href="./references#CD007950-fig-0118" title="">Analysis 3.54</a>). </p> </section> <section id="CD007950-sec-0165"> <p><b>Preterm birth (less than 37 weeks' gestation)</b></p> <p>In one study (<a href="./references#CD007950-bbs2-0001" title="CzeizelA , FritzG . Randomized trial of periconceptional vitamins. JAMA1989;262:1634. CzeizelA , RodeK . Trial to prevent first occurrence of neural tube defects by periconceptional multivitamin supplementation. Lancet1984;2(8393):40. CzeizelAE . Controlled studies of multivitamin supplementation on pregnancy outcomes. Annals of the New York Academy of Sciences1993;678:266‐75. CzeizelAE . Limb‐reduction defects and folic acid supplementation. Lancet1995;345(8954):932. CzeizelAE . Nutritional supplementation and prevention of congenital abnormalities. Current Opinion in Obstetrics &amp; Gynecology1995;7(2):88‐94. CzeizelAE . Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ1993;306:1645‐8. CzeizelAE . Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. American Journal of Medical Genetics1996;62(2):179‐83. CzeizelAE , DoboM . Postnatal somatic and mental development after periconceptional multivitamin supplementation. Archives of Disease in Childhood1994;70(3):229‐33. CzeizelAE , DudasI . Prevention of the first occurrence of neural‐tube defects by periconceptional vitamin supplementation. New England Journal of Medicine1992;327:1832‐5. CzeizelAE , DudasI , FritzG , TecsoiA , HanckA , KunovitsG . The effect of periconceptional multivitamin‐mineral supplementation on vertigo, nausea and vomiting in the first trimester of pregnancy. Archives of Gynecology and Obstetrics1992;251:181‐5. CzeizelAE , DudasI , MetnekiJ . Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Archives of Gynecology and Obstetrics1994;255:131‐9. CzeizelAE , MedveczkyE . Periconceptional multivitamin supplementation and multimalformed offspring. Obstetrics &amp; Gynecology2003;102:1255‐61. CzeizelAE , MetnekiJ , DudasI . Higher rate of multiple births after periconceptional vitamin supplementation. New England Journal of Medicine1994;330(23):1687‐8. CzeizelAE , MetnekiJ , DudasI . The effect of preconceptional multivitamin supplementation on fertility. International Journal for Vitamin and Nutrition Research1996;66:55‐8. CzeizelAE , MetnekiJ , DudasI . The higher rate of multiple births after periconceptional multivitamin supplementation: an analysis of causes. Acta Geneticae Medicae et Gemellologiae1994;43:175‐84. CzeizelAE , RockenbauerM , SusanskyE . No change in sexual activity during preconceptional multivitamin supplementation. British Journal of Obstetrics and Gynaecology1996;103:569‐73. CzeizelAE , VarghaP . Periconceptional folic acid/multivitamin supplementation and twin pregnancy. American Journal of Obstetrics and Gynecology2004;191(3):790‐4. CzeizelE , DudasI . Prevention of the first occurrence of anencephaly and spina bifida with periconceptional multivitamin supplementation (conclusion). Orvosi Hetilap1994;135(42):2313‐7. DoboM , CzeizelAE . Long‐term somatic and mental development of children after periconceptional multivitamin supplementation. European Journal of Pediatrics1998;157:719‐23. DudasI , RockenbauerM , CzeizelAE . The effect of preconceptional multivitamin supplementation on the menstrual cycle. Archives of Gynecology and Obstetrics1995;256(3):115‐23. MetnekiJ , DudasI , CzeizelAE . Higher rate of multiple births after periconceptual multivitamin supplementation. Orvosi Hetilap1996;137(43):2401‐5. ">Czeizel 1994</a>), there was no significant difference in risk of preterm births between treatment groups (RR 1.14, 95% CI 0.93 to 1.41; n = 4862 births) (<a href="./references#CD007950-fig-0119" title="">Analysis 3.55</a>). </p> </section> <section id="CD007950-sec-0166"> <p><b>Other infant outcomes</b></p> <p>No trials reported results for our other pre‐specified secondary outcomes.</p> </section> </section> <section id="CD007950-sec-0167"> <h6 class="title">Maternal</h6> <section id="CD007950-sec-0168"> <p><b>Multiple pregnancy</b></p> <p>The number of women affected by multiple pregnancy was examined in three trials (<a href="./references#CD007950-bbs2-0001" title="CzeizelA , FritzG . Randomized trial of periconceptional vitamins. JAMA1989;262:1634. CzeizelA , RodeK . Trial to prevent first occurrence of neural tube defects by periconceptional multivitamin supplementation. Lancet1984;2(8393):40. CzeizelAE . Controlled studies of multivitamin supplementation on pregnancy outcomes. Annals of the New York Academy of Sciences1993;678:266‐75. CzeizelAE . Limb‐reduction defects and folic acid supplementation. Lancet1995;345(8954):932. CzeizelAE . Nutritional supplementation and prevention of congenital abnormalities. Current Opinion in Obstetrics &amp; Gynecology1995;7(2):88‐94. CzeizelAE . Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ1993;306:1645‐8. CzeizelAE . Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. American Journal of Medical Genetics1996;62(2):179‐83. CzeizelAE , DoboM . Postnatal somatic and mental development after periconceptional multivitamin supplementation. Archives of Disease in Childhood1994;70(3):229‐33. CzeizelAE , DudasI . Prevention of the first occurrence of neural‐tube defects by periconceptional vitamin supplementation. New England Journal of Medicine1992;327:1832‐5. CzeizelAE , DudasI , FritzG , TecsoiA , HanckA , KunovitsG . The effect of periconceptional multivitamin‐mineral supplementation on vertigo, nausea and vomiting in the first trimester of pregnancy. Archives of Gynecology and Obstetrics1992;251:181‐5. CzeizelAE , DudasI , MetnekiJ . Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Archives of Gynecology and Obstetrics1994;255:131‐9. CzeizelAE , MedveczkyE . Periconceptional multivitamin supplementation and multimalformed offspring. Obstetrics &amp; Gynecology2003;102:1255‐61. CzeizelAE , MetnekiJ , DudasI . Higher rate of multiple births after periconceptional vitamin supplementation. New England Journal of Medicine1994;330(23):1687‐8. CzeizelAE , MetnekiJ , DudasI . The effect of preconceptional multivitamin supplementation on fertility. International Journal for Vitamin and Nutrition Research1996;66:55‐8. CzeizelAE , MetnekiJ , DudasI . The higher rate of multiple births after periconceptional multivitamin supplementation: an analysis of causes. Acta Geneticae Medicae et Gemellologiae1994;43:175‐84. CzeizelAE , RockenbauerM , SusanskyE . No change in sexual activity during preconceptional multivitamin supplementation. British Journal of Obstetrics and Gynaecology1996;103:569‐73. CzeizelAE , VarghaP . Periconceptional folic acid/multivitamin supplementation and twin pregnancy. American Journal of Obstetrics and Gynecology2004;191(3):790‐4. CzeizelE , DudasI . Prevention of the first occurrence of anencephaly and spina bifida with periconceptional multivitamin supplementation (conclusion). Orvosi Hetilap1994;135(42):2313‐7. DoboM , CzeizelAE . Long‐term somatic and mental development of children after periconceptional multivitamin supplementation. European Journal of Pediatrics1998;157:719‐23. DudasI , RockenbauerM , CzeizelAE . The effect of preconceptional multivitamin supplementation on the menstrual cycle. Archives of Gynecology and Obstetrics1995;256(3):115‐23. MetnekiJ , DudasI , CzeizelAE . Higher rate of multiple births after periconceptual multivitamin supplementation. Orvosi Hetilap1996;137(43):2401‐5. ">Czeizel 1994</a>; <a href="./references#CD007950-bbs2-0003" title="KirkePN , DalyLE , ElwoodJH . A randomized trial of low dose folic acid to prevent neural tube defects. Archives of Disease in Childhood1992;67:1442‐6. ">Kirke 1992</a>; <a href="./references#CD007950-bbs2-0005" title="Anon . Folate supplements prevent recurrence of neural tube defects. Nutrition Review1992;50(Suppl 1):22‐4. Anon . Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet1991;338(8760):131‐7. ">MRC 1991</a>). There was no significant evidence of a difference between women in the two treatment groups (RR 1.39, 95% CI 0.90 to 2.17; n = 7187 pregnancies) (<a href="./references#CD007950-fig-0120" title="">Analysis 3.56</a>). </p> </section> <section id="CD007950-sec-0169"> <p><b>Other maternal outcomes</b></p> <p>No trials reported on our other pre‐specified secondary outcomes.</p> </section> </section> </section> </section> <section id="CD007950-sec-0170"> <h4 class="title">(4) Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials) </h4> <section id="CD007950-sec-0171"> <h5 class="title">Primary outcomes</h5> <section id="CD007950-sec-0172"> <h6 class="title">Infant outcomes</h6> <section id="CD007950-sec-0173"> <p><b>Neural tube defects (NTDs) (all)</b></p> <p>Two of the trials (<a href="./references#CD007950-bbs2-0003" title="KirkePN , DalyLE , ElwoodJH . A randomized trial of low dose folic acid to prevent neural tube defects. Archives of Disease in Childhood1992;67:1442‐6. ">Kirke 1992</a>; <a href="./references#CD007950-bbs2-0005" title="Anon . Folate supplements prevent recurrence of neural tube defects. Nutrition Review1992;50(Suppl 1):22‐4. Anon . Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet1991;338(8760):131‐7. ">MRC 1991</a>) (1371 births) included comparisons of women receiving folic acid with micronutrients compared with women receiving the same micronutrients but without folic acid. There was a difference between groups favouring those who received the folic acid supplementation (RR 0.29, 95% CI 0.12 to 0.70) (<a href="./references#CD007950-fig-0121" title="">Analysis 4.1</a>). In all of these trials supplementation started before pregnancy, continued throughout the first trimester, involved daily supplementation and selected women with a history of a previous pregnancy affected by NTD. </p> <p>Subgroup analysis according to dose of the folic acid did not show significant differences between subgroups (<a href="./references#CD007950-fig-0122" title="">Analysis 4.2</a> to <a href="./references#CD007950-fig-0128" title="">Analysis 4.8</a>). </p> </section> <section id="CD007950-sec-0174"> <p><b>Cleft lip</b></p> <p>In the two trials (<a href="./references#CD007950-bbs2-0003" title="KirkePN , DalyLE , ElwoodJH . A randomized trial of low dose folic acid to prevent neural tube defects. Archives of Disease in Childhood1992;67:1442‐6. ">Kirke 1992</a>; <a href="./references#CD007950-bbs2-0005" title="Anon . Folate supplements prevent recurrence of neural tube defects. Nutrition Review1992;50(Suppl 1):22‐4. Anon . Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet1991;338(8760):131‐7. ">MRC 1991</a>) reporting the number of babies affected by cleft lip, there was only one case noted in the control group in one study (<a href="./references#CD007950-bbs2-0003" title="KirkePN , DalyLE , ElwoodJH . A randomized trial of low dose folic acid to prevent neural tube defects. Archives of Disease in Childhood1992;67:1442‐6. ">Kirke 1992</a>). There was no evidence of a difference between groups (RR 0.34, 95% CI 0.01 to 8.26; n = 1371 births) (<a href="./references#CD007950-fig-0129" title="">Analysis 4.9</a>). </p> </section> <section id="CD007950-sec-0175"> <p><b>Cleft palate</b></p> <p>One case of cleft palate in the folate supplementation group was found in one study (<a href="./references#CD007950-bbs2-0005" title="Anon . Folate supplements prevent recurrence of neural tube defects. Nutrition Review1992;50(Suppl 1):22‐4. Anon . Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet1991;338(8760):131‐7. ">MRC 1991</a>), although two studies reported this outcome (<a href="./references#CD007950-bbs2-0003" title="KirkePN , DalyLE , ElwoodJH . A randomized trial of low dose folic acid to prevent neural tube defects. Archives of Disease in Childhood1992;67:1442‐6. ">Kirke 1992</a>; <a href="./references#CD007950-bbs2-0005" title="Anon . Folate supplements prevent recurrence of neural tube defects. Nutrition Review1992;50(Suppl 1):22‐4. Anon . Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet1991;338(8760):131‐7. ">MRC 1991</a>); there was no significant difference between groups (RR 3.05, 95% CI 0.12 to 74.61; n = 1371 births) (<a href="./references#CD007950-fig-0137" title="">Analysis 4.17</a>). </p> </section> <section id="CD007950-sec-0176"> <p><b>Congenital cardiovascular anomalies</b></p> <p>This outcome was reported in two trials (<a href="./references#CD007950-bbs2-0003" title="KirkePN , DalyLE , ElwoodJH . A randomized trial of low dose folic acid to prevent neural tube defects. Archives of Disease in Childhood1992;67:1442‐6. ">Kirke 1992</a>; <a href="./references#CD007950-bbs2-0005" title="Anon . Folate supplements prevent recurrence of neural tube defects. Nutrition Review1992;50(Suppl 1):22‐4. Anon . Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet1991;338(8760):131‐7. ">MRC 1991</a>) and found two affected births in the folate supplementation group out of 680 births and five affected in the control group out of 691 births. There was no evidence of a difference between experimental and control groups in the number of babies with congenital cardiovascular defects irrespective of dose of drug, or history of NTDs (<a href="./references#CD007950-fig-0145" title="">Analysis 4.25</a> to <a href="./references#CD007950-fig-0152" title="">Analysis 4.32</a>). </p> </section> <section id="CD007950-sec-0177"> <p><b>Other congenital anomalies (excluding neural tube defects, cleft lip, cleft palate and cardiovascular anomalies)</b></p> <p>Two trials reported the number of babies with other birth defects (<a href="./references#CD007950-bbs2-0003" title="KirkePN , DalyLE , ElwoodJH . A randomized trial of low dose folic acid to prevent neural tube defects. Archives of Disease in Childhood1992;67:1442‐6. ">Kirke 1992</a>; <a href="./references#CD007950-bbs2-0005" title="Anon . Folate supplements prevent recurrence of neural tube defects. Nutrition Review1992;50(Suppl 1):22‐4. Anon . Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet1991;338(8760):131‐7. ">MRC 1991</a>). There was no significant evidence of a difference between groups (RR 1.39, 95% CI 0.74 to 2.62; n = 1371 births) (<a href="./references#CD007950-fig-0153" title="">Analysis 4.33</a>). </p> </section> </section> <section id="CD007950-sec-0178"> <h6 class="title">Maternal outcomes</h6> <section id="CD007950-sec-0179"> <p><b>Maternal anaemia at term (defined as Hb less than 110 g/L); red blood cell folate at term (nmol/L); serum folate at term (nmol/L)</b></p> <p>No trials reported on these outcomes.</p> </section> <section id="CD007950-sec-0180"> <p><b>Miscarriage</b></p> <p>Two trials reported the number of women with confirmed pregnancy suffering miscarriage (<a href="./references#CD007950-bbs2-0003" title="KirkePN , DalyLE , ElwoodJH . A randomized trial of low dose folic acid to prevent neural tube defects. Archives of Disease in Childhood1992;67:1442‐6. ">Kirke 1992</a>; <a href="./references#CD007950-bbs2-0005" title="Anon . Folate supplements prevent recurrence of neural tube defects. Nutrition Review1992;50(Suppl 1):22‐4. Anon . Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet1991;338(8760):131‐7. ">MRC 1991</a>); while the number of miscarriages was higher in the group receiving folic acid, the difference between groups was not significant (RR 1.08, 95% CI 0.82 to 1.41; n = 1550 pregnancies)). There were no significant differences between groups for any of the subgroups we examined (<a href="./references#CD007950-fig-0162" title="">Analysis 4.42</a> to <a href="./references#CD007950-fig-0168" title="">Analysis 4.48</a>). </p> </section> </section> </section> <section id="CD007950-sec-0181"> <h5 class="title">Secondary outcomes</h5> <section id="CD007950-sec-0182"> <h6 class="title">Infant outcomes</h6> <section id="CD007950-sec-0183"> <p><b>Anencephaly</b></p> <p>One case of anencephaly was reported in the control group in one study (<a href="./references#CD007950-bbs2-0003" title="KirkePN , DalyLE , ElwoodJH . A randomized trial of low dose folic acid to prevent neural tube defects. Archives of Disease in Childhood1992;67:1442‐6. ">Kirke 1992</a>). There was no significant difference in risk of anencephaly between the treatment groups (RR 0.34, 95% CI 0.01 to 8.26; n = 176 births) (<a href="./references#CD007950-fig-0169" title="">Analysis 4.49</a>). </p> </section> <section id="CD007950-sec-0184"> <p><b>Stillbirths</b></p> <p>Stillbirths were reported in two trials included in this comparison (<a href="./references#CD007950-bbs2-0003" title="KirkePN , DalyLE , ElwoodJH . A randomized trial of low dose folic acid to prevent neural tube defects. Archives of Disease in Childhood1992;67:1442‐6. ">Kirke 1992</a>; <a href="./references#CD007950-bbs2-0005" title="Anon . Folate supplements prevent recurrence of neural tube defects. Nutrition Review1992;50(Suppl 1):22‐4. Anon . Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet1991;338(8760):131‐7. ">MRC 1991</a>). There was no significant evidence of any difference between treatment groups in the pooled analysis (RR 0.84, 95% CI 0.16 to 4.28; n = 1371 births) (<a href="./references#CD007950-fig-0170" title="">Analysis 4.50</a>). </p> </section> <section id="CD007950-sec-0185"> <p><b>Pregnancy termination for fetal anomalies</b></p> <p>Overall, in the one study examining this outcome (<a href="./references#CD007950-bbs2-0005" title="Anon . Folate supplements prevent recurrence of neural tube defects. Nutrition Review1992;50(Suppl 1):22‐4. Anon . Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet1991;338(8760):131‐7. ">MRC 1991</a>), there were 27 pregnancies terminated for fetal anomaly; 7/677 in the women who received folic acid with other micronutrients and 20/685 in the control group who received other micronutrients supplements without folic acid. The was a difference between groups in the pooled analysis (RR 0.35, 95% CI 0.15 to 0.83; n = 1362) (<a href="./references#CD007950-fig-0171" title="">Analysis 4.51</a>). </p> </section> <section id="CD007950-sec-0186"> <p><b>Other infant outcomes</b></p> <p>No trials reported results for our other pre‐specified secondary outcomes.</p> </section> </section> <section id="CD007950-sec-0187"> <h6 class="title">Maternal</h6> <section id="CD007950-sec-0188"> <p><b>Multiple pregnancy</b></p> <p>The number of women affected by multiple pregnancy was reported in two trials (<a href="./references#CD007950-bbs2-0003" title="KirkePN , DalyLE , ElwoodJH . A randomized trial of low dose folic acid to prevent neural tube defects. Archives of Disease in Childhood1992;67:1442‐6. ">Kirke 1992</a>; <a href="./references#CD007950-bbs2-0005" title="Anon . Folate supplements prevent recurrence of neural tube defects. Nutrition Review1992;50(Suppl 1):22‐4. Anon . Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet1991;338(8760):131‐7. ">MRC 1991</a>). There was no significant evidence of a difference between women in the two treatment groups (RR 2.04, 95% CI 0.19 to 22.15; n = 1550 pregnancies) (<a href="./references#CD007950-fig-0172" title="">Analysis 4.52</a>). </p> </section> <section id="CD007950-sec-0189"> <p><b>Other maternal outcomes</b></p> <p>No trials reported on our other pre‐specified secondary outcomes.</p> </section> </section> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD007950-sec-0190" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD007950-sec-0190"></div> <section id="CD007950-sec-0191"> <h3 class="title" id="CD007950-sec-0191">Summary of main results</h3> <p>Folic acid alone or plus other vitamins and minerals prevents the incidence and recurrence of neural tube defects (NTDs). Overall, this positive response does not differ by folic acid dose (above 360 µg/day or 0.360 mg/day), or by whether folic acid was given alone or accompanied by other micronutrients. </p> <p>The evidence does not support any protective or negative effect of folic acid supplementation on other congenital anomalies or maternal outcomes, including miscarriage. </p> <p>No included trials assessed biochemical outcomes including maternal blood folate or anaemia at term. </p> </section> <section id="CD007950-sec-0192"> <h3 class="title" id="CD007950-sec-0192">Overall completeness and applicability of evidence</h3> <p>This review addresses the effects and safety of folic acid supplementation or folic acid with other micronutrients versus no treatment/placebo or other micronutrients (without folic acid) during the periconceptional period and the first trimester of pregnancy. This review updates an earlier Cochrane Review (<a href="./references#CD007950-bbs2-0174" title="De‐RegilLM , Fernández‐GaxiolaAC , DowswellT , Peña‐RosasJP . Effects and safety of periconceptional folate supplementation for preventing birth defects. Cochrane Database of Systematic Reviews2010, Issue 10. [DOI: 10.1002/14651858.CD007950.pub2] ">De‐Regil 2010</a>). </p> <p>To reduce the risk of NTDs for women capable of becoming pregnant, the recommendation is to take 400 μg (0.4 mg) of folic acid daily from fortified foods, supplements, or both, in addition to consuming food folate from a varied diet beginning at least one month before conception (<a href="./references#CD007950-bbs2-0114" title="Institute of Medicine. Folate. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. National Academy Press, 1998:196‐303. ">IOM 1998</a>; <a href="./references#CD007950-bbs2-0170" title="WHO , UNICEF , UNU . Iron deficiency anaemia: assessment, prevention and control. A guide for programme managers. Report from a the WHO/UNICEF/UNU consultation, 6‐10 December 1993. Geneva: World Health Organization, 2001. ">WHO/UNICEF/UNU 2001</a>). Expert panels suggest that supplemental intake in this population should range between 400 μg (0.4 mg) and 800 μg (0.8 mg) (<a href="./references#CD007950-bbs2-0154" title="US Preventive Services Task Force. Folic acid for the prevention of neural tube defects: US Preventive Services Task Force recommendation statement. Annals of Internal Medicine2009;150(9):626‐31. ">US Preventive Services Task Force 2009</a>). The first recommendations were based on the amount needed to maintain an adequate haematological status, and the protective role of folic acid against NTDs was later confirmed with a public health supplementation trial carried out in China from 1993 to 1995 which showed a reduction in the occurrence of NTDs of 40% to 85% (from the south and north of the country, respectively) (<a href="./references#CD007950-bbs2-0074" title="BerryRJ , LiZ , EricksonJD , LiS , MooreCA , WangH , et al. Prevention of neural‐tube defects with folic acid in China. China‐U.S. collaborative project for neural tube defect prevention. New England Journal of Medicine1999;341(20):1485‐90. ">Berry 1999</a>). The results of this review clearly show that periconceptional folic acid supplementation reduces the recurrence of NTDs and although there is only one trial assessing first time occurrence of NTDs (with wide confidence intervals that cross the null value) no events were found among women supplemented with folic acid (<a href="./references#CD007950-bbs2-0001" title="CzeizelA , FritzG . Randomized trial of periconceptional vitamins. JAMA1989;262:1634. CzeizelA , RodeK . Trial to prevent first occurrence of neural tube defects by periconceptional multivitamin supplementation. Lancet1984;2(8393):40. CzeizelAE . Controlled studies of multivitamin supplementation on pregnancy outcomes. Annals of the New York Academy of Sciences1993;678:266‐75. CzeizelAE . Limb‐reduction defects and folic acid supplementation. Lancet1995;345(8954):932. CzeizelAE . Nutritional supplementation and prevention of congenital abnormalities. Current Opinion in Obstetrics &amp; Gynecology1995;7(2):88‐94. CzeizelAE . Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ1993;306:1645‐8. CzeizelAE . Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. American Journal of Medical Genetics1996;62(2):179‐83. CzeizelAE , DoboM . Postnatal somatic and mental development after periconceptional multivitamin supplementation. Archives of Disease in Childhood1994;70(3):229‐33. CzeizelAE , DudasI . Prevention of the first occurrence of neural‐tube defects by periconceptional vitamin supplementation. New England Journal of Medicine1992;327:1832‐5. CzeizelAE , DudasI , FritzG , TecsoiA , HanckA , KunovitsG . The effect of periconceptional multivitamin‐mineral supplementation on vertigo, nausea and vomiting in the first trimester of pregnancy. Archives of Gynecology and Obstetrics1992;251:181‐5. CzeizelAE , DudasI , MetnekiJ . Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Archives of Gynecology and Obstetrics1994;255:131‐9. CzeizelAE , MedveczkyE . Periconceptional multivitamin supplementation and multimalformed offspring. Obstetrics &amp; Gynecology2003;102:1255‐61. CzeizelAE , MetnekiJ , DudasI . Higher rate of multiple births after periconceptional vitamin supplementation. New England Journal of Medicine1994;330(23):1687‐8. CzeizelAE , MetnekiJ , DudasI . The effect of preconceptional multivitamin supplementation on fertility. International Journal for Vitamin and Nutrition Research1996;66:55‐8. CzeizelAE , MetnekiJ , DudasI . The higher rate of multiple births after periconceptional multivitamin supplementation: an analysis of causes. Acta Geneticae Medicae et Gemellologiae1994;43:175‐84. CzeizelAE , RockenbauerM , SusanskyE . No change in sexual activity during preconceptional multivitamin supplementation. British Journal of Obstetrics and Gynaecology1996;103:569‐73. CzeizelAE , VarghaP . Periconceptional folic acid/multivitamin supplementation and twin pregnancy. American Journal of Obstetrics and Gynecology2004;191(3):790‐4. CzeizelE , DudasI . Prevention of the first occurrence of anencephaly and spina bifida with periconceptional multivitamin supplementation (conclusion). Orvosi Hetilap1994;135(42):2313‐7. DoboM , CzeizelAE . Long‐term somatic and mental development of children after periconceptional multivitamin supplementation. European Journal of Pediatrics1998;157:719‐23. DudasI , RockenbauerM , CzeizelAE . The effect of preconceptional multivitamin supplementation on the menstrual cycle. Archives of Gynecology and Obstetrics1995;256(3):115‐23. MetnekiJ , DudasI , CzeizelAE . Higher rate of multiple births after periconceptual multivitamin supplementation. Orvosi Hetilap1996;137(43):2401‐5. ">Czeizel 1994</a>). The evidence from early clinical trials designed to study the effect of folic acid supplementation around the time of conception on NTDs is so strong that this probably accounts for why we only found one additional randomised controlled trial looking at this matter (<a href="./references#CD007950-bbs2-0002" title="Indian Council of Medical Research (ICMR) Collaborating Centres, Central Technical Co‐ordinatingUnit . Multicentric study of efficacy of periconceptional folic acid containing vitamin supplementation in prevention of open neural tube defects from India. Indian Journal of Medical Research2000;112:206‐11. ">ICMR 2000</a>) and few observational studies published from 1995 to date that reinforce these findings (<a href="./references#CD007950-bbs2-0154" title="US Preventive Services Task Force. Folic acid for the prevention of neural tube defects: US Preventive Services Task Force recommendation statement. Annals of Internal Medicine2009;150(9):626‐31. ">US Preventive Services Task Force 2009</a>). There are no trials exploring the effect of 5MTHF during the periconceptional period, but it is very likely that the benefits of this intervention observed during the reproductive age and lactation (<a href="./references#CD007950-bbs2-0113" title="HoughtonLA , SherwoodKL , PawloskyR , ItoS , O'ConnorDL . [6S]‐5‐Methyltetrahydrofolate is at least as effective as folic acid in preventing a decline in blood folate concentrations during lactation. American Journal of Clinical Nutrition2006;83(4):842‐50. ">Houghton 2006</a>; <a href="./references#CD007950-bbs2-0119" title="LamersY , Prinz‐LangenohlR , MoserR , PietrzikK . Supplementation with [6S]‐5‐methyltetrahydrofolate or folic acid equally reduces plasma total homocysteine concentrations in healthy women. American Journal of Clinical Nutrition2004;79(3):473‐8. ">Lamers 2004</a>) might extend to pregnancy. </p> <p>Questions remain about the best dose and periodicity of folic supplementation as there is still a high prevalence of birth defects worldwide. Doses ranging from 360 μg (0.36 mg) (<a href="./references#CD007950-bbs2-0003" title="KirkePN , DalyLE , ElwoodJH . A randomized trial of low dose folic acid to prevent neural tube defects. Archives of Disease in Childhood1992;67:1442‐6. ">Kirke 1992</a>) to 6000 μg (6 mg) (<a href="./references#CD007950-bbs2-0015" title="ChenG , SongX , JiY , ZhangL , PeiL , ChenJ , et al. Prevention of NTDs with periconceptional multivitamin supplementation containing folic acid in China. Birth Defects Research2008;82(8):592‐6. ">Chen 2008</a>) a day have proven to be effective in preventing both occurrence and recurrence of NTDs; this wide response to supplementation may be determined by the baseline blood folate concentrations in each population. Improving nutrition surveillance in order to find the appropriate dose and supplementation scheme is crucial to promote a cost‐effective public health policy that can reach a larger number of people. </p> <p>There are no clinical trials that review the effect of weekly periconceptional folate supplementation for the prevention of birth defects. The weekly iron and folic acid supplementation programme (WIFS) studies (<a href="./references#CD007950-bbs2-0102" title="Fernández‐GaxiolaAC , De‐RegilLM . Intermittent iron supplementation for reducing anaemia and its associated impairments in menstruating women. Cochrane Database of Systematic Reviews2011, Issue 12. [DOI: 10.1002/14651858.CD009218.pub2] ">Fernandez‐Gaxiola 2011</a>; <a href="./references#CD007950-bbs2-0165" title="World Health Organization. Guideline Intermittent iron supplementation for menstruating women. Geneva: World Health Organization, 2011 (accessed 26 December 2013). ">WHO 2011</a>) have proven that weekly supplementation is an effective preventive intervention to control iron deficiency among childbearing age women, with good compliance. There is no information on the impact of such schemes on birth defects. Two published studies have evaluated weekly folic acid supplementation before pregnancy (not randomised controlled trials). In the first study, carried out in Mexico, women received 5000 µg (5 mg) folic acid for three months, and their red blood cell and plasma folate concentrations significantly increased (<a href="./references#CD007950-bbs2-0126" title="Martinez‐de VillarealL , Limón‐BenavidesC , Valdez‐LealR , Sánchez‐PeñaMA , Villareal‐PérezJZ . Impact of weekly administration of folic acid on folic acid blood levels. Salud Publica de Mexico2001;43(2):103‐7. ">Martinez‐de Villareal 2001</a>). This strategy was also associated with a 50% decrease in the incidence of anencephaly and spina bifida cases, and a significant reduction in infant mortality and disability after two years (<a href="./references#CD007950-bbs2-0127" title="Martinez‐de VillarealL , PérezJZ , VázquezPA , HerreraRH , Campos M delR , LópezRA , et al. Decline of neural tube defects cases after a folic acid campaign in Nuevo León, México. Teratology2002;66(5):249‐56. ">Martinez‐de Villareal 2002</a>). In the second study, conducted in New Zealand, a weekly single supplement of 2800 µg (2.8 mg) of folic acid taken for 12 weeks increased women’s red blood cell folate to concentrations associated with a reduced risk of bearing a child with a NTD (<a href="./references#CD007950-bbs2-0132" title="NorsworthyB , SkeaffCM , AdankC , GreenTJ . Effects of once‐a‐week or daily folic acid supplementation on red blood cell folate concentrations in women. European Journal of Clinical Nutrition2004;58(3):548‐54. ">Norsworthy 2004</a>). </p> <p>New studies have documented that MTHFR polymorphism may be considered a susceptible gene for cardiovascular birth defects (<a href="./references#CD007950-bbs2-0082" title="BrandalizeAP , BandinelliE , dos SantosPA , RoisenbergI , Schüler‐FacciniL . Evaluation of C677T and A1298C polymorphisms of the MTHFR gene as maternal risk factors for Down syndrome and congenital heart defects. American Journal of Medical Genetics. Part A2009;149A(10):2080‐7. ">Brandalize 2009</a>; <a href="./references#CD007950-bbs2-0125" title="MarinhoC , AlhoI , GuerraA , RegoC , AreiasJ , BichoM . The methylenetetrahydrofolate reductase gene variant (C677T) as a susceptibility gene for tetralogy of Fallot. Revista Portuguesa de Cardiologia2009;28(7‐8):809‐12. ">Marinho 2009</a>). If MTHFR is associated with congenital heart defects (i.e. Tetralogy of Fallot), this may in part explain the lack of effect of periconceptional folic acid supplementation on cardiovascular malformations, and may warrant further study for opportunities for preventing other birth defects. </p> <p>This review found a protective effect against birth defects with the use of folic acid combined with other micronutrients. From a metabolic perspective, it is clear that niacin, thiamin, vitamin B<sub>6</sub>, and vitamin B<sub>12</sub> influence reactions that include folate. The possibility that other micronutrients apart from folic acid may have an additional protective effect has been a matter considered in several more recent studies (<a href="./references#CD007950-bbs2-0093" title="CzeizelAE . The primary prevention of birth defects: multivitamins or folic acid?. International Journal of Medical Sciences2004;1(1):50‐61. ">Czeizel 2004</a>; <a href="./references#CD007950-bbs2-0106" title="GohYI , BollanoE , EinarsonTR , KorenG . Prenatal multivitamin supplementation and rates of congenital anomalies: a meta‐analysis. Journal of Obstetrics and Gynaecology Canada: JOGC2006;28:680‐9. ">Goh 2006</a>; <a href="./references#CD007950-bbs2-0152" title="ThompsonMD , ColeDE , RayJG . Vitamin B12 and neural tube defects: the Canadian experience. American Journal of Clinical Nutrition2009;89(2):697S‐701S. ">Thompson 2009</a>). </p> <p>All the trials included in this review were performed before many countries introduced mandatory flour fortification with folic acid. In the US, for example, the flour fortification programme was designed so that typical folic acid intake would be increased by approximately 100 µg/day and that the risk of intakes greater than 1000 µg/day (the FDA's tolerable upper level of daily intake) would be minimal. Results showed that the typical intake of folic acid from fortified foods is more than twice as high as originally predicted (<a href="./references#CD007950-bbs2-0139" title="QuinlivanEP , GregoryJF3rd . The impact of food fortification on folic acid intake in Canada. Canadian Journal of Public Health2003;94(2):154. ">Quinlivan 2003</a>). Even though the effectiveness of mandatory folic acid fortification programmes has been documented by a decline in the prevalence of NTDs in the United States, Canada, Costa Rica, Chile, and South Africa (<a href="./references#CD007950-bbs2-0077" title="BerryRJ , BaileyL , MulinareJ , BowerC . Folic Acid Working Group. Fortification of flour with folic acid. Food Nutrition Bulletin2010;31(Suppl 1):S22‐35. ">Berry 2010</a>), fortified foods (mandatory and not) might be providing relatively large amounts of folic acid to the entire population and some authors have suggested that the recommendation of supplementing 400 µg/day of folic acid in addition to dietary folate to women planning to become pregnant deserves to be reviewed. However, they acknowledge the lack of certainty on the minimum dose of supplemental folic acid that is effective for reducing NTDs occurrence (<a href="./references#CD007950-bbs2-0094" title="DaryO . Nutritional interpretation of folic acid interventions. Nutrition Reviews2009;67(4):235‐44. ">Dary 2009</a>). </p> <p>The force of the results makes this an intervention that can be applied in most settings for reducing NTDs rates. However, the women in the trials included in this review had Caucasian, Anglo‐Saxon, Anglo‐American and Indian backgrounds and the evidence suggests that the presence of gene polymorphisms (i.e. MTHFR gene mutation) is more prevalent among people of Latin origins (<a href="./references#CD007950-bbs2-0109" title="Guéant‐RodriguezRM , GuéantJL , DebardR , ThirionS , HongLX , BronowickiJP , et al. Prevalence of methylenetetrahydrofolate reductase 677T and 1298C alleles and folate status: a comparative study in Mexican, West African, and European populations. American Journal of Clinical Nutrition2006;83(3):701‐7. ">Guéant‐Rodriguez 2006</a>), thus the findings may slightly differ across all population groups. Also, there is still a need to understand the applicability of these results in endemic malaria regions where antifolate antimalarial drugs are being used, and in women living with HIV/AIDS, receiving or not receiving antiretroviral therapy. </p> <p>Women in the trials included in this review were actively planning pregnancy and attending for preconception care. It is estimated that 80 million women each year have unwanted or unintended pregnancies (<a href="./references#CD007950-bbs2-0105" title="GlasierA , GülmezogluAM , SchmidGP , MorenoCG , VanLookPF . Sexual and reproductive health: a matter of life and death. Lancet2006;368(9547):1595‐607. ">Glasier 2006</a>), and women seeking preconception care may be more affluent and more educated, or be seeking care as they are at high risk after previous pregnancy complications (<a href="./references#CD007950-bbs2-0092" title="CzeizelAE . Ten years of experience in periconceptional care. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology1999;84:43‐9. ">Czeizel 1999b</a>; <a href="./references#CD007950-bbs2-0097" title="ElsingaJ , van derPal‐de BruinK , leCessieS , deJong‐PotjerL , Verloove‐VanhorickS , AssendelftW . Preconception counselling initiated by general practitioners in the Netherlands: reaching couples contemplating pregnancy [ISRCTN53942912]. BMC Family Practice2006;7:41. ">Elsinga 2006</a>). These women may be more likely to comply with prescribed supplementation schemes, and the same level of compliance and effect may not be achieved by other groups. </p> </section> <section id="CD007950-sec-0193"> <h3 class="title" id="CD007950-sec-0193">Quality of the evidence</h3> <section id="CD007950-sec-0194"> <h4 class="title">Quality of the individual trials</h4> <p>The included trials were rated as unclear or low risk of bias considering allocation concealment and blinding, and pooling results in meta‐analysis resulted in consistent protective results. Having said this, in trials where only a subset of the original randomised sample became eligible to experience many of the outcomes measured, results may be at risk of bias and not simple to interpret. In all the trials included in this review, studies recruited non‐pregnant women (albeit women who may have been planning pregnancy) and inevitably only a proportion of those randomised had confirmed pregnancy during the study periods. As the focus of the review was on pregnancy outcomes, we decided that denominators would include only those women who became pregnant. </p> <p>Restricting the analyses to pregnant women may have led to the size of the treatment effect for some outcomes being either over or under‐estimated. It is possible that women who became pregnant may have been different in a number of respects from those that did not, and that the intervention may have had a different effect on those women that did or did not become pregnant. It is possible that the intervention may have an impact on the ability to become pregnant or to sustain a pregnancy during the very early stages (before pregnancy confirmation) although there is no strong evidence from the studies included in this review or in the literature to suggest that this was likely to have been the case. One study (<a href="./references#CD007950-bbs2-0001" title="CzeizelA , FritzG . Randomized trial of periconceptional vitamins. JAMA1989;262:1634. CzeizelA , RodeK . Trial to prevent first occurrence of neural tube defects by periconceptional multivitamin supplementation. Lancet1984;2(8393):40. CzeizelAE . Controlled studies of multivitamin supplementation on pregnancy outcomes. Annals of the New York Academy of Sciences1993;678:266‐75. CzeizelAE . Limb‐reduction defects and folic acid supplementation. Lancet1995;345(8954):932. CzeizelAE . Nutritional supplementation and prevention of congenital abnormalities. Current Opinion in Obstetrics &amp; Gynecology1995;7(2):88‐94. CzeizelAE . Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ1993;306:1645‐8. CzeizelAE . Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. American Journal of Medical Genetics1996;62(2):179‐83. CzeizelAE , DoboM . Postnatal somatic and mental development after periconceptional multivitamin supplementation. Archives of Disease in Childhood1994;70(3):229‐33. CzeizelAE , DudasI . Prevention of the first occurrence of neural‐tube defects by periconceptional vitamin supplementation. New England Journal of Medicine1992;327:1832‐5. CzeizelAE , DudasI , FritzG , TecsoiA , HanckA , KunovitsG . The effect of periconceptional multivitamin‐mineral supplementation on vertigo, nausea and vomiting in the first trimester of pregnancy. Archives of Gynecology and Obstetrics1992;251:181‐5. CzeizelAE , DudasI , MetnekiJ . Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Archives of Gynecology and Obstetrics1994;255:131‐9. CzeizelAE , MedveczkyE . Periconceptional multivitamin supplementation and multimalformed offspring. Obstetrics &amp; Gynecology2003;102:1255‐61. CzeizelAE , MetnekiJ , DudasI . Higher rate of multiple births after periconceptional vitamin supplementation. New England Journal of Medicine1994;330(23):1687‐8. CzeizelAE , MetnekiJ , DudasI . The effect of preconceptional multivitamin supplementation on fertility. International Journal for Vitamin and Nutrition Research1996;66:55‐8. CzeizelAE , MetnekiJ , DudasI . The higher rate of multiple births after periconceptional multivitamin supplementation: an analysis of causes. Acta Geneticae Medicae et Gemellologiae1994;43:175‐84. CzeizelAE , RockenbauerM , SusanskyE . No change in sexual activity during preconceptional multivitamin supplementation. British Journal of Obstetrics and Gynaecology1996;103:569‐73. CzeizelAE , VarghaP . Periconceptional folic acid/multivitamin supplementation and twin pregnancy. American Journal of Obstetrics and Gynecology2004;191(3):790‐4. CzeizelE , DudasI . Prevention of the first occurrence of anencephaly and spina bifida with periconceptional multivitamin supplementation (conclusion). Orvosi Hetilap1994;135(42):2313‐7. DoboM , CzeizelAE . Long‐term somatic and mental development of children after periconceptional multivitamin supplementation. European Journal of Pediatrics1998;157:719‐23. DudasI , RockenbauerM , CzeizelAE . The effect of preconceptional multivitamin supplementation on the menstrual cycle. Archives of Gynecology and Obstetrics1995;256(3):115‐23. MetnekiJ , DudasI , CzeizelAE . Higher rate of multiple births after periconceptual multivitamin supplementation. Orvosi Hetilap1996;137(43):2401‐5. ">Czeizel 1994</a>) suggested small but statistically significant differences in confirmed pregnancy rates in women in the intervention and control groups (71.3% versus 67.9% respectively); however, this finding may have occurred by chance or been confounded by the use of in vitro fertilisation by some women (<a href="./references#CD007950-bbs2-0075" title="BerryRJ , KihlbergR , DevineD . Impact of misclassification of in vitro fertilisation in studies of folic acid and twinning: modelling using population based Swedish vital records. BMJ2004;330:815. ">Berry 2004</a>). The possible difference between groups in one trial (<a href="./references#CD007950-bbs2-0001" title="CzeizelA , FritzG . Randomized trial of periconceptional vitamins. JAMA1989;262:1634. CzeizelA , RodeK . Trial to prevent first occurrence of neural tube defects by periconceptional multivitamin supplementation. Lancet1984;2(8393):40. CzeizelAE . Controlled studies of multivitamin supplementation on pregnancy outcomes. Annals of the New York Academy of Sciences1993;678:266‐75. CzeizelAE . Limb‐reduction defects and folic acid supplementation. Lancet1995;345(8954):932. CzeizelAE . Nutritional supplementation and prevention of congenital abnormalities. Current Opinion in Obstetrics &amp; Gynecology1995;7(2):88‐94. CzeizelAE . Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ1993;306:1645‐8. CzeizelAE . Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. American Journal of Medical Genetics1996;62(2):179‐83. CzeizelAE , DoboM . Postnatal somatic and mental development after periconceptional multivitamin supplementation. Archives of Disease in Childhood1994;70(3):229‐33. CzeizelAE , DudasI . Prevention of the first occurrence of neural‐tube defects by periconceptional vitamin supplementation. New England Journal of Medicine1992;327:1832‐5. CzeizelAE , DudasI , FritzG , TecsoiA , HanckA , KunovitsG . The effect of periconceptional multivitamin‐mineral supplementation on vertigo, nausea and vomiting in the first trimester of pregnancy. Archives of Gynecology and Obstetrics1992;251:181‐5. CzeizelAE , DudasI , MetnekiJ . Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Archives of Gynecology and Obstetrics1994;255:131‐9. CzeizelAE , MedveczkyE . Periconceptional multivitamin supplementation and multimalformed offspring. Obstetrics &amp; Gynecology2003;102:1255‐61. CzeizelAE , MetnekiJ , DudasI . Higher rate of multiple births after periconceptional vitamin supplementation. New England Journal of Medicine1994;330(23):1687‐8. CzeizelAE , MetnekiJ , DudasI . The effect of preconceptional multivitamin supplementation on fertility. International Journal for Vitamin and Nutrition Research1996;66:55‐8. CzeizelAE , MetnekiJ , DudasI . The higher rate of multiple births after periconceptional multivitamin supplementation: an analysis of causes. Acta Geneticae Medicae et Gemellologiae1994;43:175‐84. CzeizelAE , RockenbauerM , SusanskyE . No change in sexual activity during preconceptional multivitamin supplementation. British Journal of Obstetrics and Gynaecology1996;103:569‐73. CzeizelAE , VarghaP . Periconceptional folic acid/multivitamin supplementation and twin pregnancy. American Journal of Obstetrics and Gynecology2004;191(3):790‐4. CzeizelE , DudasI . Prevention of the first occurrence of anencephaly and spina bifida with periconceptional multivitamin supplementation (conclusion). Orvosi Hetilap1994;135(42):2313‐7. DoboM , CzeizelAE . Long‐term somatic and mental development of children after periconceptional multivitamin supplementation. European Journal of Pediatrics1998;157:719‐23. DudasI , RockenbauerM , CzeizelAE . The effect of preconceptional multivitamin supplementation on the menstrual cycle. Archives of Gynecology and Obstetrics1995;256(3):115‐23. MetnekiJ , DudasI , CzeizelAE . Higher rate of multiple births after periconceptual multivitamin supplementation. Orvosi Hetilap1996;137(43):2401‐5. ">Czeizel 1994</a>) was not borne out in other studies examining conception rates in the two treatment groups as the numbers of women with confirmed pregnancy were very similar in intervention and control groups (<a href="./references#CD007950-bbs2-0002" title="Indian Council of Medical Research (ICMR) Collaborating Centres, Central Technical Co‐ordinatingUnit . Multicentric study of efficacy of periconceptional folic acid containing vitamin supplementation in prevention of open neural tube defects from India. Indian Journal of Medical Research2000;112:206‐11. ">ICMR 2000</a>; <a href="./references#CD007950-bbs2-0003" title="KirkePN , DalyLE , ElwoodJH . A randomized trial of low dose folic acid to prevent neural tube defects. Archives of Disease in Childhood1992;67:1442‐6. ">Kirke 1992</a>; <a href="./references#CD007950-bbs2-0005" title="Anon . Folate supplements prevent recurrence of neural tube defects. Nutrition Review1992;50(Suppl 1):22‐4. Anon . Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet1991;338(8760):131‐7. ">MRC 1991)</a>. </p> <p>Interpreting the results from the review for potentially overlapping outcomes may not be straightforward and there was insufficient information in trial reports for us to be clear about whether outcomes were mutually exclusive. It was likely, but not certain, that the same fetus may have been counted in more than one outcome. For example, where NTDs were detected, these same pregnancies may have been included in the figures for pregnancy termination, but we cannot assume that all detected anomalies led to pregnancy termination. Results for outcomes such as pregnancy termination for fetal anomaly therefore need to be interpreted with caution. </p> </section> <section id="CD007950-sec-0195"> <h4 class="title">Overall quality of the evidence for primary outcomes</h4> <p>For the main comparison supplementation with folate versus no intervention, placebo or other micronutrients without folate, the overall quality of the evidence for neonatal outcomes was high for NTDs, whereas, it was of low quality for cleft lip, cleft palate, congenital cardiovascular anomalies, and other congenital anomalies (<i>see</i><a href="./full#CD007950-tbl-0001">summary of findings Table for the main comparison</a>). In spite of some concerns about an unclear risk of selection bias for trials reporting on NTDs, we refrained from downgrading the quality of the evidence due to the large magnitude of the effect. In addition to the methodological concerns, the quality of the body of evidence for cleft lip, cleft palate, congenital cardiovascular and other congenital anomalies were further downgraded due to very wide confidence intervals, encompassing both large benefit and harm. The overall quality of the evidence for maternal outcomes was rated as moderate for miscarriage (<i>see</i><a href="./full#CD007950-tbl-0002">summary of findings Table 2</a>). </p> </section> </section> <section id="CD007950-sec-0196"> <h3 class="title" id="CD007950-sec-0196">Potential biases in the review process</h3> <p>There were a number of potential biases in the review process. We attempted to minimise bias in several ways: two review authors independently assessed eligibility for inclusion, and data extraction, assessments of risk of bias and data entry were checked by two authors. However, carrying out reviews is not an exact science and may require a number of subjective judgements; it is possible that a different review team may have reached different decisions regarding assessments of eligibility and risk of bias. We would encourage readers to examine the <a href="./references#CD007950-sec-0213" title="">Characteristics of included studies</a> tables to assist in the interpretation of results. </p> </section> <section id="CD007950-sec-0197"> <h3 class="title" id="CD007950-sec-0197">Agreements and disagreements with other studies or reviews</h3> <p>The conclusions of this update do not change in comparison with the previous Cochrane Review (<a href="./references#CD007950-bbs2-0174" title="De‐RegilLM , Fernández‐GaxiolaAC , DowswellT , Peña‐RosasJP . Effects and safety of periconceptional folate supplementation for preventing birth defects. Cochrane Database of Systematic Reviews2010, Issue 10. [DOI: 10.1002/14651858.CD007950.pub2] ">De‐Regil 2010</a>). Our results are consistent with <a href="./references#CD007950-bbs2-0078" title="BlencoweH1 , CousensS , ModellB , LawnJ . Folic acid to reduce neonatal mortality from neural tube disorders. International Journal of Epidemiology2010;Apr;39(Suppl 1):10‐21. ">Blencowe 2010</a> and <a href="./references#CD007950-bbs2-0140" title="RamakrishnanU , GrantF , GoldenbergT , Zongrone , A , MartorellR . Effect of women's nutrition before and during early pregnancy on maternal and infant outcomes: a systematic review [Effect]. Paediatric and Perinatal Epidemiology2012;26(Suppl 1):285–301. ">Ramakrishnan 2012</a> and in showing a protective effect of daily folic acid supplementation (alone or in combination with other micronutrients) in preventing NTDs, with a similar effect for recurrence. However, <a href="./references#CD007950-bbs2-0078" title="BlencoweH1 , CousensS , ModellB , LawnJ . Folic acid to reduce neonatal mortality from neural tube disorders. International Journal of Epidemiology2010;Apr;39(Suppl 1):10‐21. ">Blencowe 2010</a> reported a different (and significant) effect on first occurrence of NTDs due to the inclusion of observational studies. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD007950-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD007950-fig-0001" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/full#CD007950-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies." data-id="CD007950-fig-0002" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/full#CD007950-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Methodological quality summary: review authors' judgements about each methodological quality item for each included study." data-id="CD007950-fig-0003" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Methodological quality summary: review authors' judgements about each methodological quality item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/full#CD007950-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 1 Neural tube defects (All)." data-id="CD007950-fig-0004" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 1 Neural tube defects (All). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 2 Neural tube defects (by scheme)." data-id="CD007950-fig-0005" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 2 Neural tube defects (by scheme). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 3 Neural tube defects (by daily dose)." data-id="CD007950-fig-0006" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 3 Neural tube defects (by daily dose). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 4 Neural tube defects (by timing of supplementation)." data-id="CD007950-fig-0007" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 4 Neural tube defects (by timing of supplementation). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 5 Neural tube defects (by history of an affected pregnancy ‐recurrence)." data-id="CD007950-fig-0008" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 5 Neural tube defects (by history of an affected pregnancy ‐recurrence). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 6 Neural tube defects (by folate compound)." data-id="CD007950-fig-0009" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 6 Neural tube defects (by folate compound). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 7 Neural tube defects (by micronutrient composition)." data-id="CD007950-fig-0010" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 7 Neural tube defects (by micronutrient composition). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 8 Neural tube defects (by malaria setting at time of the study)." data-id="CD007950-fig-0011" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 8 Neural tube defects (by malaria setting at time of the study). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 9 Cleft lip (All)." data-id="CD007950-fig-0012" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 9 Cleft lip (All). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-001-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 10 Cleft lip (by scheme)." data-id="CD007950-fig-0013" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 10 Cleft lip (by scheme). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-001-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-001-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 11 Cleft lip (by daily dose)." data-id="CD007950-fig-0014" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 11 Cleft lip (by daily dose). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-001-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-001-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 12 Cleft lip (by timing of supplementation)." data-id="CD007950-fig-0015" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 12 Cleft lip (by timing of supplementation). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-001-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-001-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 13 Cleft lip (by history of an affected pregnancy ‐recurrence)." data-id="CD007950-fig-0016" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 13 Cleft lip (by history of an affected pregnancy ‐recurrence). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-001-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-001-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 14 Cleft lip (by folate compound)." data-id="CD007950-fig-0017" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 14 Cleft lip (by folate compound). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-001-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-001-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 15 Cleft lip (by micronutrient composition)." data-id="CD007950-fig-0018" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 15 Cleft lip (by micronutrient composition). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-001-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-001-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 16 Cleft lip (by malaria setting at the time of the study)." data-id="CD007950-fig-0019" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 16 Cleft lip (by malaria setting at the time of the study). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-001-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-001-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 17 Cleft palate (All)." data-id="CD007950-fig-0020" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.17</div> <div class="figure-caption"> <p>Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 17 Cleft palate (All). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-001-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-001-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 18 Cleft palate (by scheme)." data-id="CD007950-fig-0021" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.18</div> <div class="figure-caption"> <p>Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 18 Cleft palate (by scheme). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-001-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-001-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 19 Cleft palate (by daily dose)." data-id="CD007950-fig-0022" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.19</div> <div class="figure-caption"> <p>Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 19 Cleft palate (by daily dose). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-001-20" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-001-20.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 20 Cleft palate (by timing of supplementation)." data-id="CD007950-fig-0023" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-20.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.20</div> <div class="figure-caption"> <p>Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 20 Cleft palate (by timing of supplementation). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-20.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-001-21" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-001-21.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 21 Cleft palate (by history of an affected pregnancy ‐recurrence)." data-id="CD007950-fig-0024" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-21.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.21</div> <div class="figure-caption"> <p>Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 21 Cleft palate (by history of an affected pregnancy ‐recurrence). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-21.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-001-22" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-001-22.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 22 Cleft palate (by folate compound)." data-id="CD007950-fig-0025" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-22.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.22</div> <div class="figure-caption"> <p>Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 22 Cleft palate (by folate compound). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-22.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-001-23" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-001-23.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 23 Cleft palate (by micronutrient composition)." data-id="CD007950-fig-0026" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-23.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.23</div> <div class="figure-caption"> <p>Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 23 Cleft palate (by micronutrient composition). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-23.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-001-24" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-001-24.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 24 Cleft palate (by malaria setting at the time of the study)." data-id="CD007950-fig-0027" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-24.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.24</div> <div class="figure-caption"> <p>Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 24 Cleft palate (by malaria setting at the time of the study). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-24.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-001-25" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-001-25.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 25 Congenital cardiovascular anomalies (All)." data-id="CD007950-fig-0028" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-25.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.25</div> <div class="figure-caption"> <p>Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 25 Congenital cardiovascular anomalies (All). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-25.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-001-26" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-001-26.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 26 Congenital cardiovascular anomalies (by scheme)." data-id="CD007950-fig-0029" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-26.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.26</div> <div class="figure-caption"> <p>Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 26 Congenital cardiovascular anomalies (by scheme). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-26.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-001-27" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-001-27.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 27 Congenital cardiovascular anomalies (by daily dose)." data-id="CD007950-fig-0030" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-27.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.27</div> <div class="figure-caption"> <p>Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 27 Congenital cardiovascular anomalies (by daily dose). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-27.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-001-28" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-001-28.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 28 Congenital cardiovascular anomalies (by timing of supplementation)." data-id="CD007950-fig-0031" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-28.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.28</div> <div class="figure-caption"> <p>Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 28 Congenital cardiovascular anomalies (by timing of supplementation). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-28.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-001-29" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-001-29.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 29 Congenital cardiovascular anomalies (by history of an affected pregnancy ‐recurrence))." data-id="CD007950-fig-0032" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-29.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.29</div> <div class="figure-caption"> <p>Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 29 Congenital cardiovascular anomalies (by history of an affected pregnancy ‐recurrence)). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-29.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-001-30" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-001-30.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 30 Congenital cardiovascular anomalies (by folate compound)." data-id="CD007950-fig-0033" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-30.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.30</div> <div class="figure-caption"> <p>Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 30 Congenital cardiovascular anomalies (by folate compound). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-30.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-001-31" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-001-31.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 31 Congenital cardiovascular anomalies (by micronutrient composition)." data-id="CD007950-fig-0034" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-31.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.31</div> <div class="figure-caption"> <p>Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 31 Congenital cardiovascular anomalies (by micronutrient composition). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-31.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-001-32" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-001-32.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 32 Congenital cardiovascular anomalies (by malaria setting at the time of the study)." data-id="CD007950-fig-0035" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-32.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.32</div> <div class="figure-caption"> <p>Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 32 Congenital cardiovascular anomalies (by malaria setting at the time of the study). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-32.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-001-33" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-001-33.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 33 Other congenital anomalies (All)." data-id="CD007950-fig-0036" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-33.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.33</div> <div class="figure-caption"> <p>Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 33 Other congenital anomalies (All). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-33.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-001-34" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-001-34.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 34 Other congenital anomalies (by scheme)." data-id="CD007950-fig-0037" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-34.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.34</div> <div class="figure-caption"> <p>Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 34 Other congenital anomalies (by scheme). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-34.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-001-35" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-001-35.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 35 Other congenital anomalies (by daily dose)." data-id="CD007950-fig-0038" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-35.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.35</div> <div class="figure-caption"> <p>Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 35 Other congenital anomalies (by daily dose). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-35.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-001-36" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-001-36.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 36 Other congenital anomalies (by timing of supplementation)." data-id="CD007950-fig-0039" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-36.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.36</div> <div class="figure-caption"> <p>Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 36 Other congenital anomalies (by timing of supplementation). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-36.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-001-37" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-001-37.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 37 Other congenital anomalies (by history of an affected pregnancy ‐recurrence)." data-id="CD007950-fig-0040" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-37.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.37</div> <div class="figure-caption"> <p>Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 37 Other congenital anomalies (by history of an affected pregnancy ‐recurrence). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-37.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-001-38" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-001-38.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 38 Other congenital anomalies (by folate compound)." data-id="CD007950-fig-0041" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-38.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.38</div> <div class="figure-caption"> <p>Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 38 Other congenital anomalies (by folate compound). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-38.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-001-39" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-001-39.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 39 Other congenital anomalies (by micronutrient composition)." data-id="CD007950-fig-0042" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-39.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.39</div> <div class="figure-caption"> <p>Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 39 Other congenital anomalies (by micronutrient composition). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-39.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-001-40" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-001-40.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 40 Other congenital anomalies (by malaria setting at the time of the study)." data-id="CD007950-fig-0043" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-40.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.40</div> <div class="figure-caption"> <p>Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 40 Other congenital anomalies (by malaria setting at the time of the study). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-40.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-001-41" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-001-41.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 41 Miscarriage (All)." data-id="CD007950-fig-0044" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-41.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.41</div> <div class="figure-caption"> <p>Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 41 Miscarriage (All). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-41.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-001-42" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-001-42.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 42 Miscarriage (by scheme)." data-id="CD007950-fig-0045" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-42.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.42</div> <div class="figure-caption"> <p>Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 42 Miscarriage (by scheme). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-42.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0046"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-001-43" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-001-43.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 43 Miscarriage (by daily dose)." data-id="CD007950-fig-0046" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-43.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.43</div> <div class="figure-caption"> <p>Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 43 Miscarriage (by daily dose). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0046">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-43.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0047"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-001-44" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-001-44.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 44 Miscarriage (by timing of supplementation)." data-id="CD007950-fig-0047" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-44.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.44</div> <div class="figure-caption"> <p>Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 44 Miscarriage (by timing of supplementation). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0047">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-44.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0048"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-001-45" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-001-45.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 45 Miscarriage (by history of an affected pregnancy ‐recurrence)." data-id="CD007950-fig-0048" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-45.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.45</div> <div class="figure-caption"> <p>Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 45 Miscarriage (by history of an affected pregnancy ‐recurrence). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0048">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-45.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0049"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-001-46" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-001-46.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 46 Miscarriage (by folate compound)." data-id="CD007950-fig-0049" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-46.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.46</div> <div class="figure-caption"> <p>Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 46 Miscarriage (by folate compound). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0049">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-46.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0050"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-001-47" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-001-47.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 47 Miscarriage (by micronutrient compound)." data-id="CD007950-fig-0050" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-47.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.47</div> <div class="figure-caption"> <p>Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 47 Miscarriage (by micronutrient compound). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0050">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-47.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0051"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-001-48" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-001-48.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 48 Miscarriage (by malaria setting at the time of the study)." data-id="CD007950-fig-0051" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-48.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.48</div> <div class="figure-caption"> <p>Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 48 Miscarriage (by malaria setting at the time of the study). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0051">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-48.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0052"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-001-49" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-001-49.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 49 Spina bifida." data-id="CD007950-fig-0052" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-49.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.49</div> <div class="figure-caption"> <p>Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 49 Spina bifida. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0052">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-49.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0053"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-001-50" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-001-50.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 50 Anencephaly." data-id="CD007950-fig-0053" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-50.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.50</div> <div class="figure-caption"> <p>Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 50 Anencephaly. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0053">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-50.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0054"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-001-51" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-001-51.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 51 Stillbirths." data-id="CD007950-fig-0054" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-51.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.51</div> <div class="figure-caption"> <p>Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 51 Stillbirths. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0054">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-51.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0055"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-001-52" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-001-52.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 52 Elective termination of pregnancy for fetal anomalies." data-id="CD007950-fig-0055" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-52.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.52</div> <div class="figure-caption"> <p>Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 52 Elective termination of pregnancy for fetal anomalies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0055">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-52.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0056"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-001-53" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-001-53.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 53 Low birthweight (less than 2500 g)." data-id="CD007950-fig-0056" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-53.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.53</div> <div class="figure-caption"> <p>Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 53 Low birthweight (less than 2500 g). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0056">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-53.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0057"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-001-54" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-001-54.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 54 Macrosomia (birthweight greater than 4000 g)." data-id="CD007950-fig-0057" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-54.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.54</div> <div class="figure-caption"> <p>Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 54 Macrosomia (birthweight greater than 4000 g). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0057">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-54.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0058"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-001-55" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-001-55.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 55 Preterm birth (less than 37 weeks' gestation)." data-id="CD007950-fig-0058" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-55.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.55</div> <div class="figure-caption"> <p>Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 55 Preterm birth (less than 37 weeks' gestation). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0058">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-55.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0059"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-001-56" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-001-56.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 56 Multiple pregnancy." data-id="CD007950-fig-0059" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-56.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.56</div> <div class="figure-caption"> <p>Comparison 1 Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials), Outcome 56 Multiple pregnancy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0059">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-001-56.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0060"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Supplementation with folic acid alone versus no treatment or placebo (one trial), Outcome 1 Neural tube defects (All)." data-id="CD007950-fig-0060" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Supplementation with folic acid alone versus no treatment or placebo (one trial), Outcome 1 Neural tube defects (All). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0060">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0061"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Supplementation with folic acid alone versus no treatment or placebo (one trial), Outcome 2 Miscarriage (All)." data-id="CD007950-fig-0061" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Supplementation with folic acid alone versus no treatment or placebo (one trial), Outcome 2 Miscarriage (All). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0061">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0062"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Supplementation with folic acid alone versus no treatment or placebo (one trial), Outcome 3 Spina bifida." data-id="CD007950-fig-0062" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Supplementation with folic acid alone versus no treatment or placebo (one trial), Outcome 3 Spina bifida. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0062">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0063"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Supplementation with folic acid alone versus no treatment or placebo (one trial), Outcome 4 Anencephaly." data-id="CD007950-fig-0063" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Supplementation with folic acid alone versus no treatment or placebo (one trial), Outcome 4 Anencephaly. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0063">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0064"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Supplementation with folic acid alone versus no treatment or placebo (one trial), Outcome 5 Elective termination of pregnancy for fetal anomalies." data-id="CD007950-fig-0064" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 Supplementation with folic acid alone versus no treatment or placebo (one trial), Outcome 5 Elective termination of pregnancy for fetal anomalies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0064">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0065"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 1 Neural tube defects (All)." data-id="CD007950-fig-0065" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 1 Neural tube defects (All). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0065">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0066"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 2 Neural tube defects (by scheme)." data-id="CD007950-fig-0066" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 2 Neural tube defects (by scheme). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0066">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0067"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 3 Neural tube defects (by daily dose)." data-id="CD007950-fig-0067" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 3 Neural tube defects (by daily dose). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0067">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0068"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 4 Neural tube defects (by timing of supplementation)." data-id="CD007950-fig-0068" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 4 Neural tube defects (by timing of supplementation). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0068">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0069"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-003-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-003-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 5 Neural tube defects (by history of an affected pregnancy ‐recurrence)." data-id="CD007950-fig-0069" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 5 Neural tube defects (by history of an affected pregnancy ‐recurrence). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0069">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0070"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-003-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-003-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 6 Neural tube defects (by folate compound)." data-id="CD007950-fig-0070" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 6 Neural tube defects (by folate compound). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0070">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0071"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-003-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-003-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 7 Neural tube defects (by micronutrient composition)." data-id="CD007950-fig-0071" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.7</div> <div class="figure-caption"> <p>Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 7 Neural tube defects (by micronutrient composition). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0071">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0072"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-003-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-003-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 8 Neural tube defects (by malaria setting at time of the study)." data-id="CD007950-fig-0072" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.8</div> <div class="figure-caption"> <p>Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 8 Neural tube defects (by malaria setting at time of the study). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0072">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0073"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-003-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-003-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 9 Cleft lip (All)." data-id="CD007950-fig-0073" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.9</div> <div class="figure-caption"> <p>Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 9 Cleft lip (All). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0073">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0074"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-003-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-003-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 10 Cleft lip (by scheme)." data-id="CD007950-fig-0074" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.10</div> <div class="figure-caption"> <p>Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 10 Cleft lip (by scheme). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0074">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0075"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-003-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-003-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 11 Cleft lip (by daily dose)." data-id="CD007950-fig-0075" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.11</div> <div class="figure-caption"> <p>Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 11 Cleft lip (by daily dose). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0075">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0076"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-003-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-003-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 12 Cleft lip (by timing of supplementation)." data-id="CD007950-fig-0076" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.12</div> <div class="figure-caption"> <p>Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 12 Cleft lip (by timing of supplementation). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0076">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0077"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-003-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-003-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 13 Cleft lip (by history of an affected pregnancy ‐recurrence)." data-id="CD007950-fig-0077" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.13</div> <div class="figure-caption"> <p>Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 13 Cleft lip (by history of an affected pregnancy ‐recurrence). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0077">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0078"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-003-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-003-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 14 Cleft lip (by folate compound)." data-id="CD007950-fig-0078" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.14</div> <div class="figure-caption"> <p>Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 14 Cleft lip (by folate compound). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0078">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0079"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-003-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-003-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 15 Cleft lip (by micronutrient composition)." data-id="CD007950-fig-0079" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.15</div> <div class="figure-caption"> <p>Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 15 Cleft lip (by micronutrient composition). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0079">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0080"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-003-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-003-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 16 Cleft lip (by malaria setting at the time of the study)." data-id="CD007950-fig-0080" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.16</div> <div class="figure-caption"> <p>Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 16 Cleft lip (by malaria setting at the time of the study). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0080">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0081"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-003-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-003-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 17 Cleft palate (All)." data-id="CD007950-fig-0081" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.17</div> <div class="figure-caption"> <p>Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 17 Cleft palate (All). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0081">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0082"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-003-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-003-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 18 Cleft palate (by scheme)." data-id="CD007950-fig-0082" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.18</div> <div class="figure-caption"> <p>Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 18 Cleft palate (by scheme). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0082">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0083"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-003-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-003-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 19 Cleft palate (by daily dose)." data-id="CD007950-fig-0083" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.19</div> <div class="figure-caption"> <p>Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 19 Cleft palate (by daily dose). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0083">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0084"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-003-20" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-003-20.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 20 Cleft palate (by timing of supplementation)." data-id="CD007950-fig-0084" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-20.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.20</div> <div class="figure-caption"> <p>Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 20 Cleft palate (by timing of supplementation). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0084">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-20.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0085"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-003-21" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-003-21.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 21 Cleft palate (by history of an affected pregnancy ‐recurrence)." data-id="CD007950-fig-0085" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-21.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.21</div> <div class="figure-caption"> <p>Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 21 Cleft palate (by history of an affected pregnancy ‐recurrence). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0085">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-21.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0086"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-003-22" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-003-22.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 22 Cleft palate (by folate compound)." data-id="CD007950-fig-0086" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-22.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.22</div> <div class="figure-caption"> <p>Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 22 Cleft palate (by folate compound). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0086">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-22.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0087"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-003-23" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-003-23.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 23 Cleft palate (by micronutrient composition)." data-id="CD007950-fig-0087" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-23.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.23</div> <div class="figure-caption"> <p>Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 23 Cleft palate (by micronutrient composition). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0087">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-23.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0088"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-003-24" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-003-24.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 24 Cleft palate (by malaria setting at the time of the study)." data-id="CD007950-fig-0088" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-24.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.24</div> <div class="figure-caption"> <p>Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 24 Cleft palate (by malaria setting at the time of the study). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0088">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-24.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0089"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-003-25" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-003-25.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 25 Congenital cardiovascular anomalies (All)." data-id="CD007950-fig-0089" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-25.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.25</div> <div class="figure-caption"> <p>Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 25 Congenital cardiovascular anomalies (All). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0089">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-25.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0090"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-003-26" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-003-26.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 26 Congenital cardiovascular anomalies (by scheme)." data-id="CD007950-fig-0090" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-26.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.26</div> <div class="figure-caption"> <p>Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 26 Congenital cardiovascular anomalies (by scheme). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0090">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-26.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0091"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-003-27" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-003-27.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 27 Congenital cardiovascular anomalies (by daily dose)." data-id="CD007950-fig-0091" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-27.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.27</div> <div class="figure-caption"> <p>Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 27 Congenital cardiovascular anomalies (by daily dose). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0091">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-27.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0092"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-003-28" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-003-28.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 28 Congenital cardiovascular anomalies (by timing of supplementation)." data-id="CD007950-fig-0092" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-28.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.28</div> <div class="figure-caption"> <p>Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 28 Congenital cardiovascular anomalies (by timing of supplementation). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0092">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-28.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0093"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-003-29" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-003-29.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 29 Congenital cardiovascular anomalies (by history of an affected pregnancy ‐recurrence))." data-id="CD007950-fig-0093" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-29.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.29</div> <div class="figure-caption"> <p>Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 29 Congenital cardiovascular anomalies (by history of an affected pregnancy ‐recurrence)). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0093">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-29.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0094"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-003-30" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-003-30.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 30 Congenital cardiovascular anomalies (by folate compound)." data-id="CD007950-fig-0094" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-30.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.30</div> <div class="figure-caption"> <p>Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 30 Congenital cardiovascular anomalies (by folate compound). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0094">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-30.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0095"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-003-31" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-003-31.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 31 Congenital cardiovascular anomalies (by micronutrient composition)." data-id="CD007950-fig-0095" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-31.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.31</div> <div class="figure-caption"> <p>Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 31 Congenital cardiovascular anomalies (by micronutrient composition). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0095">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-31.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0096"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-003-32" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-003-32.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 32 Congenital cardiovascular anomalies (by malaria setting at the time of the study)." data-id="CD007950-fig-0096" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-32.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.32</div> <div class="figure-caption"> <p>Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 32 Congenital cardiovascular anomalies (by malaria setting at the time of the study). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0096">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-32.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0097"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-003-33" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-003-33.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 33 Other congenital anomalies (All)." data-id="CD007950-fig-0097" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-33.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.33</div> <div class="figure-caption"> <p>Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 33 Other congenital anomalies (All). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0097">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-33.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0098"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-003-34" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-003-34.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 34 Other congenital anomalies (by scheme)." data-id="CD007950-fig-0098" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-34.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.34</div> <div class="figure-caption"> <p>Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 34 Other congenital anomalies (by scheme). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0098">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-34.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0099"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-003-35" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-003-35.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 35 Other congenital anomalies (by daily dose)." data-id="CD007950-fig-0099" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-35.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.35</div> <div class="figure-caption"> <p>Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 35 Other congenital anomalies (by daily dose). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0099">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-35.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0100"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-003-36" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-003-36.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 36 Other congenital anomalies (by timing of supplementation)." data-id="CD007950-fig-0100" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-36.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.36</div> <div class="figure-caption"> <p>Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 36 Other congenital anomalies (by timing of supplementation). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0100">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-36.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0101"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-003-37" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-003-37.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 37 Other congenital anomalies (by history of an affected pregnancy ‐recurrence)." data-id="CD007950-fig-0101" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-37.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.37</div> <div class="figure-caption"> <p>Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 37 Other congenital anomalies (by history of an affected pregnancy ‐recurrence). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0101">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-37.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0102"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-003-38" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-003-38.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 38 Other congenital anomalies (by folate compound)." data-id="CD007950-fig-0102" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-38.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.38</div> <div class="figure-caption"> <p>Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 38 Other congenital anomalies (by folate compound). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0102">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-38.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0103"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-003-39" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-003-39.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 39 Other congenital anomalies (by micronutrient composition)." data-id="CD007950-fig-0103" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-39.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.39</div> <div class="figure-caption"> <p>Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 39 Other congenital anomalies (by micronutrient composition). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0103">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-39.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0104"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-003-40" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-003-40.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 40 Other congenital anomalies (by malaria setting at the time of the study)." data-id="CD007950-fig-0104" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-40.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.40</div> <div class="figure-caption"> <p>Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 40 Other congenital anomalies (by malaria setting at the time of the study). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0104">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-40.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0105"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-003-41" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-003-41.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 41 Miscarriage (All)." data-id="CD007950-fig-0105" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-41.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.41</div> <div class="figure-caption"> <p>Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 41 Miscarriage (All). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0105">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-41.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0106"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-003-42" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-003-42.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 42 Miscarriage (by scheme)." data-id="CD007950-fig-0106" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-42.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.42</div> <div class="figure-caption"> <p>Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 42 Miscarriage (by scheme). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0106">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-42.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0107"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-003-43" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-003-43.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 43 Miscarriage (by daily dose)." data-id="CD007950-fig-0107" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-43.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.43</div> <div class="figure-caption"> <p>Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 43 Miscarriage (by daily dose). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0107">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-43.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0108"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-003-44" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-003-44.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 44 Miscarriage (by timing of supplementation)." data-id="CD007950-fig-0108" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-44.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.44</div> <div class="figure-caption"> <p>Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 44 Miscarriage (by timing of supplementation). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0108">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-44.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0109"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-003-45" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-003-45.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 45 Miscarriage (by history of an affected pregnancy ‐recurrence)." data-id="CD007950-fig-0109" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-45.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.45</div> <div class="figure-caption"> <p>Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 45 Miscarriage (by history of an affected pregnancy ‐recurrence). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0109">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-45.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0110"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-003-46" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-003-46.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 46 Miscarriage (by folate compound)." data-id="CD007950-fig-0110" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-46.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.46</div> <div class="figure-caption"> <p>Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 46 Miscarriage (by folate compound). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0110">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-46.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0111"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-003-47" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-003-47.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 47 Miscarriage (by micronutrient compound)." data-id="CD007950-fig-0111" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-47.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.47</div> <div class="figure-caption"> <p>Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 47 Miscarriage (by micronutrient compound). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0111">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-47.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0112"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-003-48" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-003-48.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 48 Miscarriage (by malaria setting at the time of the study)." data-id="CD007950-fig-0112" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-48.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.48</div> <div class="figure-caption"> <p>Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 48 Miscarriage (by malaria setting at the time of the study). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0112">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-48.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0113"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-003-49" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-003-49.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 49 Spina bifida." data-id="CD007950-fig-0113" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-49.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.49</div> <div class="figure-caption"> <p>Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 49 Spina bifida. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0113">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-49.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0114"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-003-50" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-003-50.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 50 Anencephaly." data-id="CD007950-fig-0114" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-50.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.50</div> <div class="figure-caption"> <p>Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 50 Anencephaly. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0114">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-50.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0115"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-003-51" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-003-51.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 51 Stillbirths." data-id="CD007950-fig-0115" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-51.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.51</div> <div class="figure-caption"> <p>Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 51 Stillbirths. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0115">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-51.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0116"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-003-52" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-003-52.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 52 Elective termination of pregnancy for fetal anomalies." data-id="CD007950-fig-0116" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-52.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.52</div> <div class="figure-caption"> <p>Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 52 Elective termination of pregnancy for fetal anomalies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0116">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-52.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0117"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-003-53" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-003-53.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 53 Low birthweight (less than 2500 g)." data-id="CD007950-fig-0117" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-53.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.53</div> <div class="figure-caption"> <p>Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 53 Low birthweight (less than 2500 g). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0117">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-53.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0118"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-003-54" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-003-54.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 54 Macrosomia (birthweight greater than 4000 g)." data-id="CD007950-fig-0118" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-54.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.54</div> <div class="figure-caption"> <p>Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 54 Macrosomia (birthweight greater than 4000 g). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0118">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-54.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0119"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-003-55" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-003-55.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 55 Preterm birth (less than 37 weeks' gestation)." data-id="CD007950-fig-0119" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-55.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.55</div> <div class="figure-caption"> <p>Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 55 Preterm birth (less than 37 weeks' gestation). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0119">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-55.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0120"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-003-56" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-003-56.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 56 Multiple pregnancy." data-id="CD007950-fig-0120" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-56.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.56</div> <div class="figure-caption"> <p>Comparison 3 Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials), Outcome 56 Multiple pregnancy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0120">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-003-56.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0121"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 1 Neural tube defects (All)." data-id="CD007950-fig-0121" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 1 Neural tube defects (All). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0121">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0122"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 2 Neural tube defects (by scheme)." data-id="CD007950-fig-0122" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 2 Neural tube defects (by scheme). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0122">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0123"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 3 Neural tube defects (by daily dose)." data-id="CD007950-fig-0123" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 3 Neural tube defects (by daily dose). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0123">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0124"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-004-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-004-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 4 Neural tube defects (by timing of supplementation)." data-id="CD007950-fig-0124" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 4 Neural tube defects (by timing of supplementation). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0124">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0125"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-004-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-004-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 5 Neural tube defects (by history of an affected pregnancy ‐recurrence)." data-id="CD007950-fig-0125" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 5 Neural tube defects (by history of an affected pregnancy ‐recurrence). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0125">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0126"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-004-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-004-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 6 Neural tube defects (by folate compound)." data-id="CD007950-fig-0126" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.6</div> <div class="figure-caption"> <p>Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 6 Neural tube defects (by folate compound). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0126">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0127"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-004-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-004-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 7 Neural tube defects (by micronutrient composition)." data-id="CD007950-fig-0127" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.7</div> <div class="figure-caption"> <p>Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 7 Neural tube defects (by micronutrient composition). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0127">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0128"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-004-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-004-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 8 Neural tube defects (by malaria setting at time of the study)." data-id="CD007950-fig-0128" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.8</div> <div class="figure-caption"> <p>Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 8 Neural tube defects (by malaria setting at time of the study). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0128">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0129"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-004-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-004-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 9 Cleft lip (All)." data-id="CD007950-fig-0129" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.9</div> <div class="figure-caption"> <p>Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 9 Cleft lip (All). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0129">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0130"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-004-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-004-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 10 Cleft lip (by scheme)." data-id="CD007950-fig-0130" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.10</div> <div class="figure-caption"> <p>Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 10 Cleft lip (by scheme). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0130">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0131"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-004-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-004-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 11 Cleft lip (by daily dose)." data-id="CD007950-fig-0131" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.11</div> <div class="figure-caption"> <p>Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 11 Cleft lip (by daily dose). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0131">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0132"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-004-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-004-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 12 Cleft lip (by timing of supplementation)." data-id="CD007950-fig-0132" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.12</div> <div class="figure-caption"> <p>Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 12 Cleft lip (by timing of supplementation). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0132">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0133"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-004-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-004-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 13 Cleft lip (by history of an affected pregnancy ‐recurrence)." data-id="CD007950-fig-0133" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.13</div> <div class="figure-caption"> <p>Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 13 Cleft lip (by history of an affected pregnancy ‐recurrence). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0133">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0134"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-004-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-004-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 14 Cleft lip (by folate compound)." data-id="CD007950-fig-0134" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.14</div> <div class="figure-caption"> <p>Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 14 Cleft lip (by folate compound). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0134">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0135"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-004-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-004-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 15 Cleft lip (by micronutrient composition)." data-id="CD007950-fig-0135" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.15</div> <div class="figure-caption"> <p>Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 15 Cleft lip (by micronutrient composition). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0135">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0136"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-004-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-004-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 16 Cleft lip (by malaria setting at the time of the study)." data-id="CD007950-fig-0136" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.16</div> <div class="figure-caption"> <p>Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 16 Cleft lip (by malaria setting at the time of the study). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0136">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0137"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-004-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-004-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 17 Cleft palate (All)." data-id="CD007950-fig-0137" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.17</div> <div class="figure-caption"> <p>Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 17 Cleft palate (All). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0137">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0138"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-004-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-004-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 18 Cleft palate (by scheme)." data-id="CD007950-fig-0138" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.18</div> <div class="figure-caption"> <p>Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 18 Cleft palate (by scheme). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0138">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0139"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-004-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-004-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 19 Cleft palate (by daily dose)." data-id="CD007950-fig-0139" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.19</div> <div class="figure-caption"> <p>Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 19 Cleft palate (by daily dose). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0139">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0140"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-004-20" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-004-20.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 20 Cleft palate (by timing of supplementation)." data-id="CD007950-fig-0140" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-20.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.20</div> <div class="figure-caption"> <p>Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 20 Cleft palate (by timing of supplementation). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0140">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-20.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0141"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-004-21" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-004-21.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 21 Cleft palate (by history of an affected pregnancy ‐recurrence)." data-id="CD007950-fig-0141" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-21.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.21</div> <div class="figure-caption"> <p>Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 21 Cleft palate (by history of an affected pregnancy ‐recurrence). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0141">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-21.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0142"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-004-22" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-004-22.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 22 Cleft palate (by folate compound)." data-id="CD007950-fig-0142" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-22.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.22</div> <div class="figure-caption"> <p>Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 22 Cleft palate (by folate compound). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0142">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-22.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0143"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-004-23" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-004-23.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 23 Cleft palate (by micronutrient composition)." data-id="CD007950-fig-0143" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-23.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.23</div> <div class="figure-caption"> <p>Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 23 Cleft palate (by micronutrient composition). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0143">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-23.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0144"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-004-24" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-004-24.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 24 Cleft palate (by malaria setting at the time of the study)." data-id="CD007950-fig-0144" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-24.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.24</div> <div class="figure-caption"> <p>Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 24 Cleft palate (by malaria setting at the time of the study). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0144">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-24.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0145"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-004-25" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-004-25.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 25 Congenital cardiovascular anomalies (All)." data-id="CD007950-fig-0145" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-25.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.25</div> <div class="figure-caption"> <p>Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 25 Congenital cardiovascular anomalies (All). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0145">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-25.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0146"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-004-26" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-004-26.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 26 Congenital cardiovascular anomalies (by scheme)." data-id="CD007950-fig-0146" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-26.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.26</div> <div class="figure-caption"> <p>Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 26 Congenital cardiovascular anomalies (by scheme). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0146">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-26.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0147"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-004-27" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-004-27.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 27 Congenital cardiovascular anomalies (by daily dose)." data-id="CD007950-fig-0147" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-27.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.27</div> <div class="figure-caption"> <p>Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 27 Congenital cardiovascular anomalies (by daily dose). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0147">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-27.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0148"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-004-28" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-004-28.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 28 Congenital cardiovascular anomalies (by timing of supplementation)." data-id="CD007950-fig-0148" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-28.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.28</div> <div class="figure-caption"> <p>Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 28 Congenital cardiovascular anomalies (by timing of supplementation). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0148">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-28.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0149"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-004-29" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-004-29.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 29 Congenital cardiovascular anomalies (by history of an affected pregnancy ‐recurrence))." data-id="CD007950-fig-0149" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-29.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.29</div> <div class="figure-caption"> <p>Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 29 Congenital cardiovascular anomalies (by history of an affected pregnancy ‐recurrence)). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0149">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-29.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0150"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-004-30" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-004-30.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 30 Congenital cardiovascular anomalies (by folate compound)." data-id="CD007950-fig-0150" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-30.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.30</div> <div class="figure-caption"> <p>Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 30 Congenital cardiovascular anomalies (by folate compound). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0150">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-30.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0151"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-004-31" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-004-31.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 31 Congenital cardiovascular anomalies (by micronutrient composition)." data-id="CD007950-fig-0151" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-31.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.31</div> <div class="figure-caption"> <p>Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 31 Congenital cardiovascular anomalies (by micronutrient composition). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0151">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-31.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0152"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-004-32" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-004-32.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 32 Congenital cardiovascular anomalies (by malaria setting at the time of the study)." data-id="CD007950-fig-0152" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-32.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.32</div> <div class="figure-caption"> <p>Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 32 Congenital cardiovascular anomalies (by malaria setting at the time of the study). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0152">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-32.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0153"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-004-33" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-004-33.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 33 Other congenital anomalies (All)." data-id="CD007950-fig-0153" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-33.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.33</div> <div class="figure-caption"> <p>Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 33 Other congenital anomalies (All). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0153">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-33.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0154"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-004-34" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-004-34.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 34 Other congenital anomalies (by scheme)." data-id="CD007950-fig-0154" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-34.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.34</div> <div class="figure-caption"> <p>Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 34 Other congenital anomalies (by scheme). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0154">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-34.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0155"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-004-35" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-004-35.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 35 Other congenital anomalies (by daily dose)." data-id="CD007950-fig-0155" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-35.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.35</div> <div class="figure-caption"> <p>Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 35 Other congenital anomalies (by daily dose). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0155">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-35.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0156"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-004-36" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-004-36.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 36 Other congenital anomalies (by timing of supplementation)." data-id="CD007950-fig-0156" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-36.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.36</div> <div class="figure-caption"> <p>Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 36 Other congenital anomalies (by timing of supplementation). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0156">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-36.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0157"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-004-37" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-004-37.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 37 Other congenital anomalies (by history of an affected pregnancy ‐recurrence)." data-id="CD007950-fig-0157" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-37.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.37</div> <div class="figure-caption"> <p>Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 37 Other congenital anomalies (by history of an affected pregnancy ‐recurrence). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0157">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-37.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0158"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-004-38" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-004-38.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 38 Other congenital anomalies (by folate compound)." data-id="CD007950-fig-0158" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-38.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.38</div> <div class="figure-caption"> <p>Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 38 Other congenital anomalies (by folate compound). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0158">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-38.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0159"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-004-39" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-004-39.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 39 Other congenital anomalies (by micronutrient composition)." data-id="CD007950-fig-0159" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-39.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.39</div> <div class="figure-caption"> <p>Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 39 Other congenital anomalies (by micronutrient composition). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0159">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-39.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0160"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-004-40" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-004-40.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 40 Other congenital anomalies (by malaria setting at the time of the study)." data-id="CD007950-fig-0160" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-40.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.40</div> <div class="figure-caption"> <p>Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 40 Other congenital anomalies (by malaria setting at the time of the study). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0160">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-40.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0161"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-004-41" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-004-41.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 41 Miscarriage (All)." data-id="CD007950-fig-0161" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-41.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.41</div> <div class="figure-caption"> <p>Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 41 Miscarriage (All). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0161">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-41.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0162"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-004-42" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-004-42.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 42 Miscarriage (by scheme)." data-id="CD007950-fig-0162" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-42.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.42</div> <div class="figure-caption"> <p>Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 42 Miscarriage (by scheme). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0162">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-42.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0163"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-004-43" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-004-43.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 43 Miscarriage (by daily dose)." data-id="CD007950-fig-0163" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-43.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.43</div> <div class="figure-caption"> <p>Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 43 Miscarriage (by daily dose). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0163">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-43.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0164"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-004-44" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-004-44.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 44 Miscarriage (by timing of supplementation)." data-id="CD007950-fig-0164" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-44.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.44</div> <div class="figure-caption"> <p>Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 44 Miscarriage (by timing of supplementation). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0164">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-44.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0165"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-004-45" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-004-45.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 45 Miscarriage (by history of an affected pregnancy ‐recurrence)." data-id="CD007950-fig-0165" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-45.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.45</div> <div class="figure-caption"> <p>Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 45 Miscarriage (by history of an affected pregnancy ‐recurrence). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0165">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-45.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0166"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-004-46" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-004-46.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 46 Miscarriage (by folate compound)." data-id="CD007950-fig-0166" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-46.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.46</div> <div class="figure-caption"> <p>Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 46 Miscarriage (by folate compound). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0166">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-46.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0167"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-004-47" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-004-47.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 47 Miscarriage (by micronutrient compound)." data-id="CD007950-fig-0167" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-47.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.47</div> <div class="figure-caption"> <p>Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 47 Miscarriage (by micronutrient compound). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0167">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-47.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0168"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-004-48" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-004-48.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 48 Miscarriage (by malaria setting at the time of the study)." data-id="CD007950-fig-0168" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-48.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.48</div> <div class="figure-caption"> <p>Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 48 Miscarriage (by malaria setting at the time of the study). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0168">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-48.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0169"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-004-49" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-004-49.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 49 Anencephaly." data-id="CD007950-fig-0169" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-49.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.49</div> <div class="figure-caption"> <p>Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 49 Anencephaly. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0169">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-49.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0170"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-004-50" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-004-50.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 50 Stillbirths." data-id="CD007950-fig-0170" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-50.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.50</div> <div class="figure-caption"> <p>Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 50 Stillbirths. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0170">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-50.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0171"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-004-51" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-004-51.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 51 Elective termination of pregnancy for fetal outcomes." data-id="CD007950-fig-0171" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-51.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.51</div> <div class="figure-caption"> <p>Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 51 Elective termination of pregnancy for fetal outcomes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0171">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-51.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007950-fig-0172"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/urn:x-wiley:14651858:media:CD007950:CD007950-CMP-004-52" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_t/tCD007950-CMP-004-52.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 52 Multiple pregnancy." data-id="CD007950-fig-0172" src="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-52.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.52</div> <div class="figure-caption"> <p>Comparison 4 Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials), Outcome 52 Multiple pregnancy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-fig-0172">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/media/CDSR/CD007950/image_n/nCD007950-CMP-004-52.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD007950-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Supplementation with folate versus no intervention, placebo or other micronutrients without folate (neonatal outcomes)</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Population:</b> all women who become pregnant or were 12 or less weeks' pregnant at the time of the intervention<br/> <b>Setting:</b> the studies took place in nine high‐income countries and one low‐middle‐income country<br/> <b>Intervention:</b> supplementation with folate<br/> <b>Comparison:</b> no intervention, placebo or other micronutrients without folate </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with no intervention, placebo or other micronutrients without folate</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with supplementation with folate</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Neural tube defects (All)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 0.31<br/> (0.17 to 0.58) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>6708<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/> <b>high</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>13 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>4 per 1000<br/> (2 to 7) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>35 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>11 per 1000<br/> (6 to 20) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Cleft lip (All)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 0.79<br/> (0.14 to 4.36) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>5612<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1 per 1000<br/> (0 to 6) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>2 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>2 per 1000<br/> (0 to 9) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Cleft palate (All)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>RR 0.73<br/> (0.05 to 10.89) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>5612<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1 per 1000<br/> (0 to 8) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>0 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>0 per 1000</p> <p>(0 to 0)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Congenital cardiovascular anomalies (All)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 0.57<br/> (0.24 to 1.33) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>5612<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>5 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>3 per 1000<br/> (1 to 7) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>5 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>3 per 1000<br/> (2 to 10) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Other congenital anomalies (All)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 0.94<br/> (0.53 to 1.66) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>5612<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>4,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>16 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>15 per 1000<br/> (8 to 26) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>17 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>16 per 1000<br/> (8 to 26) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Neonatal death</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>not pooled</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0<br/> (0 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No trial assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Most studies contributing data had design limitations (selection bias was unclear). </p> <p><sup>2</sup> Authors refrained from downgrading the quality of the evidence due to the large magnitude of effect. </p> <p><sup>2</sup> Wide confidence interval crossing the line of no effect &amp; few events. </p> <p><sup>3</sup> Wide confidence interval crossing the line of no effect. </p> <p><sup>4</sup> Statistical Heterogeneity (I² &gt; 60%). Variation in direction. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Supplementation with folate versus no intervention, placebo or other micronutrients without folate (neonatal outcomes)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/full#CD007950-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD007950-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Supplementation with folate versus no intervention, placebo or other micronutrients without folate (maternal outcomes)</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Population:</b> all women who become pregnant or were 12 or less weeks' pregnant at the time of the intervention<br/> <b>Setting:</b> the studies took place in nine high‐income countries and one low‐middle‐income country<br/> <b>Intervention:</b> supplementation with folate<br/> <b>Comparison:</b> no intervention, placebo or other micronutrients without folate </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with no intervention, placebo or other micronutrients without folate</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with supplementation with folate</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Maternal anaemia at or near term (All)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>not pooled</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>0<br/> (0 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>No trial assessed this outcome.</p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>not pooled</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>not pooled</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Maternal red blood cell folate at or near term (All)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>not estimable</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean maternal red blood cell folate at or near term (All) in the intervention group was 0 undefined more (0 more to 0 more) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>not pooled</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0<br/> (0 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No trial assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serum folate at or near term</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>not pooled</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0<br/> (0 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No trial assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Miscarriage (All)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 1.10<br/> (0.94 to 1.28) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>7391<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>99 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>109 per 1000<br/> (93 to 127) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>96 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>106 per 1000<br/> (90 to 123) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Most studies contributing data had design limitations (selection bias was unclear). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Supplementation with folate versus no intervention, placebo or other micronutrients without folate (maternal outcomes)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/full#CD007950-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007950-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Neural tube defects (All) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6708</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [0.17, 0.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Neural tube defects (by scheme) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6708</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [0.17, 0.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Daily supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6708</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [0.17, 0.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Neural tube defects (by daily dose) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6708</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [0.17, 0.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 400 µg (0.4 mg) folic acid or less per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>261</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.17 [0.01, 4.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 More than 400 µg (0.4 mg) folic acid per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6447</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [0.17, 0.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Neural tube defects (by timing of supplementation) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6708</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [0.17, 0.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Periconceptional period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6708</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [0.17, 0.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Neural tube defects (by history of an affected pregnancy ‐recurrence) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6708</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [0.17, 0.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1846</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.18, 0.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4862</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.07 [0.00, 1.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Neural tube defects (by folate compound) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6708</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [0.17, 0.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Folic acid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6708</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [0.17, 0.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Neural tube defects (by micronutrient composition) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6623</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.18, 0.63]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Folate alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>709</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.24 [0.08, 0.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 Folate + multiple micronutrients</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5914</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [0.18, 0.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Neural tube defects (by malaria setting at time of the study) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6708</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [0.17, 0.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6708</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [0.17, 0.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Cleft lip (All) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5612</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.14, 4.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Cleft lip (by scheme) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5612</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.14, 4.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 Daily supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5612</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.14, 4.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Cleft lip (by daily dose) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5612</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.14, 4.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1 400 µg (0.4 mg) folic acid or less per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>261</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.17 [0.01, 4.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.2 More than 400 µg (0.4 mg) folic acid per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5351</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.30 [0.29, 5.80]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Cleft lip (by timing of supplementation) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5612</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.14, 4.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1 Periconceptional period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5612</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.14, 4.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Cleft lip (by history of an affected pregnancy ‐recurrence) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5612</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.14, 4.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.1 Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1456</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.17 [0.01, 4.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.2 No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4156</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.30 [0.29, 5.80]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Cleft lip (by folate compound) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5612</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.14, 4.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.1 Folic acid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5612</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.14, 4.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Cleft lip (by micronutrient composition) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5527</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.26, 3.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.1 Folate alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>598</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.2 Folate + multiple micronutrients</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4929</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.26, 3.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Cleft lip (by malaria setting at the time of the study) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5612</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.14, 4.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.1 No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5612</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.14, 4.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Cleft palate (All) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5612</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.05, 10.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Cleft palate (by scheme) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5612</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.05, 10.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.1 Daily supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5612</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.05, 10.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Cleft palate (by daily dose) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5612</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.05, 10.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.1 More than 400 µg (0.4 mg) folic acid per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5351</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.05, 10.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.2 400 µg (0.4 mg) folic acid or less per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>261</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 Cleft palate (by timing of supplementation) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5612</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.05, 10.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.1 Periconceptional period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5612</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.05, 10.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21 Cleft palate (by history of an affected pregnancy ‐recurrence) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5612</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.05, 10.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>21.1 Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1456</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.05 [0.12, 74.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>21.2 No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4156</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [0.01, 4.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">22 Cleft palate (by folate compound) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5612</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.05, 10.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>22.1 Folic acid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5612</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.05, 10.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">23 Cleft palate (by micronutrient composition) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5612</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.05, 10.76]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>23.1 Folate alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>598</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.02 [0.12, 73.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>23.2 Folate + multiple micronutrients</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [0.01, 4.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">24 Cleft palate (by malaria setting at the time of the study) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5612</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.05, 10.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>24.1 No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5612</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.05, 10.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">25 Congenital cardiovascular anomalies (All) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5612</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.24, 1.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">26 Congenital cardiovascular anomalies (by scheme) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5612</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.24, 1.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>26.1 Daily supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5612</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.24, 1.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">27 Congenital cardiovascular anomalies (by daily dose) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5612</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.24, 1.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>27.1 400 µg (0.4 mg) folic acid or less per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>261</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [0.01, 2.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>27.2 More than 400 µg (0.4 mg) folic acid per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5351</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.66 [0.27, 1.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">28 Congenital cardiovascular anomalies (by timing of supplementation) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5612</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.24, 1.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>28.1 Periconceptional period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5612</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.24, 1.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">29 Congenital cardiovascular anomalies (by history of an affected pregnancy ‐recurrence)) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5612</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.24, 1.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>29.1 Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1456</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [0.08, 2.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>29.2 No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4156</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.23, 1.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">30 Congenital cardiovascular anomalies (by folate compound) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5612</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.24, 1.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>30.1 Folic acid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5612</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.24, 1.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">31 Congenital cardiovascular anomalies (by micronutrient composition) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5351</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.66 [0.27, 1.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>31.1 Folate alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1195</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.68 [0.11, 4.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>31.2 Folate + multiple micronutrients</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4156</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.23, 1.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">32 Congenital cardiovascular anomalies (by malaria setting at the time of the study) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5612</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.24, 1.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>32.1 No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5612</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.24, 1.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">33 Other congenital anomalies (All) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5612</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.53, 1.66]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">34 Other congenital anomalies (by scheme) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5612</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.53, 1.66]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>34.1 Daily supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5612</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.53, 1.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">35 Other congenital anomalies (by daily dose) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5612</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.53, 1.66]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>35.1 400 µg (0.4 mg) folic acid or less per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>261</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.32, 2.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>35.2 More than 400 µg (0.4 mg) folic acid per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5351</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.40, 2.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">36 Other congenital anomalies (by timing of supplementation) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5612</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.53, 1.66]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>36.1 Periconceptional period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5612</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.53, 1.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">37 Other congenital anomalies (by history of an affected pregnancy ‐recurrence) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5612</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.53, 1.66]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>37.1 Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1456</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.27 [0.69, 2.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>37.2 No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4156</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.36, 1.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">38 Other congenital anomalies (by folate compound) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5612</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.53, 1.66]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>38.1 Folic acid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5612</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.53, 1.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">39 Other congenital anomalies (by micronutrient composition) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5612</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.58, 1.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>39.1 Folate alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>598</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.26 [0.34, 4.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>39.2 Folate + other micronutrients</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.50, 1.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">40 Other congenital anomalies (by malaria setting at the time of the study) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5612</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.53, 1.66]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>40.1 No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5612</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.53, 1.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">41 Miscarriage (All) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7391</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [0.94, 1.28]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">42 Miscarriage (by scheme) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7391</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [0.94, 1.28]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>42.1 Daily supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7391</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [0.94, 1.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">43 Miscarriage (by daily dose) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7391</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [0.94, 1.28]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>43.1 400 µg (0.4 mg) folic acid or less per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>281</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.31 [0.57, 3.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>43.2 More than 400 µg (0.4 mg) folic acid per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [0.86, 1.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">44 Miscarriage (by timing of supplementation) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7391</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [0.94, 1.28]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>44.1 Periconceptional period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7391</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [0.94, 1.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">45 Miscarriage (by history of an affected pregnancy ‐recurrence) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7391</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [0.94, 1.28]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>45.1 Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2033</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.68, 1.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>45.2 No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5358</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.15 [0.98, 1.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">46 Miscarriage (by folate compound) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7391</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [0.94, 1.28]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>46.1 Folic acid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7391</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [0.94, 1.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">47 Miscarriage (by micronutrient compound) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7283</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.90, 1.28]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>47.1 Folate alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>795</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.66, 1.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>47.2 Folate + multiple micronutrients</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6488</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.74, 1.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">48 Miscarriage (by malaria setting at the time of the study) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7370</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.77, 1.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>48.1 No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7370</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.77, 1.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">49 Spina bifida <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4546</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [0.06, 1.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">50 Anencephaly <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4807</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.36 [0.13, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">51 Stillbirths <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6597</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.54, 2.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">52 Elective termination of pregnancy for fetal anomalies <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.29 [0.15, 0.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">53 Low birthweight (less than 2500 g) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5048</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.13 [0.84, 1.52]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">54 Macrosomia (birthweight greater than 4000 g) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4862</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.79, 1.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">55 Preterm birth (less than 37 weeks' gestation) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4862</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.14 [0.93, 1.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">56 Multiple pregnancy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7280</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.38 [0.89, 2.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Supplementation with any folate versus no intervention, placebo or other micronutrients without folate (five trials)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007950-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Supplementation with folic acid alone versus no treatment or placebo (one trial)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Neural tube defects (All) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>111</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.43 [0.08, 2.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Miscarriage (All) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>111</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.05, 13.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Spina bifida <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>111</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.43 [0.04, 4.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Anencephaly <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>111</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.43 [0.04, 4.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Elective termination of pregnancy for fetal anomalies <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>111</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.28 [0.01, 6.83]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Supplementation with folic acid alone versus no treatment or placebo (one trial)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007950-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Neural tube defects (All) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6512</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [0.16, 0.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Neural tube defects (by scheme) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6512</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [0.16, 0.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Daily supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6512</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [0.16, 0.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Neural tube defects (by daily dose) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6512</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [0.16, 0.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 400 µg (0.4 mg) folic acid or less per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>176</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.01, 8.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 More than 400 µg (0.4 mg) folic acid per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6336</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [0.15, 0.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Neural tube defects (by timing of supplementation) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6512</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [0.16, 0.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Periconceptional period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6512</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [0.16, 0.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Neural tube defects (by history of an affected pregnancy ‐recurrence) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6512</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [0.16, 0.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1650</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.17, 0.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4862</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.07 [0.00, 1.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Neural tube defects (by folate compound) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6513</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [0.16, 0.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Folic acid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6513</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [0.16, 0.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Neural tube defects (by micronutrient composition) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6512</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [0.16, 0.64]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Folate alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>598</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.15 [0.04, 0.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 Folate + multiple micronutrients</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5914</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [0.18, 0.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Neural tube defects (by malaria setting at time of the study) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6512</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [0.16, 0.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6512</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [0.16, 0.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Cleft lip (All) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5527</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.26, 3.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Cleft lip (by scheme) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5527</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.26, 3.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 Daily supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5527</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.26, 3.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Cleft lip (by daily dose) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5527</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.26, 3.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1 400 µg (0.4 mg) folic acid or less per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>176</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.01, 8.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.2 More than 400 µg (0.4 mg) folic acid per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5351</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.30 [0.29, 5.80]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Cleft lip (by timing of supplementation) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5527</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.26, 3.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1 Periconceptional period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5527</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.26, 3.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Cleft lip (by history of an affected pregnancy ‐recurrence) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5527</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.26, 3.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.1 Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.01, 8.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.2 No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4156</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.30 [0.29, 5.80]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Cleft lip (by folate compound) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5527</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.26, 3.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.1 Folic acid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5527</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.26, 3.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Cleft lip (by micronutrient composition) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5527</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.26, 3.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.1 Folate alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>598</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.2 Folate + multiple micronutrients</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4929</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.26, 3.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Cleft lip (by malaria setting at the time of the study) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5527</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.26, 3.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.1 No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5527</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.26, 3.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Cleft palate (All) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5527</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.05, 10.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Cleft palate (by scheme) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5527</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.05, 10.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.1 Daily supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5527</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.05, 10.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Cleft palate (by daily dose) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5527</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.05, 10.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.1 400 µg (0.4 mg) folic acid or less per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>176</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.2 More than 400 µg (0.4 mg) folic acid per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5351</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.05, 10.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 Cleft palate (by timing of supplementation) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5527</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.05, 10.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.1 Periconceptional period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5527</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.05, 10.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21 Cleft palate (by history of an affected pregnancy ‐recurrence) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5527</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.05, 10.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>21.1 Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.05 [0.12, 74.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>21.2 No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4156</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [0.01, 4.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">22 Cleft palate (by folate compound) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5527</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.05, 10.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>22.1 Folic acid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5527</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.05, 10.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">23 Cleft palate (by micronutrient composition) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5527</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.05, 10.76]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>23.1 Folate alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>598</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.02 [0.12, 73.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>23.2 Folate + multiple micronutrients</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4929</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [0.01, 4.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">24 Cleft palate (by malaria setting at the time of the study) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5527</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.05, 10.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>24.1 No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5527</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.05, 10.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">25 Congenital cardiovascular anomalies (All) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5527</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.25, 1.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">26 Congenital cardiovascular anomalies (by scheme) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5527</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.25, 1.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>26.1 Daily supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5527</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.25, 1.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">27 Congenital cardiovascular anomalies (by daily dose) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5527</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.25, 1.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>27.1 400 µg (0.4 mg) folic acid or less per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>176</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [0.01, 4.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>27.2 More than 400 µg (0.4 mg) folic acid per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5351</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.66 [0.27, 1.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">28 Congenital cardiovascular anomalies (by timing of supplementation) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5527</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.25, 1.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>28.1 Periconceptional period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5527</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.25, 1.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">29 Congenital cardiovascular anomalies (by history of an affected pregnancy ‐recurrence)) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5527</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.25, 1.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>29.1 Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.11, 2.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>29.2 No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4156</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.23, 1.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">30 Congenital cardiovascular anomalies (by folate compound) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5527</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.25, 1.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>30.1 Folic acid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5527</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.25, 1.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">31 Congenital cardiovascular anomalies (by micronutrient composition) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5527</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.25, 1.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>31.1 Folate alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>598</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.06, 16.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>31.2 Folate + multiple micronutrients</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4929</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.23, 1.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">32 Congenital cardiovascular anomalies (by malaria setting at the time of the study) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5527</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.25, 1.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>32.1 No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5527</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.25, 1.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">33 Other congenital anomalies (All) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5527</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.54, 1.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">34 Other congenital anomalies (by scheme) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5527</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.54, 1.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>34.1 Daily supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5527</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.54, 1.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">35 Other congenital anomalies (by daily dose) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5527</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.54, 1.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>35.1 400 µg (0.4 mg) folic acid or less per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>176</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.34, 3.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>35.2 More than 400 µg (0.4 mg) folic acid per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5351</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.40, 2.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">36 Other congenital anomalies (by timing of supplementation) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5527</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.54, 1.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>36.1 Periconceptional period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5527</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.54, 1.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">37 Other congenital anomalies (by history of an affected pregnancy ‐recurrence) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5527</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.54, 1.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>37.1 Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.39 [0.74, 2.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>37.2 No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4156</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.36, 1.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">38 Other congenital anomalies (by folate compound) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5527</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.54, 1.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>38.1 Folic acid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5527</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.54, 1.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">39 Other congenital anomalies (by micronutrient composition) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5527</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.59, 1.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>39.1 Folate alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>598</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.26 [0.34, 4.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>39.2 Folate + other micronutrients</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4929</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.51, 1.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">40 Other congenital anomalies (by malaria setting at the time of the study) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5527</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.54, 1.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>40.1 No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5527</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.54, 1.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">41 Miscarriage (All) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7187</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.87, 1.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">42 Miscarriage (by scheme) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7187</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.87, 1.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>42.1 Daily supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7187</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.87, 1.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">43 Miscarriage (by daily dose) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7187</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.87, 1.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>43.1 400 µg (0.4 mg) folic acid or less per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>188</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.31 [0.51, 3.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>43.2 More than 400 µg (0.4 mg) folic acid per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6999</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.81, 1.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">44 Miscarriage (by timing of supplementation) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7187</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.87, 1.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>44.1 Periconceptional period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7187</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.87, 1.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">45 Miscarriage (by history of an affected pregnancy ‐recurrence) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7187</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.87, 1.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>45.1 Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1829</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.56, 1.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>45.2 No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5358</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.15 [0.98, 1.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">46 Miscarriage (by folate compound) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7187</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.87, 1.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>46.1 Folic acid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7187</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.87, 1.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">47 Miscarriage (by micronutrient compound) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7187</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.09 [0.92, 1.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>47.1 Folate alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>684</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.66, 1.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>47.2 Folate + multiple micronutrients</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6503</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.09 [0.85, 1.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">48 Miscarriage (by malaria setting at the time of the study) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7187</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.87, 1.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>48.1 No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7187</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.87, 1.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">49 Spina bifida <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4435</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.26 [0.03, 2.31]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">50 Anencephaly <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4611</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.38 [0.12, 1.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">51 Stillbirths <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6512</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.09 [0.56, 2.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">52 Elective termination of pregnancy for fetal anomalies <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6999</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.29 [0.15, 0.57]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">53 Low birthweight (less than 2500 g) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5048</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.13 [0.84, 1.52]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">54 Macrosomia (birthweight greater than 4000 g) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4862</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.79, 1.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">55 Preterm birth (less than 37 weeks' gestation) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4862</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.14 [0.93, 1.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">56 Multiple pregnancy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7187</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.39 [0.90, 2.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Supplementation with folate plus other micronutrients versus other micronutrients without folate (four trials)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007950-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Neural tube defects (All) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.29 [0.12, 0.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Neural tube defects (by scheme) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.29 [0.12, 0.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Daily supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.29 [0.12, 0.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Neural tube defects (by daily dose) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.29 [0.12, 0.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 400 µg (0.4 mg) folic acid or less per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>176</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.01, 8.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 More than 400 µg (0.4 mg) folic acid per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1195</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.29 [0.12, 0.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Neural tube defects (by timing of supplementation) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.29 [0.12, 0.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Periconceptional period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.29 [0.12, 0.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Neural tube defects (by history of an affected pregnancy ‐recurrence) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.29 [0.12, 0.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.29 [0.12, 0.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Neural tube defects (by folate compound) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.29 [0.12, 0.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Folic acid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.29 [0.12, 0.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Neural tube defects (by micronutrient composition) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [0.13, 0.78]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Folate alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>598</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.15 [0.04, 0.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 Folate + multiple micronutrients</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>773</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.49 [0.16, 1.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Neural tube defects (by malaria setting at time of the study) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.29 [0.12, 0.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.29 [0.12, 0.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Cleft lip (All) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.01, 8.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Cleft lip (by scheme) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.01, 8.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 Daily supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.01, 8.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Cleft lip (by daily dose) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.01, 8.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1 400 µg (0.4 mg) folic acid or less per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>176</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.01, 8.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.2 More than 400 µg (0.4 mg) folic acid per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1195</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Cleft lip (by timing of supplementation) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.01, 8.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1 Periconceptional period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.01, 8.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Cleft lip (by history of an affected pregnancy ‐recurrence) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.01, 8.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.1 Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.01, 8.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Cleft lip (by folate compound) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.01, 8.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.1 Folic acid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.01, 8.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Cleft lip (by micronutrient composition) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.01, 8.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.1 Folate alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>598</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.2 Folate + multiple micronutrients</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>773</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.01, 8.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Cleft lip (by malaria setting at the time of the study) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.01, 8.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.1 No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.01, 8.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Cleft palate (All) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.05 [0.12, 74.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Cleft palate (by scheme) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.05 [0.12, 74.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.1 Daily supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.05 [0.12, 74.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Cleft palate (by daily dose) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.05 [0.12, 74.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.1 400 µg (0.4 mg) folic acid or less per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>176</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.2 More than 400 µg (0.4 mg) folic acid per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1195</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.05 [0.12, 74.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 Cleft palate (by timing of supplementation) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.05 [0.12, 74.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.1 Periconceptional period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.05 [0.12, 74.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21 Cleft palate (by history of an affected pregnancy ‐recurrence) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.05 [0.12, 74.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>21.1 Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.05 [0.12, 74.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">22 Cleft palate (by folate compound) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.05 [0.12, 74.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>22.1 Folic acid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.05 [0.12, 74.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">23 Cleft palate (by micronutrient composition) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.02 [0.12, 73.84]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>23.1 Folate alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>598</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.02 [0.12, 73.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>23.2 Folate + multiple micronutrients</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>773</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">24 Cleft palate (by malaria setting at the time of the study) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.05 [0.12, 74.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>24.1 No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.05 [0.12, 74.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">25 Congenital cardiovascular anomalies (All) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.11, 2.31]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">26 Congenital cardiovascular anomalies (by scheme) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.11, 2.31]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>26.1 Daily supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.11, 2.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">27 Congenital cardiovascular anomalies (by daily dose) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.11, 2.31]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>27.1 400 µg (0.4 mg) folic acid or less per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>176</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [0.01, 4.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>27.2 More than 400 µg (0.4 mg) folic acid per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1195</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.68 [0.11, 4.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">28 Congenital cardiovascular anomalies (by timing of supplementation) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.11, 2.31]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>28.1 Periconceptional period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.11, 2.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">29 Congenital cardiovascular anomalies (by history of an affected pregnancy ‐recurrence)) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.11, 2.31]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>29.1 Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.11, 2.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">30 Congenital cardiovascular anomalies (by folate compound) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.11, 2.31]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>30.1 Folic acid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.11, 2.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">31 Congenital cardiovascular anomalies (by micronutrient composition) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.11, 2.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>31.1 Folate alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>598</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.06, 16.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>31.2 Folate + multiple micronutrients</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>773</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.36 [0.05, 2.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">32 Congenital cardiovascular anomalies (by malaria setting at the time of the study) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.11, 2.31]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>32.1 No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.11, 2.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">33 Other congenital anomalies (All) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.39 [0.74, 2.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">34 Other congenital anomalies (by scheme) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.39 [0.74, 2.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>34.1 Daily supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.39 [0.74, 2.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">35 Other congenital anomalies (by daily dose) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.39 [0.74, 2.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>35.1 400 µg (0.4 mg) folic acid or less per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>176</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.34, 3.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>35.2 More than 400 µg (0.4 mg) folic acid per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1195</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.62 [0.74, 3.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">36 Other congenital anomalies (by timing of supplementation) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.39 [0.74, 2.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>36.1 Periconceptional period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.39 [0.74, 2.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">37 Other congenital anomalies (by history of an affected pregnancy ‐recurrence) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.39 [0.74, 2.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>37.1 Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.39 [0.74, 2.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">38 Other congenital anomalies (by folate compound) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.39 [0.74, 2.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>38.1 Folic acid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.39 [0.74, 2.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">39 Other congenital anomalies (by micronutrient composition) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.39 [0.73, 2.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>39.1 Folate alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>598</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.26 [0.34, 4.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>39.2 Folate + other micronutrients</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>773</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.43 [0.69, 2.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">40 Other congenital anomalies (by malaria setting at the time of the study) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.39 [0.74, 2.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>40.1 No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.39 [0.74, 2.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">41 Miscarriage (All) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1550</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.82, 1.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">42 Miscarriage (by scheme) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1550</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.82, 1.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>42.1 Daily supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1550</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.82, 1.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">43 Miscarriage (by daily dose) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1550</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.82, 1.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>43.1 400 µg (0.4 mg) folic acid or less per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>188</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.31 [0.51, 3.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>43.2 More than 400 µg (0.4 mg) folic acid per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1362</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [0.80, 1.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">44 Miscarriage (by timing of supplementation) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1550</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.82, 1.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>44.1 Periconceptional period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1550</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.82, 1.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">45 Miscarriage (by history of an affected pregnancy ‐recurrence) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1550</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.82, 1.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>45.1 Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1550</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.82, 1.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">46 Miscarriage (by folate compound) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1550</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.82, 1.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>46.1 Folic acid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1550</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.82, 1.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">47 Miscarriage (by micronutrient compound) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1550</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.82, 1.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>47.1 Folate alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>684</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.66, 1.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>47.2 Folate + multiple micronutrients</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>866</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.18 [0.81, 1.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">48 Miscarriage (by malaria setting at the time of the study) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1550</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.82, 1.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>48.1 No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1550</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.82, 1.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">49 Anencephaly <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>176</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.01, 8.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">50 Stillbirths <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.16, 4.28]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">51 Elective termination of pregnancy for fetal outcomes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1362</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.15, 0.83]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">52 Multiple pregnancy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1550</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.04 [0.19, 22.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Supplementation with folate plus other micronutrients versus the same other micronutrients without folate (two trials)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007950.pub3/references#CD007950-tbl-0006">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD007950.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD007950-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD007950-note-0010">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD007950-note-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD007950-note-0008">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD007950-note-0006">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ja#CD007950-note-0005">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD007950-note-0004">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD007950-note-0007">Polski</a> </li> <li class="section-language"> <a class="" href="pt#CD007950-note-0017">Português</a> </li> <li class="section-language"> <a class="" href="ru#CD007950-note-0003">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD007950-note-0002">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD007950-note-0009">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007950\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007950\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007950\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007950\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007950\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007950\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007950\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007950\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007950\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007950\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007950\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007950\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007950\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007950\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007950\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007950\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007950\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007950\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=Oy81c7tH&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007950.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD007950.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD007950.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD007950.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007950.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740716275771"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD007950.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740716275775"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD007950.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d9b889cbc1bf6',t:'MTc0MDcxNjI3Ni4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 